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Abstract
This thesis examines the relationship between environmental regulation, innovation, and com-
petitiveness. Specifically, it investigates the impact of regulatory stringency on innovation in the
chemical industry by analyzing the evolution of innovative activity in highly regulated technological
areas in the European Union from 1976 to 2003.
A direct quantitative measure of regulatory impact on innovation was constructed by trans-
forming the economic measurement problem into a technological classification issue. The specific
regulation investigated was the EU Council Directive 76/769/EEC, which contains 986 restrictions
imposed on the marketing and use of 939 chemical substances. These restrictions were linked to 17
technological fields in the International Patent Classification. The data on patent applications was
extracted from the ESPACE Bulletin database maintained by the European Patent Office. Given
the increasing regulatory stringency, four questions were investigated: Did regulation spur patenting
activity? Has there been a change in the geographical origin of patents? Has there been an increase
in patenting concentration? Has there been a change in the direction of the patenting trend? These
issues were examined at the aggregated level using descriptive statistics, panel data regressions, and
the study of technological trend. Four case studies were conducted to illustrate strategies utilized
by European and non-European firms.
I found that most restrictions were imposed during the years of 1997 and 2003 and affected
mainly technological areas associated with agrochemicals, polymers, and paints and dyes. In overall
regulatory stringency impacted positively patenting activity. However, top players were impacted
negatively. Consequently, there was a reduction in the concentration of innovative activity in highly
regulated technological areas. Major changes occurred in areas in which the largest number of
restrictions were imposed. There was an overall increase in innovations associated with new processes
and formulations, indicating increased incremental innovation and a shift from patenting in regulated
to non-regulated applications. Hence, there was increasing patenting activity in areas that did not
depend on novel substances or did not have an opportunity to innovate in non-regulated uses. By
contrast, there was a sharp fall in the number of applications in areas in which these conditions
did not exist. Two explanations for these results are proposed: “new” technologies benefit from
regulatory stringency while “old” technologies are discouraged; regulation spurs the development of
substitutes better adapted to the actual regulatory framework.
Moreover, this thesis shows that the Porter hypothesis is supported for the chemical industry.
Yet, this occurs not because firms innovate under more stringent regulation, but because it stimulates
new entrants in the market of innovation.
Keywords Porter hypothesis; innovation; environment, health, and safety regulations; chemical
industry; chemicals regulation; and environmental economics.
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Chapter 1
Introduction
This thesis addresses important topics that have been a priority on the world agenda
since the UN Conference on Development and the Environment (Earth Summit,
1992). At that conference, delegations from 175 countries and 2,400 representatives
from non-governmental organizations reached an agreement on the Climate Change
Convention that later on led to the creation of the Kyoto Protocol. Even after being
ratified by 162 countries, the biggest criticism of this international agreement is that
it causes loss of competitiveness as it restricts emissions of Greenhouse Gases.
In February of 2001, the European Commission presented the White Paper on
future chemicals policy to the European Parliament, European Council, and other
bodies. This new chemicals policy called REACH (Registration, Evaluation, and
Authorization for Chemicals) was intensely debated by European and non-European
governments, industrial and non-governmental organizations. The main concern was
the threat of loss of competitiveness by European industries in international markets,
and extra costs for overseas industry in the European market.
More recently, in 2006 the Intergovernmental Panel on Climate Change (IPCC)
disclosed the Fourth Assessment Report with new findings on the natural drivers of
climate change. This document has strong suggestions for policy makers to restrict
their regulations, due to the fear of climate chaos in the future. In December of 2009,
the Fifteenth Conference of the Parties to the UN Framework Convention on Climate
Change (COP15 – Copenhagen Climate Conference) failed to reach an agreement to
update or even replace the Kyoto protocol. Still, developed and developing economies
fear that any restriction on emissions of greenhouse gases will reduce their produc-
tivity and harm their firms already suffering with what is believed to be the biggest
economic crisis since the Great Depression, in the 1930s.
These examples illustrate how important it is to clarify the relationship between
environmental regulation, innovation, and competitiveness. These issues are of in-
ternational concern, yet there is no common consensus on the topic. The difficulty
of measuring regulatory stringency is one of the main problems faced by economists.
Recently, researchers have been focussing on specific industrial sectors and analyzing
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different regulatory designs. These studies have a common theme, looking at how
regulation should be designed in order to incentivise and not harm innovation.
This research initially displays a broad picture of the history of the chemical
industry since the nineteenth century. Chapter 2 helps the reader to understand the
importance of R&D and innovation in this industry.
The subsequent Chapter 3 describes the regulatory framework of the chemical
industry. The regulations under concern are detailed, and also how the empirical
economic literature has evolved on the debate on the relationship between environ-
mental regulation and possible impacts over manufacturing firms (e.g. location choice,
competitiveness, and innovation). The two main hypothesis that intensified the de-
bate since the 1990s are described. This review enables a precise the analysis of the
impact of social regulations over the chemical industry chain, and the identification
of the most relevant controls imposed on chemical firms which must be investigated.
After this analysis Chapter 4 develops a quantitative measure of regulatory strin-
gency over technological areas associated with the chemical industry in the European
Union from 1976 to 2003. The methodology is exemplified for a better understanding.
The main affected technological fields are highlighted, and these findings corroborate
with previous studies supporting the methodology employed.
Chapter 5 consists of a deep analysis of the evolution of innovative activity in these
highly regulated technological fields. Four research questions are investigated: has an
increase or decrease in patenting occurred? Has there been a change in the country
of origin of patents? Has there been any increase in patenting concentration? Has
there been a change in the direction of patenting? New methodologies are employed
to investigate the evolution of the technological path. The period investigated, from
1990 to 2006, was chosen because first most studies focus on the 1970s and 1980s,
and second this period represents the highest increase of regulatory stringency in the
European Union.
Four case studies were developed to better understand the strategies traced by
European and non-European firms. Chapter 6 portrays a summary of these four
firms which were leading the innovative activity in the investigated regulated areas
in the beginning of the 1990s and have their history associated with the development
of these technological fields.
Chapter 7 summarizes the results obtained by this research, the main contribu-
tions of this thesis to the literature, its originality, and possible directions and open
questions for future research.
2
Chapter 2
The Chemical Industry
The history of the chemical industry can be characterized by three different techno-
logical cycles which spurred waves of innovation and development. These three major
eras were stimulated by scientific developments on organic and inorganic chemistry
starting from the 1700s.
The birth of the chemical industry in the nineteenth century was marked by the
era of dyes. The growth of the textile industry and developments of the organic
chemistry since the eighteenth century enabled the development of synthetic dyes.
This era marked the initial development of the production of synthetic chemicals in
large scale.
The production of synthetic dyes started simultaneously in five countries GB
(1857), France (1858), Germany (1858), and Switzerland (1859). By 1878, the devel-
opment of better processes for the production of azo-dyes propitiated a rise in variety
of new dyes. By the beginning of the twentieth century, the majority of dyes sold in
the market were azo-dyes. The growth of the dye industry came along with the large
production of different chemical intermediates which started being applied in other
industrial sectors (Murmann and Homburg, 2001).
A second technological cycle which characterizes the evolution of the chemical
industry was the era of agrochemicals. The synthetic production of agrochemicals in
industrial scale started over the 1940s. Up to the 1960s there was a continue growth
in demand given the previously uncontrolled or poorly controlled crop problems.
However, over the 1970s, the introduction of new agrochemicals started to decrease
and new products were based on new formulations of existing substances.
Since the end of the 1980s companies which invested in R&D for the development
of new substances started to face the competition of an increasing number of firms
producing generic agrochemicals. Known by its heavy regulatory framework, this
sector faces today the challenge of finding environmentally safer substances. Similar
to the pharmaceutical industry, after the 1980s the number of new substances has
been falling. Given the increasing rules to market new products the time needed to
face all regulatory requirements has increased, leaving few years of patent protection
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to recover all investments (Hartnell, 1996).
The third major technological cycle was the era of polymers. Even though the first
synthetic polymers were developed still over the nineteenth century and the synthetic
rubber had a major role by the turn of the century, it was just during the II World
War that this industry found major importance and started its fast development.
Up to today, 79% of all plastics belong to five families of polymeric resins: pol-
yethylenes (PE), polypropylenes (PP), styrenics (PS), acrylics (PMMA), and vinyls
(PVC). These portray the group of macromolecular commodities. Another group of
polymers are the engineering which correspond to 11% of the volume and 34% of
value of all plastic consumption. The last group of polymers are the specialties that
together with the engineering polymers have special resistance in different ranges
of temperatures and high mechanical performance. Today, the major developments
in the macromolecular technology is on blendings of polymers (mix of substances),
expanding the number of new materials with specific required characteristics by the
market (Utracki, 2002).
Since the 1980s with major breakthroughs which propitiated the development of
two new technological fields – nano and biotechnology – these three major groups
which describe the evolution of the chemical industry received new vitality. Today,
there are new fields of research and development in order to the development of new
products that can substitute the use or need for certain dyes, agrochemicals, and
materials.
The chemical industry today
The chemical industry is considered the first “high technology” industry and it is
responsible for important changes in manufacturing since the late nineteenth century
(Vithoontien, 2004). As a research-intensive industry, development and growth rely
historically on the interaction between research institutes, firms and governments to
create a highly innovative sector that serves as an important source of knowledge
spillovers and technology diffusion (Cesaroni and Arduini, 2001).
As a highly diversified and complex sector, it now produces over 70, 000 differ-
ent chemicals (Lenz and Lafrance, 1996), which include chemicals derived from life
sciences (pharmaceuticals, pesticides and products of modern biotechnology), prod-
ucts for consumer care, basic commodities, and specialities (OECD, 2001). These
chemicals are produced in quantities that vary from less than a single ton to more
than 10, 000 tons per year. Basic chemicals are produced in the largest volumes -
the majority of these are intermediate goods for other industries, mainly chemical,
metal, glass, and electronics - while the rest are directly sold to consumers.
Supply chains in the industry are long, complex, and vertically and horizontally
differentiated. In the 1980s and 1990s, mergers and acquisitions resulted in increasing
concentration within the industry. Differences in environmental regulatory regimes
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are identified as one of the causes of concentration given that the relative cost of
compliance with the regulation is higher for small firms than for larger firms (Mahdi,
Nightingale, and Berkhout, 2002). The high concentration of large multinational
firms is also a characteristic of the chemical industry, since firms have been obliged
to increase in size so that they can more easily carry the high fixed costs of chemical
plants, the high level of R&D investment, and the costs associated with a highly qual-
ified work force, besides the need for marketing strategies to expand in geographically
disperse markets (Cesaroni and Arduini, 2001). As a result, chemical firms in the
United States (US), Europe and Japan have a similar structure.
Basic chemicals represent a mature market with few changes in the substances
produced in the largest amounts over the last 50 years. Not only has the compo-
sition of this group remained largely unchanged, but there has been little variation
in the rank order of production volume (Wittcoff and Reuben, 1996). Typically,
plants use continuous operations with high energy consumption and low profit mar-
gins (OECD, 2001). This characterizes a higher investment in process innovation
rather than product innovation, which are mainly incremental. Downstream firms
have higher heterogeneity on firm sizes, as a result of more investment on riskier
research and product innovation.
In the 1990s, 16 countries produced approximately 80% of the total world output
of chemical products. In decreasing order, are US, Japan, Germany, China, France,
UK, Italy, Korea, Brazil, Belgium and Luxembourg, Spain, the Netherlands, Taiwan,
Switzerland and Russia (OECD, 2001).
In 1998, world sales of chemicals were estimated at US$ 1, 500 billion. This rep-
resents more than twice the size of the world market for telecommunication services
and equipment. In 2000, the chemical industry accounted for 7% of global income
and 9% of international trade (OECD, 2001). In 2003, it was responsible for the
consumption of 7% of world energy (Vithoontien, 2004).
The chemical industry employs over 10 million people worldwide, but employ-
ment decreased 7.5% over the last 10 years as the industry has become more capital
intensive, with higher needs for qualified employees (OECD, 2001). In the EU, the
chemical industry leads all the manufacturing sectors in terms of value added per em-
ployee (CEFIC, 2005). Large companies account for high production volumes, even
though the majority of enterprises have less than 50 employees and are responsible
for the large diversity of chemicals produced in small quantities (Vithoontien, 2004).
This innovative industry requires a range of human, technical and financial inputs.
The availability of financial capital and highly educated people are the main issues
which determine the location of chemical firms and their research centers (Mahdi,
Nightingale, and Berkhout, 2002). The chemical industry is important because its
products are significant for all manufacturing industries, maintaining agricultural
production, and providing health care. Nevertheless, there is a lack of studies on
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significant aspects of the industry, most importantly the impact of regulation on
innovation, since it is a highly regulated industry and innovation is critical for its
maintenance.
What drives innovation?
Prices do not always reflect the true scarcity and social costs of all resources. Pure
market forces emerging in a competitive non-regulated economy might not induce
resource or pollution saving technological progress, and do not guarantee the desirable
direction of innovation (Nelissen and Requate, 2004). Environmental policy can be
an instrument to direct the technological progress, for example, driving toward new
products that require less resources as input, or less energy in its consumption, or
more efficient processes.
Horbach (2006) studied the drivers for environmental innovations. He points out
that general innovation theory fails to analyze the influence of environmental policy,
because it focuses solely on technology push (initial phase) and market pull (diffu-
sion phase) factors as the driving forces of innovations. The former represents the
physical and knowledge capital that a firm accumulates by investing in R&D, human
capital, and equipment. The latter expresses the market influence given a change of
preferences by consumers caused by social awareness and environmental conscious-
ness, demanding more environmentally friendly products. Environmental regulation
(for example, incentive based instruments or regulatory approaches) and institutional
structure (for example, political opportunities of environmentally oriented groups, or-
ganization of information flow, existence of innovation networks) should have a major
influence on the direction towards environmental innovation.
Firms’ incentive to innovate is a quantifiable benefit that they enjoy from develop-
ing a new technology. Firm’s strategies to reduce emissions may be either to reduce
output (final products), or to keep it constant and employ an abatement technol-
ogy. Abatement technology may be end-of-pipe technology (gross emissions remain
unchanged and are subsequently decreased) or process integrated technologies, im-
proving process efficiency and decreasing emissions (Nelissen and Requate, 2004).
Less hierarchical organizations and participation in groups and networking activities
are some management strategies which influence innovation positively, and prepare
firms to give better and faster response to environmental regulation (Mazzanti and
Zoboli, 2006b).
Investment on risky innovative activity depends on the expectation of future ben-
efits. In the case of product innovation, given the high costs generally related for
new chemicals, investments must be protected. That is the reason why the chemical
industry is known by its propensity to patent innovations.
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Chapter 3
Regulatory Framework
From the view point of the chemical industry itself, the ability to innovate by devel-
oping more efficient processes, and by introducing new and better products is what
characterizes competition. Given that it is a science-based, the chemical industry
uses its own resources to support R&D projects (Mahdi, Nightingale, and Berkhout,
2002). Consequently, a precise understanding of the impact of regulation on innova-
tion is a fundamental issue for the strategic development of the chemical industry.
The aim of this chapter is to present an overview of the regulation which impacts
the chemical industry, and show how the economic literature has been exploring this
issue.
Initially, it is addressed definitions regarding regulation theory and specifically
environment, health, and safety regulations. More specifically, it will be examined in
more detail the regulatory framework to which the chemical industry is subjected to
in several countries, and how regulation may impact chemical firms and its industrial
chain.
To illustrate how diverse the design of laws may be, it is provided a brief summary
of the chemicals regulation in the European Union, US, and Japan. This overview
shows how Nations may design in a distinct way their laws even with the same
purpose, and this may influence differently firms.
Lastly, it is discussed empirical findings regarding the possible impacts of social
regulations concerning human health and environmental protection on the manu-
facturing industry, with a main concern to high polluting industrial sectors and the
chemical industry. This literature review shows the main findings of the economic lit-
erature concerning regulation, innovation, and competitiveness. First it is described
the development of the main debated theories, followed by empirical papers which
look at manufacturing industries in an aggregated form, and afterward specific studies
on high polluting sectors.
Studies which analyzed the impact of chemicals regulation on chemical firms are
highlighted, and a special attention is given to the relationship between regulatory
stringency and innovation. Section five concludes this chapter.
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This section initially discusses environment, health, and safety regulations within
the context of regulation theory, some characteristics and definitions. In order to
subsequently examine the possible impact of regulation over the chemical industry,
it is described the main regulatory framework to which the chemical industry is
subjected with respect to human health and environmental protection. Furthermore,
an analysis of where the regulation acts over the industry chain is provided.
Two branches of laws are detached to better examine the impact of regulation on
the chemical industry. The first is environmental legislation concerning the protec-
tion of air, water and soil from pollution. Its scope and structure is highly diversified,
being unfeasible a full comparison between countries. The second regards specific reg-
ulations concerning the manufacture and commercialization of chemical substances.
While this legislation also varies in different countries the scope is more delimited,
making comparisons easier to carry out.
3.1 Environmental, health, and safety regulations
To define and subsequently measure regulation is a challenge. Besides, over the
twentieth century different kinds of regulations arose together with the growth in
complexity and diversity of economic activities. Specifically, environmental, health
and safety regulations emerged in this scenario characterized by a set of instruments,
combined and implemented in different ways, differing in each country. This makes
a broader analysis of its stringency highly complex, as there are overlapping layers of
different regulations ruling a single activity. Furthermore, the combination of different
instruments will have a different result than the isolated performance of them, then
they cannot be in principle analyzed separately and afterward the results will be their
combination.
Regulations are commonly classified into three distinct groups: anti-trust, eco-
nomic, and health, safety and environmental regulations. Anti-trust policies, are
based on the premise that an efficient functioning of markets require conditions close
to perfect competition paradigm. These policies therefore aim at impeding the for-
mation and the abuse of market power. The presence of natural monopolies as in the
cases of electricity and water supply industries are the basis of the second group of
regulation. The aim here is to define policies that allow to obtain acceptable results
in terms of efficiency and in terms of the distribution of the surplus between pro-
ducers and consumers, also in the presence of firms with strong market power. The
focus of this research is in a third group of regulations, which may act in different
ways in order to mainly minimize the effect of externalities. This set of policies, also
called “social regulations,” include laws regarding the protection of the environment,
the safety of the product for the consumers, and the health and safety of workers.
Market failures caused by the presence of externalities, imperfect information,
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and imperfect competition are motivations for the development of different laws and
policies. In order to apply these rules there are several mechanisms. The imposition
of taxes, for example, is a technique which gives the regulator the possibility of
manipulating prices and making product more or less attractive, influencing economic
behavior. The objective of the regulator shall be to balance the different interests
between sellers and buyers, firms and consumers, or even to transfer welfare from one
to another group.
Economic theory describes the objective of the regulator as to maximize public
interest. However, several issues influence the design of a new policy. There are
several theories which try to model the best political environment for the development
of a regulation. One of the most well known is the “Capture Theory” by George
Stigler, which states that the regulator will act in favor of the economic interest
that it serves. As a matter of fact, there are competing private and public interests
which influence the regulator. In order to design a new law in a market with diverse
industries and different-size firms, there are several technical, economic, and political
factors to which the regulator is influenced by (Viscusi, Vernon, and Jr., 1996).1
In the nineteenth century, the large scale production of soda ash, sulphuric acid,
caustic soda, and dyes gave birth to the inorganic and organic chemical industry we
know today. After 1850, with the advent of the industrial revolution the demand for
more chemical substances as input for all other industries that were being developed
increased. England, Germany, and the US were the precursors followed by Japan,
and other western European countries. It took more than sixty years for environment
and human health impacts of chemicals start to be considered and discussed widely
by society.
The US Clean Air Act was the precursor of the environmental regulation. In 1970,
the US Environmental Protection Agency (EPA) was created with the objective to
monitor, establish standards, and enforce the new law. In the following years, a huge
growth of regulations occurred in most industrialized countries. In 1976, Europe
suffered the consequences of the Seveso disaster in Italy, and in 1982 developed the EU
Directive 82/501/EEC for the control of major-accidents hazards caused by dangerous
substances.
Regulations, interpreted as extra costs, are also accused of being responsible for
market concentration in different sectors such the chemical industry. Nevertheless, if
social regulations excludes inefficient firms from the market it will be a gain for more
efficient firms which will have increased their place in the market. This will increase
the productivity of the overall market, even if reducing the number of firms.
The decision to regulate or not raises several issues. Irrationality caused by a
1Each country has defined procedures to design a new policy. Section 3.3 provides a more detailed
explanation on the mechanism for the development of European Union regulations, and details the US,
Japan and EU chemicals regulation.
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wrong perception of risk and uncertainty related to possibility of future harm, are
some of these issues. For instance, a cost-benefit approach can be developed in order
to evaluate the future policy. This is based on the principle that you can measure the
costs of the regulation and the benefits which it will bring to society. Using water
quality as an example, while it increases also the cost to increase water quality grows.
There will be a moment where the the total cost of the policy will be higher than the
value of the benefit obtained with water quality. Thus, the optimal policy would be
the one which obtains the maximum net benefits-costs, or when the marginal benefits
will be equal to the marginal costs.
Nonetheless, with new areas of technology emerging (e.g. biotech and nanotech-
nology) and high speed of a variety of new products reaching the market, the uncer-
tainty related to future risks or benefits brings new challenges to the regulator. There
will be the need to opt between a conservative and preventive policy and possibly
harming the development of such technologies, or being aware but not regulating in a
‘wait and see’ attitude. In the case of new technological branches, it can take several
decades for science to develop methods of research to assure the safety of a new prod-
uct. As quoted before, in the case of the chemicals industry it took several decades
for not only the general public and government, but also the industry to realize all
harm those products could cause.
A cost-benefit analysis asks if a given industrial activity or product should or not
be regulated in the present time. What is not traditionally employed is to evaluate
the option of delaying the new policy. Financial economists have the concern with
the optimal timing for the investment. Similarly, by having a risky policy which is
costly and the benefits cannot be evaluated, the regulator aims that the present value
of expected benefits of the new law today to be equal or exceed the present value of
expected costs added to the value of the option to ‘wait.’
The problem the regulator faces is to choose a plan for making these sequential
and irreversible expenditures through time. New information might change the policy
scenario originally designed, altering the initial choice of when to regulate. Thus,
uncertainty is present when the future net benefits of regulating or not are not known
at the time of the decision making.
Another issue which challenges economists devoted to this topic is how to measure
non-monetary benefits such environmental preservation, or workers and consumers
health and safety. How much society is willing to pay to diminish the probability for a
negative effect on human health or environment? The present value of how much one
will earn over its lifetime, or how much one will pay of taxes contributing to society
are possible alternatives of measures (Viscusi, Vernon, and Jr., 1996). Nonetheless,
each economic activity has different impacts and risks associated, as well as the
consumption behavior of different groups in society. These heterogeneity highlights
other issues that the regulator must face when defining a new policy.
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Given the fact that the benefits sought by the regulator (e.g. air and water
quality) do not directly result from market transactions, the regulator will then try
to estimate the future social benefits to justify the real costs imposed by a new policy
over the government, consumers, and firms.
3.2 Environmental regulation
Environmental regulation aims to protect the environment and human health from
exposure to hazardous substances and pollutant releases from processes developed
by a firm. The chemical industry is in particular affected given the complexity of its
processes, and variety of chemical substances that are used as raw material, interme-
diates, and disclosed as products, byproducts, and waste.
As stated previously, the regulator acts in situations of market failure: incom-
plete markets, externalities, non-exclusion, non-rival consumption, non-convexities,
and asymmetric information. On environmental economics the classic theory was
proposed by Ronald H. Coase in 1960 concerning externalities.
Negative externalities occur when in a transaction a third party experiences costs
although it is not compensated. This externality has no market price and it is an
effect of the production or the consumption activity, affecting other producers and
other consumers impeding the Pareto optimality. These externalities emerge as a
result of common resources (or not privately owned, e.g. public goods) and negative
effects of today’s acts on future generations. In these situations the best for the
consumer and the supplier (which are executing the transaction) is not necessarily
the best for the society which will have to cope with other costs.
The Coase theorem postulates that economic efficiency is obtained when there is
a full allocation of property rights, despite of to who they are initially allocated. The
market will then determine the final allocations considering the value to the different
parties and the freedom of individual choice, aiming zero transaction costs.
This theorem gave rise to intense debate. When dealing with one transaction a
contract could be enough for allocating all costs. However, in a society there is a
need for the imposition of regulation because it would be impossible to coordinate
all actions and the incidence of free-riders (Viscusi, Vernon, and Jr., 1996).
How regulatory policy should be designed? Several policy instruments were de-
signed in order to obtain maximum efficiency imposing minimum costs. These policy
instruments are commonly described as follows (OECD, 1997b; Nelissen and Requate,
2004):
Command and Control Criticized by being not flexible, this instrument acts di-
rectly on the activity that affects the environment. It can impose technological
and emission limits, forcing firms to adopt the ‘best available technology,’ or
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fuel quality standards. It may require firms to previously ask the regulator
authorization for localization choice and installation of plants.
Economic A more flexible instrument, includes market-based tools which are in-
tended to motivate firms to reduce emissions through prices, giving them the
flexibility of deciding how much they want to emit or abate. It also includes
emission taxes (where prices for emissions are administrated by a regulator),
subsidies and grants on abatement emissions, and fines for non compliance.
Voluntary agreements Developed by private or public institutions, aim to improve
a firm’s environmental performance through commitment and disclosure of in-
formation.
A set of standards establishes a maximum acceptable behavior by the pollutant.
Nevertheless, the choice of policy instruments is more complex and will depend on
the nature of the pollution source and its consequences. For instance, command and
control instruments might be more effective if there is the need for fast results or to
eliminate a certain emissions or substances. Both economic and command and control
instruments follows the “polluter pays principle” (also called “producer responsibility
principle” – PRP). However, in the last decades the debate over he development of
economic instruments such environmental taxes and emissions trading, preferred by
economists, grew. Economic instruments operate balancing marginal abatement costs
which cover all polluting sources.
Environmental (also called pollution) taxes provide a continuing incentive for firms
to diminish pollution emissions over time, as it will always pay for all external costs in
a dynamic efficiency environment. Taxes internalize external costs and the regulator
has no need to obtain any information regarding individual abatement costs.
The market scheme is an economic instrument popular among economists. A
certain number of permits (equivalent to a certain quantity of pollution) are allocated
to each polluting agent per a defined period of time. After each period this number
of permits will decline. The market for permits is then established and each agent
will decide if will be better to sell its permits and reduce its pollution emissions, or
to buy permits and be allowed to pollute more. This choice will depend on the price
of the permit and the cost for each agent to reduce its pollution emissions.
This flexibility will enable the minimization of the abatement costs for each firm,
and also the regulator will have no need of looking for information regarding each
plant abatement costs. In a perfect market, the equilibrium will be reached when
marginal abatement costs are equal to the permit price. This policy is in general
limited to large polluters given its complexity and high transaction costs to establish
the market. A significant number of large firms, that are able to deal with the trading
scheme, would increase the possibility of success.
Under competitive conditions, market-based instruments are a guide to an equal-
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ization of marginal abatement costs across firms (Nelissen and Requate, 2004). A
study on the impact of European policy on end-of-cycle vehicles, regulation imposed
on 2000, shows that the dynamic efficiency of the economic instrument introduced
in complex and systemic industrial settings will depend crucially on which sector of
the industrial chain is directly regulated (Mazzanti and Zoboli, 2006a). The mar-
ket power, relationship with other activities, position in the innovation process, and
their technological and organizational capabilities are key issues for the success and
efficiency of the regulation. Mazzanti and Zoboli suggest that these kind of regula-
tions, economic instruments based on the “producer responsibility principle,” should
be considered when the target to be achieved depends highly on innovation.
More recently, research has been devoted to the involvement of industry in the
regulatory development. Puller (2004) models the interaction between the regulator
and an oligopoly in order to observe the equilibrium among innovation, regulation,
and welfare. Because regulation is ‘welfare improving’ just when industry innovates
enough to reduce the costs of greener products, the regulator may lower standards to
not inflict socially expensive policy. He concludes that, in an oligopoly, the raise of
competition will mitigate the low incentives of lax regulation. Consequently, regula-
tory commitment is not critical.
Environmental regulation may be described as an umbrella involving several laws
regarding the protection of human health, safety, and the environment. It is designed
in various ways in each country, with a broad scope. In general, it is not sector
specific. This kind of regulation, which has emerged in US over the 1970s, has
been disseminated all over the world. When analyzing competitiveness, it is not
anymore a matter of regulated and unregulated countries, but different combinations
of instruments being employed.
3.2.1 Regulation, competitiveness, and firm performance
The economic literature initially observed in a global perspective a world divided
between regulated and non-regulated countries, and asked the questions: how firms
behave in this situation, and which is the impact of this behavior on the country’s
economy, hence, on its competitiveness? Over the 1970s and 1980s, with the develop-
ment of telecommunications, there was a fear that the production would move away
from industrialized countries with increasingly regulation, and would raise the un-
employment rates. “North-south” models were developed to look at what determines
the location choice of firms and evaluate if environmental regulation was a significant
issue.
Later on, but still in an aggregated level, researchers started to explore the impact
of regulatory stringency on the manufacturing industry and its key factor of develop-
ment: innovation. The increasingly complexity and stringency of regulation and the
advent of different regulatory instruments, have possibly caused different impacts in
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each industry since the key factors of firms’ development vary among them. Labor
force, capital, raw material, product and process innovation, for example, have dif-
ferent levels of importance for each industrial sector. Consequently, the impact of
regulatory stringency would be industry specific.
More recently, since results from the analyses on manufacturing industry suggested
heterogeneous impacts among industrial sectors, economists focused their studies on
highly pollutant sectors, therefore highly regulated, to determine the relationship be-
tween regulation and firm’s performance: innovation, productivity, and profitability.
A number of sectorial studies have been published making possible the development
of more complex sector specific models and measures of regulatory stringency. Be-
fore entering on the different aggregation levels of empirical studies, this section will
present the different theories which arose along with the growth of environmental
concern, on the relationship of regulation and technological change.
Since the 1970s, a number of studies have claimed that environmental regulation
impacts negatively on the innovative process of firms while others have argued the
contrary. Eads (1980) has examined the possible influences that regulations on the
environment, health and safety of workers, and safety of consumer products might
have on technical change in firms. Four possible outcomes that these regulations
might cause in the innovative activity of firms are defined:
1. Regulation may divert resources that otherwise might be used to fund research.
2. Regulation may change the firm’s ability to calculate the payoffs to investments
in research and developments.
3. Regulation may alter the proportion of benefits that are properly classifiable as
“externalities”, and this may change the nature of research the firm is likely to
undertake.
4. Regulation may change the optimal institutional patterns for performing certain
types of research. (Eads, 1980, pg. 51)
If regulation diverts resources that otherwise would be deployed to R&D, this
would cause a major negative impact on innovation. As the perception of risk in-
creases, firms would avoid investments on innovation given future uncertainties. Con-
versely, other scholars believe that this would be a temporary phenomenon.
Even though Eads (1980, pg. 54) states that regulation can affect both the level
and direction of innovative activity, there are not sufficient studies to generate a
convincing conclusion to this argument, and there should be greater efforts to make
a better environment for innovative activities rather than changing the regulations
that are suggested to be harmful.
For some authors (see Davies, 1983) a decrease in the number of players, given
the raise on regulatory costs, means a decrease in the number of innovations. Firms
defend the opposite idea, i.e. that larger firms innovate more than several small firms.
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According to Mahdi, Nightingale, and Berkhout (2002, pg. 25), most studies
which claim that regulation causes a negative impact on industrial innovation share
three basic assumptions: first, a decrease in the number of innovations is bad for
an industry, second, that this is an irreversible process, and third, that increasing
compliance costs are the main factor decreasing industrial innovation.
Generally, these studies have suggested that the main consequence of restrictive
regulation is an increase in production costs. This assumption justified the belief
that the impact of environmental regulation causes loss of competitiveness and can
induce firms to move to countries where the marginal social cost of production would
be lower, as people in less regulated – usually poorer countries – would have a lower
marginal valuation on the environment. This orthodox view has been called the
“Pollution Havens Hypothesis” (Wu, 2000).
Nonetheless, another branch of research aims to demonstrate that restrictive reg-
ulation might incentivize innovation and, consequently, a competitive gain. In 1990,
the economist Michael Porter argued in his book “The Competitive Advantage of
Nations” that regulatory restrictions in specific firms gave them a competitive advan-
tage with respect to firms from less regulated countries. His arguments, based on case
studies and other causal evidence on international trade, show that nations with more
restrictive regulation had a gain in competitiveness on the regulated products in the
world market. Subsequently, in his essay published in Scientific American (Porter,
1991, pg 96), he stated that in other studies the conflict between environmental pro-
tection and economic competitiveness is a false dichotomy. It stems from a narrow
view of sources of prosperity and a static view of competition. From his analysis he
concludes that strict product regulations can also prod companies into innovating to
produce less polluting or more resource-efficient products that will be highly valued
internationally.
Porter and van der Linde (1995) list several arguments showing why regulation
can bring competitive advantages to firms. As postulated by Nelson and Winter
(1982), firms use rules of thumb with respect to their innovative behavior given huge
uncertainties concerning the success of R&D. For Porter and van der Linde (1995),
regulation would signal firms potential technological improvements on their processes
in order to eliminate hazardous inputs and increase efficiency, to reduce uncertainties
related to R&D investments on environmental innovation, and to create pressure for
the development of innovative activity.
Innovation can occur to counterbalance environmental regulation. These inno-
vation offsets arise because firms learn from pollution problems they might have.
They act in order to reduce emissions, the amount of hazardous substances used,
generated, and to improve efficiency. Or even environmental impacts are already
incorporated during the research period, developing products and processes offsets.
Nevertheless, non or relatively lax environmental regulation can favor the adoption of
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end-of-pipe technologies or secondary treatment solutions, and discourage investment
on efficiency and cleaner products (Porter and van der Linde, 1995).
According to this view, such restrictions are a positive force driving firms to be
more competitive in the world market. Other authors refer to this possibility as the
“Porter Hypothesis.” Over the last fifteen years, the most important debate on the
relationship among environmental regulation, innovation, and competitiveness has
centered upon the Porter Hypothesis.
Jaffe and Palmer (1997) identify three possible interpretations for the Porter Hy-
pothesis. The first states that some kinds of environmental regulation – specifically
the ones that focus in outcomes rather than processes – provide incentives for in-
novation. The second version states that environmental regulation stimulates some
types of innovations, since it constrains a firm’s profits and, as a result, the firm will
rearrange their investments focusing in certain kinds of R&D. The third interpreta-
tion, identified as the ‘strong’ version, states that a new regulation induces firms to
look for new products and processes that will obey the regulation and also be more
profitable.
Regulation can be an opportunity promoting new areas, giving incentives to re-
search on cleaner products and more efficient processes. It reduces risk and raises the
value of “green” products. Since not all innovation is socially desirable, regulation can
be an instrument to incentivize innovation, disincentivize it, or change its direction.
3.2.2 Regulation, country competitiveness, and location choice
Some studies use macroeconomic models to investigate differences of competitiveness
in more or less regulated countries. Mainly, these studies use aggregated data on
manufacturing industries, and they reach no consensus on whether there is a gain
or loss of competitiveness. Future investments and location choice of each industry
depend on many other factors and, in some cases, the restrictiveness of the regulation
would be irrelevant on the choice for a country. These models consider factors such
as intellectual property rights policy, law enforcement, differences between industries,
possible future harmonization of regulation internationally, and the asymmetries that
can arise. Most of these studies have used data from free trade areas, such as NAFTA2
and APEC3 (see Sturm and Ulph, 2002; Unteroberdoerster, 2003; Maria and Smul-
ders, 2004; Taylor and Levinson, 2005; Mulatu, Florax, and Withagen, 2004).
In 1995 Jaffe, Peterson, Portney, and Stavins (1995) published a survey on the
impact of environmental regulation on the competitiveness of the manufacturing in-
dustry in the US. They discuss which are possible indicators of competitiveness such
as the efficiency of nations when producing manufactured goods. A country would
export goods in which they are more efficient when producing, and would import
2North American Free Trade Agreement.
3Asia-Pacific Economic Cooperation.
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those in which they are less efficient on producing. They propose alternative indica-
tors of competitiveness such: the comparison between net exports of highly regulated
goods and less regulated goods; the shift of production of pollution-intensive goods
from highly regulated to less regulated countries; and the shift of investments of
highly regulated industries from their own home country, to overseas less regulated
economies.
Empirical studies point out that the difficulties on quantifying competitiveness
and environmental regulation are main reasons for not reaching precise conclusions.
Despite that, as Jaffe, Peterson, Portney, and Stavins (1995) also conclude, the im-
pact of environmental regulation vary among industries, and foreign regulations may
also affect national firms given that it may affect investment decisions. The authors
observe that when a firm chooses a location it considers several factors such as its
needs for the different kinds of labor force (high skilled or poorly qualified workers),
the availability of raw materials, the political and economic risks, and the infras-
tructure. Thus, environmental regulation will be one more issue for managers and
investors to deal with, and depending of the industry needs it might have a small
impact on the final decision.
In addition, the reality of the world in 2000s is much different from the 1970s
and 1980s. Emerging markets might attract industries given its increasing domestic
demand with a higher potential than industrialized economies, with a lower rate of
growth.
Even though recent empirical studies have been describing some statistically sig-
nificant pollution haven effect, Brunnermeier and Levinson (2004) in their survey on
the relationship between environmental regulation and industry location, conclude
that there is not enough evidence to draw policy conclusions. Accordingly to the au-
thors the measures of regulatory stringency normally employed in these studies have
several important drawbacks. Moreover, also the selection of the industrial sample
(pool of all industries or “dirty industries”) may also hide other causal elements.
Most studies quoted by Brunnermeier and Levinson use data from the 1970s and
1980s. Over this period, there were financial incentives for firms from industrial-
ized countries to move to developing economies. To obtain loans inside their home
countries, firms faced newly imposed environmental rules on the installation of new
industrial plants. At the same time, firms had access to funding, without environ-
mental requirements, for the developments of their projects on developing economies.
In the 1980s, this led to some criticism over the World Bank lending practices (Niel-
son and Tierney, 2003). International financing agents were also accused of financing
“dirty” projects on developing economies, but requesting high environmental stan-
dards for projects on developed economies. This might have favored the creation of
pollution havens.
Kirkpatrick and Shimamoto (2005) studied the effect of environmental regulation
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on the location choice of Japanese Foreign Direct Investment. To measure the re-
strictiveness of regulation in Japan in comparison to other countries, they used the
number of environmental international treaties signed by each country. Data from
foreign direct investment (FDI) in Japan was extracted from a survey on newly estab-
lished and mergers and acquisitions of Japanese iron and steel, non-ferrous metals,
industrial chemicals, pulp and paper, and non-metallic mineral products’ firms, from
1992 to 1997. They found no support for the pollution havens hypothesis. Host coun-
tries’ distance from Japan and market size were shown to be relevant to the location
choice, while labor costs were not significant.
From their analysis environmental regulation is found to be a significant variable,
illustrating that firms tend to move to countries with more stringent environmental
regulations. This might be explained by the fact that “dirty” firms want to avoid
future uncertainties, such as the imposition of new standards or being responsible
for cleaning-up past pollution. Thus, regulatory stability is one of the main factors
influencing location choice for foreign investment (Kirkpatrick and Shimamoto, 2005).
The results shown in Kirkpatrick and Shimamoto (2005) are partially confirmed by
Co, List, and Qui (2004). These authors focus on US foreign direct investment (FDI)
data, from 1982 to 1992, in two sectors: food and related products, and chemical
and related products. These sectors were chosen because of their different pollu-
tion intensities. They show that capital flows in the chemical industry were more
affected by environmental standards than in the food industry. As shown previously
by Kirkpatrick and Shimamoto (2005), they found that for a group of firms stricter
environmental standards are an important aspect in attracting foreign investment,
however only for developed economies. In the case of developing countries stricter
environmental standards may reduce FDI. Moreover, they also find that stringent
intellectual property rights (IPR) is directly related to FDI (depending on how sen-
sitive the industry is to IPR). This fact could then favor developing economies with
higher IPR protection.
When analyzing previous empirical works on the impact of regulatory stringency
on net exports over the 1970s and 1980s, Jaffe, Peterson, Portney, and Stavins (1995)
found that most studies find no significant relationship, also for chemical, metals,
mining, and pulp and paper sectors (pollution-intensive firms). Nonetheless, all these
empirical studies while comparing environmental regulations of different countries fall
on the same problem of qualitative or questionable proxies of regulatory stringency.
Along with this drawback, given the complexity on defining and finding a proper indi-
cator of competitiveness, most empirical studies focus on the impact of environmental
regulation on innovation (as a proxy for competitiveness).
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3.2.3 Regulation and innovation in the manufacturing industry
In this section I review the empirical literature that investigates the relationship be-
tween stringent health, safety, and environmental regulation and innovation of man-
ufacturing firms. To better illustrate this review, two empirical studies on the US
manufacturing firms over the 1970s and 1980s, believed to be particularly relevant,
are carefully examined. The key variables in which I will focus are the proxies for
regulatory stringency and innovation, given that a main issue is how economists have
been measuring these variables to be able to capture empirically the relationship be-
tween them and their influences on firm performance and pollution reduction. Table
3.1 lists the two contributions and their main features.
Table 3.1: Empirical analyses on manufacturing industry: regulation and innovation.
Authors (Year) Country Period Measure of innovation Measure of regulation
Jaffe and Palmer
(1997)
US 1975 – 1991
1. R&D expenditures
2. Patents (granted)
Pollution abatement costs and expen-
ditures
Brunnermeier and
Cohen (2003)
US 1983 – 1992
Environmental patents
(granted)
1. Pollution abatement costs and ex-
penditures 2. Number of pollution-
related inspections
In the studies over the US manufacturing industry, the authors used as proxy
for regulatory stringency the US census survey on pollution abatement cost and
expenditure, so called “PACE survey.” It consists of a questionnaire where firms
declare abatement costs and expenditures related to compliance with governmental
policy. The survey included answers from firms with more than twenty employees,
from 1973 to 1994 (excluding 1987). Data on approximately 17,000 firms are available
aggregated in 2, 3, and 4 digit SIC (Standard Industrial Classification) code levels.4
The survey intends to estimate a direct measure of costs of environmental policy.
In spite of it all, the use of data extracted from the PACE survey has also its draw-
backs. Firms might have interest on over estimating costs to signal to the regulator
a higher stringency in order to obtain some advantage in a negotiation process of a
future policy change. Also, it can under estimate the costs of the regulation given
that it can be difficult to measure all costs related to the process control which will
improve the quality of the product, save raw material and utilities (water and energy),
and by consequence, reduce emissions and compliance costs with the regulation. For
instance, the adoption costs of end-of-pipe technologies can be easily calculated, while
the effect of other measures for guaranteeing less residues and less consumption of
raw materials, such changes on the production process to obtain higher efficiency, can
4Unfortunately, the US Census Bureau stopped compiling the PACE survey in 1995. In 2001, a report
on 1999 data was released but with a different methodology from the previous surveys, and was widely
criticized (see Becker and Shadbegian, 2004).
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be harder to be calculated. When the firm is improving the quality of its products
reducing impurities it is by consequence consuming less raw materials and reducing
emissions of pollutants. This provides environmental benefits but can be incentivized
by economic motivations rather than by regulation.5
In order to overcome the drawbacks associated with the PACE survey, Brunner-
meier and Cohen (2003) also used the number of water pollution-related and the
number of air pollution-related inspections by state and federal agencies as alterna-
tive proxies for regulatory stringency. These measures can be interpreted as proxies
of the level of law enforcement.
Turning now to the dependent variable of the analysis, three different proxies to
measure firm innovation are commonly chosen: R&D expenditures, number of patents
(applied or granted), and number of environmental patents (applied or granted). The
choice of which proxy to use will determine the issues that can be studied and the
interpretation of the results which are achieved.
Research and development expenditures are commonly used as a proxy for in-
novation, assuming that the amount of innovative activity is directly related to the
amount invested by the firm in R&D. This is not necessarily true for all industrial
sectors or in all periods of time. For example, the study by Thomas (1990) showed
the continuos increase in R&D investments since 1955 by pharmaceutical firms in the
US, but a sharp decrease of new marketed chemical entities after 1960 (the period
analyzed went until 1980). However, an increase in R&D expenditures may suggest
that firms noticed possible technological opportunities, demand for novel products
and processes, but not necessarily that the number of innovations increased or de-
creased. Still, the theory states that regulation may divert resources which otherwise
would be used in R&D, may alter the quantity of innovation, and may change the
direction of the innovation (Eads, 1980). Regardless, in the case of industries which
do not have the propensity to protect their innovations through patents, R&D can
be a better proxy.
Another proxy commonly used to measure innovation is the number of patents,
applied or granted, related to the industrial sector under investigation. There are two
issues which might be problematic when using this proxy. First, patents are a direct
measure of innovation but not all industrial sectors have the same tendency to patent
their new products and processes. For instance, some firms might prefer industrial
secrecy to protect their discoveries. Second, there are problems when relating the
patents classification, based on technological areas, to industrial sectors. Despite this
fact, the use of all patents as measure of innovative activity is able to capture overall
5For instance, Jaffe, Peterson, Portney, and Stavins (1995) cite other main issues that might cause
problems on the interpretation associated with empirical analyses with this data. It has no baseline. Even
non regulated firms might invest in cleaner technologies for other reasons such as more efficient processes,
saving inputs, if a firm wants to keep a good relationship with the community close by or if they want to
invest in its image as a greener brand.
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innovation of a given sector.
For instance, Jaffe and Palmer (1997) discourse over the problematic classification
of patents by industry. The industry of origin is not known by the patent office.6
The patent classification by industry used by them was extracted in accordance with
the US Patent Office concordance table. The two authors demonstrate two possible
sources of misallocation of a patent. First, firms do not necessarily innovate on
their core technologies. Second, pollution control capital goods can be equivocally
assigned to the capital good using industry, and not supplying industry, which may
or may not be the same. On highly aggregated studies, when evaluating the overall
manufacturing industry for example, these drawbacks may be diminished.
Finally, when looking at the relationship among environmental regulation and in-
novation, the researcher may wish to focus not on the overall innovative activity, but
just on environmentally friendly products and processes. Therefore, “environmental”
or “green” patents (applied or granted) may be used to measure a specific kind of
innovation. Still, available patent statistics do not explicitly classify patents as “en-
vironmental” or “green.” Hence, if a researcher wishes to study the evolution of such
technologies, s/he will have to develop first a sensible definition and an algorithm
to extract them from the statistics available from the patent office databases. Less
resource-consuming and more efficient processes will, as a consequence, reduce pol-
lution. However, they are more difficult to be defined and extracted from a patents
database.
As already discussed, innovations associated with more efficient processes can be
motivated by regulatory reasons as well as by economic reasons. A higher rate of
conversion (input/ raw material to output/ final product) will reduce costs with raw
material, and an increase in productivity may convert in higher profits. Nevertheless,
the use of environmental patents as dependent variable will show if regulatory strin-
gency has incentivized the development of product innovations not associated with
higher productivity and profitability. Parallel studies should investigate these other
factors.
The literature regarding green technology grew in the last decade, but how to
define environmentally friendly innovations and extract from patents database these
products and processes still raises doubts. In a study on the dynamics of environ-
mental innovations, Oltra and Jean define “clean technology” as input substitution
and savings, pollution control and prevention technologies, in-process recycling, and
radically new cleaner production process (2005, pg. 191).
In order to develop an empirical analysis on the development of environmental
technologies by the European chemical firms, Arduini and Cesaroni (2004) classified
these innovations into three categories: end-of-pipe, recycling, and clean technolo-
6The patent document contains the inventor, but not necessarily the firm or industry by which the
inventor belongs to, or if s/he works for one.
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gies. The first two focus on purification, decontamination, treatment of waste, and
recycling, and had their data obtained from patent statistics following a keywords
search. The third category, differently from the first two, cannot be extracted from a
patents database because of its complexity as it is based on an ex-ante intervention
in order to avoid pollution: a strategic decision regarding several aspects of the firm’s
production process. Clean technologies are based on prevention of pollution, and not
purification and recovery. In order to obtain evidence on the development of such,
Arduini and Cesaroni used case studies.
As noticed, the widespread definition used of environmental or green patents in
economic studies are related to product innovations that focus on pollution reduction,
mainly end-of-pipe technologies related to waste-water treatment, air pollutant filters,
and recycling. For instance, Brunnermeier and Cohen obtained their data filtering
patents related to hazardous or toxic waste destruction or containment, recycling or
reusing waste, acid rain prevention, solid waste disposal, alternative energy sources,
air pollution prevention and water pollution prevention.(2003, pg. 282).7 A brief
summary of the results of the two studies here discussed are shown in Table 3.2.
Table 3.2: Empirical analyses on manufacturing industry: results.
Authors (Year) Dependent variable Results
Jaffe and Palmer
(1997)
1. R&D expenditures
2. Patents granted
1. Relationship between environmental regulation and inno-
vation statistically significant but small in magnitude 2. Sta-
tistically not significant
Brunnermeier and
Cohen (2003)
Environmental patents
granted
Positive and statistically significant relationship between
stricter environmental regulation and the number of environ-
mental patents
Jaffe and Palmer (1997) used a panel data to see wether environmental regulation
stimulated or not innovation. They estimated two models: first, using R&D expen-
diture by private manufacturing firms as a proxy for innovation, and the other using
total successful patent applications.8
Jaffe and Palmer did not find any statistically significant relationship between
regulatory compliance costs and general patenting activity, but they did establish a
positive relationship for R&D expenditures, even if small in magnitude. They stated
that this inconsistency occurs because of the highly aggregated nature of the data,
the difficulty of classifying patents by industry of origin, and the limitation of using
7Extracted from the Office of Technology Assessment and Forecast of the United States Patent and
Trademark Office.
8In the former, there were also as regressor government R&D expenditure within the industry, and, in
the latter, they include a variable of successful patent applications by foreign corporations in the US Patent
and Trademark Office (USPTO). This control variable was inserted for two motives: first, because there
are differences in the number of patents from industry to industry; second, to check if there was a gain of
competitiveness of US firms if compared to foreign firms.
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the PACE survey as regulatory stringency.
The panel data estimated by Brunnermeier and Cohen investigated the rela-
tionship between environmental regulation and successful number of environmental
patent applications of the US manufacturing industries. From the USPTO database
they extracted 3, 680 of such patents related to environmental technologies. Other
regressors used which were judge to affect environmental innovation were industry
size and concentration, as indicators of market structure, among others.
Brunnermeier and Cohen found a statistically significant positive relationship be-
tween stricter environmental regulation and the number of environmental patents
(although it did not imply larger profits), but with a very small correlation between
the two variables. Both studies suggest that further research with less aggregated
data is necessary to clarify the relationship between regulatory pressures, innovation,
and competitiveness of manufacturing firms.
The investigation of the relationship between all patents produced and regulatory
stringency may help identify if there was an increase in innovative activity given
regulatory stringency. Even so, quantity of innovation does not mean quality of
innovation (in a technological or environmental perspective).
Just a more detailed study would be able to identify if there was a change on
the direction of the innovation which can happen in two ways: new technologies will
be “cleaner” technologies (e.g.: more efficient processes and better products with less
residues); or a technological area will be substituted by another. For example, if
R&D expenditures and environmental patents are used in the same study, it can be
measured if an increase on regulatory stringency made firms invest more on research
to find solutions for the regulatory constrains; and if the same volume of R&D ex-
penditures were diverted to find solutions for regulatory constrains. Regulation can
raise costs or even withdraw certain products or processes from the market, becoming
viable competing goods from another technological branch.
Some insights can be withdrawn from the results reached by this literature. Cer-
tainly, the effect of environmental regulation on innovation, if there is any, is not
immediate. Furthermore, the difficulties of measuring the impact and confirming a
hypothesis shows that there must be a large variation among manufacturing indus-
tries, and even between sub-sectors within a single industry. This high variability
of costs of regulation and the different importance of innovation among different
industrial sectors limit general conclusions.
3.2.4 High polluting industries
Jaffe, Peterson, Portney, and Stavins (1995) on their survey on environmental reg-
ulation and the US manufacturing industry, observed that the industrial sectors of
pulp and paper, chemicals, petroleum and coal, and primary metals are the ones
which show the highest pollution abatement expenditures in the PACE survey. Jaffe
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and Palmer (1997) also identified the sectors of metal products, pulp and paper,
petroleum refining, and chemicals the ones which need to be more investigated.9 As
signalized by these and other studies on the manufacturing industry, sectorial stud-
ies have focused on industries with massive emissions of pollutants, or with high
regulatory costs, or even with specific regulatory framework.
This section discourse over empirical analyses on industries considered to be highly
polluting and, as consequence, highly regulated. The aim is to illustrate how the ef-
fect of health, safety, and environmental policies on firms’ performance have been
empirically studied over the years. Also, how regulation has been measured, and
which are the main issues regarding the effect of regulation on these specific indus-
trial sectors. First, are examined some empirical studies on the impact of stringent
regulation on innovation, and later it is illustrated the literature on the impact of
different policy instruments in innovative activity.
Innovation
Two papers which analyzed the impact of environmental regulation on the R&D
expenditures of the Japanese industry are outlined in this section. First, Hamamoto
(2006) studied high polluting manufacturing sectors over the 1960s and 1970s, and
second, Hibiki, Arimura, and Takeba (2007) analyzed the automobiles industrial chain
over the 1990s. Their key features are described in Table 3.3.
Table 3.3: Empirical analyses on Japanese high polluting sectors: key variables.
Authors (Year) Industry Period
Measure of
innovation
Measure of regulation
Hamamoto (2006)
Pulp and pa-
per; chemicals;
petroleum and
coal products; iron
and steel; and
nonferrous metals
and products.
1. 1966 – 1976
2. 1972 – 1982
R&D expen-
ditures
1. Pollution control expendi-
ture. 2. Sum of pollution control
expenditure with the change in
charge payments required by the
Japanese Compensation Law for
Pollution-Related Health Dam-
age.
Hibiki, Arimura,
and Takeba (2007)
Auto-industry
chain
1990 – 2002
R&D expen-
ditures
Annual level of motor vehicle ex-
haust gas standards.
Hamamoto (2006) studied five sectors which had the highest pollution abatement
control expenditures in Japan over the 1960s and 1970s: pulp and paper, chemicals,
petroleum and coal products, iron and steel, and nonferrous metals and products. In
order to evaluate the regulatory stringency he chose two measures: pollution control
expenditure10 and the sum of this value with a change in charge payments required
9Chemical and allied products sector represents 12.91% PACE as percentage of total capital expenditures,
while rubber and miscellaneous plastic products sector represents 1.95%, showing the high heterogeneity
along the industrial chain (data for 1991).
10Only abatement capital costs for complying with environmental regulation obtained from the Japanese
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by the Japanese Compensation Law for Pollution-Related Health Damage. This law
entered into force in 1973 and required firms that emit SO2 to pay a compensation
fee equivalent to their emissions. To develop his analysis, Hamamoto estimated two
models: first looking at the effect of stringent regulation on R&D expenditures, and
later on average age of capital stock.
The paper by Hibiki, Arimura, and Takeba (2007) estimated a panel data with 75
assembling, manufacturing, and body manufacturing firms, analyzing the impact of
the exhaust gas regulation, established initially in 1966, in the different sectors of the
Japanese auto-industry chain. At first, just carbon monoxide (CO) was regulated. In
the late 1970s, nitrogen oxides (NOx), hydrocarbons (HC), and particulate matter
(PM) emissions were also controlled first for gasoline and later for diesel-engine
vehicles.11 To build the proxy for regulatory stringency, the authors used the year
of 1989 as a baseline, adjusted the level of emission standards to unit of each kind
of automobile, and estimated the following years adding the relative value for each
kind of automobile. There is an increasing trend of stringency of the exhaust gas
emission standards. This data was compared with the evolution of R&D investments
and firms’ productivity in the auto-industry.
A summary of the results obtained by both studies on the impact of specific
regulations in innovative activity of Japanese high polluting sectors are illustrated in
Table 3.4.
Table 3.4: Empirical analyses on Japanese high polluting sectors: results.
Authors (Year) Dependent variable Result
Hamamoto (2006)
1. R&D expenditures
2. Average age of capital
stock
1. Significant positive relationship between pollution con-
trol expenditures and R&D expenditures 2. Negative sig-
nificant relationship between pollution control expendi-
tures and average age of capital stock
Hibiki, Arimura,
and Takeba (2007)
R&D expenditures
Regulation stimulates R&D expenditure of firms in the
auto-industry
Results obtained by Hamamoto indicate that stringent regulation represented by
pollution control expenditures of the Japanese high polluting sectors incentivized
firms to increase R&D expenditures, from 1966 to 1976. It affected negatively the
average age of capital stock possibly incentivizing the modernization of firms. In
order to adapt to less polluting processes, firms might have changed the technology
they were using.
The study by Hibiki, Arimura, and Takeba, found different impacts of regulatory
stringency over the auto-industry chain. Their results suggest that regulation stimu-
report on Investment Plans in Major Industries, developed by the Ministry of International Trade and
Industry.
11Motorbikes had to adapt to the regulation just after 1998.
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lates R&D expenditure in a higher rate for assembling firms than in ‘parts and body’
manufacturing firms, and assembling firms suffer a direct effect of regulation on their
productivity. This effect was not observed for the other firms from this industry.
The authors underline the highly innovative behavior of the auto-industry and
the pressures which these firms have been facing. Mainly after the 1990s, different
sectors of the society have been demanding “cleaner” cars given the major importance
of everyday automobiles’ emissions of greenhouse gases to the quality of the air in
urban areas, and in the global warming. The burn of fossil fuels is responsible for
emissions of several pollutants in the air, and it is controlled by not only the Japanese,
but also other governments, in order to avoid the excess of pollutants which can cause
harm to human health and the environment.
Both studies found a positive relationship between regulatory stringency and R&D
investments on these high polluting sectors in different levels. However, the first study
analyzed data over the 1960s and 1970s, which cannot be extrapolated to more recent
years. Also, the second paper which investigated the 1990s, focus on the auto-industry
chain, with particularities previously stated that impedes any extrapolation of results
to other industrial sectors.
Different policy instruments
Another branch of research analyzes regulatory instruments and their effects on
firms. Nelissen and Requate (2004) studied microeconomic models which investigate
the relationship between different policy tools and the incentive for the development
of environmental technologies, in different economic environments. Price mechanism
instruments are shown to perform better than command and control policies just when
the regulator is able to anticipate the technological development. However, under
imperfect market conditions, the results are not clear. The authors conclude that
emission taxes might be a better option in two situations: when there is a long term
commitment to the levels of policy instruments; or, under “myopic” environmental
policies, when the regulator cannot observe perfectly the technological level of firms.
Most research regarding the effect of different policy instruments in innovative
activity of firms are theoretical studies (Popp, Newell, and Jaffe, 2009). Perhaps
because there are still few market-based instruments implemented and not enough
data to develop empirical comparison between different policies.
The market-based system created in 1990 by the US Clean Air Act (CAA) was
studied by Popp (2003). He examined the impact of different policy instruments on
the efficiency of “cleaner” technologies in the US energy production plants, in specific
the flue gas desulfurization units technology (FGD). The key variables of his paper
are illustrated in Table 3.5.
Popp investigated if the change in policy regimes, imposed by the CAA (1990),
caused a change in the innovative behavior of the US energy production plants. He
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Table 3.5: Empirical analysis on highly polluting industries: key variables.
Author (Year) Industry Period Measure of innovation Measure of regulation
Popp (2003)
Coal fired elec-
tric power plants
1985 – 1997 Stock of knowledge
Vector of dummy variables indi-
cating the type of regulatory in-
strument: command and control
or market-based.
analyzed the influence of the policy shift, from ‘command and control’ to ‘market-
based’ system, on innovations associated with sulfur dioxide (SO2) pollution control
(end-of-pipe) technologies. Moreover, how these policy instruments impacted differ-
ently on environmental innovative activity.12
Previous to the CAA, the regulator required power plants to utilize the ‘best avail-
able technology’ in order to reduce SO2 emissions. After 1990, the CAA established
a market for SO2 permits. Differently from command and control rules, in a market-
based system firms have the choice of deciding for the most cost-effective method of
emissions reduction. Two hypotheses were raised by Popp: innovation under com-
mand and control rules focus on lowering costs rather than increasing efficiency; and
under market-based regimes, firms are free to choose between increasing efficiency or
lowering costs.
Popp identified three different regulatory stages. In the first stage, emission rates
of SO2 were regulated for boilers built from 1971 to 1977. The second stage required
higher emission control for plants built from 1978 to 1990. The third, imposed after
1990, allocated to firms tradable emissions allowances, creating a market with a
national emissions limit.13
In a first regression, the author aimed to measure the effect of knowledge on
removal efficiency of 186 plants that use coal and have flue gas desulfurization (FGD)
units in the US, from 1985 to 1997. The dependent variable indicated the removal
efficiency of the FGD unit, and the key explanatory variables the stock of knowledge
before and after 1990.14 In a second regression, Popp investigated if the real operating
and maintenance costs varies with innovation. Thus, if the new technologies are more
cost effective.15 The summarized results are shown in Table 3.6.
12In a second paper, Popp (2006a) develops a similar analysis for regulatory regimes of NOx in the US. In
a third paper by Popp (2006b) examined the relationship among NOx and SO2 regulations and air pollution
control technologies, innovation and diffusions in the US, Germany, and Japan. He investigated whether,
through patent information, the regulatory pressure in one country influenced innovation in another country.
13Popp extracted patent data from nine different classification codes related to SO2 pollution control to
identify innovative activity along these different stages.
14Stock of knowledge was calculated assuming a decay rate and diffusion rate of 0.10 and 0.25, respectively.
Other independent variables are the different regulatory stages which may affect each power plant, indicated
by a vector of dummy variables (indicating 1 when defined policy affects the power plant), and the price of
low-sulfur coal in the year the FGD unit started operating.
15The key explanatory variables are knowledge stocks, before and after 1990, calculated with the same
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Table 3.6: Empirical analysis on highly polluting industries: results.
Author (Year) Dependent variable Results
Popp (2003)
Removal efficiency of
the FGD unit
Command and control: Efficiency of FGD units fall as emissions
limits increase; knowledge stock had no effect on removal ef-
ficiency. Market-based: New technology had a positive effect
on removal efficiency.
Results demonstrate that efficiency of FGD units fall as emission limits increase.
Before 1990, knowledge stock had no effect on removal efficiency, while after 1990,
the new technologies had a statistically positive effect on removal efficiency. The
imposition of standards, minimum efficiency goals of FGD units, lead to lower removal
efficiencies. In addition, knowledge stock had a negative effect on operating costs in
all three phases.
A similar study by Lange and Bellas (2005) also analyzed the change in regulatory
regime imposed by the CAA in 1990. Their aim was to verify the effect of this
change over scrubber costs. They found that scrubbers installed under the market-
based regime became cheaper to purchase and operate in the short run, but the rate
of diminishing costs did not perseverate in the following years. Summarizing, the
authors state that the adoption of policies that offer greater incentives for innovation
provides for a great leap forward in cost reductions, but not necessarily subsequent
ongoing progress (2005, pg. 555). They also showed that in the long run, the market-
based policy expanded the potential market of competing firms producing scrubbers.
Frondel, Horbach, Rennings, and Requate (2004) analyzed firm-level data with
the objective of understanding the relevant variables which have incentivized the
development of environmentally friendly innovations in German firms.16 They showed
that firms consider technology standards to be important or very important, but
data demonstrates that market-based instruments have also grown in importance.
Chemical, rubber, and plastics industries find that the maintenance of their corporate
image is a strong incentive for environmental friendly management strategies. The
survey also points that Environmental Management Systems (EMS) adopted by firms
in order to improve firm’s image, diminish costs with more efficient processes and
waste management, and helped firms to comply with the regulation.
The existing empirical literature on the impact of different policy tools on tech-
decay and diffusion rates as before. Other independent variables are two vectors of FGD unit characteristics
(one with time variant, and the other non-time variant characteristics) and a vector indicating policy regime.
16The data constituted of 899 facilities from the manufacturing industry. They had three main research
questions. First, which are the responses of the industry, on their management, to different kinds of en-
vironmental policies? Second, how much does market forces or regulation influences firms’ decision to
innovate or improve their environmental performance? Third, how can the regulator influence on better
firms’ environmental performance?
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nology and pollution reduction suggests better technological efficiency and pollution
reduction under market-based instruments. However, the literature is still incipient
to withdraw any conclusions, and results might differ in the short to the long run.
3.2.5 Remarks
The previous sections analyzed empirical studies concerning the impact of environ-
mental regulation on different industrial sectors regarding two hypothesis: first, the
orthodox view, which considers regulatory stringency as extra costs for firms; and
second, the Porter’s view, which considers regulatory stringency as an incentive for
innovation.
The empirical studies regarding location choice of firms signalized that firms might
give preference to already regulated countries, minimizing future regulatory uncer-
tainty. Only for developing economies that Co, List, and Qui (2004) indicated a
negative relationship between regulatory stringency and FDI investments.
When looking at the relationship between environmental regulation and innova-
tion, most studies which used aggregated data on the manufacturing industry do
not find any statistically significant relationship. Others find a positive, but small,
relationship between these two variables.
In any case, these studies are not a strong support for the Porter’s view. First,
because of the highly aggregated nature of the data. There is a high heterogeneity
among the manufacturing industries, and specifically with respect to the importance
of environmental regulation and innovation. Second, as previously discussed, because
of the drawbacks of the proxies employed. When analyzing the manufacturing indus-
try, if choosing as proxy for innovation patents, it might be measuring properly some
sectors and not others which do not have propensity to patent their innovation.17
The proxy for environmental regulation used by the different empirical studies is
even more complex to be evaluated.
When looking at specific industrial sectors, highly impacted by environmental
regulation, most studies do find support for the Porter’s view. However, a positive
relationship between regulatory stringency and innovation, not necessarily will gen-
erate higher profits and competitive advantage for firms, as the Porter hypothesis
states.
Furthermore, empirical studies regarding different policy instruments are not con-
clusive. It was found that under command and control or market-based tools, dif-
ferent kinds of innovation were developed. Nevertheless, this might occur just in the
short-run. These results were based on the US CAA regulation and the impact on
17For instance, Bernauer, Engels, Kammerer, and Seijas (2006) gave some examples of how to better
evaluate innovative activity proposing empirical researcher to examine analyze the number of environmental
innovations within each field of innovation, distinguish product to process innovation, and measure the
environmental relevance of such innovations. However, it is not clear if these suggestions are feasible.
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power plants (which emitted SO2). Still, there are few examples of market-based
instruments in practice nowadays with enough data to reach better empirical results,
and indicate the best policy tool to induce the desired environmental output.
Overall, empirical evidence here illustrated found a small or no correlation be-
tween environmental regulation and innovation, which does not mean support for the
orthodox view.
3.3 Product regulation
In the first half of the twentieth century, environmental problems caused by the
chemical industry were treated as localized phenomena. In the 1950s and 1960s,
spurred on by disasters such as the Chisso-Minamata disease in Japan,18 a wider
mobilization occurred in industrialized countries to prevent future tragedies. Over
this period, few substances had their risk fully identified, and regulatory controls
over production and industrial waste were almost non-existent. There was also a
lack of methodologies to study the impact of chemical substances on the environment
and the human health. For example in the US, even though the US Food and Drug
Administration (FDA) had already been created in 1906, it was only in 1938, with the
introduction of the Food, Drug, and Cosmetic act, that firms started to be obliged to
give evidence of safety prior to market a new substance. However, such legislation did
not prevent the occurrence of important accidents; for instance it did not impede the
use of thalidomide by pregnant women in the 1950s and 1960s, causing deficiencies
in thousands of children around the world.
Product regulation that we are going to analyze with more detail targets the
manufacture and market of chemical substances, and is part of the category of regu-
lations regarding product safety to the human health and the environment. With an
increasing number of product liability cases in the US, firms started to be considered
responsible for all consequences of recurrent accidents due to lack of product safety,
even though it is not always possible to prove the cause-effect relationship, linking a
chemical substance to a certain disease.
Most product regulations consider that consumers do not have access to all rele-
vant information about the product. Because of this asymmetry, the consumer is not
able to evaluate the risks s/he is being exposed to, and to decide for the safer good.
Firms can choose to disclose or not all information regarding safety and quality of
their goods. However, increasingly Governments have been imposing specific forms
of labeling to several products in order to indicate their hazards (e.g. cigarettes and
alcoholic beverages). The regulator might wish to signal the consumer of a possible
risk, even if not corroborated by all scientific community. In order to avoid labeling
18It was caused by a long period of industry discharges of methyl mercury on Minamata Bay, identified
in the end of the 1950s.
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firms might choose to change their formulation, substituting possible risky substances
by others with verified safety (Viscusi, Vernon, and Jr., 1996).
Nowadays, several countries have rules for stock, production, and commercializa-
tion of chemical substances. The focus of these rules are mainly industrial chemicals
which are produced in large scale, but not only. In each country this group of laws
called “chemicals regulation” may vary in their scope, but usually they include a no-
tification process, in order to request permission assuring safety to use or market a
new substance, and a list of possibly toxic substances which are prohibited or limited
in their manipulation and utilization.
In order to illustrate how diverse are these rules in different countries, a descrip-
tion of the existing rules regarding the notification and commercialization of chemical
substances in the EU, US, and Japan is provided next. These three examples have
rules for stock, production process, and commercialization of chemicals. The Euro-
pean Union and Japan also have a classification procedure and a list of dangerous
substances, which imposes restrictions on their use. In the US, there are two im-
portant lists: first, a list of hazardous substances which must have an emergency
plan for possible accidents; and second, a priority list of substances which should be
removed from contaminated areas (it considers substances which were not properly
disposed in the soil, lakes, and rivers until the 1960s). Finally, this section analyzes
studies which investigated the relationship of the chemicals, drugs, or agrochemicals
regulations and the technological development of the industry.
3.3.1 European Union
The European Union established recently a new chemicals regulation which is under
implementation. Among the objectives of this new regulation – REACH – was to
compile several directives into a single document, and eliminate asymmetries caused
by regulations imposed on different periods. Next, the previous and actual chemicals
regulation in the European Union are described.
• Council Directive 67/548/EEC: Deals with the classification, packaging and labeling of dan-
gerous substances.
– 6th amendment: Directive 79/831/EEC, introduced a notification system for “new” sub-
stances (placed on the market after 18 September 1981).
– 7th amendment: Directive 92/32/EEC, added the Safety Data Sheet (SDS) as a tool for
professional user.
– Directive 2006/121/EC enters into force on 1 June 2008. It adapts the Directive to the
new regulation REACH. It re-establishes the purpose of this regulation as classification,
packaging and labeling of substances dangerous to man or the environment, excluding
notification and risk assessment.
• Council Directive 76/769/EEC: Deals with marketing and use of dangerous substances and
31
3. REGULATORY FRAMEWORK
preparations. Contains more than 900 substances with restrictions for use and market place-
ment.
• Council Regulation 93/793/EEC: Deals with evaluation and control of existing substances.
Requires a notification procedure to evaluate the risks of existing substances listed at EINECS
(European inventory of existing commercial chemical substances).
– Commission Regulation 94/1488/EC: Sets the principles for the assessment of risks to
man and the environment of existing substances in accordance with council Regulation
93/793/EEC.
• Council Directive 99/45/EC: Deals with classification, packaging and labeling of dangerous
preparations.
• European Parliament and Council Regulation 2006/1907/EC: It concerns the registration,
evaluation, authorization and restriction of chemicals (REACH). It amends the Directive
99/45/EC, and repeals Council Regulation 93/793/EEC, Commission Regulation 94/1488/EC19,
Council Directive 76/769/EEC, and Commission Directives 91/155/EEC20 , 93/67/EEC21,
93/105/EC22 and 2000/21/EC23. It also establishes the European Chemicals Agency (ECHA).
Directive 67/548/EEC and its 7th amendment, Council Directive 92/32/EEC
(30 April 1992)
The objective of this Directive is to have a unique notification system, collection of
information, classification and labeling, for the whole EU market. The main concern
of the regulation is toward human health and the environment, through the safe use
by workers, downstream firms, and final consumers.
Under the 6th amendment the substance to be notified should be “new” for the
company. Even if a substance was already in the market or produced by another
manufacturer, every new importer/ manufacturer is required to notify it. The 7th
amendment changed this procedure, and a “new” substance is now defined as being
new to the market. Notification is required by the first producer or importer of the
substance.
There are two lists which contain all chemical substances commercialized in EU
territory. EINECS (European INventory of Existing Commercial chemical Sub-
stances) contains 100,204 substances introduced in the market until 18 September
1981 and ELINCS (European List of Notified Chemical Substances) which contains
19Principles for the assessment of risks to man and the environment of existing substances in accordance
with Council Regulation 93/79/EEC.
20Detailed arrangements for the system of specific information relating to dangerous preparations in
implementation of Article 10 of Council Directive 88/379/EEC.
21Principles for assessment to risks to man an the environment of substances notified in accordance with
Council Directive 67/548/EEC.
22Adds Annex VII D, containing information required for the technical dossier referred to in Article 12 of
the 7th amendment of Council Directive 67/548/EEC.
23Concerns the list of Community legislation referred to in the fifth indent of Article 13(1) of Council
Directive 67/548/EEC.
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4,381 substances.24, with different rules for its notification procedure Existing sub-
stances account for more than 99% of the volume of chemicals in the European market
(Knight, 2007).
Exemptions
The Directive 67/548/EEC and its amendments deals with all chemical sub-
stances25, which are not included on the EINECS, with exception to: medicinal
products26 (for human or veterinary use); cosmetics27; mixture of substances which,
in the form of waste, are covered by specific regulation28; pesticides; radioactive sub-
stances covered by specific regulation29; food-stuffs; animal feeding stuffs; and other
substances or preparations for which Community notification or approval procedures
exists and for which requirements are equivalent to the Directive.
Polymers must be notified when it contains more than 2% of a new substance
which is not on the EINECS.
Substances produced in small volumes (less than 10 kg per year per manufacturer),
substances placed on the market on limited quantities (not exceeding 100 kg per
manufacturer per year) for R&D purposes, or substances placed on the market also
for R&D purposes (with a maximum period of one year) do not have to be notified
for its use.
Substances placed on the market in quantities of less than one tonne per annum
per manufacturer have a reduced notification procedure.
Procedure
The Directive 67/548/EEC requires the production of a standard set of data
according to the tonnage which will be produced in the EU per year. The data is
collected through specific tests following the Good Laboratory Practice (GLP). A
notification dossier must be submitted to the competent authority in the Member
State 45 days before its commercialization. The quantity of information requested
will depend on the quantity produced per year by the manufacturer.
The first notifier can ask for a ten years period of confidentiality on part of the in-
formation on a chemical substance, if it is justifiable for intellectual property reasons.
If this is the case, the second notifier will need to negotiate with the first notifier to
obtain the information.
24More information can be obtained at http://ecb.jrc.it/esis/
25Defined by Council Directive 92/32/EEC as chemical elements and their compounds in the natural
state or obtained by any production process, including any additive necessary to preserve the stability of the
products and any impurity deriving from the process used, but excluding any solvent which may be separated
without affecting the stability of the substance or changing its composition.
26Covered by Council Directive 65/65/EEC.
27Covered by Council Directive 76/768/EEC amended by Council Directive 86/199/EEC.
28Council Directives 75/442/EEC and 78/319/EEC.
29Council Directive 80/836/EEC.
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The dossier contains technical information about the substance including pro-
posals for classification, labeling and the safety data sheet. The regulator will then
classify, label and prepare a summary of the dossier. If the substance is considered
hazardous, the Member State competent authority will send the summary to the Eu-
ropean Commission (Directorate-General for the Environment, Nuclear Safety and
Civil Protection - DG XI) who will then send it to all the other competent author-
ities from each EU Member State. The competent authorities will have six months
to make suggestions for labeling and classification of the substance. The European
Commission is also responsible for adding the substances to the ELINCS. Hazardous
substances are also added to the Annex I of the Directive.
Estimated costs
In 1998, Neven and Schubert published a detailed comparison of the regulatory re-
quirements for the notification of new chemical substances in the EU, US, and Japan.
There was criticism mainly from the industry, over asymmetry in the European reg-
ulation (giving different treatments to ‘existing’ and ‘new’ chemical substances), and
on the high fixed costs required to market a new substance in the European Union.
Criticism claimed that the regulatory framework in Europe was harming innovative
activity of European chemical firms. As result of this debate and the issues it raised,
a White Paper setting out proposals for a new regulation for the Registration, Eval-
uation, Authorization, and Restriction of Chemicals (REACH), was adopted by the
European Commission in 2001.
The costs30 are shown in Table 3.7 according to the number of tests required per
volume produced/ imported31. In addition to the costs set out below, there is also a
fee to file the notification dossier which varies in each Member State.
Table 3.7: Estimated costs of EU chemicals regulation
Tests requirements (Volume) Laboratory Costs
Annex VII C (< 100 kg) 15, 000 – 20, 000
Annex VII B (100 kg – 500 kg) 25, 000 – 30, 000
Annex VII A (500 kg – 1 tonne) 75, 000 – 85, 000
Annex VIII Level 1 175, 000 – 250, 000
Annex VIII Level 2 275, 000 – 325, 000
30This data were extracted from the work by Neven and Schubert (1998), with values in ECU (European
Currency Unit) for the year of 1998.
31Annex VIII Level 1 is applied when the substance placed in the market reaches 100 tons per year per
manufacturer or 500 tons per manufacturer. And, Level 2 is applied when the substance placed in the
market reaches 1, 000 tons per year per manufacturer or 5, 000tons per manufacturer.
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REACH
Besides replacing a number of existing directives, which intends to simplify the
extensive regulatory framework that has been created in the past decades, REACH
has two main innovations. The regulation brings to an end the different treatments
between “new” and “existing” substances. REACH requires that substances will be
differentiated between phase-in (produced before the entry into force of REACH) and
non-phase-in substances. REACH also transfers responsibility for carrying out the
risk assessment from the Member State to the producers and importers of a chemical
substance. Risk assessment will be ‘use specific.’ Each downstream user is required
to declare how it uses the chemical substance, and the manufacturer is required to
produce a risk assessment document with specific instructions for each situation.
The regulation also creates the European Chemicals Agency (ECHA) which will be
responsible for the scientific, technical and administrative management of the REACH
system.
REACH will be fully implemented in eleven years time, starting from 2007. It will
take a year to set up the Agency, while it will take ten years to fully register approx-
imately 30, 000 substances, with priority given to chemicals produced or imported at
larger tonnages and of high concern.
Exemptions
This regulation is not applied to radioactive substances32; waste33; substances
used in medicinal products (for human or veterinary use)34; substances used in food
or feeding stuffs35, including the use as food additive36, flavoring37, as an additive in
feeding stuffs38, in animal nutrition39; preparations in the finished state intended for
medicinal products40, cosmetic products41, medical devices42, food or feeding stuffs43.
There is a temporary exemption for the use of substance for R&D: producer or
importer will have five years time to use a substance in the R&D purposes without
having to register it.
Other exemptions of registration include basic elements, such as nitrogen, where
32Council Directive 96/29/Euratom.
33As defined by European Parliament and Council Directive 2006/12/EC.
34Scope of the European Parliament and Council Regulation 2004/726/EC, Directives 2001/82/EC and
2001/83/EC.
35In accordance to Regulation 2002/178/EC.
36Council Directive 89/107/EEC.
37Council Directive 88/388/EEC, Commission Decision 1999/217/EC, and European Parliament and
Council Regulation 96/2232/EC.
38European Parliament and Council Regulation 2003/1831/EC.
39Council Directive 82/471/EEC.
40Regulation 2004/726/EC, Council Directives 2001/82/EC and 2001/83/EC.
41Council Directive 76/768/EEC.
42Council Directive 1999/45/EC.
43In accordance to Regulations 2002/178/EC and 2003/1831/EC, and Council Directives 89/107/EEC,
88/388/EEC (including Decision 1999/217/EC), and 82/471/EEC.
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the hazards and risks are well known, naturally-occurring substance (which are not
chemically modified), by-products (unless they are imported or placed in the market),
and substances which result from an incidental chemical reaction.
Procedure
The procedure consists of four steps. The first step is registration, which requires
the development of required tests and risk assessment reports by the manufacturer
or importer of the chemical substance. Data-sharing on vertebrate animal tests is
required in order to minimize the use of animals in vivo testing. The second step is
the evaluation of the data by the European Chemicals Agency and perceived risks
will be investigated. If the substance has properties of very high concern, it will
be required to go through authorization. A list of substances of very high concern
will be made available by the Agency. The manufacturer or importer will need to
demonstrate that all risks will be properly controlled, what the socioeconomic benefits
of using the substance are, or alternative procedures which will improve the safety
and diminish the risks of the new substance. The authorization is awarded or rejected
by the Commission. The fourth step consists of restrictions which may be imposed
on certain substances, and that can include conditions or even prohibitions on use.
Estimated costs and possible impacts
Several studies have measured possible costs and mapped impacts of REACH.
These were commissioned by a number of organizations including the European Com-
mission, non-profit organizations, industry associations, and government.
Other studies investigated possible impacts on innovation, environment and health,
the economics of large firms and SMEs, expected costs, and potential for using Q-
SARs (Qualitative and Quantitative Structure-Activity Relationships). Case studies
have also been developed looking at different chemical firms and other industries
(RPA, 2006; KPMG, 2005; ISI, Foundation, Nordbeck, and IPTS, 2005; GmbH and
Consulting, 2005).
The European Commission commissioned an impact assessment study, from KPMG.
As part of this study, a table was published setting out estimates of testing costs
agreed in 2004, and an updated registration costs (for 2005) for full testing of new
substances by tonnage, in a minimum Q-SAR scenario. Table 3.8 illustrates the
values in Euros, and the volumes in tons (KPMG, 2005, pg. 13).
3.3.2 The US
The US chemicals notification regulation is ruled by the Toxic Substances Control
Act (TSCA), enacted in 1976, and its following amendments. The TSCA regulates
the introduction of new chemicals in the US market with the aim of protecting human
health and environment from unnecessary risks. It consists of four titles: provisions
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Table 3.8: Estimated costs of REACH.
Tests requirements Laboratory Registration Total
Costs Costs
Annex V (1 – 10) 8, 702 5, 900 14, 602
Annex VI (10 – 100) 151, 573 11, 150 162, 723
Annex VII (100 – 1, 000) 243, 467 38, 630 282, 097
Annex VIII (> 1, 000) 278, 213 44, 950 323, 163
for the control of toxic substances, asbestos hazard emergency response, indoor ran-
dom abatement, and lead exposure reduction.
The US Environmental Protection Agency (EPA) is the responsible for adminis-
tering the regulation. It can solicit new tests, ban the manufacture or import of a
highly hazard substance. It is also responsible for an inventory of commercial sub-
stances imported to, or produced in, the US market. The so called “TSCA inventory”
is not easily available for reasons of commercial confidentiality. The EPA must be
contacted if complete data or information on the number of notified substances is
required. However it may not always be possible to disclose specific information on
the substances.
Exemptions
This regulation excludes agrochemicals (pesticides), pharmaceutical products (for
human and animal use), cosmetics, nuclear material, ammunitions, tobacco and to-
bacco products, food, food additives, and animal feeding stuffs.
In 2002, the minimum volume for reporting was raised. Substances produced in
small volumes, i.e. 11, 340 kg per year, are part of the ‘Low Volume Exemption’
(LVE). Substances for R&D use, or which are expected to have low releases and low
exposure, or which are being imported for marketing tests and do not present risks,
can also be exempted or very little information will be required.
Procedure
The firm must submit “all data available” to the US EPA. If necessary, the reg-
ulator will request more information. It is expected that the EPA pre-manufacture
notice (PMN) dossier will contain technical data on the chemical substance and on
the process, such as, volume produced, byproducts, use, environmental and human
exposure. If EPA considers the substance as “high risk” it can prohibit its use. In
the US there is no classification procedure as there is in the EU.
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Estimated costs
Because the regulation does not require a specific list of information that must be
delivered to the competent authority, Neven and Schubert (1998) did not estimate
the costs of the procedure. However, there are minimum data on physical-chemical
properties, human exposure information and environmental releases of the process
that firms may already have for their internal research, and are delivered to the
regulator.
A fee to submit costs US$ 2, 500.00, but in the case of SMEs or intermediate
substances being notified, the fee can fall to US$ 100.00.
3.3.3 Japan
The Chemical Substances Control Law (CSCL) was created in 1973 and had its most
recent revision in 2003. It aims to protect the environment and human health from
persistent and harmful chemical substances.
Exemptions
The CSCL excludes specified poisons, stimulants and narcotics which are ruled
by specific regulations. It is different from the EU and the US in that it does not
focus on industrial chemicals, it has few exemptions, and includes pharmaceutical
products, food additives and cosmetics.
Substances produced in small volumes (1 tonne per year) do not have to be notified
for use. Notification is also not required for intermediates, even if they are transported
from one chemical plant to another of the same firm.
Polymers which show to be stable, and are insoluble in water and other specific or-
ganic solvents, are considered safe and therefore exempted. Otherwise, other chemical
analysis will be required.
Byproducts can be exempted if they represent less than 1% of the total quantity
of the product.
The ‘Low Volume Exemption’ (LVE) permits reduced requirements for a new
substance produced or imported in quantities less than 1, 000 kg per year, combining
all producers and importers.
Procedure
A first defined set of data is initially submitted. Subject to the result of these
tests, more information about the new chemical substance may be required. All data
need to be submitted in accordance to the ‘Good Laboratory Practice’ (GLP) rules.
The new substance will be classified by the regulator.
The first required test is on biodegradability. If the substance is biodegradable no
more tests will be required. If it is poorly biodegradable, a bioaccumulation test will
then be solicited. Q-SARs or analysis by analogy can be used in order to simulate
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the bioaccumulation result. The dossier must also contain physical-chemical and
ecotoxicological data.
The classification is divided in three categories: class 1, class 2, and designated.
Class 1 is a list of prohibited substances given their high bioaccumulative capacity, risk
for human health, and low biodegradability. Class 2 corresponds to substances with
low biodegradability, but also low bioaccumulation, and risk to human health. These
two categories of substances will be labeled, have production and import controlled,
and have defined guidelines for preventing pollution. Designated substances have
low biodegradability, low bioaccumulation and low risk to human health. Labeling is
not obligatory. However, the quantity of a substance produced and imported can be
controlled.
The national authority will add the new substance to the Inventory of Chemical
Substances (ENCS). Chemicals notified since 20 August 1974 are considered new,
and the substances placed in the market before this date are considered existing.
Estimated costs
Neven and Schubert (1998) showed a range of estimated costs for the Japanese
notification procedure, shown in Table 3.9 (Values in ECU for 1998). No fee is
required by the national authorities.
Table 3.9: Estimated costs of the Japanese chemicals regulation.
Level of Requirements Laboratory Costs
Advanced Report (AR) 10, 000 – 12, 500
Specified Class 1 AR +0
Designated AR +(20, 000 to 25, 000)
Specified Class 2 AR +(50, 000 to 60, 000)
3.3.4 Remarks
There are sensitive differences between these regulatory frameworks. On the one
hand, US environmental regulations are characterized by litigation and jurispru-
dence. On the other hand, in the EU regulations are used to bring detailed rules
and standards already defined. The chemicals regulation are an example of these
characteristics.
As described in this section, there are sensitive differences between all three reg-
ulatory frameworks. The EU and the US have adopted a regulation to deal with
industrial chemicals, and Japan has designed a regulation for all chemicals entering
the Japanese market. The European framework has a list of defined tests which must
be submitted depending of the volume produced. The Japanese framework is built
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on a ‘tree structure,’ where further tests are required on the basis of the results of
preliminary ones. Lastly, the US asks for ‘all data available,’ and depending of the
analysis of the report provided by firm, more tests may be required.
Regarding costs, Fleischer, Kelm, and Palm (2000) illustrated a comparison with
data supplied by Cytec, for the year of 1998. The company illustrated their costs
for complying with the regulation in the EU, the US, and Japan. A summary of the
data is shown in Table 3.10 in US $ (1998).
Table 3.10: Estimated costs of the different chemicals regulations in US$ (1998).
Tests Costs of all tests EU Japan USA
Toxicity 107, 220 97, 220 72, 500 8, 220
Environmental 166, 100 46, 100 120, 000 0
Physical/Chem Properties 33, 500 33, 500 10, 400 0
Total 306, 820 176, 820 202, 900 8, 220
For the EU and Japan, these costs may vary. The real costs for the former depend
on the tonnage, and for the latter on the result of the bioccumulation test. If a firm
has a worldwide market, the total cost of notifying a new product will not be the
sum of the costs of the regulation on each country. For example, given that several
tests are common to the different countries, a European firm decided to sell a new
substance in the US market will add to the requested dossier by the US EPA just tests
which are not demanded by the EU regulator. This may correspond to an advantage
to firms that can expand their markets, being able to recover faster the regulatory
cost compared to firms which act in just one market.
3.3.5 Product regulation and firm performance
The first two studies detailed in this section analyzed the US data on pharmaceuti-
cal and pesticide sectors, respectively. Thomas (1990) and Ollinger and Fernandez-
Cornejo (1998) main concern was on the impact of regulatory stringency on firm size
and market concentration. The key variables utilized by them are described in Table
3.11.
Thomas (1990) investigated the distribution of impacts of the US FDA regula-
tions over US different-size pharmaceutical firms. It was an attempt to explain why
occurred a drastic fall on the introduction of new chemical substances from phar-
maceutical firms in the beginning of the 1960s (dropping by 90%) even with the
continuous increase of R&D expenditures. In addition, why the lower innovative ac-
tivity did not impede that the real market value of the larger pharmaceutical firms
had doubled in the same period, from 1960 to 1970. Similarly, the aim of Ollinger
and Fernandez-Cornejo (1998) was to study the impact of regulatory costs in mar-
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Table 3.11: Empirical analyses of high polluting industries in the US: key variables.
Authors (Year) Industry Period Measure of innovation Measure of regulation
Thomas (1990) Pharmaceutical 1960 – 1980
Stock of R&D expen-
ditures.
Productivity trends on UK to iso-
late US regulatory effects.
Ollinger and
Fernandez-
Cornejo (1998)
Pesticide 1972 – 1989
Lagged research to
sales ratio.
1. Environmental and health test-
ing costs as a fraction of research
expenditures. 2. Pollution com-
pliance capital expenditures di-
vided by sales (pollution abate-
ment costs).
ket structure, through the analysis of key technological features of the US pesticides
industry, from 1972 to 1989.
Both studies associated the impact of regulatory stringency over innovative activ-
ity, to a growth in competitive advantage for some firms, and disadvantage for others,
in the US market. A group of firms would obtain higher profits with a lower number
of innovations, causing changes in the industries’ market structure.
In science-based industries, such as pharmaceuticals and agrochemicals, technical
change depends highly on other issues such advances on scientific basic research.
Because of that, Thomas (1990) chose to study the impact of regulatory stringency
on firm size and not directly on technical change. The impact of a breakthrough
innovations on basic chemistry is not easily perceived in an empirical model, and
firms size is an easier variable to be evaluated. For this group of industries it is more
complex to develop an empirical model with the proper variables to better explain
innovative activity. To empirically investigate these effects, both studies identified the
main regulations which impacted these sectors and drew different proxies to perceive
these regulatory effects.
For Thomas (1990), the number of new drugs and their annual sales depend on
R&D stock, factors of technical change, and regulatory effects.44 In addition, annual
profits45 are determined by the number of new drugs and their annual sales. On his
analysis, the ratio of annual profits by R&D stock should be constant with respect to
R&D stock if firms with different dimensions of R&D investments experienced neither
competitive advantage or disadvantage in R&D. He concluded that firms with a higher
R&D investments (large firms) have a competitive advantage in comparison to firms
with a lower capacity of R&D investments (smaller firms). This reasoning would
explain the high stability of the ranking (by size) of pharmaceutical firms in the US,
from 1960 to 1980.
Thomas (1990, pg. 500) analyzed the effect of the 1962 amendments to the 1938
US Food, Drug, and Cosmetic Act which included: proof of effectiveness, clinical
44Regulatory effects are abated by an annual depreciation rate of the R&D stock.
45Annual profits generated by R&D stock.
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testing, good manufacturing practices and good laboratory practices, and “me-too”
drugs.46 In 1960, to market a new drug it was needed 3 years of testing, and by 1970
this period grew up to 10 years, and reached 12 years by 1980.
To be able to disentangle the effects of the regulation on US firms from other ef-
fects, Thomas chose an international comparison approach, using UK firms as a con-
trol group. Regulatory differences would be represented by an international residue
(controlling for firm size). Even so, two problems were highlighted. First, the level
os regulatory stringency has also increased in the UK, so this measure will depict the
difference between the two regulations. Second, there were no controls for other fac-
tors which would also impact the development of new drugs and their sales. However,
Thomas (1990) considered that these would not impact firm size.
Ollinger and Fernandez-Cornejo (1998) verified if a rise in regulatory costs would
cause a concentration of the market. The reasoning is that the number of pesticide
firms in the market decreases with a decrease in demand, or with an increase in
R&D, regulatory costs, or competition. They used two variables to represent reg-
ulatory stringency: environment and health testing costs as a fraction of research
expenditures, and pollution abatement costs (pollution compliance capital expendi-
tures divided by sales). Both extracted from a survey on the US pesticide industry.
Conversely, Thomas (1990) argued that in the case of pharmaceutical firms, the
use of drug testing costs for regulatory compliance would not be a good measure of
regulatory stringency. Several other factors impacted positively and negatively these
costs such technological developments of drug testing and the development of new
therapies after 1960s. Differently from previous decades, there were new approaches
on drug development which required new technical methodologies for testing. Table
3.12 shows a summary of the results obtained in both studies.
Table 3.12: Empirical analyses of high polluting industries in the US: results.
Authors (Year) Dependent variable Results
Thomas (1990)
1. Number of innova-
tions. 2. Sales of inno-
vations.
Larger firms were not affected by the regulatory restrictive-
ness, but benefited from the tendency that smaller ones had
of leaving the market.
Ollinger and
Fernandez-
Cornejo (1998)
Number of innovative
firms.
Pollution abatement costs and industry demand had no sig-
nificant impact on the number of innovative firms. Product
regulation and R&D have a negative effect on the number of
innovative firms.
Using the productivity trends of UK-owned pharmaceutic firms as the net effects
of the US-owned FDA regulation, Thomas (1990) estimated two models expressed
in constant elasticity form. First, explaining the number of new chemical entities,
46Pre-market testing for safety and efficacy was then required for all new drugs in the market, even being
‘generic” or “similar” products.
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and second, explaining sales of pharmaceutical innovations in the period from 1960
to 1980, by firm per year.
An innovation released in a given year is linked to R&D expenditures of several
previous years. In addition, firms might not introduce any new drug in certain years,
while one or more new drugs in other years. Thomas cites two possible effects of
the US FDA regulation on pharmaceutical firms: an increase on the required time to
market a new product, and a reduction in productivity. Thus, with the same amount
of R&D expenditure, firms will need more time to market less new drugs.
This study obtained mixed results. There was no relationship between innovation
and firm size before 1962. However, in the following years (selecting certain intervals),
large firms achieved higher sales for innovations. Although in the pooling of years,
from 1963 to 1980, this effect was not significant.47.
Thomas highlighted three main conclusions from his study. First, US large and
small firms experienced different effects on their productivity after 1962. Second,
comparing US to UK large firms after 1970, the innovative productivity was equiv-
alent, inferring that there was no effect of US FDA regulation on US large firms.
Third, there was a small decline on new substances developed by large US firms and
an important growth on sales of these new substances. The same effect did not occur
for small US firms or all-sizes UK firms, which experienced a small or any increase
on sales of new drugs. This infers a reduction on the productivity of small US firms
after 1962. Yet, large US firms experienced an advantage compared to their small
counterparts. Large firms were not affected by the regulatory restrictiveness, but
benefited from the tendency that smaller ones had of leaving the market.48
Ollinger and Fernandez-Cornejo (1998) developed different empirical models to
analyze the impact of regulatory costs on market structure. The first explored the
impact of product regulation (environmental and health testing costs) on the number
of innovative firms in the US pesticide industry, and the other three models explored
different combined effects. They defined innovative firms as agrochemical firms that
conduct R&D and inserted new pesticides in the market over the period under study.49
Their results showed that product regulation had a negative effect on the number
47The competitiveness of firms were also evaluated given the sum of the elasticities associated with the
number of innovations, and sales of innovations (in terms o R&D expenditures) In the US, this sum increased
by five times, indicating a decrease on competitiveness of small firms. In the UK, there was a decrease in this
sum of elasticities, indicating that smaller firms gained certain competitive advantage. It must be noticed
that by 1960, UK large pharmaceutic firms (in R&D expenditures) were comparable to medium-size ones
in the US.
48However, Thomas argues that in the 1980s innovation costs were more than doubled compared to 1962
and the market became more globalized. Consequently, the possible competitive advantage in 1962 would
be less likely to happen in the 1980s, since these large firms would loose competitiveness internationally.
49Other explanatory variables were: fraction of research expenditures, pollution abatement costs (pollution
compliance capital expenditures divided by sales), lagged research to sales ratio, farm sector demand, stage
of the industry growth cycle (proxy for the toughness of competition).
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of innovative firms. In addition, increasing product regulation costs affected more
small than large firms, favoring the expansion of foreign-based firms in the US market.
Higher sunk regulatory costs encouraged firms to exit the industry, and innovative
firms were acquired by other innovative firms, affecting negatively the number of
firms in the industry. Pollution abatement costs had no significant effect. In the
period investigated, health and environment testing costs increased from 17% to 47%
of total research costs.
The global results suggest that internationalized firms are shown to have a com-
petitive advantage over firms which operate just locally. Since their products can
be introduced in different markets, they can reduce R&D risks and recover regula-
tory costs (considering some common tests for different countries). Thus, product
regulation may encourage foreign expansion.
The mixed results obtained by Thomas might be explained given the drawbacks of
the measure of regulatory stringency. For that, Ollinger and Fernandez-Cornejo were
benefitted by the survey data available on the US pesticide industry to extract the
evolution of costs of the regulations (even though the survey also has its drawbacks,
as previously discussed in this chapter).
Both studies analyzed industrial sectors which have specific product regulations,
and have in innovation a key feature for their development and competitiveness.
The period investigated depicts the first decades of the introduction of this kind of
rules, and even though they cannot be generalized, these results already show the
importance that product regulation has over science-based industries. Possibly, even
more than pollution abatement expenditures, which are associated with more general
environmental regulation.
Chemicals regulation
Much has been said about the different regulatory frameworks for chemicals
adopted by the EU, the US and Japan, and how these differences could harm do-
mestic firms. Specifically, two studies developed by the Institute for Prospective
Technological Studies (IPTS) in Seville (Spain), a European Commission Joint Re-
search Centre, were published in 1998 and in 2000, respectively. These describe and
compare the regulatory framework of the European Union and its two major competi-
tors: US and Japan. Both complemented the debate on the regulatory asymmetry
in Europe, treating substances that were marketed until 1981 (existing) differently
from substances that were marketed afterward (new). Today, in the European mar-
ket, there are more than 100, 000 “existing” substances and less than 5, 000 “new”
substances. This exigent and non-flexible regulatory framework has been accused of
having harmed innovation of the European chemical industry.
More than the imposition of new tests (in 1981), the 6th amendment50 to the
50Directive 79/831/EEC.
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Council Directive 67/548/EEC created a regulatory asymmetry, and gave firms no
incentive for the development of substitutes for chemicals already in the market.
The apparent lack of exigencies of the US regulation, and the ‘simplified’ Japanese
framework might have driven, initially, more attention from the industry to those
markets.
In aggregated numbers, Neven and Schubert (1998) showed that between 1979
and 1996 there were 25, 545 notifications of new chemical substances in the US. From
1987 to 1996 there were 2, 335 notifications in Japan. In the EU, from 1983 to 1996,
there were 4, 514. These numbers illustrate the large differences between new sub-
stances in the US market compared to the EU, and also suggest a certain advantage
of new substances in the Japanese market compared to the EU. However, Mahdi,
Nightingale, and Berkhout (2002) showed that the number of notifications of new
substances in Europe grew since 1983 with a minor break in 1994. The notification
of new substances in the US has been declining from 1994 down to 1999 (the last year
investigated by the study). Specifically in this year, there were more notifications of
new substances in the EU than in the US.
One possible explanation for this trend is that, in the 1990s, market globalization
might have diminished the impact of the EU regulation. In a more globalized market,
larger firms have a competitive advantage in contrast to smaller firms. Firms which
commercialize their products in different markets have lower fix costs to comply with
each country’s regulation. Besides, companies might also have needed time to learn
about the new regulatory framework, in order to be more efficient when submitting
all requested information. Furthermore, over the 1980s firms operating in Europe
might have exploited as much as possible their already marketed products.
Clearly, the debate over the 6th amendment to the Council Directive 67/548/EEC
is more complex. For highly toxic and persistent substances, the Japanese regulation
can be more costly because for substances with these characteristics the required
tests are more complex and expensive. In the US, the regulator can solicit more tests
which will raise considerably the expenses of the notification procedure. Nonetheless,
for low risk substances, the European regulatory framework has a higher fixed cost.
The initial fall of innovative activity after an increasing of regulatory costs might
have signalized a redesigned of firms’ strategy toward innovation. A focused approach
may help the development of new products with higher aggregated value, which will be
more valorized in the market by consumers, or even, will have competitive advantages
in other highly regulated nations.
The second study by IPTS (Fleischer, Kelm, and Palm, 2000) developed a deeper
analysis of the impact of the 6th amendment to the Council Directive 67/548/EEC
on innovation in European firms. Several proxies for innovation (e.g. innovation
counts, R&D expenditures, patents, notification counts) and other economic perfor-
mance indicators are examined in their research. They claimed that the difference
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in the regulatory regimes – fixed testing requirements in the EU in contrast to risk-
contingent testing in US and Japan – were responsible for a lower innovative and
economic performance of the EU chemical industry. The conclusions concerning the
effect of the chemicals notification system on European firms might have been too
strong. From a static view, they were considered a permanent outcome.
A higher regulatory cost will not necessarily lead to a higher expenditure on R&D
to cope with the new rules. As previously discussed, the legislation can change the
direction of innovative activity, and the same R&D investment can be concentrated
on more environmentally friendly research.
Another assumption provided by this second study states that, with higher costs
needed to market a new substance, the budget for R&D will be lower. Even if this is
true, there is no valuation of the quality of the new substance in terms of profitability,
health, and environmental safety. Quantity is not necessarily quality, or a decrease
in the number of new substances is not necessarily bad for the industry.
Much of the importance given to the harm of the product regulation is based
on the assumption that innovations in the chemical industry are generally based on
formerly new substances (Fleischer, Kelm, and Palm, 2000, pg. 147). Product in-
novation is more important to downstream chemical firms, therefore the importance
of this regulatory framework is not the same for all firms in the industrial chain.
Furthermore, reasoning in the sense of technological cycles, new chemical substances
are derived from the diffusion of innovative chemical processes which will allow, tech-
nologically and economically, the development of new substances in industrial scale.
The importance of process innovation cannot be diminished in the chemical industry.
Fleischer, Kelm, and Palm (2000) collected extremely important data. However,
the interpretation of these might have overestimated the effect of the EU chemicals
regulation on the economic and innovation results of the EU chemical industry. With-
out a proper econometric analysis, it is not possible to verify if there is a positive or
negative correlation between those variables and its size.
The high fix costs of the EU system in comparison with others can have caused
an impact on the innovation and competitiveness of the European chemical sector.
However, these claims are not well funded and there are contradictions on the indi-
cators used. Comprehensively, the impact must be analyzed separately on the short
run and on the long run.
3.4 Impact of regulation on the chemical industry
Different regulations can be compared according to their effectiveness and efficiency.
Kahn (1988) analyses the degree to which regulation achieves its final purpose, and
the cost and time spent imposing such regulatory policy. Another approach is to
detach restrictiveness from flexibility of a regulation. Following Oates (1996), the
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stringency of a regulation is influenced by regulatory standards and enforcement.
In addition, flexibility is influenced by the exceptions that regulation may allow.
Regulation can be characterized by three factors: design, stringency, and efficiency
(SQW, 2006). However, it is difficult to disentangle these factors, and the relationship
among them is not linear.
Jaffe, Peterson, Portney, and Stavins (1995) proposed a taxonomy of all costs
of environmental regulation. They summed Government costs on developing, moni-
toring, and enforcing the environmental regulations, with firm expenditure costs to
comply with the regulation. They also add to this taxonomy possible negative effects
which could cause transition costs and social impacts on unemployment rate and eco-
nomic security. They map the chain of costs from the development of the regulation
until the possible economic impacts on firms.
Conversely, in order to analyze the impact of regulation on specifically the chemical
industry – and subsequently measure it – I chose a different path, evaluating the
industrial chain and evidencing where and how the environmental, health, and safety
regulations may affect chemical firms. This analysis focus on the perspective of the
firm, allowing to detach the key impacts for firms in different sections of the industrial
chain. Thus, knowing which kind of regulations are more relevant for firms in this
industry (and its different sectors), it is easier to evaluate the possible costs and to
search for relevant measures of regulatory stringency which can be used as proxy on
empirical studies.
Figure 3.1 describes the structure of the chemical industry, from raw materials to
the final consumers. Given the dependency in different levels of all other manufac-
turing and agro-industry on the chemical industry, regulation which directly impacts
chemical firms will also indirectly have an effect over all other manufacturing firms
which use chemicals. Not only is the impact perceived directly by firms having to
deal with their own expenditures on pollution reduction, but also input prices of reg-
ulated raw material will be higher. However, production costs may also reduce as a
consequence of the increase in productivity (more efficient processes), which in turn
can be converted into lower product prices.
A chemical firm is mainly affected by altering the its costs of production and
imposing constraints on the production process. Following the production flow, en-
vironmental, health, and safety regulations can:
Restrict input: it prohibits or restricts the use of certain substances, or utilities
(water, air, and energy).
Impose controls over the production process: it may create emission standards,
efficiency goals, or require the adoption of latest end-of-pipe technology.
Impose controls on the final product: new substances must be notified for its
use and commercialization. Safety tests must be delivered to the regulator in
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Raw Materials: Petroleum, Coal, and Minerals
Processing and Refining
Bulk Inorganics and Organics
Chemical Processing
Industrial Chemicals, Fertilizers, Resins, 
Elastomers, Dyestuffs, Fibers, among others
Speciality Chemicals Consumer Care Products Life Science Products Other Industries
Consumers
Figure 3.1: The structure of the chemical industry.
order to launch a new product.
Given this categorization, Figure 3.2 illustrates how industry-wide environmental
regulation impacts the chemical industry. It may restrict the use of energy and water
in a chemical plant or impose emission standards on an industrial area, limiting or
prohibiting the release of hazardous substances resulting from chemical processes, or
efficiency standards to firms. These kinds of regulations are usually imposed by a
group of laws which focus the control over a certain area. For example, to control the
concentration of CO2 in the atmosphere of a metropolitan region, the regulator might
limit traffic and industrial emissions, according to the hours of the day or weather
forecast. The regulator will search for an equilibrium given the existing economic
activities in the area.
When looking at the chemicals regulation, Figure 3.3 illustrates how it acts, impos-
ing rules to the stock, transport, use, and disposal (to avoid future contamination) of
chemicals. It may impact firms banning or restricting chemical substances which are
inputs. Additionally, it may demand higher quality of the final product (minimizing
residues). If the chemical process is not well regulated, the final product may carry
other by-products or even not converted raw material. Furthermore, the chemicals
regulation may require a higher control of the production process, and subsequently
it restricts the output given that it requires pre-market safety and quality test for
new products.
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Industrial chain
Industry-wide environmental regulation
Raw materials
+
utiities
Production process:
waste (emissions)
+
byproducts
Final
products
Restricts input:
e.g. use of utilities 
Controls production process:
e.g. emission  or efficiency standards
Figure 3.2: The different regulatory impacts on the production chain 1.
This kind of regulation might be more relevant to intermediate and downstream
chemical firms that use a wider branch of chemicals as raw material, and manufacture
products which are sold to individual consumers, subjected to higher health and safety
controls. One must recall that the output of a chemical firm is the input of another
chemical firm, propagating the impact all over the industrial chain.
Industrial chain
Chemicals regulation
Raw materials
+
utiities
Production process:
waste (emissions)
+
byproducts
Final
products
Restricts input:
e.g. limits or prohibits the
use of certain chemicals
as raw material
Controls the
production process:
e.g. limits residues
on the final product
Restricts output:
e.g. imposing pre-market
safety and quality tests
Figure 3.3: The different regulatory impacts on the production chain 2.
Chemical plants are idealized to be closed systems in mass and energy to reach
the highest efficiency and minimize waste of raw material, utilities (air, water, and
energy), and maximize the final product. Even so, the second law of thermodynamics
states that even if no energy enters or leaves the system, the potential energy of the
state will always be less than that of the initial state. This loss is called entropy.
Generalizing this result to the chemical process, emissions and byproducts are loss of
the system (entropy) and will always occur. But, it can be minimized with regulatory
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stimulus. Firms will be motivated to search for thermodynamic, and not economic,
efficiency. More efficient processes will reduce pollution (entropy).
Basic chemicals producers have a higher interest on increasing their efficiency
than downstream firms. Even though it is not possible to achieve a totally closed
process, efficiency is a crucial factor of competitiveness for producers of commodities,
not protected by intellectual property and by consequence less able to use prices to
obtain higher profits.
In the last century, these two groups of regulations have been advancing together
with the chemical industry. Knowledge diffusion is crucial to diminish the asymmetry
of information existent between regulator and industry. The ‘producer responsibility
principle’ is a way of conferring responsibility proportionally to the specialist knowl-
edge (with respect to substances’ hazard and possible technological improvements)
held by the industry. However, given the speed of technological developments, there
will always be a gap between innovation and knowledge of possible ‘new’ hazards.
Regulation is needed to optimize the system, to stimulate efficiency of the con-
sumption of finite goods (inputs). It should aim to minimize pollution (entropy), and
maximize the use of resources in a given time.
3.5 Conclusion
This chapter has defined the regulations regarding environment, health, and safety
which arouse in the second half of the twentieth century. At the same time, the
empirical literature concerning the relationship between these regulations and firm
performance, with a specific focus on innovation, was exemplified in order to show
the main hypothesis that economists have been investigating.
The review showed that initially economists focused their concern on the loss
of competitiveness by firms from industrialized and regulated countries. Regulation
would represent extra costs, incentivizing production plants to be transfered to less
regulated countries, what was called the “Pollution Havens” hypothesis.
The debate orbited around studies which investigated the variables that affect
the location choice of firms to studies on the impact of these regulations on firm
performance. Specifically, the impact on innovation was stressed when Porter (1991)
postulated that firms under more stringent regulation would be incentivized to in-
novate, thus would gain competitiveness in the foreign market. This was called the
“Porter Hypothesis.”
The objective of this review was to illustrate the evolution of the economic studies
together with the development and diffusion of environmental regulations around the
globe. At first, the studies focused on aggregated data on the manufacturing indus-
tries and with time moved to specific industrial sectors which are highly regulated.
Still, even if some empirical results indicate that stringent regulation may have in-
50
3.5 CONCLUSION
centivized innovation on firms, results cannot be generalized mainly because of the
difficulty on obtaining a proper measure of regulatory stringency.
Starting from the 1990s, researchers emphasized their studies on specific regula-
tions, or regulatory instruments, in order to obtain more precise measures of strin-
gency and thus more reliable conclusions. In the absence of good measures to evaluate
all social regulations, the strategy has been to reveal some aspects of the impact of
regulation in specific industries.
In order to better investigate the relationship between innovation and regulatory
stringency in the chemical industry, the chemicals regulation was analyzed in three
different markets: EU, US, and Japan. This overview illustrated different possibilities
of establishing a control over the production and commercialization of chemicals.
The relevance of the impact of this kind of product regulation over science-based
sectors was illustrated with other two studies on the agrochemical and pharmaceutical
sectors.
Finally, an analysis of the impact of environmental and product regulations over
the chemical industry chain, provided a better understanding of how and where these
controls might affect chemical firms. From this analysis was clarified the major role
of the product regulation and the importance of developing a deeper study of the
relationship between the chemicals regulation and innovation in the chemical industry.
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Chapter 4
Measuring Regulatory Stringency
The effect of environmental regulation on innovation by firms and on competitiveness
by countries has been a source of theorizing and debate for more than half a century.
In particular, the chemical industry, that arose in Europe and the US at the end
of the 19th century, has been prone to accidents that have impacted the environ-
ment. Indirectly, these accidents can be seen as responsible for the gradual growth of
environmental consciousness and, beginning in the 1970s, the development of envi-
ronmental regulation, first in the industrialized countries and later in the developing
world.
Since the late 1980s, debates about the impact of health, safety, and environmental
regulation on manufacturing industries have taken place. For governments and policy
makers, the possible development of pollution havens in less regulated countries and
the possible loss of innovative competitiveness in more regulated countries are the
main issues. At the same time, consumers, workers, and environmental organizations
have exerted pressure on governments to impose more extensive controls on pollution.
Among economists, there is still no consensus over whether innovation and com-
petitiveness are impacted positively or negatively by increasingly stringent regulation.
The critical issue is how to quantify regulatory restrictiveness in order to empirically
determine the impact of regulation. Some proxies used by researchers – such as the
number of international environmental agreements signed by a country or the num-
ber of visits of an environmental agency per year to firms – have been criticized for
being too loose, only an indirect measure or for not being industry specific. Hence,
these studies do not provide an adequate foundation for designing effective regulatory
policies which will not harm industrial innovation.
From the view point of the chemical industry, as a science-based activity, the main
form of competition is taken by innovating in developing more efficient processes and
in introducing new and better products. This depends on its own resources to support
R&D projects (Mahdi, Nightingale, and Berkhout, 2002). Consequently, a precise
understanding of the impact of regulation on innovation is a fundamental issue for
the chemical industry, given that innovation is a core competitiveness issue.
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In order to study this questions, it is first necessary to examine the industry chain
and related technological areas. The chemical industry can be initially divided be-
tween its organic and inorganic sectors. The former is characterized by the use of
organic raw materials such as coal, petroleum, and natural gas, and its products are
mainly petrochemicals. The latter uses inorganic raw materials such as phosphate
rock, salt, sulfur, and sodium carbonate to produce, for example, fertilizers, sulphur
acid, and caustic soda. From these two branches are derived intermediate and spe-
ciality chemicals which are sold to chemical firms, to other industrial sectors, or to
the final consumer.
In terms of the International Patent Classification (IPC) the chemical industry,
based on the ISIC codes from 23 to 25, which covers organic raw materials, produc-
tions of chemicals in general, rubber, and plastic products, is related to more than
thirty technological areas (Schmoch, Laville, Patel, and Frietsch, 2003)1. Within
these technological areas fourteen are specific to chemicals technology (from C01 to
C14) while the others are mainly related to final products such as drugs, foodstuffs,
and agrochemicals. The technological areas which were included in this research are
detailed in the following section.
Health, safety, and environmental regulation impacts chemical firms in different
ways depending upon the firms’ position in the chain of production. First, regulations
can restrict input, prohibiting or restricting the use of certain substances, or limiting
the use of utilities (water, air and energy). Second, they impose controls on the
production process with emission standards, efficiency goals, and the imposition of
the latest end-of-pipe technology. Third, regulations imposes controls on the final
product, such as safety tests that must be presented to regulators before marketing
of a product can commence.
In the first two cases, general and industry-wide environmental regulations are
the main responsible for restrictions. This is a group of laws, usually not industry
specific, but applicable to all economic activities, which aims to protect the envi-
ronment and human health from exposure to hazardous substances and pollutant
releases from processes developed by firms, transport, and energy generation. Gen-
eral environmental regulation impacts a chemical firm by limiting or prohibiting the
release of hazardous substances from chemical processes. The chemical industry is
particularly affected by these regulations given the complexity of its processes and
the variety of chemical substances which are used as raw materials, intermediates,
1The International Patent Classification (IPC) administered by the World Intellectual Property Organi-
zation (WIPO) is based on the Strasbourg Agreement Concerning the international Patent Classification,
and entered into force in 1975. This research is based on the seventh edition, IPC-7, and considered two
levels on the classification, for example, A01 or B27. The International Standard of Industrial Classification
of All Economic Activities codes cited are: ISIC 23, on the manufacture of coke, refined petroleum products
and nuclear fuel; ISIC 24, on the manufacture of chemicals and chemical products; and ISIC 25, on the
manufacture of rubber and plastics products.
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final products, byproducts, and waste.
This study focuses on those regulations that specifically regulate the manufac-
ture and commercialization of chemicals, imposing costs and limiting applications.
The chemical substances regulations involve two kinds of impact: the restriction or
prohibition of chemical substances to manufacture specific products; and imposition
of safety standards to market a new product in order to protect the final consumer
from unnecessary exposure. Examples of chemicals regulation are the prohibition of
the use of mercury in the production of toys and the imposition of tests to assure
the safety to the environmental and human health of a new textile dye. Even if the
impact may relate directly to the firm which uses the substance as an input, regula-
tion will have an indirect impact on the entire industry chain. The supplier of the
regulated substance and the buyer of the final product may also indirectly suffer.
The main motivation for focusing exclusively on chemicals regulation is the im-
portance placed on it by industry, government, and non-governmental organizations
in debates over the new chemicals policy of the European Union. In February 2001,
the European Commission presented the White Paper on future chemicals policy to
the European Parliament, European Council, and other bodies2. This new chemicals
policy named REACH (Registration, Evaluation, and Authorization for Chemicals)
was the source of intensive debates among governments, industry representatives, and
non-governmental organizations for seven years. The main issue addressed was the
threat of loss of competitiveness by European industries in international markets and
possible additional costs for the foreign firms in the European market.
Another reason for focusing on chemicals regulation is that it is directed to users,
producers, and commercializers of chemical substances. Thus, this regulation can be
categorized as industry specific – even though it also impacts other industrial sectors
– impacting all the links that make up the production chain of the chemical industry,
from the choice of raw materials to the market of products. Moreover, this form of
regulation has not yet been used by economists as a direct proxy to study the impact
of regulation on the chemical industry.
This chapter is divided as follows. Section Two describes the methodology and
data employed to the development of a measure of regulatory stringency illustrated
with examples. Section Three discusses the results which can be derived from the
final measure. And Section Four concludes this chapter with the advantages granted
by this measure and an evaluation of possible future applications.
2The European Commission Enterprise and Industry has a specific website on the debate and his-
torical background of the new chemicals policy, REACH. More information can be found at http:
//ec.europa.eu/enterprise/reach/whitepaper/index_en.htm, or historical background at http://ec.
europa.eu/enterprise/reach/whitepaper/background_en.htm.
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4.1 Measuring the level of regulatory stringency
Regulations regarding the market and use of chemical substances exist in many coun-
tries. In the European Union, the European Council is responsible for defining general
political guidelines for the Member States, and it combines the President of the Eu-
ropean Commission and the Heads of the Member States of the EU. The European
Commission is responsible for presenting proposals for European law and by carry-
ing out common policies. The operation of the common european market – as for
the establishment of common rules for marketing, labeling, and commercialization of
chemicals – are an important focus of the European Council (Commission, 2007).
Policies are developed after consultation of the main stakeholders involved, advi-
sory bodies which will develop impact assessment studies and collect information with
experts on the topics involved. The EU Directives define goals that must be achieved
by every Member State with a predefined period of time, and it must be internalized
by each Member State, adapting their laws in order to meet these objectives.
In 1976 the European Commission created a set of common rules for all EU
member states, which applies to all firms who wish to use or commercialize chemical
substances in the European market:
Council Directive 76/769/EEC on the approximation of the laws, regulations and ad-
ministrative provisions of the Member States relating to restrictions on the marketing
and use of certain dangerous substances and preparations.
The Council Directive under study, the Council of the European Communities
establish these rules with the aim of protecting the public and all that use such sub-
stances and preparations; contributing to the protection of the environment; restor-
ing, preserving and improving the quality of human life; unifying different existing
rules in the Member States that goes against the well functioning of the common
market. The Council Directive EEC/76/769 also inserts restrictions imposed by the
Council of the OECD on 13 February 1973 on polychlorinated biphenyls (PCB) which
is dangerous for human health, and restricts polychlorinated terphenyls (PCT) which
are shown to entail similar risks with the idea of gradually ban all PCBs and PCTs
(Council, 2004).
In order to quantify the regulation, restrictions imposed by the Council Directive
76/769/EEC and its subsequent amendments were linked to seventeen technological
areas in the IPC. These areas were chosen given the restrictions imposed on each
substance and the importance they have to processes and products of the chemical
industry.
Restrictions which affected technological areas related to other industries were
not assigned. Thus, certain restrictions imposed on chemical substances were not
linked to any technological area. Also, given that some restrictions may impact
different products or processes, certain restrictions may have been linked to more
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than one technological areas. Table 4.1 shows the technological areas which had
impacts assigned.
Table 4.1: IPC Code
A23 Foods or foodstuffs; their treatment, not covered by other classes.
A01 Agriculture; forestry; animal husbandry; hunting; trapping; fishing.
A61 Medical or veterinary science; hygiene.
B05 Spraying or atomising in general; applying liquids or other fluent materials to surfaces, in
general.
B27 Working or preserving wood or similar material; nailing or stapling machines in general.
C01 Inorganic chemistry.
C02 Treatment of water, waste water, sewage, or sludge.
C03 Glass; mineral or slag wool.
C04 Cements; concrete; artificial stone; ceramics; refractories.
C05 Fertilizers; manufacture thereof.
C06 Explosives; matches.
C07 Organic chemistry.
C08 Organic macromolecular compounds; their preparation or chemical working-up; compositions
based thereon.
C09 Dyes; paints; polishes; natural resins; adhesives; miscellaneous compositions; miscellaneous
applications of materials.
C10 Petroleum, gas or coke industries; technical gases containing carbon monoxide; fuel; lubrifi-
cants; peat.
C11 Animal and vegetable oils, fats, fatty substances and waxes; fatty acids therefrom; detergents;
candles.
C14 Skins; hides; pelts; leather.
In the following subsections more details are provided on the link of regulatory
restrictions to technological areas. First, it is described the content of the Council
Directive and the sources of information used in order to link with a good precision
each restriction to technological areas. Second, detailed examples clarify the method-
ology employed. And, third, the circumstances where restrictions were not linked to
any technological area, judged to have had no impact on products or processes of the
chemical industry, are explained.
4.1.1 Regulated substances and sources of industrial applications
The regulation under study was published in 1976 and amended 39 times up to 2003,
having 28 amendments included restrictions to chemical substances. Restrictions
are defined as constraints imposed on the use or commercialization of chemical sub-
stances. Some substances have been regulated more than once. Hence there are more
restrictions than regulated chemical substances. For example, mercury was restricted
twice, first in 1976 and later in 1998. In total, the Directive contains 986 restrictions
imposed on the market and use of 939 chemical substances. Table 4.2 shows the
number of amendments and the number of regulated substances for each year.
The majority of substances are classified into four categories which imposed the
same restrictions on all the substances belonging to the given category. There are two
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Table 4.2: Summary of the Council Directive 76/769/EEC
Year # amendments # regulated substances
1976 0 2
1979 1 1
1982 2 1
1983 2 15
1985 2 2
1989 2 11
1991 5 5
1994 3 1
1996 1 8
1997 4 796
1998 1 1
1999 3 26
2001 3 13
2002 3 2
2003 6 102
2004 1 0
Total 39 986
additional categories, flammability and danger, which have no substances restricted
in the regulation under study, but related to Directive 67/548/EEC responsible for
the classification, packaging, and labeling of dangerous substances have norms which
must be applied by producers. These categories are shown in Table 4.3.
Substances classified on Annex I of the Directive 76/769/EEC as carcinogens,
mutagens, and toxic for reproduction, have also been subdivided in category 1, which
have their risk already scientifically confirmed, and category 2, when there are strong
assumptions of risk. There are no differences between the restrictions imposed on
both groups.
Nevertheless, until 1996 regulated substances in the Directive were not aggregated
into classes. Initially, metals such as mercury and lead were regulated, followed by
aromatics substances such as benzene. In total, there are seventy four restrictions
imposed on a total of sixty nine substances which do not fit into the above classifica-
tion. Table 4.4 shows the number of restrictions which were imposed individually on
substances per year. Afterward, the majority of the restrictions imposed on the above
categories excludes medicinal, cosmetic, and fuel products. This is shown clearly on
Section Three, where the final result shows that the technological areas involved on
these products are not shown to be heavily regulated.
In order to link the restrictions of a substance to technological areas, two main
sources of industrial applications were used. The first was the European Chem-
ical Substances Information System (ESIS) maintained by the Consumer Product
Safety and Quality Unit (CPS&Q)3. The ESIS compiles information on chemicals
3Previously known as the European Chemicals Bureau (ECB), the CPS&Q is part of the Institute for
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Table 4.4: Council Directive 76/769/EEC: Restrictions not imposed on groups of substances
Year # restrictions
1976 2
1979 1
1982 1
1983 15
1985 2
1989 11
1991 5
1994 1
1996 8
1997 0
1998 1
1999 9
2001 10
2002 2
2003 6
Total 74
which are part of the European inventory of existing commercial chemical substances
(EINECS), the European list of notified chemical substances (ELINCS), and other
lists4. The search on ESIS can be undertaken with the substance name, its molecular
formula or CAS number5, and will show all information available for the substance
under investigation.
Specifically, one of the documents present in the ESIS database is the chemical
data-set from the International Uniform Chemical Information Database (IUCLID).
Section one contains general information on the company that produces or imports
the substance (name, country, contact information), the chemical name, type, clas-
sification, labeling, range of quantity produced or imported, source and occupation
exposure limits, precautionary and emergency measures, information on water, air,
and soil pollution caused by waste disposal and accident, and use pattern type (in-
dustrial or not) and category (for the production of which product, on R&D, or other
uses). Section two contains data on physical-chemical characteristics such as melt-
ing and boiling point, density, vapor pressure, solubility, flammability, among others.
Section three deals with the environmental fate and pathways, containing data on
photo-degradation, biodegradation, bioaccumulation, chemical stability on soil and
Health and Consumer Protection (IHCP) a Joint Research Center (JRC) of the European Commission. The
ESIS database ca be reached at http://ecb.jrc.it/esis/.
4No-longer polymers (NLP), biocidal products Directive (BPD), Persistent, bioccumulative and toxic
(PBT), and very persistent and very bioccumulative substances (PBT and vPvB), Classification and La-
beling substances or preparations, Export and import chemicals listed in Annex I of EEC 304/2003, High
Production Volume chemicals (HPVCs) and Low production volume chemicals (LPVCs); IUCLID Chemical
Data Sheets, IUCLID Export Files, OECD-IUCLID Export Files, EUSES Export Files, Priority Lists, Risk
Assessment process and tracking system in relation to Council Regulation (EEC) 793/93.
5CAS: Chemical Abstracts Service provided by the American Chemistry Society.
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water, and monitoring data of limits on air, water, soil, and food. Section four con-
tains data on ecotoxicity of aquatic and terrestrial organisms. Section five details
acute toxicity, oral, dermal, and inhalation toxicity, corrosiveness and irritability on
eyes and skin, genetic toxicity, carcinogenicity, toxicity to reproduction. Section six
lists all references to the document. Finally, Section seven details risk assessment
of chemicals. Other remarks are quoted on the different sections and most of the
information available are experimental results from firms on the effects of substances
on animals and humans.
The information available at the IUCLID data-set is reported by firms and com-
piled by the CPS&Q in a document. In this study I extracted information on use
pattern of each substance. The data-set lists use patterns and categories, for exam-
ple, “industrial” and “used in synthesis in the chemical industry,” respectively. The
information provided is not detailed and, unfortunately, not all chemicals under in-
vestigation have a IUCLID data-set document and also not all substances which have
it exhibit the use pattern. For these reasons other sources of information were needed
in order to obtain more detailed data to properly assign chemicals to technological
areas.
The second main source of information was the US Environmental Protection
Agency (EPA) website, which has data on industrial applications of toxic substances6.
A search was conducted with the chemical name or CAS number of regulated sub-
stances resulting on a list of information compiled by the EPA. In particular, the
EPA has consumer fact-sheets which describe in some detail where and how danger-
ous chemicals are found and used, what are their trade names, and why they have
been regulated in the US. For example, the use of benzene is described as a building
block for making plastics, rubber, resins and synthetic fabrics like nylon and polyester,
among other uses7.
Other US governmental agencies were also used as source of information, mainly
the National Institute for Occupational Safety and Health (NIOSH) and the National
Toxicology Program (NTP)8. Chemical data-sheets provided by private companies
were also consulted. However, the compilers of these documents do not always signal
all applications of a substance. Moreover, most common information available about
regulated substances are not industrial uses, but exposure limits in the work envi-
ronment and symptoms of contamination. Patent documents and scientific papers
were also consulted in the case of more rare substances for precise use information
was unavailable from the preceding sources. Nevertheless, there remain restricted
substances which have no industrial use, but which are produced as a consequence of
the degradation or combustion of other substances.
6USEPA at http://www.epa.gov/.
7http://www.epa.gov/safewater/dwh/c-voc/benzene.html, visited on 28 July 2008.
8NIOSH at http://www.cdc.gov/niosh/, and NTP at http://ntp.niehs.nih.gov/.
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4.1.2 Linking restricted substances to technological areas
This section provides some detailed examples to help better understand how the
relationship between restricted substances and technological areas was traced.
Before entering the discussion of the examples it is important to stress few re-
lated matters. When linking regulated substances to technological areas restrictions
assigned are only related to possible impacts on the chemical industry, even though
they may also impact other industries. With respect to the Directive under consider-
ation, most of the restrictions do not refer to pharmaceuticals, cosmetics, and fuels,
which have each specific regulatory framework. Therefore, technological areas related
to these final products do not appear as highly restricted in the data generated by
this study.
The following examples were chosen in order to illustrate all kinds of substances
and restrictions that are found in the Directive. This sample includes substances
which were regulated several times over the years; classified in classes or regulated
singularly; which impacted the basic chemicals or used on final products. The sam-
ple also contains substances used on other than the chemical industry, or with no
commercial application, or not industrially produced.
Mercury
Mercury occurs naturally in the environment when released from volcanoes, or
from the combustion of organic fuels and waste incineration, which may also liberate
mercury. Human contamination generally occurs from contaminated food, contami-
nated air, or skin contact with the metal9.
Environmental agencies are mainly worried on identifying where the pollutant is
present in the environment, and most contamination has been shown to result from
energy production and the ingestion of contaminated fish10. Little information is
available on actual and past industrial applications of mercury.
Even though is a well known metal, it was only in the second half of the twentieth
century that mercury was recognized as a dangerous substance and was banned from
a number of applications. Actual information is based on current applications. How-
ever, a search for past industrial uses is needed to assign technological areas which
were restricted at the time of the regulation.
Information on past uses and contamination sources may be found on the EPA
webpage dedicated to mercury11. Combustion of coal is the major source of release
of mercury into the environment, which occurs on coal-burning power plants, and
9National Toxicology Program (NTP) at http://cerhr.niehs.nih.gov/common/mercury.html, visited
in 16 november 2007.
10The most famous case of contamination of mercury was on the population of Minamata Bay caused
by Japanese Chisso Corporation (a fertilizer company and later on petrochemical), which for a long period
discharged methyl mercury on the sea. The contamination was identified at the end of the 1950s.
11http://www.epa.gov/mercury/, visited in 13 November 2007.
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on iron and steel production. In these cases, mercury release is a consequence of
the production process, given that mercury is a contaminant in coal and not an
input. In the case of chlor-alkali plants, mercury is used as an essential catalyst.
Mercury and its compounds are also raw materials used in the production of pes-
ticides, fungicides, latex paints, and explosives. Other sectors which use the metal
are pharmaceuticals and cosmetics in the production of diuretics, antibiotics, dental
amalgam, skin-lightening creams, and soaps12. Mercury is also commonly found in
consumer products such as thermometers, switches, and fluorescent light bulbs. It
is commonly used at the R&D phase, as a laboratory chemical, and as a reagent in
inorganic and toxicology experiments13. The electronic industry also uses the metal
in batteries and semiconductors.
Mercury was not classified in any of the listed categories. Hence, the Directive
contains three separate set of regulations over mercury or compounds in 1976, 1989,
and 1998. The restrictions imposed are shown next followed by the technological
areas assigned as impacted by the regulation.
1976 Mercury may not be used as substances and constituents of preparations intended for use: (a)
to prevent the fouling by micro-organisms, plants or animals of: – the hulls of boats,– cages,
floats, nets and any other appliances or equipment used for fish or shellfish farming, – any
totally or partly submerged appliances or equipment; (b) in the preservation of wood; (c) in
the impregnation of heavy-duty industrial textiles and yarn intended for their manufacture;
(d) in the treatment of industrial waters, irrespective of their use.
Technological areas assigned In 1976 regulation restricts the use of mercury as a fungicide
in certain products. Technological areas B27, C02, and C09 were assigned as impacted.
They refer first to the application of substances to preserve wood and other equipments
which may contain fungicides with mercury; second, to formulas which deal with the
treatment of industrial waters that may also contain mercury on the process and it is
clearly prohibited by the regulation; and, third, to substances added to the formulas of
dyes and paints with the purpose of creating a protective coat to different materials.
1989 Mercury compounds may not be used as substances and constituents of preparations intended
for use: (a) to prevent the fouling by micro-organisms, plants or animals of: – the hulls of
boats, – cages, floats, nets and any other appliances or equipment used for fish or shellfish
farming, – any totally or partly submerged appliances or equipment; (b) in the preservation
of wood; (c) in the impregnation of heavy-duty industrial textiles and yarn intended for their
manufacture; (d) in the treatment of industrial waters, irrespective of their use.
Technological areas assigned In 1989 regulation expanded the previous rule to all mercury
compounds. For the motivations given above the same technological areas were assigned:
B27, C02, and C09.
12A compound is a substance (molecule) which contain different elements bonded. Mercury compounds
can be organic or inorganic substances which contain mercury in its structure.
13http://www.epa.gov/epaoswer/hazwaste/mercury/con-prod.htm, visited in 13 November 2007.
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1998 Mercury: Member States shall prohibit, as from 1 January 2000 at the latest, the marketing of
batteries and accumulators, containing more than 0,0005% of mercury by weight, including in
those cases where these batteries and accumulators are incorporated into appliances. Button
cells and batteries composed of button cells with a mercury content of no more than 2% by
weight shall be exempted from this prohibition.
Technological areas assigned In 1998 the regulation focused other than chemical processes
or products, causing no impact on the chemical industry. Given this, there were no
technological areas assigned.
Monomethyl-dibromo-diphenyl methane (DBBT)
No information could be obtained from the databases quoted previously, perhaps
because the substance was banned from the European market in 1991.
A data-sheet from BASF clarifies the industrial applications of this substance as
an organic reagent used in the synthesis of boron enolates, an intermediate in organic
chemistry used to produce building blocks for basic commodities and drugs14.
1991 DBBT: The marketing and use of this substance and of preparations and products containing
it shall be prohibited.
Technological areas assigned The technological area C07 related to organic chemistry was
assigned as impacted by the regulation.
Benzene
This substance is an important input for the organic industry chain, employed in
several organic processes. The ESIS database brings summarized information on the
industries which use benzene as input. The EPA provides more detailed information
on industrial applications of benzene and its role in pollution15.
Benzene is an important organic solvent for the extraction of oils and fats from
seeds and nuts, and is also used in the production of waxes, resins, inks, paints,
plastics and rubber. It is an intermediate for basic industry in the manufacture of
paints, lacquers, varnishes, aniline, dyestuffs, adhesives, and coatings. Benzene is
also used for artistic printing and preparation of lithographic inks in the graphic arts
industries, and as a thinner for paints. It is present in significant measure in fossil
fuels, lubricants, and additives. Combustion of coal and oil derivatives results the
majority of emissions released into the environment.
It is used in dry cleaning and in the production of detergents (alkylbenzenes) as
a degreasing agent. It is a raw material in the synthesis of several polymers such as
styrene (polystyrene plastics and synthetic rubbers), phenol (phenolic resins), cyclo-
hexane (nylon), and maleic anhydride (polyester resins). It is also an intermediate in
14http://www.basf.com/inorganics/pdfs/tech_datasheet/DBBT.pdf and http://www.basf.com/
inorganics/products/developmental/dbbt_toluene.html, visited in 16 December 2007.
15http://www.epa.gov/ttn/uatw/hlthef/benzene.html, visited on 20 December 2007.
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the production of drugs, biocides, and explosives, besides being used as a laboratory
chemical.
Benzene was regulated in three different years, and in 1997 it was included in the
Appendix I of the Directive, labelled as a carcinogenic substance Category 1.
1982 Not permitted in toys or parts of toys as placed on the market where the concentration of
benzene in the free state is in excess of 5 mg/kg of the weight of the toy or part of toy.
Technological areas assigned This restriction was linked to the IPC areas C08 and C09.
The former refers to macromolecules such as polymers, and the latter to the production
of dyes and paints, among others. These are used in the production of toys, and may
contain residues of benzene if the processes are not well controlled.
1989 May not be used in concentrations equal to, or greater than, 0,1% by mass in substances or
preparations placed on the market.
However, this provision shall not apply to: (a) motor fuels which are covered by Directive
85/210/EEC; (b) substances and preparations for use in industrial processes not allowing for
the emission of benzene in quantities in excess of those laid down in existing legislation; (c)
waste covered by Directives 75/442/EEC (4) and 78/319/ EEC (5).
Technological areas assigned This regulation amplified the scope of the previous restric-
tion to substances and preparations placed on the market with a number of exemptions.
More technological areas were assigned besides the previous ones, C08 and C09, which
now the restriction impacts on polymers and paints for all other applications of benzene.
A01, A61, C05, and C11 were included as technological areas impacted. They are related
to agrochemicals, medical preparations, medical and cosmetics preparations, mixtures
(additions of additives) for fertilizers, and the extraction of oils and productions of
detergents, respectively.
1997 Without prejudice to the other points of Annex I to Directive 76/769/EEC: May not be used
in substances and preparations placed on the market for sale to the general public in individual
concentration equal to or greater than: either the concentration specified in Annex I to Council
Directive 67/548/EEC, or the concentration specified in point 6, Table VI, of Annex I to
Council Directive 88/379/EEC, where no concentration limit appears in Annex I to Directive
67/ 548/EEC.
Without prejudice to the implementation of other Community provisions relating to the clas-
sification, packaging and labeling of dangerous substances and preparations, the packaging of
such substances and preparations must be marked legibly and indelibly as follows: ‘Restricted
to professional users.’
By way of derogation, this provision shall not apply to: (a) medicinal or veterinary products as
defined by Council Directive 65/65/EEC; (b) cosmetic products as defined by Council Directive
76/768/EEC; (c) motor fuels which are covered by Council Directive 85/210/EEC, mineral
oil products intended for use as fuel in mobile or fixed combustion plants, fuels sold in closed
systems (e.g. liquid gas bottles); (d) artists’ paints covered by Council Directive 88/379/EEC.
Technological areas assigned This regulation again expanded the previous restrictions,
including exemptions for medical and veterinary use, artist paints, and cosmetics, which
have specific regulations. The IPC areas assigned were as before, A01, C05, C06, C08,
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C09, and C11, excluding this time IPC-A61 related to drugs and cosmetic formulas,
exempted by the regulation.
Even though benzene is heavily employed in basic organic processes, in neither
year it was linked to IPC C07 (organic chemistry). This is because regulated sub-
stances were not related to all technological areas in which they are used, but just
to those which might have been impacted by the restriction. The Directive mainly
focuses on the diminution or removal of a substance from the final product, with the
aim of minimizing or eliminating residues. Rarely impacts industrial consumers of
intermediate chemicals.
Carbon tetrachloride
Data on industrial uses of carbon tetrachloride was found on the ESIS database
and more detailed information was extracted from the EPA website.16
Carbon tetrachloride can act as a solvent, degreasing agent, chemical intermedi-
ate, and catalyst. By the end of the 1980s, in the US, most production of carbon
tetrachloride was related to the synthesis of fluorocarbons. These have a number of
applications such as propellants, solvents, lubrificants, and pharmaceutical products.
It works as a solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins. In
relation to macromolecular technology it acts also as an intermediate product and
catalyst in diverse synthesis, among them, organic chlorination processes. Carbon
tetrachloride is also employed in dry cleaning agents, fire extinguishers, soaps, insec-
ticides, fungicides, and drugs. It is also a fuel additive, a laboratory chemical, and
has diverse applications in the electronic industry.
Carbon tetrachloride was restricted on a single occasion, as follows:
1996 May not be used in concentrations equal to or greater than 0,1% by weight in substances and
preparations placed on the market for sale to the general public and/or in diffusive applications
such as in surface cleaning and cleaning of fabrics.
Without prejudice to the application of other Community provisions on the classification, pack-
aging and labeling of dangerous substances and preparations, the packaging of such substances
and preparations containing them in concentrations equal to or greater than 0,1% shall be
legible and indelibly marked as follows: ‘For use in industrial installations only.’
By way of derogation this provision shall not apply to: (a) medicinal or veterinary products
as defined by Directive 65/65/EEC, as last amended by Directive 93/39/EEC; (b) cosmetic
products as defined by Directive 76/768/EEC, as last amended by Directive 93/35/EEC.
Technological areas assigned This restriction imposed limitations on the concentration of
carbon tetrachloride in products placed on the market. Drugs and cosmetics are exempt.
Technological areas assigned were C07, C08, C09, and C11, related to organic chemistry;
macromolecular technology; lacquers and varnishes; and oils, fats, soaps, and waxes,
respectively.
16http://www.epa.gov/safewater/dwh/t-voc/carbonte.html and http://www.epa.gov/ttn/atw/
hlthef/carbonte.html, visited in 20 December 2007.
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Differently from benzene, carbon tetrachloride is a chemical intermediate in or-
ganic synthesis which acts in the middle of the organic chemical industry chain.
Residues in the final products are more likely to arise if there are problems in the
control of the chemical process. For this motive, the organic chemistry technological
area – C07 – was assigned.
1-Methyl-3-nitro-1-nitrosoguanidine
The safety data sheet provided by the American National Institutes of Health and
the article by Kilgore and Greenberg (1961) describes the use of 1-methyl-3-nitro-1-
nitrosoguanidine in experimental research in drugs17. In 1997 it was regulated and
classified by the Directive as carcinogenic Category 2, and the following restriction
was imposed:
1997 Without prejudice to the other points of Annex I to Directive 76/769/EEC: May not be used
in substances and preparations placed on the market for sale to the general public in individual
concentration equal to or greater than: either the concentration specified in Annex I to Council
Directive 67/548/EEC, or the concentration specified in point 6, Table VI, of Annex I to
Council Directive 88/379/EEC, where no concentration limit appears in Annex I to Directive
67/ 548/EEC.
Without prejudice to the implementation of other Community provisions relating to the clas-
sification, packaging and labeling of dangerous substances and preparations, the packaging of
such substances and preparations must be marked legibly and indelibly as follows: ‘Restricted
to professional users.’
By way of derogation, this provision shall not apply to: (a) medicinal or veterinary products as
defined by Council Directive 65/65/EEC; (b) cosmetic products as defined by Council Directive
76/768/EEC; (c) motor fuels which are covered by Council Directive 85/210/EEC, mineral
oil products intended for use as fuel in mobile or fixed combustion plants, fuels sold in closed
systems (e.g. liquid gas bottles); (d) artists’ paints covered by Council Directive 88/379/EEC.
Technological areas assigned Given that the substance was found to have no industrial
scale application, it was judged that the regulation had no impact on any industrial
process or product. Thus, no technological areas were assigned.
Benzidine, its salts and derivatives
Benzidine is an aromatic amine compound which has been regulated five times,
alone or in conjunction with its salts and derivatives. The substance profile provided
by American National Toxicology Program specifies the use of the benzidine as an
important intermediate in the production of dyeing compounds such as azo dyes,
sulfur dyes, fast color salts, and has also other laboratory applications. Past uses
quoted by the document are in plastics, rubber, and laboratory tests18.
17http://dohs.ors.od.nih.gov/pdf/1-methyl-3-nitro-1-nitrosoguanidine%20REVISED.pdf, visited
on 20 December 2007.
18http://ntp.niehs.nih.gov/ntp/roc/eleventh/profiles/s020benz.pdf, visited in 15 January 2008.
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Other documents were also used as sources of information. Articles on the jour-
nal Dyes and Pigments, such as Liua, Yulana, and Qian (2004), also quote benzidine
as an intermediate for the production of dyes. The main advantage noted in the
specialized literature on benzidine-derived dyes is its characteristics of fixing in cot-
ton. Its derivatives are employed in the synthesis of dyes, pigments, paints, rubber
compounding agents, and a wide range of other organic chemicals. It has also an
application as a laboratory chemical mainly in research and development purposes.
In 1997, benzidine, 4,4’-diaminobiphenyl, biphenyl-4,4’-ylenediamine, and also
salts of benzidine were classified as carcinogenic Category 1. In 1999, benzidine-based
azo dyes and 4,4’-diarylazobiphenyl dyes were classified as carcinogenic Category 2.
Finally, in 2003, benzidine was included in the list of Azocolourants in the Appendix
of the Directive. The following restrictions were imposed on chemicals from 1983 to
2003:
1983 Benzidine and its derivatives may not be used in jokes and hoaxes or in objects intended to
be used as such, for instance as a constituent of sneezing powder and stink bombs. However,
Member States may tolerate on their territory stink bombs containing not more than 1,5 ml.
Technological areas assigned The technological area C09, which also refers to pigments,
was assigned given that the chemical may be present in sneezing powder and stink
bombs.
1989 Benzidine and its salts may not be used in concentrations equal to or greater than 0,1% by
weight in substances and preparations placed on the market. However, this provision shall
not apply to waste containing one or more of these substances and covered by Directives
75/442/EEC and 78/319/EEC.
Technological areas assigned This new rule restricted the concentration of benzidine and
its salts to all substances and preparations placed on the market. The technological
areas assigned were C08 and C09, the former because of the impact on the processes of
production of plastics and rubbers, and the latter because of the generalized impact on
the production of dyes, paints, and pigments in general. The limitations imposed do not
prohibit the use of benzidine and its salts as an industrial intermediate, but do impose
a greater control on the industrial process to avoid residues in the final product.
1997 Benzidine; 4,4’-diaminobiphenyl; biphenyl-4,4’-ylenediamine, and salts of benzidine: With-
out prejudice to the other points of Annex I to Directive 76/769/EEC: May not be used in
substances and preparations placed on the market for sale to the general public in individual
concentration equal to or greater than: either the concentration specified in Annex I to Coun-
cil Directive 67/548/EEC, or the concentration specified in point 6, Table VI, of Annex I to
Council Directive 88/379/EEC, where no concentration limit appears in Annex I to Directive
67/ 548/EEC.
Without prejudice to the implementation of other Community provisions relating to the clas-
sification, packaging and labeling of dangerous substances and preparations, the packaging of
such substances and preparations must be marked legibly and indelibly as follows: ‘Restricted
to professional users.’ By way of derogation, this provision shall not apply to: (a) medici-
nal or veterinary products as defined by Council Directive 65/65/EEC; (b) cosmetic products
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as defined by Council Directive 76/768/EEC; (c) motor fuels which are covered by Council
Directive 85/210/EEC, mineral oil products intended for use as fuel in mobile or fixed com-
bustion plants, fuels sold in closed systems (e.g. liquid gas bottles); (d) artists’ paints covered
by Council Directive 88/379/EEC.
Technological areas assigned The assigned technological areas were the same as in 1989:
C08 and C09. This rule was a generalization of the previous regulation which already
affected benzidine and its salts, however including exceptions.
1999 Benzidine-based azo dyes, 4,4’-diarylazobiphenyl dyes, with the exception of those specified
elsewhere in Annex I to Directive 67/548/EEC: Without prejudice to the other points of
Annex I to Directive 76/769/EEC: May not be used in substances and preparations placed
on the market for sale to the general public in individual concentration equal to or greater
than: either the concentration specified in Annex I to Council Directive 67/548/EEC, or the
concentration specified in point 6, Table VI, of Annex I to Council Directive 88/379/EEC,
where no concentration limit appears in Annex I to Directive 67/ 548/EEC. Without prejudice
to the implementation of other Community provisions relating to the classification, packaging
and labeling of dangerous substances and preparations, the packaging of such substances and
preparations must be marked legibly and indelibly as follows: ‘Restricted to professional users.’
By way of derogation, this provision shall not apply to: (a) medicinal or veterinary products as
defined by Council Directive 65/65/EEC; (b) cosmetic products as defined by Council Directive
76/768/EEC; (c) motor fuels which are covered by Council Directive 85/210/EEC, mineral
oil products intended for use as fuel in mobile or fixed combustion plants, fuels sold in closed
systems (e.g. liquid gas bottles); (d) artists’ paints covered by Council Directive 88/379/EEC.
Technological areas assigned Restrictions were not applied to benzidine itself, but azodyes
derived from benzidine. Again, technological areas affected were C08 and C09.
2003 Benzidine: Azodyes which, by reductive cleavage of one or more azo groups, may release one
or more of the aromatic amines listed in the Appendix, in detectable concentrations, i.e. above
30 ppm in the finished articles or in the dyed parts there of, according to the testing methods
listed in that Appendix, may not be used in textile and leather articles which may come into
direct and prolonged contact with the human skin or oral cavity, such as: clothing, bedding,
towels, hairpieces, wigs, hats, nap and other sanitary items, sleeping bags, footwear, gloves,
wristwatch straps, handbags, purses/wallets, briefcases, chair covers, purses worn round the
neck, textile or leather toys and toys which include textile or leather garments, yarn and
fabrics intended for use by the final consumer. fibers 2. Furthermore, the textile and leather
Articles referred to in point 1 above may not be placed on the market unless they conform
to the requirements set out in that point. By way of derogation, until 1 January 2005, this
provision shall not apply to textile articles made of recycled fibers if the amines are released by
residues deriving from previous dyeing of the same fibers and if the listed amines are released
in concentrations below 70 ppm. 3. Azodyes, which are contained in the List of azodyes that
is here by added to the Appendix, may not be placed on the market or used for coloring textile
and leather articles as a substance or constituent of preparations in concentrations higher than
0,1% by mass. 4. Not later than 11 September 2005, the Commission shall, in the light of
new scientific knowledge, review the provisions on azocolourants.
Technological areas assigned In 2003 a general rule for azodyes was implemented, limiting
residues of azocolourants listed in the Annex I of the Directive, specifying applications
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which have direct contact with the final consumer, such as textiles, leather, and toys. The
technological area assigned was C09 given that more specific restrictions were applied
on the use of benzidine in the production of azodyes. The technological area C14, which
refers to leather chemical treatment and tanning, was not included given that benzidine
azodyes are not commonly use in the tanning of leather products.
Benzo[a]pyrene; benzo[d,e,f ]chrysene
BaP, as it is commonly known, is a polycyclic aromatic hydrocarbon which is not
manufactured and has no commercial uses registered. As quoted by the US EPA Tox-
icity and Exposure Assessment for ChildrenÕs Health – TEACH Chemical Summary
– among other sources of information (e.g. Risk Assessment Information System –
US RAIS), BaP is not produced commercially but derives from incomplete combus-
tion of organic materials such as wood, oil, coal, cigarettes, motor vehicle exhaust,
and smoked, grilled, or charcoal-broiled foods. It also occurs as a consequence of
the industrial processes in asphalt, siderurgy, and metallurgy (emissions from coke
ovens). High incidence of skin cancer among workers in these sectors during last two
centuries has been attributed to the emissions of BaP19.
BaP was classified in 1997 as toxic for reproduction, carcinogen and mutagen
Category 2. Although it appears three times in the Directive, the restrictions imposed
is the same for all three categories.
1997 Without prejudice to the other points of Annex I to Directive 76/769/EEC: May not be used
in substances and preparations placed on the market for sale to the general public in individual
concentration equal to or greater than: either the concentration specified in Annex I to Coun-
cil Directive 67/548/EEC, or the concentration specified in point 6, Table VI, of Annex I to
Council Directive 88/379/EEC, where no concentration limit appears in Annex I to Directive
67/ 548/EEC. Without prejudice to the implementation of other Community provisions re-
lating to the classification, packaging and labeling of dangerous substances and preparations,
the packaging of such substances and preparations must be marked legibly and indelibly as
follows: ‘Restricted to professional users.’ By way of derogation, this provision shall not ap-
ply to: (a) medicinal or veterinary products as defined by Council Directive 65/65/EEC; (b)
cosmetic products as defined by Council Directive 76/768/EEC; (c) motor fuels which are
covered by Council Directive 85/210/EEC, mineral oil products intended for use as fuel in
mobile or fixed combustion plants, fuels sold in closed systems (e.g. liquid gas bottles); (d)
artists’ paints covered by Council Directive 88/379/EEC.
Technological areas assigned The regulation refers to substances and preparations placed
on the market and excludes fuels, which could be a source of BaP residual emissions.
Substances which were regulated by the Directive but are not manufactured or commer-
cialized by the industry had no technological areas assigned as impacted.
19US EPA TEACH Chemical Summary at http://www.epa.gov/teach/chem_summ/BaP_summary.pdf;
and RAIS Toxicity Profile at http://rais.ornl.gov/tox/profiles/bap_c.shtml.
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2-Bromopropane
The American National Toxicological Program and the US EPA cite the use of 2-
bromopropane as a laboratory reagent, and a solvent on aerosol, inks, and adhesives.
It is also a contaminant in the production process of 1-bromopropane20.
2- Bromopropane was classified in 2003 by the Directive as toxic for reproduction
Category 1.
2003 Without prejudice to the other points of Annex I to Directive 76/769/EEC May not be used in
substances and preparations placed on the market for sale to the general public in individual
concentration equal to or greater than: either the concentration specified in Annex I to Direc-
tive 67/548/EEC, or the concentration specified in point 6, Table VI, of Annex I to Directive
88/379/EEC where no concentration limit appears in Annex I to Directive 67/548/EEC.
Without prejudice to the implementation of other Community provisions relating to the clas-
sification, packaging and labeling of dangerous substances and preparations, the packaging of
such substances and preparations must be marked legibly and indelibly as follows: ‘Restricted
to professional users.’
By way of derogation, this provision shall not apply to: (a) medicinal or veterinary products as
defined by Directive 65/65/EEC; (b) cosmetic products as defined by Directive 76/768/EEC;
(c) motor fuels which are covered by Council Directive 85/210/EEC, mineral oil products
intended for use as fuel in mobile or fixed combustion plants, fuels sold in closed systems (e.g.
liquid gas bottles); (d) artists’ paints covered by Directive 88/379/EEC.
Technological areas assigned 2-bromopropane is a contaminant present during the syn-
thesis of 1-bromopropane. Given this, the restriction impose greater controls on the
industrial process of production and use of 1-bromopropane. The technological areas
assigned were C07 and C09, which refer respectively to organic chemistry; and inks and
adhesives technologies.
4.1.3 Restrictions not associated with any technological area
In the previous section several examples on how restrictions were linked to techno-
logical areas were described. Nevertheless, some restrictions were not linked to any
technological area for different motivations. From the total of 986 restrictions, 705
(or 71.5%) were considered to have no impact over technological areas of the chemical
industry.
First, there were restrictions imposed on chemicals judged to impact technolog-
ical areas not related to the chemical industry. As an example the case of mer-
cury when regulated in 1998. Second, there were restrictions imposed on substances
with no industrial application previously registered. For example, 1-methyl-3-nitro-
1-nitrosoguanidine, regulated in 1997, is only used in R&D. Third, there were restric-
tions imposed on substances not produced commercially, but involuntary byproducts
of industrial processes, for example, Benzo[a]pyrene (BaP).
20USEPA at http://www.epa.gov/Ozone/fedregstr/64fr8043.pdf; and the US NTP at http://ntp.
niehs.nih.gov/?objectid=BD3C3B10-123F-7908-7B87D2DD5D55E4F4, visited in 18 January 2008.
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The fourth case, responsible for omitting the majority of the restrictions, were re-
strictions imposed on petroleum derivatives which were considered to be ineffective.
The regulation imposed quantitative limits of the presence of substances used in the
beginning of the basic organic industry chain on products to final consumers. The
regulation was considered to be incompatible to its regulated substances. When re-
strictions seemed to have no impact, or even indirect effects on the chemical industry,
no technological areas were assigned.
In 1997 a range of petroleum extracts, derivatives from the distillation process
were regulated. From the lighter extracts, temperatures which vary from −40◦C
to 390◦C, it is produced fuel gas and naphtha. The naphtha is the basis for the
production of petrochemicals, and also from where it is derived gasoline, diesel, and
other fuels. Extracts derived from higher temperatures, in the range from 370◦C to
> 540◦C, are the source of lubricants, heavy fuels, and asphalt.
From the naphtha, the basic organic industry produces ethane, propane and
butane, substances from which the primary petrochemicals (olefins, aromatics and
methanol) are derived. Petrochemical intermediates are then produced from the con-
version of these products into more complex molecules through other intermediates,
polymerization processes and other chemical reactions.
All these petroleum extracts were classified as carcinogens Category 2 and received
the following restriction:
1997 Without prejudice to the other points of Annex I to Directive 76/769/EEC: May not be used
in substances and preparations placed on the market for sale to the general public in individual
concentration equal to or greater than: either the concentration specified in Annex I to Council
Directive 67/548/EEC, or the concentration specified in point 6, Table VI, of Annex I to
Council Directive 88/379/EEC, where no concentration limit appears in Annex I to Directive
67/ 548/EEC.
Without prejudice to the implementation of other Community provisions relating to the clas-
sification, packaging and labeling of dangerous substances and preparations, the packaging of
such substances and preparations must be marked legibly and indelibly as follows: ‘Restricted
to professional users.’ By way of derogation, this provision shall not apply to: (a) medici-
nal or veterinary products as defined by Council Directive 65/65/EEC; (b) cosmetic products
as defined by Council Directive 76/768/EEC; (c) motor fuels which are covered by Council
Directive 85/210/EEC, mineral oil products intended for use as fuel in mobile or fixed com-
bustion plants, fuels sold in closed systems (e.g. liquid gas bottles); (d) artists’ paints covered
by Council Directive 88/379/EEC.
The restriction imposes quantitative limits of the presence of extracts of petroleum
distillation, used in the beginning of the basic organic industry chain, on products
to final consumers. Professional use is permitted, and cosmetics, pharmaceuticals,
and fuels are excluded from this regulation. There is a remote possibility of these
substances finish as a residue in the final product, given the very large number of
processes and transformations in which they are involved. The restriction was con-
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sidered to be incompatible to the regulated substances. It was then decided to not
assign any technological areas as impacted by this regulation.
4.2 Findings
In this section I report descriptive statistics on the evolution of the restrictions im-
posed on the different technological areas. Overall, 281 restrictions were linked to
seventeen technological areas. The majority, 145 (51.6%), were linked each to more
than one technological area. Table 4.5 shows the distribution of restrictions per
technological area, and Table 4.6 shows the relative growth of restrictions on each
technological area, from 1976 to 2003.21
Covering the entire Directive three technological areas account for more than 70%
of the total impact. They are: C09, A01, and C08, which received respectively 33.3%,
18.9%, and 19.0% of the total impact mapped. Among the other technological areas
under investigation, none accounted for more than 6.0% of restrictions.
Analyzing the relative stringency growth, three technological areas show increas-
ing relative stringency: A01, C11, and C14. Other four show decreasing relative
stringency: A61, B05, B27, and C02. This can be partially explained by the change
on the organization of the regulation starting from 1997. A common restriction was
established to all substances classified as Carcinogen, Mutagen, and Toxic for Repro-
duction, which were almost all chemicals regulated afterward. In these three classes
the restrictions excluded medicinal products, cosmetics, and fuels which may impact
technological areas A61, B05, and C10. Another feature of this common restriction is
that it imposes limits on substances on final products, thus it diminished the restric-
tions on technological areas mostly related to intermediate products sold to other
firms, or industrial processes which occur to treat other than the core product of the
firm (e.g. may impact technological area C02 which refers also to the treatment of
industrial waste water).
Figure 4.1 shows the evolution of the three most restricted technological areas for
the whole period. Two “jumps” in the number of restrictions of all three most im-
pacted technological areas stand out. These occurred in 1997 and 2003 when amend-
ments added to the regulation inserted the majority of the restricted substances.
The restrictions over the technological areas A01, C08, and C09, were expanded to
its sub-technological areas in order to facilitate the analysis. Next, these IPC groups
are described in more details.
21The complete table with all data is available at the link https://docs.google.com/fileview?
id=0BwlprME39J-LNWE5NWI5NGQtZWY2MC00MDhkLWEwNzQtYzg2ZTNkNDBjZTg4&hl=en_GB or http://tiny.cc/
p7faa.
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Figure 4.1: The evolution of the number of restrictions imposed on the three most regulated
technological areas from 1976 to 2003.
4.2.1 IPC-A01
Agriculture; forestry; animal husbandry; hunting; trapping; and fishing.
The technological area A01 focus on agriculture, forestry, animal husbandry, hunt-
ing, trapping, and fishing. All restrictions classified in this technological area were
related to the subarea A01N, which refers to the preservation of bodies of humans or
animals or plants or parts thereof, including biocides (pesticides and herbicides).
The subarea A01N is directly related to the agrochemicals industry. Part of life-
science, this industry uses as input basic and speciality chemicals, producing formu-
lations directed to other firms or individual consumers.
This finding corroborates with previous studies which cite the agrochemicals in-
dustry as being highly regulated. For example, the regulatory costs of the agrochem-
ical industry has already been the focus of the study by Ollinger and Fernandez-
Cornejo (1998) in the US for the period from 1972 to 1989. Over the investigated
period, the authors found out that the health and environment testing increased from
17% to 47% of total research costs, which negatively affected the number of firms in
the industry, impacting more smaller than larger firms.
4.2.2 IPC-C08
Organic macromolecular compounds; their preparation or chemical working-up; com-
positions based thereon.
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Technological area C08 refers to products and processes related to organic macro-
molecular substances – commonly known as polymers (e.g. rubbers and plastics) –
and their compositions. The measure of regulatory stringency was then expanded
to the sub technological areas, detailed in Table 4.7. The subareas C08K, C08J,
and C08F, with 39.5%, 25.5%, and 14.0% of the total restrictions imposed, exhibited
most of the impact. Table 4.8 shows the measure of regulatory stringency inside the
IPC-C08, and Figure 4.2 the evolution of the most impacted subareas.
Table 4.7: IPC-C08
C08B Polysaccharides; derivatives thereof.
C08C Treatment or chemical modification of rubbers.
C08F Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated
bonds.
C08G Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon
unsaturated bonds.
C08H Derivatives of natural macromolecular compounds.
C08J Working-up; general processes of compounding; after-treatment not covered by subclasses C08B,
C08C, C08F, C08G.
C08K Use of inorganic or non-macromolecular organic substances as compounding ingredients.
C08L Compositions of macromolecular compounds.
Table 4.8: Measure of regulatory stringency for the IPC-C08
Year C08C C08F C08G C08J C08K C08L
1982 1
1983 1 2 2 1
1985 1 2 2 3
1989 3 2 2 3 4
1991 3 2 2 5 4
1996 5 2 4 4 7 4
1997 14 16 11 30 37 4
1999 14 17 11 31 43 4
2003 18 22 11 40 62 4
The subarea C08K refers to the use of inorganic or non-macromolecular organic
substances as compounding ingredients for macromolecular products. Different chem-
icals are added to the a macromolecular substance with the aim of giving certain char-
acteristics and physicochemical properties to the final product, such as malleability,
resistance, color, and others. In the case of the subarea C08K, the compounding ingre-
dients can be, for example, fibers (e.g. asbestos), biocides, paints, inks, lubrificants,
and detergents.
The subarea C08J refers to processes of treating or compounding macromolecular
substances. These include the process of making solutions, powdering, or plasticiz-
ing; the manufacture of shaped articles containing macromolecular substances; chem-
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Figure 4.2: Cumulative number of restrictions imposed on subareas C08F, C08J, and C08K.
ical modification or coating of shaped articles made of macromolecular substances;
working-up of macromolecular substances to porous or cellular articles or materials;
processes of recovery or working-up of waste materials such as solvents, additives,
unreacted monomers and polymers.
Finally, C08F is specific to processes and catalysts used in the development of
macromolecular substances obtained by reactions only involving carbon-to-carbon
unsaturated bonds, which are reactions which occur bonding one carbon atom to
another22.
The development of the link between restricted substances to the subarea C08 was
more difficult to map given the complexity of the technology. The development and
use of polymers are present in all manufacturing industries, as hence this is a techno-
logical area which impacts different industrial sectors. Given these characteristics, it
is not possible to make a direct relation between this technological area to an specific
industrial sector.
Macromolecular technology is used in the automobiles, toys, textiles, furniture,
and in the production of many other products. For example, the automobiles industry
has research on more resistant and non flammable polymers for the production of
cars. Shoes and textiles are other two examples of sectors which also do research
macromolecular technology.
However, there are sectors focused on macromolecular technology, the plastic and
rubber producers. The former is characterized by SMEs which produce a large variety
22Another technological sub-area, C08G, refers to macromolecular substances obtained by otherwise than
above.
78
4.2 FINDINGS
of plastic products, buying resins and different speciality chemicals and developing
formulations. The latter is characterized by a small number of large companies pro-
ducing tires, which account for half of the production value of rubber (Commission,
2004).
Among the restrictions imposed on the majority of substances linked to the C08
technological area the prohibition of several substances on macromolecular products
used on toys and textiles can be highlighted. A more detailed study of the effects of
the stringency of the regulation in this technological area would be necessary to see
which industrial sectors have been most impacted.
4.2.3 IPC-C09
Dyes; paints; polishes; natural resins; adhesives; miscellaneous compositions; miscel-
laneous applications of materials.
Technological area C09 related to a wide branch of products and processes related
to coats, dyes, paints, natural resins, adhesives, and related compositions described in
Table 4.9. After detailed study of the subareas, shown in Table 4.10, it was observed
that four were the most heavily impacted. The main two are C09D and C09B, with
respectively 37% and 32% of all restrictions. The former covers technologies on
paints, inks, related products and processes. The latter mainly covers organic dyes,
its products and processes. The evolution of these two subgroups is described in
Figure 4.3.
Table 4.9: IPC-C09
C09B Organic dyes or closely-related compounds for producing dyes; mordants; lakes.
C09C Treatment of inorganic materials, other than fibrous fillers, to enhance their pigmenting or filling proper-
ties; preparation of carbon black.
C09D Coating compositions; chemical paint or ink removers; inks; correcting fluids; wood stains; pastes or solids
or solids for coloring or printing; use of materials therefor.
C09F Natural resins; french polish; drying-oils; driers (siccatives); turpentine.
C09G Polishing compositions other than french polish; ski waxes.
C09H Preparation of glue or gelatin.
C09J Adhesives; adhesive processes in general (non-mechanical part); adhesive processes not provided for else-
where; use of materials as adhesives.
C09K Materials for applications not otherwise provided for; applications of materials not otherwise provided for.
The other two detached subareas are C09J and C09C, with respectively 14% and
13% of the all restrictions. These two subareas related to adhesives, their products
and processes; and physical and chemical treatment of inorganic materials to improve
their pigmenting and filling properties.
The IPC C09 related directly to the paints and dyes industrial sectors, which has
been also noted in the previous literature as being highly regulated. Porter (1990)
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Table 4.10: Measure of regulatory stringency for the IPC-C09
Year C09B C09C C09D C09J
1976
1979 1
1982 1 1
1983 3 4
1985 3 1 6 2
1989 7 6 11 3
1991 7 7 13 4
1994 7 7 13 4
1996 7 7 20 6
1997 43 21 65 27
1998 43 21 65 27
1999 48 27 74 29
2001 49 27 75 29
2002 49 27 76 29
2003 87 35 102 38
Figure 4.3: Cumulative number of restrictions imposed on only sub-areas C09B and C09D
cited the paints industry as one of the most regulated manufacturing industries in
the US23. In a more recent study, Brusoni (2004) also focused on the European paints
industry, studying the impact of regulation on the reduction of VOC emissions and
the innovative behavior of European firms.
23In his book, he shows that this sector gained competitiveness over the years, and justifies it given the
regulatory constraints it had faced and its innovative capability.
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4.3 Conclusion
One of the main difficulties identified in the economic literature when studying the
impact of environment, health, and safety regulation on firms is finding an appropriate
measure of regulatory stringency. Various proxies have been previously used; however,
finding a quantitative measure, directly related to the industry under study, remains
difficult.
The main purpose of this study has been to develop a quantitative measure of reg-
ulatory stringency in order to examine the relationship between environment, health,
and safety regulation and innovation in the chemical industry. This measure was
created linking regulated substances to the technological areas of the IPC-7, given
the importance of chemicals regulation for the chemical industry.
This chapter has described the methodology used to quantify Council Directive
76/769/EEC from 1976 to 2003, that impacted firms that produced or commercial-
ized regulated chemical substances in the European market. The measure proposed
illustrates the evolution of regulatory stringency over technological areas related to
the chemical industry for almost thirty years.
The results show that the most regulated technological areas are A01N, C08, and
C09, related respectively to agrochemicals, macromolecules, and paints and dyes.
These findings are consistent with previous literature, supporting the methodology
used in this study. Related industrial sectors, agrochemicals, coating, inks and ad-
hesives, are also classified as part of the formulated chemicals sector which is charac-
terized by a high R&D intensity (Commission, 2004).
Even though not all aspects of environmental, health, and safety regulations are
covered, the Council Directive 76/769/EEC concerns large part of impacts caused by
regulations on all industry chain. This measure is directly related to the chemical
industry and opens room for different routes of research on the relationship between
stringent regulation and innovation.
Initially, as a first attempt to correlate the stringency of regulation with innova-
tive activity, it is necessary to compare the evolution of regulatory stringency and
patenting in Europe for the most regulated technological areas. Case studies can
help clarify some aspects of this issue, such as whether the regulated substances in
a specific technological area are crucial for the development of the sector, since they
are key substances in the chemical process. Alternatively, regulated substances are
not relevant in the overall innovation of the technological area, probably by being
easily substituted.
The fact that the measure of regulatory stringency is based on technological areas
causes some common problems for the development of empirical studies. Frequently,
the number of patents is used as a proxy for innovative activity in an industrial
sector. It is frequently noted in the economic literature is that there is no direct
81
4. MEASURING REGULATORY STRINGENCY
relationship between technological areas and industrial sectors, even though some
relational tables try to establish a convergence among both classification systems.
When studying manufacturing industry as a whole, the resulting errors are likely to
be small, but when studying a particular industry, or even sectors within an industry,
classification errors may be problematic for interpretation of empirical results.
Given this problem, there are two different routes for applying this measure in
an empirical study. One route would be to conduct a more extended study across
technological areas. There would be three possible ways of obtaining a list of firms
to have their innovative behavior examined.
The first is to extract a list of firms from the patent documents on the regulated
technological areas. A selected sample of the most representative firms would have
their innovative behavior mapped over time. A second alternative approach would be
to use the list of firms that have notified the regulator the use or commercialization
of new substances in the EU, maintained by the CPS&Q. The third approach would
be to use list of producers and importers of each regulated chemical substance (un-
fortunately there are missing data on some substances’ profiles), found at the ISIC
database.
Studying the patenting behavior of these firms along with the evolution of regula-
tory stringency could be analyzed if the regulation induced a change in the innovative
path or if a technological area was substituted by others. If the research were to fo-
cus just on the regulated technological areas, it would not be able to highlight these
changes.
For instance, the stringent regulatory framework imposed over time on the agro-
chemicals industry may have induced more investment in R&D related to genetically
modified organisms (GMOs). Instead of using chemicals to avoid certain diseases,
a new strain of plant resistant to the disease might be designed. A more extended
study on the innovative behavior of firms which were patenting on the technological
areas which have suffered from regulatory stringency would be necessary if we are to
analyze whether a technological area was substituted by another. GMOs may be a
substitute for agrochemicals, but their development is part of another field: biotech-
nology. This means that a fall in innovative activity in a technological area which
had a growth in its regulatory stringency does not mean necessarily that firms inno-
vated less. In other words, heavy regulation on a technological area can incentivize
investments on other technological areas, or even the development of new fields of
technology. These three approaches correlated to other firm level data opens new
possibilities of more detailed empirical studies.
The second route would be to use the measure of regulatory stringency developed
in this research as a proxy for econometric studies on the previous cited industrial
sectors, particularly associated with the most regulated technological areas. Even
though there are several problems when transferring technological area data to in-
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dustrial sectors, the quantitative measure on A01N, C09B, and C09D are found to be
a consistent proxy of regulatory stringency on, respectively, agrochemicals, organic
dyes, and coating, paints and inks industrial sectors. This would open the possibility
of replicating previous empirical studies on a specific sector with firm level data.
The main advantage of the methodology developed in this research is that it
creates new approaches for studying the relationship between stringent regulation
and innovation.
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Chapter 5
Innovation in Regulated
Technological Areas
The study on the EU Council Directive 76/769/EEC in Chapter 4 analyzed the
evolution of the restrictions imposed on the use of and market for chemical substances
from 1976 to 2003. Each substance and its restriction was associated with the different
technological fields linked to the chemical industry. This chapter investigates the
evolution of patenting activity in these highly regulated technological areas from
1990 to 2006, from 1990 to 2006, a period during which two big jumps in the level of
regulatory stringency occurred.
The starting point of the analysis is the measure of regulatory stringency de-
veloped in the previous chapter. This measure shows that within the most heavily
regulated technological fields – A01, C08, and C09 – the most impacted areas are
A01N associated with agrochemicals; C08F, J, and K associated with organic macro-
molecular compounds; and C09B and D associated with dyes, paints, resins among
other compositions.
In order to overcome the restrictions imposed on the use of certain substances,
firms might pursue different strategies. For instance, firms might substitute the
regulated substance, change the process route, or acquire end-of-pipe equipment, new
control systems (for its processes), or more precise tools to measure residues in the
final product. Differently from previous studies which use firm-level data and employ
indirect proxies of regulatory stringency, I look at the overall patenting activity in
the most heavily regulated areas.
This chapter is organized as follows. Section 5.1 describes the data used. Section
5.2 discusses four research questions suggested by the economic literature regarding
the relationship between regulation and innovation, and also details the methodology
employed for the investigation. Section 5.3 reports the analyses developed for each
technological area. Section 5.4 concludes this chapter.
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5.1 Data
The measure of regulatory stringency is the starting point and motivation of this
chapter. Table 5.1 summarizes the evolution of this measure for those technological
fields that were most heavily impacted by the EU chemicals regulation: A01, C08,
and C09. As observed in the previous chapter there were two jumps in stringency,
in 1997 and 2003, and the areas mostly regulated in the impacted fields are A01N;
C08F, J, and K; and C09B and D.
Table 5.1: Measure of regulatory stringency for the most regulated technological areas
Year A01N C08C C08F C08G C08J C08K C08L C09B C09C C09D C09J
1976
1979 1
1982 1 1 1
1983 1 2 2 1 3 4
1984 1 2 2 1 3 4
1985 1 1 2 2 3 3 1 6 2
1986 1 1 2 2 3 3 1 6 2
1987 1 1 2 2 3 3 1 6 2
1988 1 1 2 2 3 3 1 6 2
1989 5 3 2 2 3 4 7 6 11 3
1990 5 3 2 2 3 4 7 6 11 3
1991 5 3 2 2 5 4 7 7 13 4
1992 5 3 2 2 5 4 7 7 13 4
1993 5 3 2 2 5 4 7 7 13 4
1994 5 3 2 2 5 4 7 7 13 4
1995 5 3 2 2 5 4 7 7 13 4
1996 5 5 2 4 4 7 4 7 7 20 6
1997 61 14 16 11 30 37 4 43 21 65 27
1998 61 14 16 11 30 37 4 43 21 65 27
1999 69 14 17 11 31 43 4 48 27 74 29
2000 69 14 17 11 31 43 4 48 27 74 29
2001 71 14 17 11 31 43 4 49 27 75 29
2002 72 14 17 11 31 43 4 49 27 76 29
2003 104 18 22 11 40 62 4 86 35 101 38
% 100% 12% 14% 7% 26% 40% 3% 33% 14% 39% 15%
100% 100% 100%
As observed, all the 104 restrictions imposed on the technological field A01 were
associated with area A01N. In field C08, areas C08F, J, and K received 22, 40, and 62
restrictions respectively, corresponding to 80% of the overall number of restrictions
imposed on this field. Finally, C09 received 260 restrictions, and the most impacted
areas were C09B, and D, with 86 and 101 restrictions respectively, equivalent to 72%
of the total restrictions over the field.
Some aspects associated with these technological areas and their importance to
the chemical industry must also be pointed out. Several reports relate technological
fields to industrial sectors. The work by Schmoch, Laville, Patel, and Frietsch (2003)
developed a concordance table between technological areas and industrial sectors
studying patenting applications on US, Japan, Germany, France, and UK, from 1997
to 1999.1
Each industrial sector was associated with one or more technological areas. Specif-
1They considered all applicants with at least five patent applications over this period.
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ically, pesticides and agrochemical products (NACE code 24.2) is linked just to one
technological area, A01N. Thus, the evolution of area A01N can be a good proxy to
evaluate the evolution of the innovation on pesticides and agrochemical products.
Conversely, given the complexity and variety of products and processes, the basic
chemicals sector (NACE code 24.1) is associated with forty one areas, including C08F,
C08J, C08K, C09B, and C09D. Thus, one cannot associate the evolution of the other
five technological areas here analyzed to this industrial sector.
In the analysis that follows I use patent applications as a proxy for innovative
activity. It is well known that chemical firms have a high propensity to patent their
inventions. This fact is highlighted in the OECD Patent Manual (OECD, 1994, pg.
41):
Some fields of technology lend themselves better to patenting than others. In electronics,
for example, the patenting process may not keep up with fast-moving technological
advance, so a firm may prefer to keep its inventions secret rather than seek patent
protection. [. . . ] In other fields (chemicals and engineering, to cite just two leading
areas), filing for a patent is the usual way for a firm to protect itself in the market.
Therefore, patents represent a good proxy that reflects innovative activity of the
chemical industry and consequently chemicals technology. In addition, using patent
applications a direct relationship can be established between innovation and the mea-
sure of regulatory stringency given that both use the IPC classification.
Given that the regulation I am considering affects the production and market
of products in the EU, it is reasonable to study the impact of this regulation over
innovative activity in the EU. After highlighting the most regulated technological
fields, the data on patent applications was extracted from the ESPACE Bulletin
database maintained by the European Patent Office (EPO).
The ESPACE database was chosen given the easy access to bibliographic data of
all patents applied, published, and granted in Europe since the EPO was founded.
There are more than seventy search fields, such: applicant’s country, date of filing,
applicant(s), designated contracting states, proprietor’s country, proprietor(s), clas-
sifications advanced level, all classification, inventor’s country, inventor(s), English
title, among others. The entire document can be extracted, as well as a database
format file with all information regarding patents resulted from the search.
The number of patent applications received by each EU country from 1990 to 2005
for technological fields A01, C08, and C09, are shown in Table 5.2.2 It is interesting
to observe that for most countries there are two peaks in the level of patenting
activity, the first around 1990 and the second around 2000. The table also shows
that three countries received the largest number of applications: Germany (DE),
2In this Table it was considered the first fifteen countries to join the European Community: Austria,
Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, Portugal,
Spain, Sweden, and Great Britain.
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Great Britain (GB), and France (FR). These three countries represent the largest
chemical producers and the leading economies in the EU. Germany represents 26%
of the share of chemicals sales, around 296 billion of euros; France represents 13%;
and the UK, 12% (Hadhri and Weigel, 2006).
Table 5.2: Total number of patent applications per country of filling from 1990 to 2005
A01
Year AT BE DK FI FR DE GR IE IT LU NL PT ES SE GB
1990 1,113 1,369 1,175 1,763 1,802 671 1,573 813 1,519 1,276 1,074 1,711
1991 974 1,123 1,009 1,516 1,516 815 1,337 743 1,281 1,157 924 1,449
1992 953 1,101 985 1,549 1,561 739 255 1,346 639 1,262 452 1,129 899 1,454
1993 872 996 913 1,423 1,454 686 688 1,194 613 1,195 716 1,051 893 1,375
1994 949 1,104 958 1,536 1,550 777 775 1,302 645 1,251 806 1,129 936 1,469
1995 926 1,115 967 1,636 1,650 775 782 1,394 625 1,323 804 1,163 973 1,586
1996 1,069 1,228 1,092 697 1,735 1,758 874 889 1,483 717 1,379 921 1,320 1,073 1,641
1997 1,199 1,351 1,276 948 1,960 1,961 1,016 1,040 1,724 832 1,560 1,064 1,471 1,180 1,874
1998 1,393 1,539 1,464 1,140 2,177 2,189 1,144 1,217 1,904 994 1,683 1,200 1,638 1,316 2,071
1999 1,790 1,835 1,800 1,638 2,340 2,353 1,637 1,657 2,134 1,558 1,990 1,659 1,945 1,735 2,266
2000 2,170 2,189 2,187 2,133 2,534 2,545 2,136 2,134 2,389 2,121 2,251 2,126 2,255 2,132 2,453
2001 2,075 2,091 2,071 2,041 2,321 2,332 2,042 2,037 2,207 2,038 2,124 2,044 2,118 2,061 2,268
2002 2,013 2,041 2,053 1,992 2,303 2,306 2,000 1,993 2,150 1,989 2,097 2,000 2,087 2,023 2,236
2003 1,950 1,986 1,986 1,952 2,206 2,203 1,952 1,948 2,072 1,945 2,028 1,951 2,006 1,967 2,146
2004 1,852 1,886 1,864 1,855 2,044 2,055 1,853 1,850 1,968 1,847 1,902 1,852 1,899 1,867 1,992
2005 1,967 1,990 1,969 1,960 2,107 2,118 1,961 1,963 2,050 1,959 1,985 1,961 2,004 1,974 2,087
C08
Year AT BE DK FI FR DE GR IE IT LU NL PT ES SE GB
1990 2,098 3,193 1,685 4,736 4,887 1,142 3,991 1,395 3,629 2,836 2,514 4,829
1991 1,683 2,564 1,454 4,121 4,245 1,159 3,420 1,167 2,992 2,390 2,009 4,194
1992 1,628 2,510 1,428 4,095 4,225 1,032 367 3,386 1,024 2,948 684 2,370 1,994 4,154
1993 1,584 2,463 1,248 4,035 4,142 934 935 3,325 915 2,838 1,070 2,396 1,882 4,066
1994 1,521 2,303 1,181 3,879 4,035 814 869 3,245 772 2,811 959 2,309 1,730 3,934
1995 1,525 2,259 1,149 3,813 3,991 811 842 3,192 729 2,686 956 2,243 1,682 3,843
1996 1,575 2,342 1,242 926 4,047 4,218 887 976 3,382 809 2,821 1,036 2,423 1,787 4,081
1997 1,703 2,507 1,287 1,289 4,281 4,456 974 1,051 3,601 917 2,963 1,149 2,638 1,908 4,284
1998 1,772 2,621 1,500 1,478 4,328 4,479 1,173 1,247 3,671 1,133 3,000 1,326 2,783 2,028 4,298
1999 2,236 2,812 2,114 2,116 4,517 4,701 1,940 1,996 3,802 1,890 3,211 2,021 2,999 2,396 4,483
2000 2,987 3,195 2,902 2,917 4,506 4,662 2,878 2,897 3,867 2,887 3,363 2,882 3,276 2,932 4,476
2001 3,036 3,234 2,926 2,929 4,412 4,595 2,901 2,924 3,837 2,949 3,378 2,900 3,270 2,960 4,398
2002 3,052 3,214 3,016 3,017 4,142 4,274 3,005 3,011 3,603 3,017 3,275 3,010 3,225 3,064 4,126
2003 3,093 3,242 3,092 3,105 4,184 4,340 3,082 3,099 3,670 3,095 3,363 3,088 3,316 3,136 4,202
2004 3,133 3,258 3,122 3,136 4,078 4,181 3,122 3,134 3,574 3,132 3,323 3,129 3,262 3,143 4,045
2005 3,262 3,382 3,249 3,269 4,130 4,252 3,249 3,267 3,677 3,260 3,433 3,250 3,400 3,268 4,082
C09
Year AT BE DK FI FR DE GR IE IT LU NL PT ES SE GB
1990 917 1,308 793 2,156 2,294 487 1,692 594 1,442 1,219 1,112 2,265
1991 786 1,121 723 1,940 2,085 542 1,569 533 1,289 1,106 977 2,042
1992 765 1,117 704 2,066 2,176 472 183 1,640 458 1,333 358 1,126 978 2,138
1993 797 1,120 669 2,064 2,151 478 457 1,610 419 1,297 551 1,157 928 2,110
1994 806 1,130 670 2,122 2,208 464 491 1,691 411 1,357 538 1,200 945 2,158
1995 771 1,069 651 2,123 2,259 425 441 1,706 366 1,321 490 1,141 931 2,204
1996 805 1,092 685 490 2,169 2,289 442 518 1,693 425 1,314 551 1,204 962 2,242
1997 882 1,175 755 680 2,342 2,476 525 616 1,810 481 1,472 624 1,309 1,040 2,419
1998 818 1,085 724 661 2,254 2,363 525 601 1,751 500 1,349 636 1,269 946 2,294
1999 1,111 1,301 1,076 1,063 2,363 2,493 964 1,026 1,880 930 1,516 1,013 1,469 1,196 2,405
2000 1,515 1,558 1,451 1,459 2,371 2,451 1,437 1,452 1,941 1,441 1,668 1,430 1,680 1,464 2,374
2001 1,662 1,702 1,582 1,583 2,448 2,524 1,558 1,572 2,021 1,565 1,791 1,561 1,767 1,606 2,464
2002 1,718 1,756 1,687 1,688 2,417 2,483 1,673 1,679 2,001 1,676 1,863 1,675 1,820 1,701 2,425
2003 1,777 1,808 1,765 1,768 2,454 2,531 1,754 1,754 2,077 1,751 1,948 1,753 1,909 1,777 2,469
2004 1,692 1,745 1,695 1,699 2,260 2,347 1,682 1,686 1,915 1,684 1,826 1,684 1,771 1,709 2,270
2005 1,836 1,882 1,842 1,846 2,385 2,485 1,827 1,835 2,064 1,828 1,988 1,828 1,911 1,840 2,404
Since a firm needs to patent its invention in each country where it seeks to be
guaranteed protection, then the number of inventions in the EU per year is smaller
than the sum of patent applications in these countries for that specific year. In other
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words, in Table 5.2 the same innovation appears several times, once for each country
where the patent was applied.
In order to avoid double counting the patents in my analysis, instead of considering
each EU country I will focus on Germany as a representative of the total applications
in the EU. Through out the period investigated, Germany has been the country where
the largest number of patents were sought. Therefore, it is reasonable to believe that
the vast majority of innovations applied in the EU were also applied in Germany.
5.2 Research questions
In this chapter I will concentrate on the relationship between regulatory stringency
and innovative activity, to check whether and how tighter restrictions affect innovative
behavior of economic agents. However, given that innovative activity of firms depends
on a number of different issues, the findings that I am going to highlight must be
interpreted as initial evidence. It is useful to start with a summary of the main issues
raised by the economic literature and reviewed in Chapter 3.
Since 1990, the Porter Hypothesis has been at the center of this debate. Contra-
dicting the orthodox view according to which a stricter regulation harms firms, Porter
asserts that stricter environmental regulation induces firms to innovate, leading to a
competitive advantage. As illustrated in Chapter 3, Jaffe and Palmer (1997, pg. 610)
identified three possible interpretations of the Porter Hypothesis:
1. Some kinds of environmental regulation – specifically the ones that focus in outcomes rather
than processes – provide incentives for innovation.
2. Environmental regulation stimulates some types of innovations, since it constrains a firm’s
profits and, as a result, the firm will rearrange their investments focusing in certain kinds of
R&D.
3. A new regulation induces firms to look for new products and processes that will obey the
regulation and also be more profitable.
This Chapter investigates these interpretations for each regulated technological
field.
As detailed in Chapter 3 and measured in Chapter 4, chemicals regulation focuses
on outcomes rather than processes. Consequently, according to the first interpreta-
tion, the increase of regulatory stringency will incentivize innovation.
The second and third interpretations are both associated with the change in the di-
rection of innovative activity. They state that regulatory stringency will influence the
kind of innovation that will be pursued by the firm. The motivation for this change
in innovative activity is what distinguishes them. According to the second interpre-
tation, firms change the direction of their research because they have their profits
constrained, while according to the third, firms change the focus of their research to
comply with the regulation. This chapter investigates four research questions.
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Did regulation spur patenting activity?
The first question addressed analyzes whether an increase in the stringency of
regulation incentivizes firms to innovate more. In the light of the first interpretation of
the Porter hypothesis, an increase in the regulatory stringency encourages innovative
activity. To answer this question firstly, two different aggregate levels of panel data
with fixed-effect are estimated.
npatit = α + βrestrictit + uit (5.1)
• npatit: number of patents per IPC class per year
• restrictit: number of restrictions imposed per IPC class per year
• t: year, from 1990 to 2006
• i: IPC classes
The first panel considers patent applications from the twenty seven IPC classes
belonging to the three most regulated groups: A01, C08, and C09. Among these
classes, eleven are restricted and sixteen unrestricted by this regulation. The second
panel considers just the eleven restricted classes.
Secondly, I examine the evolution of the number of patent applications in the most
heavily regulated technological areas. As explained above, the orthodox and Porterian
views about the effect of regulation on innovation are divergent. In particular, and
given the characteristics of regulation under analysis (product regulation), in the light
of the first interpretation of the Porter hypothesis an increase in the stringency of
regulation incentivizes firms to innovate more.
In order to verify if the most heavily regulated technological areas followed the
average of their respective field, the evolution in the number of applications in a
given technological area and the share with respect to the patents applied in the
technological field are examined. Therefore, the question addressed is whether a
technological area (e.g. A01N) increased more or less in comparison to its field (e.g.
A01).
In addition, to evaluate whether the two jumps in regulatory stringency (in 1997
and 2003) had an effect on patenting two regressions were computed. Dummy vari-
ables were used to identify the two regulatory jumps. In these regressions I analyzed
whether regulation caused an effect in the number or in the rate of growth of patent
applications.
The first regression proposed investigates whether regulation did not affect the
number of patent applications (H0) against the alternative hypothesis that regula-
tion caused a fall or an increase in the number of patent applications (H1). The
regression and hypotheses are the following:
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nt = α + βt+ γ1d1t + γ2d2t + ut (5.2)
• H0 : γ1 = 0 against H1 : γ1 6= 0
• H ′0 : γ2 = 0 against H
′
1 : γ2 6= 0
• H ′′0 : γ1 = γ2 = 0 against H
′′
1 : ¬(γ1 = γ2 = 0)
The second regression proposed is a spline. The aim is to verify if there was a
change in the rate of growth of patent applications after the regulatory jumps (t1 =
1997 and t2 = 2003). The spline enables to compare the rate of growth of a certain
period with the previous one. Thus, if regulation did not affect the rate of growth of
patent applications (H0) against the alternative hypothesis that regulation caused a
fall or an increase in the rate of growth of patent applications (H1). The regression
and hypotheses are the following:
nt = (α + βt) + β
′
(t− t1)d1t + β ′′(t− t2)d2t + ut (5.3)
• H0 : β′ = 0 against H1 : β′ 6= 0
• H ′0 : β
′′
= 0 against H
′
1 : β
′′ 6= 0
• H ′′0 : β
′
= β
′′
= 0 against H
′′
1 : ¬(β
′
= β
′′
= 0)
Taking into account that there might have been a time-lag between the year when
regulation becomes stricter and the year when this has an effect on patenting, I
performed two sets of regressions. First, with no lag effect so that the 1997 jump
in regulatory stringency has an effect up to 2002, while the 2003 jump will have
any effects from 2003 to 2006. Second, with one year time-lag so that the jumps in
regulatory stringency have an effect from 1998 to 2003 and from 2004 to 2006.
• nt: number of patents in a technological area per year
• t: year, from 1990 to 2006
– d1 = 1 ∀ t ∈ [1997, 2002], zero otherwise
– d2 = 1 ∀ t ∈ [2003, 2006], zero otherwise
• or
– d1 = 1 ∀ t ∈ [1998, 2003], zero otherwise
– d2 = 1 ∀ t ∈ [2004, 2006], zero otherwise
These regressions have drawbacks due to the short period of investigation. The
hypothesis tests will be valid to check for possible influences in the number or rate of
growth of patenting in regulated technological areas, although perhaps not powerful
given the small sample size. The regressions results are discussed in the following
sections and the complete tables with all parameters are provided in the Appendix
C.
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Has there been a change in the country of origin of patents?
As emphasized in Chapter 3, a central concern about regulation is that it might
cause the delocalization of production towards the so-called “pollution havens.” This
argument, which is strongly advocated by the orthodox view, states that restrictive
regulation increases production costs, justifying the belief that the impact of envi-
ronmental regulation causes loss of competitiveness and can induce firms to move to
countries where the marginal social cost of production would be lower, as people in
less regulated countries would have a lower marginal valuation on the environment.
Even though I do not investigate the location of chemical plants, I acknowledge
that regulation might have impact over location of R&D activities. Chemical plants,
mainly basic and intermediate chemicals, are not easily relocated. Still, regulation
may divert resources from firms located in the EU that would otherwise be employed
in R&D.
In order to study this issue I examine whether a change in the origin of innovative
activity occurred over the period of increasing regulatory stringency in the European
Union. I focus on the share of patents originating from EU and non-EU countries to
check whether there has been a significant change over the period under investigation.3
Two sets of regressions are computed using as dependent variable the difference
between non-EU and EU patent applications. The aim is to observe whether the two
jumps in regulatory stringency (in 1997 and 2003) caused an impact in the absolute
number or in the trend of the difference between non-EU and EU patent applications.
The regressions are similar to Equations 5.2 and 5.3, with dummy variables being
used to identify the two regulatory jumps.
The first regression verifies if regulation did not affect the the difference between
non-EU and EU patent applications (H0) against the alternative hypothesis that
regulation caused a an increase or decrease of this difference (H1). If this difference
increases it is because increased the number of patents applied in Germany originated
from non-EU countries. The regression and hypotheses are the following:
dpatentt = α + βt+ γ1d1t + γ2d2t + ut (5.4)
• H0 : γ1 = 0 against H1 : γ1 6= 0
• H ′0 : γ2 = 0 against H
′
1 : γ2 6= 0
• H ′′0 : γ1 = γ2 = 0 against H
′′
1 : ¬(γ1 = γ2 = 0)
3From 1990 to 1994 there were twelve countries (EU12): Belgium, Denmark, France, Germany, Greece,
Ireland, Italy, Luxembourg, Portugal, Spain, The Netherlands, and United Kingdom. From 1995 to 2003
there were fifteen EU countries (EU15): (adding) Austria, Sweden, and Finland. From 2004 to 2006 it
was considered the twenty five EU countries (EU25): (adding) Czech Republic, Cyprus, Estonia, Latvia,
Lithuania, Hungary, Malta, Poland, Slovenia, and Slovakia.
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The second regression is the spline to check whether there was a change in the
trend of this difference (between non-EU and EU applications in Germany) after the
regulatory jumps (t1 = 1997 and t2 = 2003) in comparison to the previous period.
Hence, if regulation did not affect this trend (H0) against the alternative hypothesis
that regulation caused a fall or an increase in this trend. The regression and hypothe-
ses are the following:
dpatentt = (α + βt) + β
′
(t− t1)d1t + β ′′(t− t2)d2t + ut (5.5)
• H0 : β′ = 0 against H1 : β′ 6= 0
• H ′0 : β
′′
= 0 against H
′
1 : β
′′ 6= 0
• H ′′0 : β
′
= β
′′
= 0 against H
′′
1 : ¬(β
′
= β
′′
= 0)
To better investigate a possible effect on the origin of the innovative activity a
one-year lag effect was also considered.
• dpatentt = (non-EU patents − EU patents), for a given technological area per year
• t: year, from 1990 to 2006
– d1 = 1 ∀ t ∈ [1997, 2002], zero otherwise
– d2 = 1 ∀ t ∈ [2003, 2006], zero otherwise
• or
– d1 = 1 ∀ t ∈ [1998, 2003], zero otherwise
– d2 = 1 ∀ t ∈ [2004, 2006], zero otherwise
The results are discussed in the following sections and the complete tables con-
taining all parameters are provided in the Appendix C.
Has there been any increase in patenting concentration?
Mahdi, Nightingale, and Berkhout (2002) state that even though regulatory strin-
gency might induce market concentration, bigger firms can take advantage of their
scale of production and spread the cost of compliance with the regulation over a
larger amount of production. Thus, one large firm might innovate more than several
small firms. Therefore, I decided to analyze whether a stricter regulation has induced
a concentration in the patenting activity.
The procedure developed for this analysis was the following. I downloaded from
the ESPACE Bulletin database information on all patents classified in the technolog-
ical areas under concern for the years 1990 and 2006. This data includes the name
and the country of the applicant among other information.
Next, I identified two groups of applicants: “top ten applicants” (first ten entities
in terms of the number of applications in a given technological area, in a given year),
and “small players” (those entities which applied for a single patent in the specified
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area in a given year). Subsequently, I compared the share of patent applications by
these two groups in the years 1990 and 2006, to investigate if stricter regulation might
have caused a concentration of innovative activity.
The ideal would be to have a proper measure of concentration or even better to
data on the distribution of the number of applications per firm, per year. Given this
impossibility, looking at these two samples – number of applications by the top ten
applicants and the “small players” – can suggest possible changes in these distributions
and give hints to help future research.4
Has there been a change in the direction of patenting?
As previously discussed, Eads (1980) states that regulation might also impact
the direction of innovative activity. Even though several authors have stressed the
importance of this issue, there is a lack of empirical analysis to demonstrate whether
or not it occurs.
The Oslo Manual (OECD, 1997a, pg. 12) describes the information which can be
obtained from the analysis of patent statistics:
Patent statistics are increasingly used in various ways by technology students as indi-
cators of the output of invention activities. The [. . . ] examination of the technologies
patented can give some hints on the directions of technological change.
Patent information is then used to verify if there was a change in the direction
of innovative activity from 1990 to 2006. In fact, the Patent Manual states (OECD,
1994, pg. 58):
The fields in which a firm takes out patents indicate its technology profile. This can be
expressed numerically, as a percentage of the firm’s patent filings by technology sector.
[. . . ] the firm’s specialization profile [. . . ] will partly reflect the firm’s innovation policy
decisions or marketing and competition strategies.
In addition (OECD, 1994, pg. 59):
Patents can be particularly helpful in identifying the direction taken by the R&D and
innovation effort of a firm [. . . ] The patent portfolios of large firms can be investigated
in order to study a company’s innovation strategy, its technological diversification and
how different fields of knowledge are combined in the firm’s activity.
In order to verify whether there was a change in the direction of innovation, I study
the evolution of IPC codes linked to the highly regulated technological areas. The
4The main pitfall of the data used in this examination was the fact the applicant name is often written
with variations in each document. Extra spaces, commas, periods, or even the applicant name written
in extent or in shorter forms made this analysis lengthly for a more accurate result. This made difficult
to identify the distributions of patent applications by firms for each technological area and their standard
deviations.
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study of the relationship of these different IPC codes can illustrate the technological
trends in a given period of time.
Patent applications are classified under one or as many IPC codes needed to
describe the innovation, its different characteristics, functionalities, and usages. As
more complex or multidisciplinary the innovation, the patent application will be
associated with more IPC codes. For example, the US E.I. Du Pont de Nemours and
Company applied the patent “Novel heterocyclic amidines and guanidines as plant
fungicides” in 1990. In order to describe this innovation, the selected codes were
C07D, indicating that it is an acyclic or carbocyclic compound, and A01N indicating
that it is used as a biocide.
Another example is the following. The firm Arkema France and the Centre Na-
tional de la Recherche Scientifique (FR) applied in 2006 the patent named “Polymer
materials containing dispersed carbon nanotubes.” The patent was classified under
these six different technological areas, all defined in Table 5.3.
Table 5.3: IPC Classification of the patent application “Polymer materials containing dis-
persed carbon nanotubes”
IPC code Definition
C01B Non-metallic elements; Compounds thereof
C08K Use of inorganic or non-macromolecular organic substances as compounding ingredients
C08L Compositions of macromolecular compounds
C09D
Coating compositions, e.g. paints, varnishes, lacquers; Filling pastes; Chemical paint or ink removers; Inks; Cor-
recting fluids; Wood stains; Pastes or solids for coloring or printing; Use of materials therefor
F16L
Pipes; Joints or fittings for pipes; Supports for pipes, cables or protective tubing; Means for thermal insulation in
general
H01B Cables; Conductors; Insulators; Selection of materials for their conductive, insulating, or dielectric properties
Starting from the classification codes the researcher can “read” the innovation and
comprehend it better, even without reading all patent document. For example, this
innovation is an electrically-conducting paint (C09D), given that it contains a con-
ductive material dispersed in non-conductive organic material (H01B). Accordingly,
it is a coating composition made of a mixture of different polymers (C08L), containing
a nonmetallic element – carbon – (C01B), and a non-macromolecular organic sub-
stance as compounding ingredient on a macromolecular compound (C08K), which was
engineered in the format of flexible pipes, nanotubes (F16L).
In order to study the technologies associated with area, for example C09D, in 1990
or 2006, the following procedure was adopted. First, all patents applied under the
classification code C09D were downloaded for the year under investigation. The set
of other codes linked to the area under consideration was recorded, the code for the
area itself being excluded.
Second, in the analysis each patent received equal weight. To obtain the patent
application profile in a given year, relative value of the classification codes per patent
was calculated. If the patent was classified under two codes, each code received
95
5. INNOVATION IN REGULATED TECHNOLOGICAL AREAS
weighting of “0.50”, if it was classified under four codes, each received weighting of
“0.25” and so forth. The sum of these weights reflects the most important codes,
portraying the innovative profile at a given time. The larger the total score of a code,
the more closely linked to the investigated area it is.
An example is provided in Table 5.4, with ten patent applications involving techno-
logical area C09B. As a result, the “patent profile” has as most important technological
areas associated with code C09B, codes C07D and G03G with 17.5% each.
Table 5.4: Example to calculate the “patent profile” in technological area C09B
Patent C09B A61K A61P A61Q C07C C07D C07K C08B D06P G01N G02F G03G G11B H04N
P
# 1: C07D C07K C08B C09B x 1 1 1 3
# 2: C07D C09B G01N x 1 1 2
# 3: C07D C09B G01N G11B x 1 1 1 3
# 4: A61K A61Q C07C C09B D06P x 1 1 1 1 4
# 5: A61K A61Q C07D C09B x 1 1 1 3
# 6: C07D C09B G02F G03G G11B x 1 1 1 1 4
# 7: A61K A61P C07C C09B x 1 1 1 3
# 8: C09B G03G x 1 1
# 9: C09B G03G H04N x 1 1 2
# 10: C09B D06P x 1 1
# 1: C07D C07K C08B C09B x 0.33 0.33 0.33 1.00
# 2: C07D C09B G01N x 0.50 0.50 1.00
# 3: C07D C09B G01N G11B x 0.33 0.33 0.33 1.00
# 4: A61K A61Q C07C C09B D06P x 0.25 0.25 0.25 0.25 1.00
# 5: A61K A61Q C07D C09B x 0.33 0.33 0.33 1.00
# 6: C07D C09B G02F G03G G11B x 0.25 0.25 0.25 0.25 1.00
# 7: A61K A61P C07C C09B x 0.33 0.33 0.33 1.00
# 8: C09B G03G x 1.00 1.00
# 9: C09B G03G H04N x 0.50 0.50 1.00
# 10: C09B D06P x 1.00 1.00
“patent profile” 9.1% 3.3% 5.8% 5.8% 17.5%3.3% 3.3% 12.5%8.3% 2.5% 17.5%5.8% 5.0% 100.0%
If the same analysis is undertaken after a period of time it may be observed
whether or not a change in the direction of innovative activity occurred. Thus, this
last research question analyzes whether the commonly associated technological areas
gained or lost importance after the increase in regulatory stringency. This relationship
characterizes the direction of the technological development and a change in the most
associated technological areas may infer a change in the pattern of investments in
R&D by the majority of the applicants. This new path can also provide indications of
whether there were changes in the direction and if they were caused by the regulation
imposed between 1990 and 2006. The Pearson χ2 test is calculated and the complete
table with all results are provided in the Appendix D.
In addition, I will further ask whether the “patent profile” represents a process or
product innovation. In the case of new products, I will ask whether the patent relates
to new formulation of existing substances (meaning incremental development) or if it
relates instead to new substances (true novel developments). The following analyses
will help clarify how this can be observed.
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5.3 Empirical analysis
5.3.1 Aggregate level: The Porter hypothesis
This analysis verifies if regulatory restrictiveness impacted positively or negatively
innovation. Two groups of IPC classes were proposed to build the panels. Table 5.5
shows the results for these panels with no lag (restrict), one-year (L1), and two-year
(L2) lag variation.
Table 5.5: Aggregate: 1990 – 2006
Sample Coefficient t-value P > |t|
A01, C08, C09
restrict 3.168 6.14 0.000 F(1,431) = 37.67 (0.000)
L1 3.411 6.63 0.000 F(1,404) = 44.02 (0.000)
L2 3.405 6.06 0.000 F(1,377) = 36.74 (0.000)
11 restricted classes
restrict 3.168 4.47 0.000 F(1,175) = 19.98 (0.000)
L1 3.411 4.94 0.000 F(1,164) = 24.43 (0.000)
L2 3.405 4.49 0.000 F(1,153) = 20.16 (0.000)
Both panels show that regulatory stringency has impacted positively patenting
activity, supporting the Porter hypothesis. The best results are observed with one
year lag-effect.
5.3.2 IPC-A01
Agriculture; forestry; animal husbandry; hunting; trapping; and fishing.
Evolution of patenting activity
Table 5.6 illustrates the evolution of the number of patent applications in the field
A01, its area A01N, and the share (A01N/A01). The technological field A01 experi-
enced an increase of 26% in the number of applications from 1990 to 2006. However,
starting from 2000 the number of applications have been declining.
Table 5.6: Patent applications in Germany: Evolution of patenting in IPC-A01 and A01N
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
A01 1802 1516 1561 1454 1550 1650 1758 1961 2189 2353 2545 2332 2306 2203 2055 2118 2267
A01N 940 768 791 724 746 756 850 897 901 913 929 801 946 870 778 918 1023
A01N/A01 0.52 0.51 0.51 0.50 0.48 0.46 0.48 0.46 0.41 0.39 0.37 0.34 0.41 0.39 0.38 0.43 0.45
The regulated area A01N increased less than its field, by 9% from 1990 to 2000.
Thus, the share of A01N has decreased over time, from 52% in 1990 to 45% in 2006.
Given that the area A01N does not show the same decreasing trend over the 2000s as
its field, since 1998 the share has remained somehow stable, with a noticeable increase
in the last two years.
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I also computed two regressions in order to verify if regulation caused a fall in
the number of patent applications or in the rate of growth. Summarized results are
illustrated in Table 5.7.5
Table 5.7: A01N: Modeling patents by OLS
Sample: 1990 - 2006 Sample: 1991 - 2006 (1 year lag)
Coefficient t-value P > |t| Coefficient t-value P > |t|
Equation 5.2
d_1 108.999 1.320 0.211 8.627 0.115 0.911
d_2 114.257 0.851 0.410 -43.742 -0.366 0.721
F(3,13) = 2.352 (0.120) F(3,12) = 3.931 (0.036)
Equation 5.3
d_1 t 27.246 1.780 0.098 11.816 0.760 0.462
d_2 t 56.328 1.660 0.120 36.954 0.851 0.411
F(3,13) = 2.911 (0.075) F(3,12) = 3.85 (0.038)
Starting with the non-lag regressions (left column) non of the null hypotheses are
rejected. Turning to the lagged regressions (right column) I fail to reject H0 and H
′
0
but marginally rejects H ′′0 . These offers at most weak evidence for regulatory effect.
In summary, technological area A01N increased although not as much as its field.
Additionally, the regressions showed no clear impact of regulation on patent applica-
tions in this technological area.
Geographic origin of patent applications
The country of origin of innovations for which application was made in Germany for
the area A01N experienced major changes over this period. Table 5.8 which looks at
the picture of the evolution in the EU and non-EU patenting in Germany, shows an
increase in the number of patent applications and the share of non-EU countries.
Table 5.8: Patent applications in Germany: EU vs non-EU patent applications in A01N
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
EU 461 324 362 316 348 364 388 378 362 327 369 312 325 301 332 350 411
0.49 0.42 0.46 0.44 0.47 0.48 0.46 0.42 0.40 0.36 0.40 0.39 0.34 0.35 0.43 0.38 0.40
non-EU 479 444 429 408 398 392 462 519 539 586 560 489 621 569 446 568 612
0.51 0.58 0.54 0.56 0.53 0.52 0.54 0.58 0.60 0.64 0.60 0.61 0.66 0.65 0.57 0.62 0.60
From 1990 to 2006 there was an increase by 28% in the number of patents originat-
ing from non-EU countries. Conversely, applications originating from EU countries
diminished by 11%. This fact is reflected in the proportion between EU and non-EU
applications, where EU innovations have decreased from 49% to 40% in the total
patenting classified under area A01N, in Germany.
Table 5.9 shows the most important countries which have been patenting in Ger-
many from 1990 to 2006, their respective share, and the total quota that these coun-
5The complete results are shown in Tables C.1 and C.2.
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tries represent over all patent applications.
Table 5.9: Patent applications in Germany: Main countries in A01N
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
DE 294 186 203 193 192 221 248 250 229 227 225 191 198 192 221 218 272
0.31 0.28 0.22 0.27
US 249 256 255 218 226 247 307 367 364 399 377 298 420 420 321 393 421
0.27 0.41 0.48 0.41
JP 140 111 107 119 102 91 99 103 105 94 85 98 89 54 50 64 61
0.15 0.11 0.06 0.06
GB 76 47 57 54 70 57 54 56 53 31 53 35 30 37 38 47 45
0.08 0.06 0.04 0.04
CH 67 65 52 49 43 49 34 38 34 62 52 42 57 61 32 55 60
0.07 0.04 0.07 0.06
FR 49 51 66 37 34 37 51 42 34 36 34 43 48 33 35 39 40
0.05 0.05 0.04 0.04
Total
share
0.93 0.93 0.94 0.93 0.89 0.93 0.93 0.95 0.91 0.93 0.89 0.88 0.89 0.92 0.90 0.89 0.88
The increase in the share of non-EU countries was mainly due to US inventors
whose share increased from 27% to 41%. Conversely, over the same period there was
a decline in patents applied by Japanese inventors, dropping from 15% down to 6%
its share. The main EU contributors, Germany, France, and Great Britain, all have
decreased in number and share of patent applications.
As anticipated in Section 5.2, I also computed two regressions in order to check
whether the change in patenting activity originating from EU and non-EU coun-
tries was impacted with the increase of regulatory stringency. The outcomes from
Equations 5.4 and 5.5 showed high F-statistics significant at p < 0.01 both with
and without lag effect, although models with one year lag exhibit higher F-statistics.
Summarized results are illustrated in Table 5.10.6
Table 5.10: A01N: Modeling patents by OLS
Sample: 1990 - 2006 Sample: 1991 - 2006 (1 year lag)
Coefficient t-value P > |t| Coefficient t-value P > |t|
Equation 5.4
d_1 107.681 1.920 0.077 94.833 1.850 0.089
d_2 74.167 0.817 0.429 8.879 0.109 0.915
F(3,13) = 10.04 (0.001) F(3,12) = 11.29 (0.001)
Equation 5.5
d_1 t 14.721 1.340 0.203 27.824 2.550 0.026
d_2 t -6.593 -0.272 0.790 23.762 0.780 0.451
F(3,13) = 9.516 (0.001) F(3,12) = 10.220 (0.001)
Starting with the non-lag regressions (left column), Eq. 5.4 marginally fails to
reject H0 and fails to reject H
′
0. Furthermore Eq. 5.5 fails to reject H0 and H
′
0.
Turning to the lagged regressions (right column), Eq. 5.4 marginally fails to reject
H0 and fails to reject H
′
0, while Eq. 5.5 rejects H0 and fails to reject H
′
0. These
6The complete results are illustrated in Tables C.13 and C.14.
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offers a weak evidence for regulatory effect of an increase of patents originated from
non-EU countries after the first regulatory knot.
In summary, from 1990 to 2006 there was an increase in the share of non-EU
applications from 51% to 60% in technological area A01N. The empirical models with
one-year lag impact fitted better the data and suggested a positive impact of the first
knot of regulatory stringency in number and rate of growth of the difference between
non-EU and EU patent applications. This indicates that EU regulation has favored
the increase of patenting from non-EU applicants in Germany.
Top applicants and the concentration of innovative activity
One of the issues under investigation concerns the effect of a stricter regulation on
the concentration of innovative activity. As set out in Section 5.2, in order to study
this issue I looked at the patenting behavior of the “top ten applicants” and of the
“small players” in 1990 and 2006. Table 5.11 shows the behavior of these two different
groups for technological area A01N.
Table 5.11: Patent applications in Germany: Top applicants and small players on techno-
logical area A01N
1990 2006
# Applications by the top ten applicants 393 355
Share of the top ten applicants 42% 35%
# Small players 257 458
# Applications by small players 225 400
Share of the small players 24% 39%
From 1990 to 2006, the top ten applicants saw a 10% decrease in their total number
of patent applications with their share of total patenting activity declining from 42%
to 35%.7 Conversely, applications by small players increased by 78% over the same
period, and this reflected also in their contribution to the total applications, from
24% up to 39%. These numbers suggest a decrease in the concentration of innovative
activity over the period under study.
It is important to stress that small players are not necessarily small firms. Table
5.12 illustrates other characteristics of the patent applications in these two years
that help clarify the previous findings. Considering all applicants, firms diminished
their total share in the patenting activity, while universities, research centers, and
individual inventors have increased their contribution, from 6% to 18%. This is also
associated with the increase in patents with more than one applicant, from 5% to 9%
of the total.
7In the Appendix B, Table B.1 illustrates the top ten applicants, their country of origin, and number of
applications.
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Table 5.12: Patent applications in Germany: Profile of applications in technological area
A01N
1990 2006
Type of applicants:
Firms 94% 82%
Universities or research centers 4% 11%
Individual inventors 2% 7%
# Applications with shared ownership 47 89
Percentage of shared ownership 5% 9%
As seen in Table 5.11 the number of small players is larger than the number
of patents applied by them. This happens because individual inventors, as well as
research centers and universities, have a more pronounced tendency to develop tech-
nology in partnership while firms rarely do this.
However, the increased role of institutions other than firms as applicants does not
by itself explain the increase by 78% on the number of patent applications by small
players. These has been an increase in the number of firms responsible for a smaller
number of patent applications in 2006 relative to 1990.
In summary, the role of small players was enhanced, and the share of the top
ten applicants decreased. Thus, innovative activity became less concentrated for
technological area A01N, from 1990 to 2006. Nevertheless, it was not possible to
correlate the regulatory stringency with patent activity.
The evolution of the relationship among technological areas
Finally, I investigated whether there was a change in the pattern of the innovation
in area A01N from 1990 to 2006. As explained in Section 5.2, the patent application
profile for both years was computed. Table 5.13 shows all those technological areas
which had a relative score greater than 1%, for at least one of the years analyzed.
There was a drastic change in the patent application profile in 1990 in comparison
with 2006. In 1990, patents in area A01N were highly concentrated in areas belonging
to field C, which has seen a reduction in relative score in 2006 from 75.4% to 46.7%.
Meanwhile, technological areas belonging to field A grew in importance, from 18.2%
to 45.8%. A Pearson χ2 test gives a value of 94.8, significant at p < 0.001 (4 df)
confirming the visual impression of a substantial difference.8
Next, Table 5.14 illustrates the areas most closely related to A01N.
In 1990, patent applications in area A01N were mainly associated with new prod-
ucts, new organic substances (codes C07C and C07D). Some examples of patents with
these characteristics are illustrated in Table 5.15.
8It was calculated based on the number of applications in each field in 1990 and 2006. The complete
table is available at Appendix D, Table D.1.
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Table 5.13: Patent applications in Germany: Associated technological areas to A01N
1990 2006
A 18.2% 45.8%
A01C <1% 1.2%
A23L 1.0% <1%
A61K 6.0% 32.9%
A61L 2.5% 2.6%
A61P 2.2% 1.5%
A61Q 1.0% 1.2%
B 3.5% 4.9%
B01J 1.4% 1.3%
B27K 1.2% 2.0%
C 75.4% 46.7%
C02F 1.8% <1%
C05G <1% 1.1%
C07C 11.6% 4.7%
C07D 42.8% 21.8%
C07F 3.7% <1%
C07H 1.0% 1.7%
C07K 1.6% 1.6%
C09D <1% 1.7%
C12N 2.4% 4.6%
C12P 1.1% <1%
C12Q <1% 1.0%
C12R 1.0% <1%
D 1.0% <1%
E <1% <1%
F <1% <1%
G <1% 1.2%
H <1% <1%
Table 5.14: A01N: Preservation of bodies of humans or animals or plants or parts thereof;
biocides; pest repellants or attractants; plant growth regulators.
IPC 1990 2006 Definition
A 18.2% 45.8% Human necessities
A61K 6.0% 32.9% Preparations for medical, dental, or toilet purposes
C 75.4% 46.7% Chemistry; metallurgy
C07C 11.6% 4.7% Acyclic or carbocyclic compounds
C07D 42.8% 21.8% Heterocyclic compounds
C07F 3.7% < 1%
Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hy-
drogen, halogen, oxygen, nitrogen, sulfur, selenium, or tellurium
C12N 2.4% 4.6%
Micro-organisms or enzymes; compositions thereof; propagating, preserving, or maintaining
micro-organisms; mutation or genetic engineering; culture media
Pearson χ2 = 192.0 (p-value = 0.000; df = 4)
Table 5.15: A01N: Example of patent applications in 1990.
Classification Patent application title Applicant name
A01N C07C C07D “1-Phenyl-piperidine-2,4-dione with herbicidal activity” Ciba-Geigy AG (CH)
A01N C07C C07D “1-Aza-butadienes and fungicides containing them” BASF AG (DE)
A01N C07C C07D
“Substituted phenoxybenzonitrile derivatives, processes for their
preparation and their use as herbicides and plant growth regulators”
Bayer AG (DE)
A01N C07C C07D “Crotonic acid amide derivatives and insecticides containing the same” SDS Biotech K.K. (JP)
A01N C07C C07D “Substituted bicycloheptandione derivatives” Nippon Soda Co. Ltd. (JP)
A01N C07C C07D “Biocidal azoxime compounds” Shell Internationale B.V. (NL)
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In 2006 this pattern has changed. Field A grew over this period given the en-
hanced importance of area A61K latter associated with medical or dental products.
Conversely, field C lost importance mainly due to the decrease of areas C07C and
C07D, both associated with new organic synthetic compounds. Some examples of
patents including area A61K are illustrated in Table 5.16.
Table 5.16: A01N: Example of patent applications in 2006.
Classification Patent application title Applicant name
A01N A61K
“Phosphoinositide modulation for the treatment of Alzheimer’s dis-
ease”
The Trustees of Columbia University
in the City of New York (US)
A01N A61K
“Facially amphiphilic polymers and oligomers, compositions thereof,
and use thereof in methods of treating cancer”
The Trustees of the University of
Pennsylvania (US) and University of
Massachusetts (US)
A01N A61K “Prevention of neurodegeneration by macrolide antibiotics” The UAB Research Foundation (US)
A01N A61K C12N
“Isolated myeloid-like bone marrow cell populations and methods of
treatment therewith”
The Scripps Research Institute (US)
A01N A61K A61P
C12N
“Method for isolating stem cells from cryopreserved dental tissue” Stiftung Caesar (DE)
In 2006 there also occurred a small increase in the relative share of area C12N as-
sociated with recent technological fields on micro-organisms and genetic engineering
(biotechnology). This growth reflects the growth of patent applications on preserva-
tion of bodies, biocides, and plant growth regulators associated with enzymes and
micro-organisms, and not to new synthetic organic compounds. Some examples are
shown in Table 5.17.
Table 5.17: A01N: Example of patent applications in 2006.
Classification Patent application title Applicant name
A01N C12N “Cancer-targeted viral vectors”
The Trustees of Columbia University in the
City of New York (US)
A01N C12N “Transgenic ungulates expressing CTLA4-IG and uses thereof” Revivicor, Inc. (US)
A01N C12N
“Recovery of tissue function following administration of B cells
to injured tissue”
ACTX, Inc. (US)
A01N C07K C12N “Insect-specific protease recognition sequences”
Pioneer-Hi-Bred International, Inc. (US)
and E.I. Du Pont de Nemours and Co. (US)
A01H A01N C07K
C12N
“Improvement of disease resistance of plant by introducing tran-
scription factor gene”
National Institute of Agrobiological Sci-
ences (JP)
Clearly, there was a change in the direction of innovative activity associated with
code A01N. The patent application profile in 1990 is undoubtedly different than the
patent application profile in 2006.
As seen in Chapter 4, in 1997 the majority of restrictions imposed were not applied
on:
(a) medicinal or veterinary products; (b) cosmetic products; (c) motor fuels, mineral oil prod-
ucts intended for use as fuel in mobile or fixed combustion plants, fuels sold in closed systems;
(d) artists’ paints.
Therefore, the change in the direction of the innovation coincides with the regula-
tion imposed on technological area A01N in 1997. There was an increase in importance
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of code A61K, the uses of which remained unrestricted by regulation.
5.3.3 IPC-C08
Organic macromolecular compounds; their preparation or chemical working-up; com-
positions based thereon.
Evolution of patenting activity
From 1990 to 2006, the number of patent applications in field C08 decreased by 9%,
with a short period of growth between 1995 and 1999. Table 5.18 illustrates the
evolution in the number of patent applications in technological field C08 and its most
regulated areas.
Table 5.18: Evolution of patent applications in Germany: IPC-C08, F, J and K.
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
C08 4887 4245 4225 4142 4035 3991 4218 4456 4479 4701 4662 4595 4274 4340 4181 4252 4447
C08F 1346 1207 1100 1189 1182 1140 1252 1325 1315 1492 1433 1410 1169 1188 1090 1115 1069
C08F/C08 0.28 0.28 0.26 0.29 0.29 0.29 0.30 0.30 0.29 0.32 0.31 0.31 0.27 0.27 0.26 0.26 0.24
C08J 1022 942 945 910 943 906 899 1016 959 1053 1049 1018 889 876 864 910 930
C08J/C08 0.21 0.22 0.22 0.22 0.23 0.23 0.21 0.23 0.21 0.22 0.23 0.22 0.21 0.20 0.21 0.21 0.21
C08K 1143 1047 963 936 931 897 986 1011 1047 1053 1089 1033 955 974 998 1021 1062
C08K/C08 0.23 0.25 0.23 0.23 0.23 0.22 0.23 0.23 0.23 0.22 0.23 0.22 0.22 0.22 0.24 0.24 0.24
The most regulated areas followed the same pattern of field C08. Areas C08F, J,
and K had small variations through the years, decreasing after 2000. Overall, these
areas dropped their number of applications by 21%, 9%, and 7%, respectively.
As explained in Section 5.2 and already demonstrated for technological area A01N,
two regressions were computed for each regulated area. Summarized results are shown
in Table 5.19.9
Starting with the unlagged regressions (left column), for area C08FH0 is marginally
rejected, H ′0 fail to be rejected, and H
′′
0 is rejected. Looking at the lagged regressions,
H0 and H
′
0 fail to be rejected, while H
′′
0 is marginally rejected.
For area C08J, unlagged regressions marginally rejected H0 and H
′′
0 , while fails to
reject H ′0. Turning to the lagged regressions non of the null hypotheses are rejected.
Lastly, for area C08K unlagged regressions marginally rejected H0 and H
′
0, while
fails to reject H ′′0 . Turning to the lagged regressions H0 is marginally rejected, while
H
′
0 and H
′′
0 fails to be rejected.
In summary there was a decrease in patenting for these three regulated areas.
From 1990 to 2006 technological area C08F showed a decrease higher than its field,
while areas C08J and K followed more closely the average behavior of their field
(C08). Regarding the proposed regressions, overall unlagged models showed more
9The complete results are illustrated in the Appendix C.
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Table 5.19: C08F, J and K: Modeling patents by OLS
Sample: 1990 - 2006 Sample: 1991 - 2006 (1 year lag)
Coefficient t-value P > |t| Coefficient t-value P > |t|
C08F
Equation 5.2
d_1 255.058 2.730 0.017 166.072 1.510 0.158
d_2 90.155 0.595 0.562 -55.731 -0.318 0.756
F(3,13) = 7.270 (0.004) F(3,12) = 4.296 (0.028)
Equation 5.3
d_1 t 24.447 1.120 0.282 -9.319 -0.355 0.729
d_2 t -48.592 -1.010 0.332 -133.175 -1.820 0.094
F(3,13) = 3.567 (0.044) F(3,12) = 2.191 (0.142)
C08J
Equation 5.2
d_1 132.557 2.740 0.017 74.620 1.170 0.266
d_2 86.659 1.100 0.289 28.195 0.277 0.786
F(3,13) = 5.374 (0.013) F(3,12) = 1.247 (0.336)
Equation 5.3
d_1 t 22.098 1.930 0.075 -1.644 -0.113 0.912
d_2 t 18.399 0.728 0.480 -22.305 -0.547 0.594
F(3,13) = 2.097 (0.150) F(3,12) = 0.259 (0.853)
C08K
Equation 5.2
d_1 148.483 2.380 0.033 111.865 2.130 0.055
d_2 210.355 2.080 0.058 151.072 1.810 0.095
F(3,13) = 1.916 (0.177) F(3,12) = 2.426 (0.116)
Equation 5.3
d_1 t 22.723 1.790 0.097 0.888 0.070 0.945
d_2 t 50.521 1.800 0.096 9.055 0.257 0.801
F(3,13) = 1.229 (0.339) F(3,12) = 0.707 (0.566)
significant results than the one-year lag ones. For areas C08F and C08J it is observed
a positive effect of the first regulatory knot (significant at p < 0.05) in the number of
applications. While for area C08K both regulatory knots are found to have a positive
effect over the number of patent applications, however the jointed effect is found not
significant. Hence, little evidence is found of a regulatory impact on both number
and trend of applications in these three regulated areas.
Geographic origin of patent applications
There was little variation in the share of EU innovations applied in Germany from
1990 to 2006. For areas C08F and J, there was a small increase in patenting from EU
countries, while for area C08K EU patents remained stable. However, over 60% of the
innovations are originated from non-EU countries. Table 5.20 shows the evolution of
patent applications in Germany from EU and non-EU countries.
Table 5.21 illustrates the patenting activity per country for these three techno-
logical areas. Three countries contribute with similar shares in these areas: US,
Germany, and Japan. For C08F and C08K the leading origin of the applications is
the US, followed by Japan and Germany for the whole period. In the case of C08J,
in 1990 the most of the patents were originated from US, followed by Japan and
Germany, while in 2006 Japan has taken the leadership over the US.
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Table 5.20: EU vs non-EU patent applications in Germany: C08F, C08J, and C08K
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
C08F
EU 482 418 370 459 438 459 477 535 499 577 515 558 460 476 434 442 411
0.36 0.35 0.34 0.39 0.37 0.40 0.38 0.40 0.38 0.39 0.36 0.40 0.39 0.40 0.40 0.40 0.38
non-EU 864 789 730 730 744 681 775 790 816 915 918 852 709 712 656 673 658
0.64 0.65 0.66 0.61 0.63 0.60 0.62 0.60 0.62 0.61 0.64 0.60 0.61 0.60 0.60 0.60 0.62
C08J
EU 350 312 325 297 354 368 349 371 332 375 369 370 252 315 307 329 354
0.34 0.33 0.34 0.33 0.38 0.41 0.39 0.37 0.35 0.36 0.35 0.36 0.28 0.36 0.36 0.36 0.38
non-EU 672 630 620 613 589 538 550 645 627 678 680 648 637 561 557 581 576
0.66 0.67 0.66 0.67 0.62 0.59 0.61 0.63 0.65 0.64 0.65 0.64 0.72 0.64 0.64 0.64 0.62
C08K
EU 385 351 315 268 312 348 352 326 335 354 357 375 342 349 354 324 365
0.34 0.34 0.33 0.29 0.34 0.39 0.36 0.32 0.32 0.34 0.33 0.36 0.36 0.36 0.35 0.32 0.34
non-EU 758 696 648 668 619 549 634 685 712 699 732 658 613 625 644 697 697
0.66 0.66 0.67 0.71 0.66 0.61 0.64 0.68 0.68 0.66 0.67 0.64 0.64 0.64 0.65 0.68 0.66
The main EU contributor is Germany which has in all three regulated areas de-
creased in number of applications, however there was little variation in the corre-
spondent share from 1990 to 2006. Other representative EU countries, France and
Great Britain, also experienced little variation in their respective share over the same
period.
The most important non-EU countries, US and JP, also saw their shares of total
patenting in all three areas diminish. The US contribution to the total number of
patent application in Germany in area C08K experienced the largest fall from its 1998
peak. Japan saw small variations in the share over of the total applications for the
areas F and K, with an increase since 1995 for area J.
In addition, from 1990 to 2006 the total share of the main EU and non-EU con-
tributors decreased for all three regulated areas from field C08. In 1990, C08F the
top five contributors summed 87% of the total applications, while in 2006 this sum
decreased to 80%. Similar numbers are observed for the other two areas. Hence,
given that occurred a decrease in the sum of the two main non-EU countries (US and
JP), other non-EU countries must have been patenting patenting more.
The following Table, 5.22, illustrates a summary of the regression results regarding
Equations 5.4 and 5.5. These were computed to check whether the patenting activity
from EU or non-EU countries were impacted by the increase of regulatory stringency
in the EU.
Starting with area C08F, unlagged regressions (left column) fails to reject H0 and
H
′
0 while rejects H
′′
0 . Lagged regression fails to reject H0 and H
′
0 while for Equation
5.4 rejects H ′′0 and Equation 5.5 fails to reject H
′′
0 .
Unlagged regressions for area C08J rejects H0, fails to reject H
′
0, and marginally
rejects H ′′0 . Lagged regressions marginally rejects H0 and fails to reject H
′
0 and H
′′
0 .
For area C08K, unlagged Equation 5.4 fails to reject H0 and H
′
0, but rejects H
′′
0 .
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Table 5.21: Origin of patent applications in Germany: C08F, C08J, and C08K
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
C08F
DE 248 216 219 266 262 251 262 279 254 300 274 259 211 244 203 195 199
0.18 0.22 0.21 0.21 0.19
US 465 437 406 421 464 425 456 467 490 517 535 432 339 360 321 326 323
0.35 0.39 0.35 0.30 0.30
JP 327 287 260 256 217 231 263 262 279 303 303 328 271 266 264 266 251
0.24 0.18 0.20 0.22 0.24
FR 58 62 25 54 26 51 69 82 76 61 72 84 63 58 50 45 49
0.04 0.06 0.05 0.05
GB 73 53 44 35 39 37 29 46 46 68 39 47 32 31 21 25 30
0.05 0.03 0.03 0.03
Total
share
0.87 0.87 0.87 0.87 0.85 0.87 0.86 0.86 0.87 0.84 0.85 0.82 0.78 0.81 0.79 0.77 0.80
C08J
DE 186 171 189 197 224 238 221 229 203 214 216 222 144 167 150 183 179
0.18 0.26 0.23 0.19 0.19
US 370 369 373 360 352 332 330 386 356 377 346 303 270 263 255 226 248
0.36 0.40 0.38 0.30 0.27
JP 241 215 189 197 170 161 188 209 219 262 286 300 298 241 238 268 261
0.24 0.18 0.21 0.34 0.28 0.28
FR 58 50 49 24 40 25 40 49 32 31 38 48 32 40 32 38 39
0.06 0.05 0.05 0.04
GB 51 34 40 29 27 25 22 27 21 35 21 20 15 25 17 19 15
0.05 0.03 0.03 0.02
Total
share
0.89 0.89 0.89 0.89 0.86 0.86 0.89 0.89 0.87 0.87 0.86 0.88 0.85 0.84 0.80 0.81 0.80
C08K
DE 214 187 170 170 204 219 213 208 191 213 213 212 211 190 173 176 191
0.19 0.24 0.21 0.20 0.18
US 377 352 329 342 324 285 321 332 386 383 336 289 289 282 268 289 321
0.33 0.33 0.37 0.29 0.30
JP 297 271 245 234 214 192 252 282 241 243 313 302 242 242 266 297 277
0.26 0.28 0.25 0.26
FR 59 43 32 27 36 39 52 46 67 34 60 59 42 49 53 48 47
0.05 0.05 0.05 0.04
GB 40 39 39 22 21 32 21 22 15 33 9 14 15 20 12 15 17
0.03 0.02 0.02 0.02
Total
share
0.86 0.85 0.85 0.85 0.86 0.86 0.87 0.88 0.86 0.85 0.85 0.85 0.84 0.80 0.77 0.81 0.80
For unlagged Equation 5.5 none of the null hypotheses are rejected. Regarding the
lagged regressions, none of the null hypotheses are rejected.
In summary, in all three regulated areas, when comparing the evolution of EU and
non-EU patent applications there was little variation through these years. Adding
to it, for area C08F regressions infer no regulatory impact of regulatory stringency
in the geographical origin of patent applications. For area C08J regressions infer an
effect of the first regulatory knot favoring non-EU applicants in Germany. Lastly,
for area C08K there is little evidence of regulatory impact on the origin of patent
applications.
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Table 5.22: C08F, J and K: Modeling patents by OLS
Sample: 1990 - 2006 Sample: 1991 - 2006 (1 year lag)
Coefficient t-value P > |t| Coefficient t-value P > |t|
C08F
Equation 5.4
d_1 70.847 1.370 0.194 94.833 1.850 0.089
d_2 54.919 0.656 0.523 8.879 0.109 0.915
F(3,13) = 3.755 (0.038) F(3,12) = 11.29 (0.001)
Equation 5.5
d_1 t 19.329 2.030 0.064 9.850 0.826 0.425
d_2 t 24.547 1.170 0.265 12.675 0.381 0.710
F(3,13) = 4.462 (0.023) F(3,12) = 1.743 (0.211)
C08J
Equation 5.4
d_1 106.480 2.170 0.050 114.361 2.250 0.044
d_2 90.620 1.140 0.276 101.010 1.250 0.235
F(3,13) = 2.559 (0.100) F(3,12) = 2.369 (0.122)
Equation 5.5
d_1 t 26.419 3.170 0.007 15.427 1.330 0.208
d_2 t 25.708 1.400 0.186 8.485 0.262 0.798
F(3,13) = 4.545 (0.022) F(3,12) = 1.188 (0.356)
C08K
Equation 5.4
d_1 118.793 2.330 0.037 88.755 1.560 0.144
d_2 181.493 2.200 0.047 158.608 1.760 0.104
F(3,13) = 2.042 (0.158) F(3,12) = 1.073 (0.397)
Equation 5.5
d_1 t 11.302 1.040 0.318 -2.798 -0.222 0.828
d_2 t 34.331 1.430 0.177 14.457 0.412 0.688
F(3,13) = 0.841 (0.495) F(3,12) = 0.359 (0.784)
Top applicants and the concentration of innovative activity
The following issue under investigation is the effect of a stricter regulation on the
concentration of innovative activity. Table 5.23 illustrates the number of applications
and the shares of the “top ten applicants” and “small players” in 1990 and 2006. The
three areas here analyzed evolved similarly, even though in different scales.
Table 5.23: Patent applications in Germany: Top applicants and small players in techno-
logical areas C08F, J, and K
C08F C08J C08K
1990 2006 1990 2006 1990 2006
# Applications by the top ten applicants 319 309 197 210 259 238
Share of the top ten applicants 24% 29% 19% 23% 23% 22%
# Small players 184 225 236 347 248 289
# Applications by small players 176 214 222 308 233 265
Share of the small players 13% 20% 22% 33% 20% 25%
From 1990 to 2006 the top ten applicants in areas C08F and J increased their
share, while for area C08K fell by 1%.10 For all three technological areas there was
10In the appendix B, Tables B.2, B.3, and B.4 list the top applicants for the technological areas C08F, J,
and K.
108
5.3 EMPIRICAL ANALYSIS
an increase in number and share of total applications by small players.
Table 5.24 illustrates other characteristics of the patent applications in these two
years that help clarify the previous findings. As already observed in technological
area A01N, in all three areas the kind of applicants also changed from 1990 to 2006.
The share of universities, research centers, and individual inventors increased their
importance. Again, it can be observed that this is associated with the increase on
the applications with shared ownership, and in the number of small players.
Table 5.24: Patent applications in Germany: Profile of technological areas C08F, J, and K
C08F C08J C08K
1990 2006 1990 2006 1990 2006
Type of applicant:
Firms 98% 92% 98% 91% 98% 94%
Universities or research centers 1% 7% 1% 6% 1% 4%
Individual inventors 1% 1% 1% 3% 1% 2%
# Applications with shared ownership 49 70 35 74 51 64
Percentage of shared ownership 4% 7% 3% 8% 4% 6%
Summarizing, there was no increase in patenting concentration. For areas C08F
and J the share of applications by small players have increased to a larger extent than
the share by the top ten players. For area C08K there was an increase in the share of
small players and a small decrease in the share of top ten players. In all cases, this
indicates a decrease in the concentration of innovative activity for all three areas,
from 1990 to 2006.11 Nevertheless, it was not possible to correlate the regulatory
stringency with the concentration of the patenting activity.
The evolution of the relationship among technological areas
In order to draw a clearer picture of how these three regulated areas have evolved,
I investigated whether there was a change in the patent application profile of areas
C08F, J, and K from 1990 to 2006. Table 5.25 shows this evolution for both years in
all three regulated areas (technological areas which scored less than 1% in both years
were not included).
Differently from patent applications in area A01N, there were no major changes in
the pattern from 1990 to 2006. Results from the Pearson χ2 test calculated comparing
the number of applications in each field in 1990 and 2006 are significant at p < 0.001
and much lower than for area A01N, valuing 15.6, 24.4, and 26.5 respectively for
regulated areas C08F, J, and K.12
There is a broader variety of related technological areas from all fields, which can
11Results regarding the increase in the share of small players seems robust. Even when defining “small
players” as entities that applied three or less patents in a given year, obtained similar results.
12The complete tables are available at Appendix D, Tables D.3, D.5, and D.7.
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Table 5.25: C08F, J, and K: Related technological areas
C08F 1990 2006 C08J 1990 2006 C08K 1990 2006
A 6.0% 8.0% A 3.3% 6.4% A 3.4% 3.2%
A61K 2.4% 3.7% A61K <1% 1.2% A61K 1.2% <1%
A61L 1.2% 2.6% A61L 1.1% 2.5%
B 9.3% 12.2% B 28.0% 24.8% B 6.9% 12.5%
B01D <1% 1.0% B01D 3.0% 1.2% B29C 1.5% 1.7%
B01F 1.0% <1% B01J 1.5% 1.4% B32B <1% 3.0%
B01J 3.7% 6.1% B05D 1.1% 1.5% B60C <1% 3.9%
B32B <1% 1.4% B29B 1.8% 2.0%
B29C 7.3% 5.2%
B29K 2.9% <1%
B29L 1.2% <1%
B32B 5.3% 7.1%
B65D <1% 1.1%
C 69.8% 67.4% C 57.5% 57.5% C 79.4% 74.6%
C04B <1% 1.7% C03C <1% 1.0% C01B <1% 1.5%
C07C 4.9% 3.9% C08F 6.0% 7.0% C04B 1.0% <1%
C07D 1.6% <1% C08G 12.8% 6.1% C07C 1.6% 1.4%
C07F 4.3% 3.8% C08K 8.0% 10.1% C07D 3.0% 1.1%
C08C 2.3% 2.4% C08L 18.1% 21.4% C07F 1.6% 1.1%
C08G 9.5% 6.0% C09D 3.3% 4.6% C08F 3.2% 3.1%
C08J 5.2% 7.5% C09J 1.6% <1% C08G 6.4% 4.5%
C08K 3.2% 4.0% C09K 2.0% 1.4% C08J 6.9% 10.4%
C08L 13.9% 16.4% C08L 41.2% 36.6%
C09D 9.2% 8.6% C09C 1.4% 2.2%
C09J 3.7% 3.8% C09D 4.3% 5.1%
C09K 1.7% 1.8% C09J 1.5% 2.0%
C10L 1.1% <1% C09K 3.4% 1.7%
C10M 2.0% 2.1%
C11D 1.3% <1%
D 2.8% 2.7% D 3.9% 2.8% D 1.8% 1.8%
D01F <1% 1.0%
D21H 1.1% <1% D01F 1.4% <1%
D06M <1% 1.0%
E 0.2% – E 0.3% 0.1% E 0.3% 0.1%
F 0.5% 0.8% F 1.2% 0.5% F 0.8% 0.9%
G 9.4% 6.5% G 2.9% 2.3% G 2.6% 2.5%
G01N <1% 1.4%
G02B 2.6% 1.9%
G03F 3.5% 1.4%
H 2.1% 2.4% H 2.9% 5.6% H 4.9% 4.3%
H01B 1.0% 1.2% H01B 2.3% 1.8%
H01M <1% 2.6%
be explained by the horizontal scope of applicability of macromolecular compounds.
Polymers are present in all kinds of products, for different industries and direct con-
sumer use. However, in all three cases and for both years, most related areas came
from field C. Next, I discuss separately the three technological areas.
C08F Starting with C08F, Table 5.26 defines its most closely related technological
areas. Through these years there was no perceptive change in the trend of the tech-
nological development or in the direction of the innovation. In addition, field C kept
the largest share of related areas, from 69.8% in 1990 to 67.4% in 2006.
The four areas highlighted in field C are associated with different compositions
within macromolecular or non-macromolecular substances (C08G), new products (C08L
and C09D), and better processes (C08J).
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Table 5.26: C08F: Macromolecular compounds obtained by reactions only involving carbon-
to-carbon unsaturated bonds
IPC 1990 2006 Definition
A 6.0% 8.0% Human necessities
A61K 2.4% 3.7% Preparations for medical, dental, or toilet purposes
B 9.3% 12.2% Performing operations; transporting
B01J 3.7% 6.1% Chemical or physical processes (e.g. catalysis, colloid chemistry; their relevant apparatus)
C 69.8% 67.4% Chemistry; metallurgy
C08G 9.5% 6.0%
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-
carbon unsaturated bonds
C08J 5.2% 7.5% Working-up; general processes of compounding; after-treatment not covered by subclasses
C08L 13.9% 16.4% Compositions of macromolecular compounds
C09D 9.2% 8.6%
Coating compositions (e.g. paints, varnishes, lacquers; filling pastes; chemical paint or ink
removers; inks; correcting fluids; wood stains; pastes pr solids for coloring or printing; use of
materials therefor)
G 9.4% 6.5% Physics
G02B 2.6% 1.9% Optical elements, systems, or apparatus
G03F 3.5% 1.4%
Photomechanical production of textured or patterned surfaces (e.g. for printing, for processing
of semiconductor devices; materials therefor; originals therefor; apparatus specially adapted
therefor)
Pearson χ2 = 24.2 (p-value = 0.001; df = 7)
The presence of area B01J is associated with improvements in the chemical process
such the use of catalysts, a key issue that affects the production process of polymers
in efficiency and costs. Areas A61K, G02B, and G03F are associated with the applica-
tion of organic macromolecular compounds in medical or dental care (e.g. dentures
and other prosthesis), optical apparatus, and photosensitive materials (e.g. screens).
Some examples of these patents area illustrated in Table 5.27.
Table 5.27: C08F: Examples of patent applications.
Year Classification Patent application title Applicant name
1990
C08F C08G C08L
G02B
“Interpenetrating network of a polyol (allyl carbonate) and epoxy
resin, and a process for the preparation thereof”
Akzo Nobel N.V. (NL)
1990 C08F C09D
“Radiation-curable blend of a cellulose ester and a multifunctional
(meth)acrylate”
Aqualon Co. (US)
1990 B01J C08F C08G
“Recovery of double metal cyanide complex catalyst from a poly-
mer”
Arco Chemical Technology L.P.
(US)
1990
C07C C07F C08F
G03F
“Cationic photo-initiated polymerization process and the prepara-
tion of relief motifs or photo-images using sulfonium salts”
BASF AG (DE)
1990 C08F G02B
“Graft copolymer, solution containing the graft copolymer, and
method of treating contact lens with the solution”
Tomei Sangyo Kabushiki
Kaisha (JP)
2006 B01J C08F C08L
“Recovery of fluorinated surfactants from a basic anion exchange
resin having quaternary ammonium groups”
3M Innovative Properties Co.
(US)
2006 B01J C01G C08F “Improved polymer halogenation process with catalyst recovery” Albemarle Corp. (US)
2006 A61K C08F “Contact drug delivery system” Auburn University (US)
2006 A61K A61Q C08F
“Use of a water-in-water emulsion polymers in the form of a thick-
ener for cosmetic preparations”
BASF SE (DE)
2006
C08C C08F C08J
C08L
“Method for inhibiting agglomeration of block copolymers” Firestone Polymers LLC (US)
The areas which grew in relative importance over the period 1990 to 2006 were
B01J and C08J both associated with process developments, C08L, associated with the
development of new products from existing substances, and A61K, associated with
medical or dental products.
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C08J Table 5.28 shows the definitions of the most relevant areas regarding C08J. In
both years, these areas belong to fields B and C.
Table 5.28: C08J:Working-up; general processes of compounding; after-treatment not covered
by subclasses C08B, C08C, C08F, C08G
IPC 1990 2006 Definition
B 28.0% 24.8% Performing operations; transporting
B29C 7.3% 5.2%
Shaping or joining plastics; shaping of substances in a plastic state, in general; after-treatment
of the shaped products (e.g. repairing)
B32B 5.3% 7.1% Layered products, i.e. products built-up of strata of flat (e.g. cellular or honeycomb, form)
C 57.5% 57.5% Chemistry; metallurgy
C08F 6.0% 7.0%
Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsatu-
rated bonds
C08G 12.8% 6.1%
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-
carbon unsaturated bonds
C08K 8.0% 10.1% Use of inorganic or non-macromolecular organic substances as compounding ingredients
C08L 18.1% 21.4% Compositions of macromolecular compounds
Pearson χ2 = 38.0 (p-value = 0.000; df = 5)
In field B, highlighted areas (B29C and B32) are associated with the production
process of articles made of polymers (e.g. joining or layering plastics). In field C, the
stressed areas are associated with macromolecular developments and compositions
(of organic or inorganic substances). Examples are shown in Table 5.29.
Table 5.29: C08J: Examples of patent applications.
Year Classification Patent application title Applicant name
1990 B29C B32B C08J
“Method for manufacturing an element with a synthetic foam
layer and element obtained by that method”
Astechnologies Inc. (US)
1990 C08G C08J
“Process for the preparation of elastic compact or cellu-
lar moulded articles on the basis of elastomers contain-
ing N-benzylurea groups, such elastomers and N-benzyl-
polyoxyalkylene-polyamines suitable therefor”
BASF AG (DE)
1990
B29C C08J C08K
C08L
“Resin composition for film and process for producing film us-
ing the same”
Mitsui Petrochemical Ind. Ltd. (JP)
1990
B29C C08F C08G
C08J C08K C08L
“Process for the production of molded article of fiber-reinforced
thermosetting resin, and materials therefor”
Toyota Jidosha Kabushiki Kaisha
(JP) and A. G. International Chem-
ical Co. Inc. (JP)
2006 B32B C08J C23C “Microporous article having metallic nano-particle coating” 3M Innovative Properties Co. (US)
2006 C08F C08J
“Aqueous dispersion of hybrid particles consisting of organic
or inorganic pigment particles and organic nano-particles and
process for preparing the same”
Topchim N.V. (BE)
2006
B60C C08J C08K
C08L
“Rubber composition for coating textile cord and tire using the
same”
Sumitomo Rubber Ind. Ltd. (JP)
2006 B32B C08J C08L
“Methods of making water-soluble film with resistance to sol-
ubility prior to being immersed in water”
The Procter and Gamble Co. (US)
From 1990 to 2006 the areas which showed a relative increase (even though small)
were B32B associated with new processes, C08F regarding new macromolecular sub-
stances, and C08K and C08L regarding new products.
C08K In both years, the two main fields associated with area C08K are B and C, as
described in Table 5.30.
Field B was responsible for 6.9% in 1990 and 12.5% in 2006 of relative importance.
The most relevant areas within this field are B32B and B60C, the former already de-
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Table 5.30: C08K: Use of inorganic or non-macromolecular organic substances as compound-
ing ingredients
IPC 1990 2006 Definition
B 6.9% 12.5% Performing operations; transporting
B32B <1% 3.0% Layered products, i.e. products built-up of strata of flat (e.g. cellular or honeycomb, form)
B60C <1% 3.9%
Vehicle tires; tyre inflation; tyre changing; connecting valves to inflatable elastic bodies in
general; devices or arrangements related to tires
C 79.4% 74.6% Chemistry; metallurgy
C07D 3.0% 1.1% Heterocyclic compounds
C08G 6.4% 4.5%
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-
carbon unsaturated bonds
C08J 6.9% 10.4% Working-up; general processes of compounding; after-treatment not covered by subclasses
C08L 41.2% 36.6% Compositions of macromolecular compounds
C09D 4.3% 5.1%
Coating compositions (e.g. paints, varnishes, lacquers; filling pastes; chemical paint or ink
removers; inks; correcting fluids; wood stains; pastes or solids for coloring or printing; use of
materials therefor)
C09K 3.4% 1.7% Materials for miscellaneous applications, not provided for elsewhere
Pearson χ2 = 107.0 (p-value = 0.000; df = 7)
scribed and the latter associated with developments of macromolecular compositions
(product innovation) to be applied in tires, elastic bodies, and related devices.
Field C represents the majority of the related technological areas, responsible for
79.4% in 1990 and 74.6% in 2006. Six technological areas were stressed. Related to
new substances there are C07D (cyclic organic substance containing other than car-
bon atoms in the ring), and C08G (macromolecular compounds). Related to product
innovation based on new formulations there are C08L (compositions of macromolec-
ular compounds) and C09D (formulations of non-macromolecular substances). The
last two areas are C08J associated with new processes and C09K associated with new
applications of substances (e.g. heat-transfer, drilling, luminescent materials, among
others). Examples are described in Table 5.31.
Table 5.31: C08K: Examples of patent applications.
Year Classification Patent application title Applicant name
1990
C07C C07D C07H
C08K C08L C09K
“Organic sulfide antioxidants” Atochem North America Inc. (US)
1990
C07F C08G C08K
C08L C09K
“Reaction products of 2-(aminoethyl) aminopropyl
alkoxysilanes with chlorosilanes”
Bayer AG (DE)
1990 A01N C07D C08K
“Composition and method for inhibiting the growth of
micro-organisms”
Zeneca Ltd. (GB)
1990
C07D C08K C08L
C09D D01F
“Brightening and light-stabilizing salts”
Sandoz-Patent-Gmbh (DE) and Sandoz
Ltd. (CH)
1990
C03C C08G C08K
C08L C09D D21H
G03F H05K
“UV curable compositions for use, in particular, in the
field of antiadherent-paper and optical fibers”
Rhone-Poulenc Chimie (FR)
2006 B32B C08K “White light diffusing thermoplastic composition” Arkema France (FR)
2006 B32B C08K “UV-Stabilized molded polycarbonate products” Bayer MaterialScience AG (DE)
2006
B60C C08C C08G
C08K C08L
“Functionalized polymers and improved tires therefrom” Bridgestone Corp. (JP)
2006 C08J C08K C09D “Method and device for producing nano-composites”
Fraunhofer-Gesellschaft zur Förderung
der angewandten Forschung e.V. (DE)
and Ruhr-Universität Bochum (DE)
2006
C08J C08K C08L
C09K
“Reactive flame retardant and flame retardant resin pro-
cessed article”
Fuji Electric Holdings Co. Ltd. (JP) and
National University Corp. Tokyo Univer-
sity of Agriculture and Technology (JP)
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The Pearson χ2 value for areas highlighted in regulated area C08K is higher than
for C08F and J. Even though it is not possible to perceive any drastic change in the
pattern of patenting from 1990 to 2006, there were some minor changes which are
interesting to remark.
First, area C08L is the one with the biggest presence on the patent applications
for both years, even though there was a decrease in its relative share (from 41.2%
to 36.6%). This area represents the compositions of macromolecular compounds,
in other words new products made of formulations just of macromolecular com-
pounds, and this might suggest that new formulations have been developed with
non-macromolecular substances which are associated with area C09D, that has in
fact increased its relative share over the same period (from 4.3% to 5.1%).
Second, the drop in the relative importance of area C07D might be associated
with the nature of the substances it represents. This area represents heterocyclic
organic substances, and a large number of such class of substances were regulated
as carcinogenic category 1 or 2. As previously explained in Section 4.1.1, given
the molecular structure regulators preventively restricted a number of substances
assuming that there is risk even if it was not scientifically confirmed, but just because
there are substances with similar structure which were found to be carcinogenic. This
might have influenced this drop in the relative importance of area C07D.
Third, there was an increase in the relative share of field B, from 6.9% to 12.5%.
Two areas were the main responsible for this increase: B60C and B32B. A speculation
one might do is that with a decrease of the relative importance of areas associated
with new substances and use of certain kinds of substances in formulations, areas
associated with processes for new uses (B32B) and applicability with guaranteed
demand (B60C) gained relative importance.
Hence, no consistent change can be perceived in the direction of innovation in the
three regulated areas which I have investigated – C08F, C08J, and C08K. Nevertheless,
a number of changes can be noticed in the pattern of innovation in specific sectors.
One possible explanation is that from field C08 this area was the one which received
the largest number of restrictions (62, against 40 for area C08J, and 22 for area C08F).
Overall an increase in technological areas associated with processes can be noticed
matched by a decrease in areas associated with new substances.
5.3.4 IPC-C09
Dyes; paints; polishes; natural resins; adhesives; miscellaneous compositions; miscel-
laneous applications of materials.
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Evolution of patenting activity
The last two technological areas analyzed in this Chapter are C09B and C09D. Their
field – C09 – experienced a peak in the patenting activity in 2001. Hence, from 1990
to 2006 there was little variation in the total number of patent applications. In spite
of that, areas C09B and D behaved in dissimilar ways as illustrated in Table 5.32.
Table 5.32: Evolution of patent applications in Germany: IPC-C09, B, and D.
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
C09 2294 2085 2176 2151 2208 2259 2289 2476 2363 2493 2451 2524 2483 2531 2347 2485 2274
C09B 302 313 323 348 292 312 271 304 258 259 270 263 272 254 240 249 228
C09B/C09 13% 15% 15% 16% 13% 14% 12% 12% 11% 10% 11% 10% 11% 10% 10% 10% 10%
C09D 871 818 888 911 963 1005 1040 1097 1106 1095 1108 1169 1112 1132 1052 1105 1155
C09D/C09 38% 39% 41% 42% 44% 44% 45% 44% 47% 44% 45% 46% 45% 45% 45% 44% 51%
Area C09B has been decreasing over the years both in absolute numbers and as
percentage of the total patents from the field C09. Conversely, C09D increased in
absolute numbers as well as in terms of its share over its field, C09. Hence, the most
highly regulated areas in field C09 have developed in opposite directions.
Area C09B is characterized by a small number of patent applications per year
and has decreased by 25%, from 1990 to 2006. In contrast, technological area C09D
increased by 33% in the total number of applications over the same period. Next,
Table 5.33 illustrates the summarized results of the computed regressions.
Table 5.33: C09B and D: Modeling patents by OLS
Sample: 1990 - 2006 Sample: 1991 - 2006 (1 year lag)
Coefficient t-value P > |t| Coefficient t-value P > |t|
C09B
Equation 5.2
d_1 -8.432 -0.430 0.674 -22.660 -1.240 0.239
d_2 -14.157 -0.446 0.663 -29.937 -1.030 0.323
F(3,13) = 12.760 (0.000) F(3,12) = 15.940 (0.000)
Equation 5.3
d_1 t -0.170 -0.045 0.965 2.417 0.615 0.550
d_2 t -1.472 -0.176 0.863 5.860 0.534 0.603
F(3,13) = 12.560 (0.000) F(3,12) = 14.240 (0.000)
C09D
Equation 5.2
d_1 37.772 0.896 0.387 -39.605 -0.909 0.381
d_2 -80.134 -1.170 0.262 -194.159 -2.800 0.016
F(3,13) = 36.000 (0.000) F(3,12) = 29.340 (0.000)
Equation 5.3
d_1 t -0.053 -0.006 0.996 -4.754 -0.408 0.691
d_2 t -41.417 -2.040 0.062 -54.883 -1.690 0.118
F(3,13) = 27.240 (0.000) F(3,12) = 15.670 (0.000)
Starting with area C09B only H ′′0 was rejected for both lagged and unlagged
regressions. These results infer no impact of regulation in the number or trend of
patenting in Germany.
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Regarding area C09D for unlagged regressions, H0 failed to be rejected, H
′
0 was
marginally rejected, and H ′′0 was rejected. Turning to lagged regressions, H0 failed
to be rejected while H ′′0 was rejected. H
′
0 was rejected for Equation 5.2 and failed
to be rejected for Equation 5.3. Lagged Equation 5.2 infer a negative impact of the
second regulatory knot in the number of applications (significant at p < 0.05), while
unlagged Equation 5.3 infer a negative impact of the second regulatory knot in the
trend of growth (significant at p < 0.1).
In short, technological area C09B decreased while area C09D increased. Computed
regressions for area C09B did not indicate any regulatory impact, while for area C09D
there is little evidence of a possible negative impact of the second regulatory knot
over the number and growth of patent applications.
Even though these results are shown to be initially contradictory it must be re-
minded first the limitations of the regressions, second the different number of restric-
tions which these areas received (101 for area C09D and 86 for area C09B), and third
the nature of the technologies associated with these areas. This last issue will be
better understood when analyzing the different patterns of patents applied in 1990
and 2006.
Geographic origin of patent applications
Table 5.34 shows the evolution of patent applications in the EU and non-EU coun-
tries for technological areas C09B and D. Areas C09B and C09D showed contrasting
behaviors, from 1990 to 2006.
Table 5.34: EU vs non-EU patent applications in Germany: C09B and C09D
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
C09B
EU 143 127 132 185 142 149 121 114 90 106 86 92 105 87 85 91 94
0.47 0.41 0.41 0.53 0.49 0.48 0.45 0.38 0.35 0.41 0.32 0.35 0.39 0.34 0.35 0.37 0.41
non-EU 159 186 191 163 150 163 150 190 168 153 184 171 167 167 155 158 134
0.53 0.59 0.59 0.47 0.51 0.52 0.55 0.63 0.65 0.59 0.68 0.65 0.61 0.66 0.65 0.63 0.59
C09D
EU 313 307 326 372 378 420 390 450 394 399 416 419 402 389 389 398 423
0.36 0.38 0.37 0.41 0.39 0.42 0.38 0.41 0.36 0.36 0.38 0.36 0.36 0.34 0.37 0.36 0.37
non-EU 558 511 562 539 585 585 650 647 712 696 692 750 710 743 663 707 732
0.64 0.62 0.63 0.59 0.61 0.58 0.63 0.59 0.64 0.64 0.62 0.64 0.64 0.66 0.63 0.64 0.63
In area C09B, the absolute number of patent applications originating from EU
and non-EU countries have decreased. From 1990 to 2006, the share of innovations
originating from EU countries have decreased from 47% down to 41%. This drop
occurred mainly after 1997.
The number of applications originating both from EU and non-EU countries in-
creased for technological area C09D. When analyzing the share of EU patent appli-
cations, they have increased until 1997 and dropped afterward. Comparing the years
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1990 and 2006 there was little variation in the share of EU and non-EU countries.
The following Table 5.35 disaggregates the data and shows the main countries
responsible for the innovations applied in Germany. Differently from the other areas,
C09B has four countries contributing with the majority of these applications. Besides
Germany, US, and Japan, also Switzerland (CH) has an important role.
Table 5.35: Origin of patent applications in Germany: C09B and C09D
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
C09B
DE 117 91 103 132 108 125 87 86 62 87 64 75 69 57 62 55 56
0.39 0.40 0.28 0.22 0.25
US 47 65 93 54 45 61 57 80 59 70 77 68 47 49 45 34 35
0.16 0.20 0.26 0.29 0.19 0.15
JP 58 67 68 65 53 47 38 51 29 35 52 53 44 57 60 72 50
0.19 0.17 0.11 0.22 0.22
CH 51 53 33 42 43 53 49 47 62 31 44 26 49 47 33 35 41
0.17 0.16 0.24 0.19 0.18
Total
share
0.90 0.88 0.92 0.84 0.85 0.92 0.85 0.87 0.82 0.86 0.88 0.84 0.77 0.83 0.83 0.79 0.80
C09D
DE 192 183 198 264 265 272 254 283 245 238 255 241 238 222 214 226 226
0.22 0.29 0.26 0.20 0.20
US 294 291 323 328 303 327 404 358 426 427 406 386 354 381 346 360 341
0.34 0.39 0.33 0.39 0.34 0.30
JP 204 178 183 177 228 227 221 234 222 229 231 315 286 293 264 297 296
0.23 0.21 0.20 0.27 0.26 0.26
CH 36 23 32 22 25 32 28 45 53 31 33 32 37 41 28 34 47
0.04 0.04 0.04 0.04
GB 45 43 53 34 37 31 44 45 39 49 39 29 28 31 41 32 36
0.05 0.04 0.03 0.03
FR 30 35 32 29 24 56 46 57 40 34 35 43 37 36 34 33 40
0.03 0.05 0.03 0.03
Total
share
0.92 0.92 0.92 0.94 0.92 0.94 0.96 0.93 0.93 0.92 0.90 0.89 0.88 0.89 0.88 0.89 0.85
Considering the main non-EU countries in area C09B, innovations originated from
the US increased in number and share over the 1990s, decreasing subsequently. Com-
paring 1990 with 2006 the US maintained its share (16% against 15%). Innovations
originating in Japan and Switzerland showed only minor share variations over the
period, with a small increase from 19% to 22% and 17% to 18%, respectively.
Conversely, the main EU contributor of area C09B – Germany – has decreased in
number and share, from 39% in 1990 to 25% in 2006. Thus, this reflected the ratio
of EU and non-EU applicants.
Patents applied in Germany in technological area C09D originated in the majority
from the US. They increased in numbers until 1999, with a subsequent decrease. The
total share also followed this pattern, but overall there was a decrease from 34% in
1990 down to 30% in 2006. The other major non-EU contributor was Japan which
saw an increase both in the number and share of patent applications, from 23% in
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1990 to 26% in 2006.
The main EU contributor for area C09D was also Germany. Innovations origi-
nating from this country increased its share over the 1990s, however lost importance
over the 2000s, varying from 22% to 20% in the whole period.
Moreover, the main countries responsible for the origin of the innovations applied
in Germany have decreased their importance for the two areas. In C09B they summed
90% in 1990 and dropped to 80% in 2006. Also in area C09D, the main countries
summed 92% in 1990, falling down to 85% in 2006. Next, results from the two
regressions computed – Equations 5.4 and 5.5 – are illustrated in Table 5.36.
Table 5.36: C09B and D: Modeling patents by OLS
Sample: 1990 - 2006 Sample: 1991 - 2006 (1 year lag)
Coefficient t-value P > |t| Coefficient t-value P > |t|
C09B
Equation 5.4
d_1 72.122 2.950 0.011 40.090 1.320 0.213
d_2 80.019 2.020 0.065 23.669 0.489 0.633
F(3,13) = 6.156 (0.008) F(3,12) = 2.536 (0.106)
Equation 5.5
d_1 t 1.767 0.310 0.761 0.866 0.134 0.895
d_2 t -9.811 -0.779 0.450 -15.588 -0.867 0.403
F(3,13) = 2.831 (0.080) F(3,12) = 2.174 (0.144)
C09D
Equation 5.4
d_1 53.373 1.200 0.253 82.310 2.510 0.028
d_2 59.762 0.826 0.423 47.264 0.906 0.383
F(3,13) = 6.126 (0.008) F(3,12) = 16.070 (0.000)
Equation 5.5
d_1 t 6.723 0.784 0.447 13.815 1.750 0.105
d_2 t -0.667 -0.035 0.972 7.305 0.332 0.746
F(3,13) = 6.140 (0.008) F(3,12) = 10.710 (0.001)
Starting with area C09B, unlagged Equation 5.4 rejectedH0 andH
′′
0 , and marginally
rejected H ′0. For unlagged Equation 5.5 and for both lagged regressions none of the
null hypothesis are rejected. Hence, these results infer a positive impact of the first
regulatory knot on the difference between non-EU and EU patent applications, sug-
gesting that an increase of applications originated from non-EU countries.
For area C09D unlagged regressions failed to reject H0 and H
′
0 while H
′′
0 was re-
jected. Lagged regressions marginally rejected H0, failed to reject H
′
0, and rejected
H
′′
0 . These results suggests an increase of applications originated from non-EU coun-
tries.
Summarizing, for technological area C09B EU innovations decreased from 47%
down to 41%, while for area C09D EU innovations showed similar shares (36% and
37%). Furthermore, the computed regressions suggested that the first regulatory knot
may have favored an increase of non-EU patent applications in Germany, for both
regulated areas.
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Top applicants and the concentration of innovative activity
The two areas under study behaved differently also with respect to the concentration
of innovative activity. This is highlighted in Table 5.37.
Table 5.37: Patent applications in Germany: Top applicants and small players in techno-
logical areas C09B and D
C09B C09D
1990 2006 1990 2006
# Applications by the top ten applicants 177 116 218 327
Share of the top ten applicants 59% 51% 25% 28%
# Small players 53 59 204 252
# Applications by small players 48 54 195 222
Share of the small players 16% 24% 22% 19%
From 1990 to 2006, the number of small players in area C09B increased by 11%,
and their share in the total applications was enhanced from 16% up to 24%.13 Con-
versely, the share of the top ten applicants dropped, from 59% down to 51%.
In the Appendix B, Table B.5 shows that there was a decrease in the difference
between the number of applications by the leading firm and the tenth applicant. The
top applicant in 1990 had forty-five applications against twenty-three in 2006, and
in both years the tenth firm had just five patent applications. These facts indicate a
decrease in the standard deviation of the distribution of number of applications per
firms, and that innovative activity became less concentrated with time.
The number of small players also increased in area C09D, by 24%. However, their
share dropped from 1990 to 2006 from 22% down to 19%.14 On the contrary, the
share of the top ten applicants increased from 25% to 28%. Thus, innovative activity
became more concentrated over this period.
Table 5.38 illustrates the variation in the kind of applicants and patents with
shared ownership, in 1990 and 2006. For both technological areas there was little
variation.
Differently from other technological areas analyzed in this chapter, the contribu-
tion of firms in C09B and C09D showed a small decrease, 2% and 3%, respectively.
This fact has reflected also in the number of applications with shared ownership,
given that universities, research centers, and individual inventors are the ones which
usually applied technologies developed in partnership. Hence, patent applications
involving more than two applicants increased from 2% to 4% in area C09B, and from
13The same analysis was done defining small players as entities that applied three or less patents. Similarly,
the share of small players increased from 27% to 45%.
14The same analysis was done defining small players as entities that applied three or less patents. Con-
sidering this definition the number of small players also increased by 31%, and the share of small players
also decreased from 37% to 36%.
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Table 5.38: Patent applications in Germany: Profile of technological areas C09B and D
C09B C09D
1990 2006 1990 2006
# Applications with shared ownership 6 10 40 67
Percentage of shared ownership 2% 4% 5% 6%
Type of applicant
Firms 99% 97% 98% 95%
Universities or research centers <1% 3% 1% 3%
Individual inventors <1% <1% 2% 2%
5% to 6% in area C09D.
In summary, for technological area C09B there was a decline in the concentration
of innovative activity, while for area C09D it became more concentrated. Nevertheless,
it was not possible to relate these changes in concentration to change in regulatory
stringency.
The evolution of the relationship among technological areas
Finally, I investigated if there was a change in the direction of the patent applications
in areas C09B and D, from 1990 to 2006. The patent application profiles for both
years and technological areas are shown in Table 5.39.
Following the definitions of the IPC, area C09B is to a large extent associated
with new substances (organic dyes), and area C09D is related to new formulations,
compositions of different (and not necessarily new) substances (organic or inorganic)
for diverse applications.
C09B Result from the Pearson χ2 test comparing the patents applied in the different
fields in 1990 and 2006 is 59.9, significant at p < 0.001.15 Next, Table 5.40 illustrates
the definitions of the most important areas and the ones that experienced substantial
changes from 1990 to 2006. In this comparison can be observed a clear change in the
pattern of innovative activity.
In 1990, patent applications in area C09B were largely associated with fields C, D,
and G. Field C was mostly represented by areas C07C, C07D, and C09D, which regard
the preparation (new process) of new organic substances with specific characteris-
tics (acyclic, carbocyclic, and heterocyclic compounds – new substances), and new
compositions for paints, inks among others. In summary, these three areas represent
mainly new substances and formulations.
In field D the most important area is D06P associated with the processes of dye-
ing of furs, leather, and textiles. Field G showed two highly pertinent areas, G03C
and G03G, associated with photographic processes for coloring and apparatus for
15The complete table is available in the Appendix D.
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Table 5.39: C09B and D: Related technological areas
C09B 1990 2006 C09D 1990 2006
A 4.2% 11.7% A 3.3% 3.6%
A61K 2.1% 6.2% A01N <1% 1.0%
A61Q 1.5% 3.6% A61L <1% 1.1%
B 9.2% 8.1% B 15.1% 20.3%
B01F <1% 1.0% B05D 5.6% 4.5%
B22F – 1.0% B32B 2.1% 2.4%
B41C – 1.4% B41C – 1.0%
B41M 7.6% 2.7% B41J 1.4% 3.5%
B41M 2.5% 4.2%
C 37.9% 52.0% C 67.7% 65.9%
C07C 6.0% 1.8% C03C <1% 1.0%
C07D 9.3% 7.1% C04B 1.6% 1.1%
C08F 1.2% <1% C07C 1.0% <1%
C08G 1.8% <1% C07D 1.2% 1.4%
C08J 1.6% <1% C08F 11.8% 7.3%
C08K 2.0% 4.1% C08G 14.6% 17.2%
C08L <1% 1.2% C08J 3.7% 4.1%
C09C 1.9% 3.6% C08K 5.7% 5.6%
C09D 6.8% 27.9% C08L 11.7% 7.8%
C09K 1.3% 1.8% C09B 2.4% 6.1%
C11D 1.7% <1% C09C 2.2% 3.0%
C09J 3.0% 2.7%
C09K 1.7% 1.5%
C23C <1% 1.7%
C25D 1.1% <1%
D 31.7% 4.9% D 2.2% 1.8%
D06P 29.3% 2.9% D21H 1.0% <1%
D21H 1.6% 1.9%
G 16.2% 21.8% G 5.7% 4.5%
G01N 1.6% 4.3% G02B <1% 1.5%
G02B 1.0% 6.9% G03F 1.0% <1%
G02F 1.0% 1.3% G11B 2.1% <1%
G03C 4.2% –
G03F 1.0% 1.8%
G03G 5.5% 1.9%
G11B 1.6% 4.6%
H 0.7% 1.5% H 4.7% 2.7%
H01B 1.4% <1%
H01L <1% 1.2%
H05K 1.1% <1%
producing multicolored copies, among others. Some examples of these patents area
illustrated in Table 5.41.
In 2006 this picture has changed. The most important fields became C (increased
its relative weight from 37.9% to 52.0%), G (increased from 16.2% to 21.8%), and A
(increased from 4.2% to 11.7%).
In field C areas associated with organic chemistry (C07) decreased, and there was
an increase in the relative score of area C09D (from 6.8% to 27.9%). These facts
indicate a drop in the development of new organic substances and an increase in
formulations of existing substances.
Field G increased its relative weight and changed its most related areas. Areas
G03C and G03G diminished, and areas G01N, G02B, and G11B increased. These last
three represent the application of organic dyes (area C09B) in methods for analysis of
physical or chemical properties of materials, in optical elements, systems or apparatus,
and in the process of manufacturing parts and accessories of apparatus for storage of
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Table 5.40: C09B: Organic dyes or closely-related compounds for producing dyes; mordants;
lakes
IPC 1990 2006 Definition
A 4.2% 11.7% Human necessities
A61K 2.1% 6.2% Preparations for medical, dental, or toilet purposes
B 9.2% 8.1% Performing operations; transporting
B41M 7.6% 2.7% Printing, duplicating, marking, or copying processes; color printing
C 37.9% 52.0% Chemistry; metallurgy
C07C 6.0% 1.8% Acyclic or carbocyclic compounds
C07D 9.3% 7.1% Heterocyclic compounds
C09D 6.8% 27.9%
Coating compositions (e.g. paints, varnishes, lacquers; filling pastes; chemical paint or ink
removers; inks; correcting fluids; wood stains; pastes or solids for coloring or printing; use of
materials therefor)
D 31.7% 4.9% Textiles; paper
D06P 29.3% 2.9%
Dyeing or printing textiles; dyeing leather, furs, or solid macromolecular substances in any
form
G 16.2% 21.8% Physics
G01N 1.6% 4.3% Investigating or analyzing materials by determining their chemical or physical properties
G02B 1.0% 6.9% Optical elements, systems, or apparatus
G03C 4.2% –
Photosensitive materials for photographic purposes; photographic processes (e.g. cine, x-ray,
color, stereo-photographic processes; auxiliary processes in photography)
G03G 5.5% 1.9% Electrography; electrophotography; magnetography
G11B 1.6% 4.6% Information storage based on relative movement between record carrier and transducer
Pearson χ2 = 130.0 (p-value = 0.000; df = 8)
Table 5.41: C09B: Examples of patent applications in 1990.
Classification Patent application title Applicant name
C09B G03G “Electrophotographic recording material” Agfa-Gevaert NV (BE)
B41M C07D C09B
D06P
“Thiazole dyes of the merocyanine type and a thermal transfer process using
these dyes”
BASF AG (DE)
C07C C09B G03C
“Improved method of synthesizing phenolic cyan-dye-forming photographic
couplers”
Eastman Kodak Co. (US)
C07D C08K C09B
“High stability pigments belonging to the 1,4-diketone pyrrole-3,4-C-
pyrroles and new pyrrole-3,4-C-pyrroles series, suitable for the purpose”
Enichem Synthesis S.p.A. (IT)
A23L A61K B01F
C07C C09B
“Process for the production of carotinoid preparations” F. Hoffmann-La Roche AG (CH)
C09B C09C “Production process of purified pigments, and purified pigments”
Fine Clay Co. Ltd. (JP) and
Kimoto & Co. Ltd. (JP)
C07D C07F C09B
G02F
“Triophene compounds having a non-linear optical activity, materials and
devices containing them”
Flamel Technologies (FR)
C09B G03C G03F “Light-sensitive composition” Fuji Photo Film Co. Ltd. (JP)
C07C C07D C09B
D06P
“Azo compounds and their use as dyes, 1-sulpho-6-carboxyl-amino naph-
thaline, its use as a diazo component and process for the production of
these compounds”
Hoechst AG (DE)
C07D C09B “Method of producing 3-dibutylamino-6-methyl-7-anilinofluoran” Yamamoto Chemicals Inc. (JP)
information (tapes, cards, or discs).
Finally, field A increased its relative share given the increase of the use of organic
dyes on medical, dental, and cosmetic products (e.g. preparations for dyeing the hair)
represented by area A61K. Some examples are shown in Table 5.42.
There are two possible regulatory causes which might explain the some of these
changes. First, as detailed in Chapter 4 and also explained for regulated area A01N,
in 1997 almost all restrictions imposed on substances were not applied to:
(a) medicinal or veterinary products; (b) cosmetic products.16
16See Table 4.3 in Chapter 4.
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Table 5.42: C09B: Examples of patent applications in 2006.
Classification Patent application title Applicant name
C09B C09D “Water-based inks for ink-jet printing” Kao Corporation (JP)
C09B C09D “Non-aqueous pigment dispersions using dispersion synergists” Agfa Graphics NV (BE)
C09B C09J C09K
G02B
“Pressure-sensitive adhesive containing near infrared absorbing coloring
matter”
API Corporation (JP)
C09B G02B “Green pigment preparations based on C.I. Pigment Green 36” BASF SE (DE)
C09B G11B
“Nitro schiff base metal complex dyes and their use in optical layers for
optical data recording”
Clariant International Ltd. (CH)
C09B G02B G02F “Pigment preparation based on an azo pigment” Clariant Produkte GmbH (DE)
C09B C09D
“Process for preparation of a novel pigmented composition for use in offset
inks”
Ciba Holding Inc. (CH)
C09B G01N “Near infrared fluorophore for the selective labeling of membranes in cells” Universität Heidelberg (DE)
A61K C07D C09B
G01N
“Biocompatible fluorescent imaging agents” Visen Medical Inc. (US)
A61K A61Q C09B “Use of cationic azacyanine dyes for coloring keratin fibers” Wella AG (DE)
Therefore, this might explain the growth in the relative importance of technolog-
ical area A61K (which had its uses not restricted by regulation).
Second, in 2003 several organic substances used in dyes (azocolourants) were re-
stricted for several applications, including:
may not be used in textile and leather articles which may come into direct and prolonged contact
with the human skin or oral cavity intended for use by the final consumer.17
All these regulated substances (azocolourants) were converted into restrictions in
technological areas C09B. Hence, this might explain drop in the relative importance
of area D06P, from 29.3% to 2.9%, given the prohibition of the use of organic dyes
(azocolourants represented by area C09B) for dyeing textiles, leather, and furs.
C09D Differently from C09B, technological area C09D experienced minor changes
over the same period. Result from the Pearson χ2 test comparing the patents applied
in the different fields in 1990 and 2006 is 39.0, significant at p < 0.001.18 The most
important fields for both years were B and C, and their main areas are defined in
Table 5.43.
In 1990, field B had as most important area B05D, associated with the after-
treatment of applied coatings19 (process innovation). Field C, responsible for the
vast majority of technological areas associated (67.7%), had three areas highly rel-
evant – C08F, G, and L – associated with the development of new macromolecules
(new substances), and compositions containing macromolecules (new formulations of
existing substances). Some examples are shown in Table 5.44.
In 2006 there were minor changes. The relative importance of field B increased
(from 15.1% to 20.3%), and its three most important areas were B05D, B41J, and
B41M. The first is associated with new processes of applying fluids to surfaces, and
17See Table 4.3 in Chapter 4.
18The complete table is available in the Appendix D.
19Intermediate treating of an applied coating preparatory to subsequent applications of liquids or other
fluent materials.
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Table 5.43: C09D: Coating compositions; chemical paint or ink removers; inks; correcting
fluids; wood stains; pastes or solids or solids for coloring or printing; use of materials
therefor
IPC 1990 2006 Definition
B 15.1% 20.3% Performing operations; transporting
B05D 5.6% 4.5% Processes for applying liquids or other fluent materials to surfaces, in general
B41J 1.4% 3.5%
Typewriters; selective printing mechanisms, i.e. mechanisms printing otherwise than from a
forme; correction of typographical errors
B41M 2.5% 4.2% Printing, duplicating, marking, or copying processes; color printing
C 67.7% 65.9% Chemistry; metallurgy
C08F 11.8% 7.3%
Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsatu-
rated bonds
C08G 14.6% 17.2%
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-
carbon unsaturated bonds
C08L 11.7% 7.8% Compositions of macromolecular compounds
C09B 2.4% 6.1% Organic dyes or closely-related compounds for producing dyes; mordants; lakes
Pearson χ2 = 73.0 (p-value = 0.000; df = 6)
Table 5.44: C09D: Examples of patent applications in 1990.
Classification Patent application title Applicant name
B05D C08F C09D “Use of a process for producing a multi-layered coating” BASF Coatings AG (DE)
C08F C08G C08K
C08L C09D C09J
“Reaction products as adhesion additives for UV curable compositions
and compositions containing same”
Dow Corning Corp. (US)
B05D C09D “Supercritical fluids as diluents in liquid spray applications of adhesives”
Union Carbide Chemicals & Plas-
tics Co. Inc. (US)
C08B C08L C09D
“Polysaccharides with alkaryl or aralkyl hydrophobes and latex compo-
sitions containing same”
Union Carbide Chemicals & Plas-
tics Co. Inc. (US)
C08F C09D “Water-based autoxidisable coating composition” Imperial Chemical Ind. Plc. (GB)
the other two represent the use associated with printers, disposition of the dyes
and accessories (e.g. ink ribbon cartridges), inking, printing processes, and after-
treatment of printed works. The relative rise of these two areas might be explained
by the increase in the development of copiers and printers from the 1990s to the
2000s.
Field C kept in 2006 the main influence on patent applications associated with the
regulated area C09D, varying from 67.7% to 65.9%. Regarding its most important
areas, increased the relative shares of areas C08G associated with processes to ob-
tain new macromolecular substances and C09B associated with the increasing use of
organic dyes in new formulations. Conversely, decreased the relative shares of areas
C08F associated with the development of new substances and C08L associated with
new formulations of only macromolecular compounds. Examples are illustrated in
Table 5.45.
In short, for technological area C09B there was clearly a change in the direction
of innovative activity. The patent application profile applied in 1990 was found to
be different than in 2006. In summary, there was a clear change in the direction of
the innovation for technological area C09B which correspond to regulations imposed
over this period, suggesting a regulatory cause in this change of path. Conversely,
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Table 5.45: C09D: Examples of patent applications in 2006.
Classification Patent application title Applicant name
C09B C09C C09D
“Modified colorants and inkjet ink compositions comprising modified
colorants”
Cabot Corp. (US)
C08F C08G C09D
“Ultraviolet-curable resin composition, ultraviolet-curable coating
material, and coated article”
DIC Corp. (JP)
B41J B41M C08F
C09D H05K
“Curable resin composition for ink-jet printing, cured object ob-
tained therefrom, and printed wiring board obtained with the same”
Taiyo Ink Mfg. Co. Ltd. (JP)
C08J C08L C09D “Multilayer silk protein films” Technische Universität München (DE)
B05D B29C B41M
C09D
“Process for producing ink and relevant to the process, ink, printed
matter and molding”
Teikoku Printing Inks Mfg. Co. Ltd.
(JP)
for area C09D, even though there were some changes of relative importance for some
technological areas, cannot be detached a change in the direction of the innovation,
in the pattern of patents applied in 2006 differently from 1990.
5.4 Findings
The aim of this chapter has been to investigate the relationship between regulatory
stringency and innovation in the chemical industry from 1990 to 2006. Other de-
terminants of innovation have not been considered and thus these findings must be
interpreted as initial and perhaps partial evidence of this relationship.
Chapter 4 identified the three most regulated technological fields by the EU chem-
icals regulation and their most restricted areas. To measure innovation, I examined
patent applications in Germany. Based on the issues raised by the economic litera-
ture, four questions were addressed by this chapter and Table 5.46 summarizes the
findings.
Table 5.46: Summarized results
Panel 1 Panel 2
1. Did regulation spur patenting activ-
ity?
yes yes
A01N C08F C08J C08K C09B C09D
1. Has an increase or decrease in
patenting occurred?
increased decreased decreased decreased decreased increased
Has the share of its technological field
increased or decreased?
decreased decreased stable increased decreased increased
2. Has there been a change in the coun-
try of origin of patents? The share of
EU patent applications has . . .
decreased increased increased stable decreased increased
3. Has there been any increase in
patenting concentration?
decreased decreased decreased decreased decreased increased
4. Has there been a change in the di-
rection of patenting?
yes no no no yes no
First, the aggregate panel showed a positive relationship between regulatory strin-
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gency and innovative activity. Specifically, only two areas – A01N and C09D – have
seen an increase in patent applications with C09D having increased at a faster rate
than its field. The remaining areas have seen a decreased number of applications over
the period analyzed – those in C08J moving in line with the field, C08K increasing
at a faster rate, and C08F and C09B losing importance in their respective fields. Re-
gressions results suggested a positive impact in applications from areas C08F, J, and
K, and a negative impact in area C09D.
Second, only two areas – A01N and C09B – have seen a decreased share of patent
applications originating from EU countries. At the same time, the major EU con-
tributors have accounted for a decreased share of total applications across all sectors
analyzed. Overall, the total share of the leading countries diminished from five to
eleven percent. This indicates a decentralization of the innovation in the world. Firms
from a broader number of countries have been patenting more. Regression results in-
ferred that regulatory stringency has favored non-EU applicants in areas A01N, C08J,
C09B, and C09D. Nevertheless, this effect might be due to the increasing patenting
activity from emerging economies over the 1990s.
For instance, previous to the TRIPS20 agreement, most emerging economies and
among other industrialized countries did not have an intellectual property rights reg-
ulation, or the existing regulation did not comprise patents for chemicals, foodstuffs,
and pharmaceuticals. This effect might have been favored an overall increase of
patenting from firms in non-EU countries.
Third, innovative activity became less concentrated in five regulated areas. There
was an overall increase in patents applied by “small players.” The only exception was
area C09D, which showed a concentration of innovative activity in the same period.
Lastly, technological areas A01N and C09B showed a clear change in the direction
of innovative activity. Both show the highest values of the Pearson χ2 test among
the investigated regulated areas. In addition, the change in the direction of the
innovation coincides with the restrictions imposed by the EU chemicals regulation.
This finding supports the view that regulation alters the direction of the innovative
efforts of economic agents.
These findings illustrate the heterogeneous behavior of innovative activity over
periods of increasing regulatory stringency in 1997 and 2003. If environment, health,
and safety regulations impact technological areas differently, this would be a reason
why previous studies have highlighted that these regulations impact industrial sectors
differently. Some specific observations should be highlighted.
Certainly, other non-regulatory factors may play a role in the development of these
technological areas. However, the impact of the chemicals regulation on innovative
activity is also heterogeneous. Restriction in the uses of the substances can have a
20TRIPS: Trade-related aspects of intellectual property rights agreement imposed on all countries which
are part of World Trade Organization – 1994.
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different impact on the various areas.
Overall, there was an increase in innovations associated with new process and
formulations – meaning more incremental innovation – and a decrease in new sub-
stances. The applicability of new patents also changed to non-regulated uses and new
technologies (e.g. biotechnology).
Areas which showed major changes over this period were also those that bore the
largest number of restrictions: A01N with 104, C09B with 86, and C09D with 101
restrictions. Conversely, areas which were more stable were also those that received
less restrictions: C08F with 22, C08J with 40, and C08K with 62 restrictions.
Despite the fact that area A01N was the most restricted, new developments and
new applications permitted it to maintain innovation, as evidenced in new patent
applications. In this case, there was an increase in patenting associated with non-
regulated usages, while patents associated with new organic substances – highly ev-
ident in 1990 – lost importance. Also, applications associated with biotechnology
grew, illustrating the possibilities opened by this technological field.
In the case of area C09D, the fact that it represents new formulations or appli-
cations of new and existing substances might have facilitated the increasing trend
in patenting. Conversely, the development of new substances is what characterizes
area C09B, which might have been a reason for the decreasing trend in the number
of innovations.
The research questions analyzed in this chapter have been inspired by Porter’s
argument that regulatory stringency positively impacts innovation and consequently
competitiveness. My results in relation to the impact of chemicals regulation on tech-
nology are mixed. My findings suggest that the impact will depend on the technolog-
ical point at the time the regulation is imposed. In other words, “new” technologies
appear to be favored by regulatory stringency while “old” technologies appear to be
disadvantaged.
The technological areas I have analyzed find themselves at different stages of the
innovation cycle. The most heavily regulated sectors in the EU are A01N (agrochemi-
cals), C09B (organic dyes) and C09D (new compositions of existing substances). Areas
A01N and C09B are associated with technologies which originated in the nineteenth
century. The early growth in the A01N sector was based around the nineteenth
century organic chemicals technology, but, over the most recent two decades that
technology has been largely substituted by biotechnology. I find that this area has
benefited from regulation in line with the Porter hypothesis. By contrast, sector
C09B where the technology remains largely based on nineteenth science and which
was subjected to specific EC regulations in 2003, has seen reduced levels of innova-
tion contrary to the Porter predictions. The regulatory impact on sector C09D, where
there is no clear link to a technological cycle, appears to have been minimal.
This evidence comes from a particular industry in a specific jurisdiction. It is
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nevertheless an industry in which regulation has been both important and contro-
versial. They have implications for chemicals regulation worldwide. If supported by
studies in other industries, they will imply that there are no simple answers to regu-
latory issues. It is nevertheless encouraging that the Porter hypothesis does appear
to be supported in relation to new technologies where innovation presumably has the
greatest potential returns.
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Chapter 6
The Innovative Behavior of Firms
In Chapter 5 I analyzed the evolution of patent applications from 1990 to 2006 in
Germany for the technological areas belonging to the most regulated fields: A01,
C08, and C09. The research questions raised by the literature were investigated in
a global perspective the direct relationship between regulated chemicals and chemi-
cals technology. The development of these heavily regulated technological areas was
described.
The aim of this Chapter is to provide a different perspective of the evolution of
regulated chemical industry over this period. In order to bring this distinct point
of view, I turn to investigate the behavior of big players in these technological areas
over the period of increasing regulatory stringency in the EU. The same analysis
developed in the previous chapter will be replicated at the firm level. Not only to
exemplify and complement the analysis of the previous findings, but also to investigate
initial evidence that the top applicants lost space to “small players” in the innovative
field. This fact goes against the conventional wisdom that says that more regulation
leads to higher concentration of the innovative activity and that bigger firms would
innovate more than several small firms. Thus, looking more closely to the firm level
is important.
From the top innovative firms seen in the previous section, two European and two
non-European were chosen, in an attempt to understand different strategies designed
by these firms through time. The OECD Patent Manual explains (OECD, 1994,
pg.59):
The patent portfolios of large firms can be investigated in order to study a company’s in-
novation strategy, its technological diversification and how different fields of knowledge
are combined in the firm’s activity.
and adds:
In fact, most large firms carry out technological activities in a range of fields broader
than their production activities in order to explore potential future areas of activity.
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As previously, innovation trends and actual technological choices may be observed
through the study of the evolution of patent portfolios.
6.1 Data and methodology
The previous chapter showed that top applicants appear to have decreased in impor-
tance on highly regulated technological areas from 1990 to 2006. Taking this into
account, three parameters were used in order to select four firms. First, they were
leaders in patent applications in the most regulated technological areas. Second they
are main responsible for the development the technological development of these tech-
nological areas since the nineteenth century. Third, preference was also given to two
firms originally from the EU and two non-EU firms. This enables to draw a parallel
analysis of the previous chapter in a firm level looking at the impact of a regulation
which applies within the European market in EU and non-EU firms.
The four selected firms are shown in Table 6.1, also their positions when they
figure among the top ten applicants in Germany (in 1990 and 2006) in the regulated
technological areas.
Table 6.1: Position of the investigated firms among the top ten applicants
Bayer BASF 3M DuPont
1990 2006 1990 2006 1990 2006 1990 2006
A01N 1 2 2 1 - - 8 8
C08F 2 - 1 1 7 8 8 4
C08J 3 - 1 1 4 3 2 2
C08K 1 - 4 4 - 8 10 1
C09B 3 - 2 3 10 - - -
C09D 1 6 5 1 7 - - 2
Throughout their existence these firms exited or entered in different business sec-
tors. From 1990 to 2006 this fact can be observed given their different positions in
the previous table. Their R&D choices are what characterizes the technology in use
today, therefore their history is mixed with the history of the chemical industry. A
brief history of these firms is provided for the reasons stated above.
Bayer (DE), BASF (DE), DuPont (US), were responsible for the evolution of
the three big technological cycles which marked the chemical industry, the eras of
synthetic dyes, agrochemicals, and polymers. The technological development that
enabled these expansions were done inside their laboratories.
3M (US), the fourth firm here analyzed, has a different approach towards chemical
technology. Since the twentieth century their business focus on a large branch of
different use products which have largely in common material-science. From magnetic
films, dental prosthesis, adhesives, and abrasives are some of the many products
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which are applications of polymeric science. This becomes clear when I study the
technological areas which are the most important in its patent portfolio. Even acting
in many other areas (such pharmaceuticals), this characteristics is what made 3M
also a leader on several technological areas related to chemicals.
These case studies focus on two research questions which were previously discussed
in Chapter 5, Section 5.2. First, Did regulation spur patenting activity? Following
the Porter hypothesis, I consider whether an increase in the stringency of regulation
incentivizes firms to innovate.
Second, has there been a change in the direction of patenting? Eads (1980) states
that regulation might also impact the direction of innovative activity. In Chapter
5 I looked at the overall patenting activity in regulated technological areas, in this
chapter I seek to verify if these firms have changed their patenting profile according
to more demanding regulation. The Patent Manual by OECD (1994, pg. 59) helps
clarify this issue:
Patents can be particularly helpful in identifying the direction taken by the R&D and
innovation effort of a firm [. . . ] The patent portfolios of large firms can be investigated
in order to study a company’s innovation strategy, its technological diversification and
how different fields of knowledge are combined in the firm’s activity.
Patent applications in Germany, from 1991 to 2006, were examined in all techno-
logical areas and respective fields. The methodology employed was a keyword search
in the ESPACE Bulletin Database. Over the 1990s and the 2000s the chemical
industry went through several corporative changes, mergers, and acquisitions. Fur-
thermore, firms designed different strategies regarding location of production plants
and research centers. Thus, I will analyze these multinationals in a global extent.1
The analysis of these firms required three steps. First, I entered the name of the
company – or parts of – and downloaded all patent applications made by each firm in
Germany, over the period 1991 to 2006. This made it possible to depict the evolution
of innovation and its origin through time.
Second, for the two years 1991 and 2006, I highlighted the complete set of tech-
nological areas to which these the patent applications related in order to observe the
technological areas in which these firms innovated. Definitions of the fields associ-
ated with the technological areas are provided in the Appendix A and a summary is
provided in Table 6.2.
Finally, I analyzed the evolution of patent applications in the most regulated
technological areas. (It was not possible to undertake this analysis for either 3M in
relation to area A01N or for DuPont in relation to area C09B, since they do not figure
1This methodology also has its shortcomings. If a firm belongs to a holding, but its name does not
contain the keywords used (related to the name of the holding) it will not be counted. Conversely, if a firm
contain the keyword used but does not belong to the major group it will not be discarded. In order to
overcome these problems I developed a brief study of the corporative structure of each firm over this period.
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Table 6.2: International Patent Classification: IPC-7
Code Definition
A Human necessities
B Performing operations and transporting
C Chemistry and metallurgy
D Textiles and paper
E Fixed constructions
F Mechanical engineering; lighting; heating; weapons; and blasting
G Physics
H Electricity
among the top ten applicants in these areas in either year or given, and 3M in relation
to area C09B because of the small number of applications.) This methodology will
become clearer after I present the first case.
In order to better organize these case studies, the complete tables illustrating
the country of origin of patent applications in regulated areas are available in the
Appendix E and their complete patent profiles (for 1991 and 2006) are available in
the Appendix F. The Pearson χ2 test is calculated and the complete tables, containing
all the results, are in the Appendix G.
6.2 Case studies
6.2.1 Bayer Group
Founded in 1863 by Friedrich Bayer and Johann Friedrich Weskott as “Friedr. Bayer
et comp.,” the company had as expertise the manufacture of synthetic dyestuffs. In
the nineteenth century, the production of synthetic dyes – derived from coal-tar –
substituted natural dyes in the market of the textile industry.
By the beginning of the twentieth century, over 80% of Bayer sales came from
exports and the company was already established in the US and Europe.2 In that
period, dyes continued as the core business of Bayer but the company had already
started its business on pharmaceuticals, basic chemicals and intermediates, rubber
synthesis, and modern polymer chemistry (with the development in the 1930s of
polyurethanes).
Crop protection research grew from an expansion of the pharmaceutical business
of Bayer by the 1970s. Over this decade, Bayer launched important anti-fungal crop
protection products. By the 1980s, Bayer had business on pharmaceuticals, crop pro-
tection, plastics and coating raw materials, specialty metals, and high-performance
ceramics.
2Russia, France, Belgium, the United Kingdom.
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Over the 1990s Bayer passed through structural transformations. In 1994 the
company regained the right to use its brand in the US and acquired an US self-
medication business that was renamed as Bayer Corporation in 1995. Still in 1994,
Bayer established a third research center on pharmaceuticals in Japan, summing up
to the ones in Europe and US. The study over its innovative activity reflects these
changes, altering the origin and the technological areas of the patents applied.
Over the 2000s there were other important acquisitions. In 2001 Bayer acquired
Lyondell Chemical Company, a US producer of raw materials for polyurethanes (poly-
mers – polyols business). Still in 2001 the company acquired the Aventis CropScience,
which became in 2002 the Bayer CropScience AG. Moreover, in 2005 Bayer acquired
the Roche consumer health business, expanding its pharmaceutical business.
The restructuring also involved the creation of other independent entities in 2003,
Bayer Chemicals AG and Bayer HealthCare AG. In 2005, Lanxess AG was created,
a spin off from Bayer Group on the businesses of chemicals and polymers.3
In order to obtain all patents applied by Bayer Group in Germany, I entered with
the keyword “bayer” in ESPACE Bulletin database, and all patent applications by
any firm or individual inventor containing “bayer” were downloaded. Subsequently,
firms or individuals not related to the Bayer Group were discarded.
Evolution of patenting activity
First I illustrate the evolution of overall patenting activity of Bayer Group. Table
6.3 shows all patents applied in Germany, irrespectively of the technological field,
classified by country of origin. The last two rows show the share of patents originating
from Germany and the US, the two most important countries in terms of number of
applications.
Table 6.3: Patent applications in Germany by Bayer Group classified per country of origin
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
DE 367 460 432 380 505 444 481 390 478 475 512 443 419 391 417 365
US 34 70 66 74 89 82 103 100 56 52 61 78 104 98 106
FR 5 2 1 3 10 8 25 13 19 23 27 14 19 20 22
BE 6 4 8 8 6 20 8 6 19 13 5 7 8 6 2 7
JP 3 10 12 11 15 12 6 7 8 6 7 4 1
CA 2 4 8 6 3 2 1 3 9 4 4 2 3 1
GB 2 3 2 3 1 2
IT 2 1 1 1 1
ES 1 1
Total 412 555 495 475 609 579 586 537 625 574 603 543 522 521 538 501
% DE 0.89 0.83 0.87 0.80 0.83 0.77 0.82 0.73 0.76 0.83 0.85 0.81 0.80 0.75 0.78 0.73
% US 0.08 0.13 0.06 0.14 0.12 0.15 0.14 0.19 0.16 0.10 0.09 0.11 0.15 0.20 0.18 0.21
There was an increase of twenty two percent in the total number of patent appli-
cations with a peak in 1999. Taken together, Germany and the US are responsible
3Information on the Bayer company was extracted from BayerGroup (2009).
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for more than ninety percent of the applications. Patent applications originated in
the US more than tripled both in absolute numbers as well as in the share of the
total, while applications originated in Germany kept stable, from 1991 to 2006.
A fixed effect panel data was estimated to better understand if regulatory strin-
gency has affected Bayer’s patent profile positively or negatively. The panel includes
all patents applied by Bayer in all technological areas from 1991 to 2006. Table 6.4
shows these results.
Table 6.4: Bayer and the Porter hypothesis: 1991 – 2006
Patent profile Coefficient t-value P > |t|
restrict -0.141 -3.86 0.000 F(1,1739) = 14.88 (0.000)
L1 -0.219 -5.89 0.000 F(1,1623) = 34.70 (0.000)
L2 -0.203 -4.97 0.000 F(1,1507) = 24.68 (0.000)
The results from the proposed panel show a significant negative impact of regula-
tory stringency on Bayer’s patenting activity. The most significant result is seen for
one-year lag effect.
The evolution of the relationship among technological areas
The second step in the analysis was to calculate the patenting profile in 1991 and
2006, to observe the share of the different technological field in these two years.4 The
results are shown in Table 6.5.
Table 6.5: Bayer Group: Patenting profile in 1991 and 2006
A B C D E F G H Total
1991 16.0% 9.4% 65.5% 2.9% 0.0% 0.4% 3.8% 2.0% 100.0%
2006 45.2% 4.3% 40.7% 0.1% 0.3% 0.7% 8.3% 0.4% 100.0%
Pearson χ2 = 265.0 (p-value = 0.000; df = 7)
The two most relevant fields are A (human necessities) and C (chemistry and
metallurgy), representing more than eighty percent for both years. Even so, there
was a change of pattern over this period. The share of field A increased from 16.0%
to 45.2%, while the share of field C decreased from 65.5% to 40.7%.
Analyzing the Bayer’s patent profile subdivided by the different technological
areas, the sum of the relative share of the regulated areas kept stable around twenty
two percent from 1991 to 2006. Table 6.6 shows the percentage of the regulated
technological areas in the patent profile.
4The methodology employed is described in Section 5.2 of Chapter 5.
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Table 6.6: Share of regulated technological areas in Bayer’s patent profile
A01N C08F C08J C08K C09B C09D Total share
1991 7.1% 3.9% 3.1% 3.7% 2.5% 2.4% 22.6%
2006 17.3% 0.2% 0.7% 1.1% – 3.0% 22.3%
As shown in this table, there was an increase in the share of patent applications
in areas A01N and C09D, while the other four areas decreased. Next, I analyze the
patenting behavior of Bayer Group in these areas.
A01N Patent applications in area A01N increased over the years. Table 6.7 illus-
trates this evolution. In addition it shows the share of applications in field A and
with respect to all patent applications by Bayer Group.5
Table 6.7: A01N: Evolution of patenting in Germany by Bayer Group
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
Total 49 84 95 87 114 109 116 85 110 109 103 111 87 109 119 118
A01N/ A 0.52 0.56 0.63 0.54 0.60 0.60 0.59 0.49 0.60 0.53 0.39 0.43 0.32 0.45 0.42 0.39
A01N/
total pat.
0.12 0.15 0.19 0.18 0.19 0.19 0.20 0.16 0.18 0.19 0.17 0.20 0.17 0.21 0.22 0.24
Applications classified in area A01N more than doubled from 1991 to 2006. How-
ever, in 1991 fifty two percent of all patents in field A were classified in area A01N
while in 2006 just thirty nine percent. This suggests that the firm has been patenting
in a wider branch of areas from field A. Considering all patents applied by Bayer, in
1991 twelve percent were classified in area A01N and in 2006 this share increased to
twenty four percent.
The next step is to analyze the direction of the innovative activity. The same
procedure employed in Chapter 5 is used, analyzing all technological areas linked to
patent applications in regulated area A01N. Table 6.8 shows the patent application
profile of area A01N in 1991 and 2006.6
From 1991 to 2006 there were few changes in the patent profile associated with area
A01N comparing to the ones found in the previous chapter. In 1991 applications were
characterized by new organic substances (C07C and C07D). In 2006 the association
with these areas decreased while areas A61K, A61P, C05G, and C12N, increased.
As observed in Chapter 5 (Section 5.3), technologies associated with areas A61K
and A61P were not regulated. Also, it was observed the increasing trend of new prod-
ucts based on new formulations (instead of new substances), and new technologies.
This fact can be observed in Bayer’s patent profile, given the increasing importance
5Number of patent applications in area A01N divided by the number of patent applications in field field
A and number of patent applications in area A01N divided by the all patent applications by Bayer Group.
6Only areas with more than one percent of relative weight are shown.
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Table 6.8: A01N: Summarized patent application profile and definitions – Bayer Group
IPC 1991 2006 Definition
A61K 3.4% 4.5% Preparations for medical, dental, or toilet purposes
A61P 1.2% 3.6% Therapeutic activity of chemical compounds or medicinal preparations
C05G – 2.4%
Mixtures of fertilizer covered individually by different subclasses of class C05; mixtures of one
or more fertilizers with materials not having a specific fertilizing activity (e.g. pesticides, soil-
conditioners, wetting agents); fertilizers characterized by their form
C07C 13.0% 11.8% Acyclic or carbocyclic compounds
C07D 71.3% 69.1% Heterocyclic compounds
C07F 5.6% –
Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen,
halogen, oxygen, nitrogen, sulfur, selenium, or tellurium
C12N – 1.8%
Micro-organisms or enzymes; compositions thereof; propagating, preserving, or maintaining micro-
organisms; mutation or genetic engineering; culture media
Pearson χ2 = 8.43 (p-value = 0.208; df = 6)
of areas C05G, associated with new substances and mixtures of fertilizers, and C12N,
associated with biotechnology.
The acquisition in 2001 of the Aventis CropScience reflected the interest of Bayer
Group in investing in technologies associated with crop growth (A01N). Table 6.9
shows some examples of patent applications by Bayer Group in 2006.
Table 6.9: A01N: Examples of patent applications in 2006.
Classification Patent application title Applicant name
A01N C12N “Methods for increasing the resistance of plants to hypoxic conditions” Bayer BioScience NV (BE)
A01N C07D “New heterocyclylethylbenzamide derivatives” Bayer CropScience SA (FR)
A01N C07C C07D
“Pesticide benzyloxy- and phenetyl- substituted phenyl-amidine deriva-
tives”
Bayer CropScience AG (DE)
A01N C07C C07D “Pesticide phenyloxy substituted phenylamidine derivatives” Bayer CropScience AG (DE)
A01N C07C C07D “Dioxazine- and oxadiazine- substituted arylamides” Bayer CropScience AG (DE)
A01N A01P A61K
A61P
“Endoparasiticide” Bayer Animal Health GmbH (DE)
A01N A01P C05G “Use of tetramic acid derivatives with fertilizers” Bayer CropScience AG (DE)
When looking at Chapter 5, it was observed that area A01N increased in number
of applications and changed in direction. This can also be observed in this case study.
Also, in the previous chapter there was a decrease in the association with areas C07C
and C07D.
C08F, C08J, and C08K The number of patent applications in highly regulated ar-
eas from macromolecular technology (C08) was stable over the 1990s and afterward
decreased. Table 6.10 illustrates this evolution showing the number of patent appli-
cations in these areas per year, the percentage of applications in each of these areas
with respect to their field C and with respect to the total number of patents applied
by Bayer Group.
Overall, area C08F decreased almost one hundred percent, C08J by sixty six per-
cent, and C08K by fifty eight percent.
The analysis of the patent profiles in these areas has pitfalls given the small
number of applications in 2006. Nevertheless, Table 6.11 shows the summarized
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Table 6.10: C08F, C08J, and C08K: Evolution of patenting in Germany by Bayer Group
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
C08F
Total 30 28 33 19 31 31 34 33 56 40 25 19 9 7 9 1
C08F/ C 0.10 0.06 0.08 0.05 0.06 0.07 0.07 0.08 0.13 0.09 0.06 0.05 0.02 0.02 0.03 0.00
C08F/
total pat.
0.07 0.05 0.07 0.04 0.05 0.05 0.06 0.06 0.09 0.07 0.04 0.03 0.02 0.01 0.02 0.00
C08J
Total 29 32 35 33 43 21 34 28 29 46 19 7 13 11 15 10
C08J/ C 0.10 0.07 0.09 0.09 0.09 0.05 0.07 0.06 0.07 0.10 0.04 0.02 0.03 0.03 0.04 0.03
C08J/
total pat.
0.07 0.06 0.07 0.07 0.07 0.04 0.06 0.05 0.05 0.08 0.03 0.01 0.02 0.02 0.03 0.02
C08K
Total 33 43 40 29 46 30 33 45 48 46 35 21 18 9 13 14
C08K/ C 0.11 0.10 0.10 0.08 0.09 0.07 0.07 0.10 0.11 0.10 0.08 0.05 0.05 0.03 0.04 0.05
C08K/
total pat.
0.08 0.08 0.08 0.06 0.08 0.05 0.06 0.08 0.08 0.08 0.06 0.04 0.03 0.02 0.02 0.03
patent application profile of areas C08F, J, and K, in 1991 and 2006.
Table 6.11: C08F, C08J, and C08K: Summarized patent application profile and definitions –
Bayer Group
IPC 1991 2006 Definition
C08F
B01J 10.0% – Chemical or physical processes (e.g. catalysis, colloid chemistry; their relevant apparatus)
C08C 12.3% – Treatment or chemical modification of rubbers
C08L 12.8% – Compositions of macromolecular compounds
C08J
B29C 3.0% 10.0%
Shaping or joining of plastics; shaping of substances in a plastic state, in general; after-treatment
of the shaped products, e.g. repairing
C08G 25.5% 33.7%
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon
unsaturated bonds
C08K 11.9% 13.7% Use of inorganic or non-macromolecular organic substances as compounding ingredients
C08L 26.9% 19.7% Compositions of macromolecular compounds
Pearson χ2 = 0.67 (p-value = 0.880; df = 3)
C08K
A61L – 14.3%
Methods or apparatus for sterilizing materials or objects in general; disinfection, sterilization, or
deodorization of air; chemical aspects of bandages, dressings, absorbent pads, or surgical articles;
materials for bandages, dressings, absorbent pads, or surgical articles
B32B – 16.7% Layered products, i.e. products built-up of strata of flat (e.g. cellular or honeycomb, form)
C08J 10.1% 9.8% Working-up; general processes of compounding; after-treatment not covered by subclasses
C08L 57.7% 31.0% Compositions of macromolecular compounds
Pearson χ2 = 16.20 (p-value = 0.001; df = 3)
In 1991 patents in area C08F were highly associated with compositions of new
or existing macromolecular substances (C08L) and new processes (C08C and B01J).
In area C08J patents were highly associated with composition of new or existing
substances (C08L and C08K), and development of new macromolecular substances
(C08G). In area C08K, patents were highly associated with composition of new or
existing macromolecular substances (C08L) and new processes (C08J).
In 2006 increased the association of area C08J with mechanical processes over
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plastics on their final state (work over final product, B29C). The previous cited areas
in 1991 kept their importance. In area C08K the association with mechanical processes
over plastic on their final state (B32B) and with objects for medical, veterinary,
or hygienization uses (A61L) increased. Overall, for both areas increased patent
applications associated with mechanical processes to manipulate the plastic object
(macromolecular compounds in their final state) and with new uses.
When comparing these findings with results obtained in Chapter 5 (Section 5.3),
there is coincidence in some technological areas. There occurred an overall increase in
technological areas associated with processes and a decrease in areas associated with
new substances. However, considering patents applied in area C08J the association
with areas C08G and C08K related to the development of new substances increased.
Nevertheless, Bayer made few 2006 patent applications in these areas.
As described in the brief history of Bayer Group, even though in 2001 there
was an acquisition of a producer of raw material for polyurethanes, associated with
classification C08G, in 2005 a spin off in the polymers business – associated with areas
C08F, J, and K – was created. This is consistent with the view that the firm wishes to
exit this market and was therefore no longer prepared to invest or innovate in these
technological areas as illustrated in Table 6.10.
C09B and D For the last two areas analyzed the overall contribution of patent
applications was small. However, these areas show different behaviors, as illustrated
in Table 6.12.7
Table 6.12: C09B and C09D: Evolution of patenting in Germany by Bayer Group
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
C09B
Total 18 40 29 25 27 17 22 11 11 9 1 2 2
C09B/ C 0.06 0.09 0.07 0.07 0.05 0.04 0.05 0.03 0.03 0.02 0.00 0.01 0.01
C09B/
total pat.
0.04 0.07 0.06 0.05 0.04 0.03 0.04 0.02 0.02 0.02
C09D
Total 25 45 50 38 60 36 50 43 57 34 30 30 32 38 41 33
C09D/ C 0.09 0.10 0.12 0.10 0.12 0.08 0.11 0.10 0.13 0.08 0.07 0.08 0.08 0.11 0.12 0.11
C09D/
total pat.
0.06 0.08 0.10 0.08 0.10 0.06 0.09 0.08 0.09 0.06 0.05 0.06 0.06 0.07 0.08 0.07
Area C09B showed a stable pattern until 1997 and thereafter decreased until
2003, when Bayer applied the last patents. Area C09D achieved a higher number of
applications over the 1990s comparing to the 2000s, however the share kept stable,
both when looking at all patent applications in field C and at the all applications by
Bayer.
7In both technological areas Germany is the origin of the vast majority of the patent applications as
observed in the Appendix E, Table E.3
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Next, Table 6.13 illustrates the summarized patent profile and definitions of the
most important areas in 1991 for both areas, and in 2006 for area C09D.
Table 6.13: C09B and C09D: Summarized patent application profile and definitions – Bayer
Group
IPC 1991 2006 Definition
C09B
C07D 13.9% – Heterocyclic compounds
D06P 48.2% – Dyeing or printing textiles; dyeing leather, furs, or solid macromolecular substances in any form
C09D
C08G 33.6% 85.5%
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon
unsaturated bonds
C08L 13.1% 4.2% Compositions of macromolecular compounds
Pearson χ2 = 5.97 (p-value = 0.015; df = 1)
In 1991 regulated area C09B was mostly associated with codes C07D and D06P.
In 2006 Bayer had left new developments associated with this technology.
In 1991 regulated area C09D was mostly associated with codes C08G and C08L. In
2006 increase the association with area C08G and decrease the association with area
C08L. In addition, a decrease in the range of areas associated with applications in 1991
to 2006, from nineteen to six areas with more than one percent in the total patent
profile is noticed (Table F.3). This indicates a more focused research on innovations
in area C09D.
When comparing this behavior with results obtained in Chapter 5, the most rele-
vant areas in 1991 coincide for both regulated areas. For area C09B, Bayer’s patenting
behavior followed the same decreasing trend observed when looking at the overall be-
havior of this regulated area. Chapter 5 showed how area C09B was highly regulated
in uses associated with code D06P. Thus, the most relevant associated area in Bayer’s
in 1991 patent applications was also the one with the highest fall when looking at
the overall patenting, coinciding with regulation imposed over the years.
For area C09D Bayer’s patenting behavior kept a stable pattern while the overall
patenting in this regulated area has increased. The most important areas – C08G
and C08L – were also previously highlighted as important in the overall patenting in
both years. However, in the case of Bayer’s applications in area C09D, area C08G
increased its importance from 33.6% to 85.5%, while when looking at overall patents
there was a smaller increase, from 14.6% to 17.2%.
As described in the brief history of the Bayer Group, in 2001 they acquired Lyon-
dell Chemical Company a US producer of raw materials for polyurethanes directly
associated with code C08G. This fact might explain the increasing relationship be-
tween areas C09D and C08G.
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Remarks
The panel data showed that regulatory stringency has impacted negatively Bayer’s
patent profile. For this firm the Porter hypothesis is not supported.
Patent applications in area A01N more than doubled in the period under investi-
gation. In 1991 area A01N was present in twelve percent of all Bayer’s applications
and in 2006 increased to twenty four percent. Applications in areas C08F, J, and K
diminished over the period under investigation. This was reflected in the rank of the
top ten applicants in these areas, disappearing from this rank in 2006. Bayer stopped
applying patents in area C09B in 2003 and in area C09D there was an increase from
1991 to 2006, however reached higher number of applications by the end of the 1990s
diminishing afterward.
Investigating the direction of patenting the Pearson χ2 was shown to be not sig-
nificant in areas A01N and C08J, while significant in areas C08K and C09D.
In summary, from 1990 to 2006 Bayer Group kept between the top ten appli-
cants in areas A01N and C09D, left the market in areas C08F and C09B, and kept a
decreasing trend in areas C08J and C08K.
This overall view corroborates with the results obtained in Chapter 5. It is noticed
an increasing trend towards process innovation and away from product innovation.
Also, new products are characterized by new formulations and new technologies.
In addition, from the analysis of the patenting profile in 1991 and 2006 it may be
observed that the technological path designed by the firm which matches with the
description of acquisitions and spin-offs detailed in the summary of the firm’s history.
This corroborates the interpretation and methodology employed because my analysis
from the patent profile reflects the history of the firm in the last decades.
6.2.2 BASF
Similarly to Bayer, Badische Anilin & Soda Fabrik (BASF) was founded in 1865
in order to supply with synthetic dyes the growing textile industry. In 1913 BASF
expanded its business to agricultural products manufacturing mineral fertilizers, given
the increasing demand for food production in Europe.
The company developed the “Haber-Bosch process” enabling the fixation of at-
mospheric nitrogen to produce synthetic ammonia, a solution for the demand of
nitrogen sources. This breakthrough process innovation was possible given the de-
velopments on catalysis technology and equipments that allowed chemical reactions
under high-pressures (gas machines and compressors). In addition, in the first half
of the twentieth century the company developed new processes for the synthesis of
methanol (another raw material which was previously dependent on wood alcohol),
urea (from ammonia and carbon dioxide), and sulfuric acid.
The 1950s marked the entrance of BASF in macromolecular technology. The
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acetylene chemistry supported the development of plastics and other raw materials
for the production of coatings.
In the 1960s BASF expanded its production plants in industrialized countries.
This expansion secured the company’s raw materials base given the importance of
basic and intermediate chemicals to the company’s business. In the 1990s BASF ex-
panded its investments in large scale chemical plants in Asia to provide petrochemi-
cals, basic and intermediate chemicals, important raw materials for the production of
different polymers, elastomers, and fibers which are used in different industries from
electronics to textile.
Over the 1990s and 2000s there were further expansions and acquisitions on several
sectors of the industry. Starting with polymers, there were investments on produc-
tion plants in the US and Europe. Polyurethane basic materials and specialties in
Germany (1990), petrochemical feedstocks in Belgium (1994), naphtha steam cracker
to produce propylene and ethylene and other feedstocks in the US (2001), polymer
dispersions for coating binders for the paper industry in Finland (2002). Further-
more, BASF acquired Honeywell’s engineering plastics business in 2003 and Johnson
Polymer resins portfolio in 2006, increasing its presence in the US market.
There were also investments in the food and agrochemicals sector. In 1999 the
company created BASF Plant Science in partnership with the Swedish seed manufac-
turer Svalof Weibull.8 In 2000 BASF acquired the crop protection business of Amer-
ican Home Products Corporation (AHP), in 2001 the vitamins business of Takeda
Chemical Industries, and in 2003 the insecticide fipronil and other selected seed treat-
ment fungicides from Bayer CropScience, increasing its portfolio and global sales of
the agricultural products division.
Other acquisitions were Merck KgaA (DE, 2005), Engelhard Corporation (US,
2006), and Degussa AG (DE, 2006), accounting for electronic chemicals, catalysts for
special pigments, and construction chemicals. In summary, over these sixteen years
the company has expanded its chemical plants in petrochemicals and intermediates
for the manufacture of polymers such plastics, elastomers to the industries from
electronic to textile.
BASF also left some businesses. In 2000 BASF created together with Bayer and
Hoechst a joint-venture on dyes to increase in competitiveness, the Dystar Textilfar-
ben GmbH & Co. Deutschland KG. BASF’s part of the largest supplier of textile
dyes (associated with technological areas C09B and C09D) was sold in 2004 to the
US private equity group Platinum Equity. In addition, in 2001 BASF sold its phar-
maceutical business to Abbott Laboratories Inc..9
The company’s name was the keyword used to obtain the patent applications in
8In 1999 BASF owned 85% of the biotechnology research company on the fields of agriculture and
nutrition, both associated with technological area A01N.
9Information on the BASF company was extracted from BASF (2008).
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Germany. All patents applied by any firm or individual inventor containing “basf” in
its name or part of were downloaded from the ESPACE Bulletin database. Subse-
quently, firms or individuals not related were selected and discarded.
Evolution of patenting activity
Overall, BASF’s patenting activity increased from 1990 to 2006. Table 6.14 shows
the number of patents applied per country of origin and the share of applications
originating from Germany and the US.
Table 6.14: Patent applications in Germany by BASF classified per country of origin
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
DE 501 502 539 448 581 622 696 600 661 652 648 598 619 621 653 800
US 39 26 54 50 37 38 29 45 45 40 42 56 30 17 24 45
JP 3 3 3 4 1 2 1 1 1 3 8
CH 3 2 3 3 1 1 2
FR 1 2
NL 2 1
IT 1 1
BR 1
DK 1
ES 1
Total 541 529 597 501 622 667 726 648 712 695 692 656 652 638 682 856
% DE 0.93 0.95 0.90 0.89 0.93 0.93 0.96 0.93 0.93 0.94 0.94 0.91 0.95 0.97 0.96 0.93
% US 0.07 0.05 0.09 0.10 0.06 0.06 0.04 0.07 0.06 0.06 0.06 0.09 0.05 0.03 0.04 0.05
There was an increase of fifty eight percent in the total number of patents applied
from 1991 to 2006. More than ninety percent of these applications applied by BASF
have originated from research centers located in Germany.
A fixed effect panel data was estimated to better understand if regulatory strin-
gency has affected BASF’s patent profile positively or negatively. The panel includes
all patents applied by BASF in all technological areas from 1991 to 2006. Table 6.15
shows these results.
Table 6.15: BASF and the Porter hypothesis: 1991 – 2006
Patent profile Coefficient t-value P > |t|
restrict -0.002 -0.07 0.945 F(1,1829) = 0.00 (0.945)
L1 -0.048 -1.66 0.097 F(1,1707) = 2.76 (0.097)
L2 -0.071 -2.35 0.019 F(1,1585) = 5.50 (0.019)
Similarly to Bayer, when analyzing BASF’s patent profile there is a small but sig-
nificant negative impact of regulatory stringency on patenting activity. Nevertheless,
this effect can be observed just with a two-year lag panel.
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The evolution of the relationship among technological areas
The following step in the analysis was to calculate BASF’s patenting profile for the
years of 1991 and 2006. Table 6.16 shows this profile in the different technological
fields, for both years.
Table 6.16: BASF: Patenting profile in 1991 and 2006
A B C D E F G H Total
1991 9.9% 11.1% 66.8% 4.8% 0.1% 1.2% 5.3% 0.8% 100.0%
2006 17.5% 12.7% 62.1% 1.9% 0.4% 1.4% 1.3% 2.6% 100.0%
Pearson χ2 = 71.00 (p-value = 0.000; df = 7)
BASF’s patenting activity is shown to be highly concentrated in field C, for both
years. The most relevant areas in this field are associated with the development of new
organic substances and their respective processes (C07C and C07D), the development
of macromolecular substances and compositions (C08F, C08L, and C08G), and coating
compositions, inks, paints (C09D). In 2006 the presence of area C08L decreased, while
C08J increased, meaning a decrease in macromolecules formulations and an increase
in after-treatment and working-up processes related to the final product (polymer).
Field A almost doubled from 1991 to 2006, being area A01N associated with
biocides the most relevant in the profile for both years. Field B, associated with
performing operations, saw a small increase in the same period. Specifically, the most
important areas in this field were associated with equipment and apparatus applied
in the chemical industry, for the separation of solids, chemical or physical processes,
catalysis, colloid chemistry, shaping or joining plastics, printing, color printing and
copying processes.10
Observing the regulated areas under investigation, Table 6.17 shows the relative
share of these six technological areas in BASF’s patent profile. The sum of these
shares saw a small increase in this period, from 27.5% to 29.3%, as observed in Table
6.17.
Table 6.17: Share of regulated technological areas in BASF’s patent profile
A01N C08F C08J C08K C09B C09D Total share
1991 6.5% 8.4% 2.0% 2.5% 3.7% 4.4% 27.5%
2006 9.9% 6.3% 4.8% 1.8% 1.0% 5.5% 29.3%
Overall, the shares of areas A01N, C08J, and C09D increased, while the shares of
areas C08F, C08K, and C09B decreased. Next, I analyze the behavior of each of these
technological areas separately.
10In 1991: B01D, B01J, and B29C. In 2006: B01D, B01J, and B41M.
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A01N Patent applications in area A01N increased by eighty four percent from 1991
to 2006. Table 6.18 illustrates the evolution of the number of patent application in
this area, the share of A01N applications in field A, and the share of A01N in all
BASF’s patent applications.
Table 6.18: A01N: Evolution of patenting in Germany by BASF
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
Total 61 44 42 51 61 91 84 103 76 64 50 52 63 80 86 112
A01N/ A 0.70 0.59 0.59 0.67 0.61 0.61 0.54 0.66 0.52 0.48 0.40 0.52 0.50 0.68 0.60 0.53
A01N/
total pat.
0.11 0.08 0.07 0.10 0.10 0.14 0.12 0.16 0.11 0.09 0.07 0.08 0.10 0.13 0.13 0.13
Considering all patents applied by BASF, the share of patents in area A01N saw
a small increase (from 11% to 13%). In contrast, considering all patents applied by
BASF in field A, the share of patents in area A01N decreased (from 70% to 53%).
Summarizing, even though there was a growth in the number of applications in this
area there was a decrease in the importance of it in its field (A). In addition, as
observed in Chapter 5, applications in this area continued growing, but not as much
as the total applications in field A01.
The next step is to analyze the direction of the innovative activity of patent
applications in area A01N. Table 6.19 shows a summarized patent profile in 1991 and
2006, for applications in area A01N by BASF.11
Table 6.19: A01N: Summarized patent application profile and definitions – BASF
IPC 1991 2006 Definition
A 2.9% 14.5% Human necessities
A01C 8.2% Planting; sowing; fertilizing
C 95.4% 81.6% Chemistry; metallurgy
C07C 21.6% 10.0% Acyclic or carbocyclic compounds
C07D 70.4% 58.5% Heterocyclic compounds
C07F <1.0% 2.4%
Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen,
halogen, oxygen, nitrogen, sulfur, selenium, or tellurium
C12N 1.8%
Micro-organisms or enzymes; compositions thereof; propagating, preserving, or maintaining micro-
organisms; mutation or genetic engineering; culture media
C23C 3.9%
Coating metallic material; coating material with metallic material; surface treatment of metallic
material by diffusion into the surface, by chemical conversion or substitution; coating by vacuum
evaporation, by sputtering, by ion implantation or by chemical vapor deposition, in general
Pearson χ2 = 18.30 (p-value = 0.003; df = 5)
From 1991 to 2006 changes can be perceived in the patent profile associated with
area A01N. For instance, in 1991 applications were mainly associated with areas in
field C and characterized by new organic substances (C07C and C07D).
In 2006 the association with areas C07C and C07D decreased even though they
continued to be the most important. Many other areas arose with smaller shares. Ap-
plications were characterized by new products such new organic substances (C07F),
11The complete patent profile is available in the Appendix F, Table F.4.
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new formulations with macromolecular compounds (C08L), new micro-organisms, en-
zymes and compositions thereof (C12N). New processes were characterized by the use
of genetic engineering (C12N) and development of catalysts (C23C). In addition, de-
velopment of new methods or apparatus for fertilizing and planting (A01C). Table
6.20 provides some examples to illustrate patent applications in 2006.
Table 6.20: A01N: Examples of patent applications in 2006.
Classification Patent application title Applicant name
A01N C23C “Film forming spreading agents”
BASF Catalysts LLC (US) and The
USA Secretary of Agriculture (US)
A01N C23C “Volumizing agents”
BASF Catalysts LLC (US) and The
USA Secretary of Agriculture (US)
A01H A01N C07K C12N “Yield increase in plants over expressing the HSRP genes” BASF Plant Science GmbH (DE)
A01C A01N C08L
“Seed dressing formulation comprising a biodegradable partially
aromatic polyester”
BASF SE (DE)
A01C A01N A01P “Triazole-based fungicidal mixtures” BASF SE (DE)
The arise of new technologies associated with regulated area A01N, such C12N on
biotechnology has been already observed in Chapter 5. Also, the increasing trend of
new processes (C23C) and new products based on new formulations instead of new
substances.
C08F, J, and K Regulated areas from macromolecular technology increased in num-
ber by 35%, 174%, and 3% respectively, from 1990 to 2006. Nevertheless, there was
a peak in 1997 and a subsequent decrease, recovering in the last years as shown in
Table 6.21.
Table 6.21: C08F, C08J, and C08K: Evolution of patenting in Germany by BASF
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
C08F
Total 74 87 105 88 91 96 135 74 105 89 91 68 67 75 61 100
C08F/ C 0.18 0.21 0.20 0.22 0.18 0.18 0.24 0.15 0.18 0.15 0.16 0.13 0.13 0.15 0.12 0.15
C08F/
total pat.
0.14 0.16 0.18 0.18 0.15 0.14 0.19 0.11 0.15 0.13 0.13 0.10 0.10 0.12 0.09 0.12
C08J
Total 27 39 38 27 53 54 67 40 53 31 38 27 28 39 48 74
C08J/ C 0.07 0.09 0.07 0.07 0.10 0.10 0.12 0.08 0.09 0.05 0.07 0.05 0.05 0.08 0.09 0.11
C08J/
total pat.
0.05 0.07 0.06 0.05 0.09 0.08 0.09 0.06 0.07 0.04 0.05 0.04 0.04 0.06 0.07 0.09
C08K
Total 35 41 37 39 39 32 46 23 35 37 26 34 22 17 29 36
C08K/ C 0.09 0.10 0.07 0.10 0.08 0.06 0.08 0.05 0.06 0.06 0.05 0.06 0.04 0.03 0.06 0.06
C08K/
total pat.
0.06 0.08 0.06 0.08 0.06 0.05 0.06 0.04 0.05 0.05 0.04 0.05 0.03 0.03 0.04 0.04
Among these three, area C08F has the highest number of applications and by
consequence the highest share of patents in field C and all patents by BASF. Nev-
ertheless, regulated areas C08F and C08K lost importance over the years while C08J
gained.
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Next I turn to observe if there was a change in the direction of the patenting
activity in these regulated areas. Table 6.22 shows their respective summarized patent
profiles and definitions of the most important technological areas associated with
them, in 1991 and 2006. For all three regulated areas field C showed the highest
shares in both years and field A emerged in 2006.12
Table 6.22: C08F, C08J, and C08K: Summarized patent application profile and definitions –
BASF
IPC 1991 2006 Definition
C08F
A 4.8% 22.0% Human necessities
A61K 3.3% 12.0% Preparations for medical, dental, or toilet purposes
A61L 7.3%
Methods or apparatus for sterilizing materials or objects in general; disinfection, sterilization, or
deodorization of air; chemical aspects of bandages, dressings, absorbent pads, or surgical articles;
materials for bandages, dressings, absorbent pads, or surgical articles
B 12.5% 12.6% Performing operations; transporting
B01J 5.7% 5.4% Chemical or physical processes, e.g. catalysis, colloid chemistry; their relevant apparatus
C 77.2% 60.3% Chemistry; metallurgy
C08G 7.5% 4.8%
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon
unsaturated bonds
C08K 10.3% 4.6% Use of inorganic or non-macromolecular organic substances as compounding ingredients
C08L 21.9% 9.4% Compositions of macromolecular compounds
C09D 8.9% 16.6%
Coating compositions (e.g. paints, varnishes, lacquers; filling pastes; chemical paint or ink re-
movers; inks; correcting fluids; wood stains; pastes pr solids for coloring or printing; use of mate-
rials therefor)
Pearson χ2 = 17.90 (p-value = 0.006; df = 6)
C08J
A 11.6% Human necessities
A61L 7.9%
Methods or apparatus for sterilizing materials or objects in general; disinfection, sterilization, or
deodorization of air; chemical aspects of bandages, dressings, absorbent pads, or surgical articles;
materials for bandages, dressings, absorbent pads, or surgical articles
B 22.3% 18.2% Performing operations; transporting
B29C 6.3% 2.5%
Shaping or joining plastics; shaping of substances in a plastic state, in general; after-treatment of
the shaped products (e.g. repairing)
B29K 6.3%
Indexing scheme associated with subclasses B29B, B29C or B29D, relating to moulding materials
or to materials for reinforcements, fillers or preformed parts, e.g. inserts
C 67.9% 55.8% Chemistry; metallurgy
C08F 8.1% 5.4%
Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated
bonds
C08G 16.9% 7.5%
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon
unsaturated bonds
C08K 14.1% 10.0% Use of inorganic or non-macromolecular organic substances as compounding ingredients
C08L 14.9% 12.5% Compositions of macromolecular compounds
C09D 5.8% 12.5%
Coating compositions (e.g. paints, varnishes, lacquers; filling pastes; chemical paint or ink re-
movers; inks; correcting fluids; wood stains; pastes pr solids for coloring or printing; use of mate-
rials therefor)
Pearson χ2 = 22.20 (p-value = 0.002; df = 7)
C08K
A 7.6% Human necessities
A61L 5.6%
Methods or apparatus for sterilizing materials or objects in general; disinfection, sterilization, or
deodorization of air; chemical aspects of bandages, dressings, absorbent pads, or surgical articles;
materials for bandages, dressings, absorbent pads, or surgical articles
C 94.1% 87.4% Chemistry; metallurgy
C08F 16.4% 10.5%
Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated
bonds
C08G 12.9% 3.0%
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon
unsaturated bonds
C08J 10.1% 16.0% Working-up; general processes of compounding; after-treatment not covered by subclasses
C08L 39.9% 33.2% Compositions of macromolecular compounds
C09D 3.9% 14.5%
Coating compositions (e.g. paints, varnishes, lacquers; filling pastes; chemical paint or ink re-
movers; inks; correcting fluids; wood stains; pastes pr solids for coloring or printing; use of mate-
rials therefor)
Pearson χ2 = 12.20 (p-value = 0.032; df = 5)
Concerning regulated area C08F, in 1991 the most important areas were associ-
12The complete patent profile is available in the Appendix F, Table F.5.
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ated with new processes and new products, substances and formulations related to
areas C08G, C08K, C08L, and C09D. In 2006 areas C08G, C08K, and C08L decreased
its importance while in field C increased the development of formulations of finished
products (C09D) and in field A increased the shares of areas associated with prepa-
rations and products for medical, dental, and toilet purposes (A61K and A61L).
The pattern observed in the patent profile of area C08F can also be observed in
the patent profiles of regulated areas C08J and C08K. When looking at findings high-
lighted in Chapter 5, technologies associated with areas A61K and A61L were not
regulated. Comparing 1991 to 2006 can be observed the trend towards the develop-
ment of new products based on new formulations (instead of new substances) and
working-up of finished products represented by, for instance, areas C09D and C08J.
C09B and D The last two areas analyzed show different patterns as illustrated in
Table 6.23. Regulated area C09B decreased by sixty five percent from 1991 to 2006.
The share of patents applied by BASF under C09B regarding all BASF’s applications
and all applications under field C has also diminished over this period, not reaching
more than ten percent.
Table 6.23: C09B and C09D: Evolution of patenting in Germany by BASF
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
C09B
Total 37 32 52 36 36 22 27 17 15 9 16 14 16 11 15 13
C09B/ C 0.09 0.08 0.10 0.09 0.07 0.04 0.05 0.03 0.02 0.02 0.03 0.03 0.03 0.02 0.03 0.02
C09B/
total pat.
0.07 0.06 0.09 0.07 0.06 0.03 0.04 0.03 0.02 0.01 0.02 0.02 0.02 0.02 0.02 0.02
C09D
Total 49 52 72 82 72 80 74 67 89 99 93 93 64 47 53 89
C09D/ C 0.12 0.13 0.14 0.20 0.14 0.15 0.13 0.14 0.15 0.17 0.17 0.18 0.12 0.09 0.10 0.14
C09D/
total pat.
0.09 0.10 0.12 0.16 0.12 0.12 0.10 0.10 0.13 0.14 0.13 0.14 0.10 0.07 0.08 0.10
The evolution of the number of patents applied in regulated area C09D by BASF
illustrate a different pattern. There was overall increase of eighty two percent in
the number of applications, however this growth was discontinued in the beginning
of the 2000s recovering after 2005. The shares regarding the total applications and
regarding field C had little variation. In 2006 ten percent of the total applications
and fourteen percent of all applications in field C were classified under area C09D.
Next, in order to observe if occurred a change in the direction of patenting from
1991 to 2006, the patent profile of these regulated areas were calculated. Table 6.24
shows the summarized patent profile and definitions of the most important areas
associated with regulated areas C09B and C09D, for both years.
Concerning the profile of area C09B, in 1991 the most important areas were associ-
ated with the use of dyes on printing and copying processes (B41M), dyeing textiles,
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Table 6.24: C09B and C09D: Summarized patent application profile and definitions – BASF
IPC 1991 2006 Definition
C09B
A 8.3% Human necessities
A23L 4.2%
Foods, foodstuffs, or non-alcoholic beverages, not covered by subclasses A23B to A23J; their prepa-
ration or treatment, e.g. cooking, modification of nutritive qualities, physical treatment; preser-
vation of foods or foodstuffs, in general
A61K 4.2% Preparations for medical, dental, or toilet purposes
B 26.5% Performing operations; transporting
B41M 25% Printing, duplicating, marking, or copying processes; color printing
C 29.2% 66.7% Chemistry; metallurgy
C07C 8.1% 8.3% Acyclic or carbocyclic compounds
C07D 10.2% 29.2% Heterocyclic compounds
C08K 18.8% Use of inorganic or non-macromolecular organic substances as compounding ingredients
C08L <1% 6.3% Compositions of macromolecular compounds
C09D 4.7%
Coating compositions (e.g. paints, varnishes, lacquers; filling pastes; chemical paint or ink re-
movers; inks; correcting fluids; wood stains; pastes pr solids for coloring or printing; use of mate-
rials therefor)
D 37.8% 12.5% Textiles and paper
D06P 34.5% 12.5% Dyeing or printing textiles; dyeing leather, furs, or solid macromolecular substances in any form
G 5.6% 12.5% Physics
Pearson χ2 = 28.60 (p-value = 0.000; df = 8)
C09D
B 20.6% 10.5% Performing operations; transporting
B05D 15.2% 3.3% Processes for applying liquids or other fluent materials to surfaces, in general
C 67.0% 85.2% Chemistry; metallurgy
C04B 5.0% 1.2%
Lime; magnesia; slag; cements; compositions thereof, e.g. mortars, concrete or like building ma-
terials; artificial stone; ceramics; refractories; treatment of natural stone
C08F 11.1% 18.1%
Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated
bonds
C08G 21.1% 28.6%
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon
unsaturated bonds
C08J 3.2% 9.6% Working-up; general processes of compounding; after-treatment not covered by subclasses
C08L 10.8% 6.3% Compositions of macromolecular compounds
Pearson χ2 = 10.30 (p-value = 0.067; df = 5)
leather, furs (D06P), and the development of new organic substances (C07C and
C07D). In 2006 increased the share of areas associated with the development of new
substances (C07C, C07D, C07F, and C08K), and new compositions of new or exist-
ing substances (C08L). Decreased the previous applications and emerged the uses for
medical or dental preparations (A61K) and food additives (A23L).
Regarding the patent profile of area C09D, in 1991 the most important areas were
associated with new products based on macromolecular compositions (C08F, C08G,
and C08L) and new processes to apply dyes, paints, lacquers, and coatings (B05D).
In 2006 there were no big changes, however increased the share of areas from field C
(from 67.0% to 85.2%). New patent applications were more concentrated on macro-
molecular technology (C08F, C08G, and C08J). Some examples of both regulated areas
are illustrated in Table 6.25.
When comparing BASF’s patenting behavior with results obtained in Chapter
5, in regulated area C09B BASF’s applications followed the same decreasing trend
observed when looking at the overall behavior of this area. The behavior of the highly
associated areas was also similar. There were less patents applied in 2006 and they
were concentrated in field C, decreasing previous uses and emerging others.
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Table 6.25: C09B and C09D: Examples of patent applications in 1991 and 2006.
Classification Patent application title Applicant name
1991
B41M C09B D06P “Use of azo-dyes for thermal transfer printing” BASF AG (DE)
C07D C09B D06P
D21H
“Biscationic azo dyes and their intermediates” BASF AG (DE)
C04B C09D “Polymer-coated concrete” BASF AG (DE)
C08G C08L C09D “Mineral oil solutions of urethane resins curable by oxydation” BASF Coatings AG (DE)
B05D C08F C08G
C09D
“Process for producing a multi-layer paint coating and aqueous paint” BASF Lacke + Farben AG (DE)
2006
C09B G02B “Green pigment preparations based on C.I. pigment green 36” BASF SE (DE)
A23L A61K C07C
C09B
“Method for producing an aqueous suspension and a powdered preparation
of one or more carotinoids”
BASF SE (DE)
C07C C08F C08J
C08K C08L C09D
“Coating material, method for the production and use thereof, for produc-
ing adhesive, corrosion-inhibiting coatings”
BASF Coatings AG (DE)
C08K C08L C09D
“Mixture containing a solvent, which can be cured with UV-A radiation,
method for its production and use thereof”
BASF Coatings AG (DE)
For instance, the development of dyes associated with code D06P was highly reg-
ulated (as seen in Chapter 5) and the overall patenting with this characteristics has
decreased. This behavior is also observed in BASF’s C09B patent profile, corroborat-
ing with a possible regulatory cause as reported in the previous chapter.
The brief history of BASF exposes that a joint-venture on textile dyes was created
in 2000 (C09B associated with D06P) and afterward sold, in 2004. The fact that
azocolorants (C09B) were highly regulated in 2003 might have influenced BASF to
exit the market of textile dyes.13
In the case of regulated area C09D, BASF’s patenting behavior followed the same
increasing trend observed when looking the overall behavior of this area (describe in
Chapter 5). The areas with highest shares illustrated in BASF’s C09D patent profile
– C08F, C08G, and C08L – were also previously seen in the previous chapter, for both
years. However, in the case of BASF’s applications there was a higher concentration
of developments in field C (macromolecular technology).
This emphasis on macromolecular technology is observed when looking at the re-
cent history of BASF. The expansion of production plants on basic and intermediate
chemicals for the production of polymers occurred in 1994, 2001, and 2002. In addi-
tion, there were acquisitions of engineering plastics and resins business in 2003 and
2004 (associated with codes C08 and C09D). Accordingly, in 1990 BASF was the fifth
in number of patent applications in regulated area C09D jumping to the first place
in 2006.
Remarks
The panel data showed that regulatory stringency has impacted negatively BASF’s
patent profile. For this firm the Porter hypothesis is not supported.
13See Table 4.3.
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Concerning the first research question, if occurred an increase or decrease in
patenting, BASF’s patent applications in areas A01N, C08F, C08J, and C09D in-
creased from 1991 to 2006. While for area C08K kept stable and for C09B decreased.
Differently from Bayer, BASF kept among the top ten applicants in the six investi-
gated areas.
When investigating the direction of patenting, the Pearson χ2 was shown to be
significant for areas A01N, C08F, C08J, C08K, and C09B, while not significant in area
C09D.
From 1991 to 2006 BASF kept among the top ten applicants in all regulated
areas. In 2006 it was the leader in the number of patent applications in four of
the six regulated areas here investigated: A01N, C08F, C08J, and C09D. As already
stated when analyzing the pattern of patenting profiles in these areas, BASF kept
innovating developing more processes, and products associated with new formulations
and working up of finished plastics.
There was an increasing trend of the association of patents on regulated areas
with areas from group “A61” where its uses, in most cases, were not restricted by
this regulation. Also, the association of technological area associated with he devel-
opment of paints and dyes for textiles, fur, and leather decreased, as previously seen
in Chapter 5, restricted in 2003.
6.2.3 DuPont
Founded in 1802 with French capital by Eleuthère Irénée du Pont, E. I. du Pont
de Nemours and Company brought to US the latest technology on powder-making,
Alfred Nobel’s invention of dynamite and smokeless powder. In spite of the devel-
opments over the nineteenth century on powder-making, DuPont is known in the
chemical engineering field by its long history in the development of macromolecular
technology.
Since the beginning of the twentieth century DuPont has invested on materials
science. The company developed the polymerization process through condensation
producing fibers, films, and plastic resins. From the forty major commercially pro-
duced polymers in the twentieth century, almost three fourths were developed by
DuPont. The new processes developed by them redesigned the polymers technology,
previously based in cellulose chemistry, enabling the development of diverse synthetic
new substances.
For instance, in the 1930s DuPont developed the synthetic rubber that substi-
tuted the natural rubber given its resistance to water, oils, heat, and solvents. With
further developments, synthetic rubber started to be applied not only in industrial
equipments and automobiles, but became popular in diverse consumer goods using
the derived materials in accessories and shoes. Since the 1950s synthetic rubbers
(neoprene) started to be essential for the production of adhesives, sealants, power
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transmission belts, hoses and tubes.14
Such experience and knowledge of synthetic fibers enabled DuPont to grow and
develop its textile and fabric division. In 1981 DuPont acquired Conoco Incorporation
– a petroleum manufacturer – securing the supply of raw material for the production
of synthetic fibers and plastics. After 1996 this line of products became a responsi-
bility of the DuPont Dow Elastomers, a joint venture made with The Dow Chemical
Company (US). Headquartered in the US, it is responsible for the production of a
variety of products from more general rubber (commodities) to high performance
fluoro-elastomers, employed on general rubber firms, chemical processing, and auto-
motive industries. After the 1990s, process innovations enabled further technological
developments, and combinations of known monomers and additives created new fam-
ilies of polymers for end-use markets.
With the development of biotechnology in the 1980s, the company initiated R&D
on synthetic polymers based on biological raw materials through fermentation pro-
cesses. The bio-polymers created a new branch of products with different applications
and characteristics, such biodegradability. In 1999 DuPont sold its Conoco shares in
order to obtain capital for investments in other fields, marking a change of focus
of the corporation from petroleum-based synthetic polymers to the development of
chemicals from different plants.
The developments of products such resins, coatings, and lacquers grew simulta-
neously to macromolecular technology. Since the 1930s, along with other chemical
companies,15 DuPont developed acrylic fibers (based on methyl methacrylate) and
improved processes for its production. In the 1950s the company started its business
of acrylic resin coatings, acrylic automobile finish lacquers, acrylic paints, and enam-
els. However, in 1983 DuPont sold its paints division and in 1993 its acrylic resins
division, keeping just the production of acrylic automotive lacquers. By the end of
the 1990s DuPont acquired the coatings subsidiary of Hoechst AG (Herberts GmbH),
this amplified the production of automotive coatings.16
The company initiated its agriculture and nutrition business in the beginning
of the twentieth century. By the 1920s it started producing seed disinfectants and
acquired other chemical companies17 in order to expand its business to inorganic
14In order to keep its name associated with the vanguardism in science-based materials, DuPont chose to
protect the commercial name of each new product through trademark. In this way, even though the patent
protection expires after fifteen to twenty-five years (depending on the country), the trademark protection
can be renewed continuously keeping the consumer link to the product, even without the monopoly over
the innovation. Some of the most well known polymeric fibers in the world were invented by DuPont: nylon
(1930s), acrylic (1940s), polyester (1950s), LycraR©, TeflonR© (1960s), SupplexR© (1980s), and TactelR©
(1990s), among others.
15Rohm & Haas and Imperial Chemical Industries (ICI).
16In 2000 DuPont became the major supplier of automotive coatings, and third largest coatings producer
in the world.
17Grasselli and Roessler & Hasslacher Chemical Company (R&H).
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insecticides and fungicides. Over the 1940s and 1950s technological developments
in crop and insect research lead to new synthetic organic herbicides. Finally, in the
1970s were introduced a new line of herbicides designed for large scale food crops.
The development of biotechnology in the 1980s allowed the expansion of research
on seeds, foods, and natural fibers. DuPont also invested in this field of research and in
1997 created the joint venture Optimum Quality Grains and in 1999 acquired Pioneer
to develop R&D on superior seed hybrids. In the 2000s DuPont drove its agricultural
division to the production of herbicide-resistant soybeans, higher-yielding, healthier
oilseeds for consumers, and crops that reduce the amount of nitrogen and phosphorous
in livestock waste. As a consequence its food division also grew focusing on soy protein
food and beverage.
The macromolecular developments was also the start-up of DuPont’s biomedi-
cal products such x-ray films in the 1930s. It expanded the industry segment in
the 1970s with diagnostic instruments and afterward technology on pathogen screen-
ing, DNA-based identification, and new materials for diapers. On pharmaceuticals
DuPont marketed its first drug in 1966 on flu prevention. In 1969 acquired Endo
Pharmaceuticals and in the 1980s New England Nuclear Corporation and American
Critical Care to expand its medicinal area on drugs, radiopharmaceutical tracers, and
hospital care products.18 In 1991 the company formed a joint venture with Merck
Pharmaceutical for drug development and in 1998 DuPont bought Merck’s part.19 In
1996 DuPont sold its diagnostic and medical instrument business and five years later
sold its pharmaceutical division.
Over the 2000s DuPont focused on five business segments: electronic and commu-
nication technologies, performance materials, coatings and color technologies, safety
and protection, and agricultural and nutrition.
In order to extract data from the ESPACE Bulletin database were applied the
keywords “nemours,” “du pont,” and “dupont” in order to minimize the risk of mis-
counting patents owned by DuPont, its divisions and joint ventures.
Evolution of patenting activity
From 1991 to 2006 occurred a six percent increase in DuPont’s patenting activity in
Germany. Table 6.26 shows the number of patents applied per country of origin and
the share of applications originated from DuPont divisions in the US. Although patent
applications have originated from fourteen different countries, more than ninety per-
cent of these came from DuPont’s divisions in the US.
The fixed effect panel data estimated for DuPont’s patent profile is shown next
in Table 6.27. Differently from Bayer and BASF, the panel estimated for DuPont
18Developments included the first transgenic mice for research and organ preservation solutions to use on
transplant procedures.
19This joint venture developed drugs such anti-hypertensives, anti-coagulants, and for HIV treatment.
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Table 6.26: Patent applications in Germany by DuPont classified per country of origin
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
US 450 343 302 290 279 305 354 351 365 333 290 307 383 375 465 492
JP 4 2 3 7 3 5 10 10 15 14 12 14 14 20 14
DE 9 7 3 7 3 3 6 2 4 3
CA 7 5 4 6 1 2 7 3 4 1 1 1 1 2
NL 9 1
CH 1 3 1 1 1 1 1
GB 2 3 3
FR 2 1 1 2 2
SE 2
ES 2
AU 1
AT 1
CN 1
BR 1
Total 482 363 314 307 293 315 374 366 384 355 307 320 398 390 487 511
%US 0.93 0.94 0.96 0.94 0.95 0.97 0.95 0.96 0.95 0.94 0.94 0.96 0.96 0.96 0.95 0.96
showed no significant relationship between regulatory stringency and the patenting
activity of the firm. Thus, regulation caused no effect on DuPont’s patent profile.
Table 6.27: DuPont and the Porter hypothesis: 1991 – 2006
Patent profile Coefficient t-value P > |t|
restrict 0.025 1.35 0.179 F(1,1874) = 1.81 (0.179)
L1 0.023 1.22 0.223 F(1,1749) = 1.49 (0.223)
L2 0.023 1.11 0.265 F(1,1624) = 1.24 (0.265)
The evolution of the relationship among technological areas
Following the analysis of DuPont’s patenting activity, its profile was calculated for the
years of 1991 and 2006. Table 6.28 shows this profile, with the share of the different
technological fields.
Table 6.28: DuPont: Patent profile in 1991 and 2006
A B C D E F G H Total
1991 5.4% 13.7% 44.1% 12.7% 0.4% 0.8% 15.1% 7.8% 100.0%
2006 8.1% 12.7% 51.0% 8.0% 0.6% 2.4% 4.8% 12.4% 100.0%
Pearson χ2 = 67.10 (p-value = 0.000; df = 7)
Over the years there were significant changes in this patenting profile. In 1991
the most important fields were C, G, and B. In 2006 field G – on physics – decreased
and the share of field H – on technologies associated with electricity – increased.
Field C had the highest shares in both years, increasing from 44.1% to 51.0%.
Technological areas associated with organic macromolecular technology (C08) and
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polishes, adhesives, miscellaneous compositions and applications of materials (C09),
were responsible for this increase. Field A in 2006 increased its share given areas
associated with human necessities such preparations for medical, dental purposes,
and selection of special materials for outerwear, details of garments, and accessories
(A41D and A61K). Field H in 2006 arose given the increasing application of organic
materials in electric devices and integrated circuits (H01L).
From 1991 to 2006 decreased the shares of mechanical methods or apparatus in the
manufacture of artificial filaments, fibers, and chemical features in the manufacture
of artificial filaments. Predominantly, these technological areas are associated with
processes and mechanical apparatus for the production of polymeric fibers (D01).
Also decreased patent applications associated with the treatment of yarns, fabrics,
feathers, or fibrous goods made from such materials (D06).
Looking at the regulated technological areas under investigation, Table 6.29 shows
the share of these six areas in DuPont’s patent profile. The sum of these shares
increased from fourteen percent in 1991 to twenty percent in 2006, illustrating an
increase of relative importance of these areas in DuPont’s patenting activity.
Table 6.29: Share of regulated technological areas in Du Pont’s patent profile
A01N C08F C08J C08K C09B C09D Total share
1991 2.5% 2.8% 3.7% 1.9% 0.4% 2.7% 14.0%
2006 2.1% 3.9% 3.3% 3.1% 0.1% 7.5% 20.0%
From 1991 to 2006 The shares of areas C08F, C08K, and mainly C09D increased,
while the other three regulated areas decreased. Next I analyze the behavior of
regulated areas with exception to area C09B, given that DuPont does not figure
among the top ten players in either years.
A01N The number of patent applications in area A01N is shown in Table 6.30,
together with the share of applications in area A01N with respect to field A and the
share with respect to all applications by DuPont in Germany. All these patents have
originated from DuPont’s divisions in the US.
Table 6.30: A01N: Evolution of patenting in Germany by DuPont
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
Total 18 14 23 12 6 16 12 10 2 7 16 15 9 17 16
A01N/ A 0.44 0.35 0.52 0.32 0.24 0.50 0.27 0.23 0.05 0.27 0.47 0.33 0.29 0.37 0.27
A01N/
total pat.
0.04 0.04 0.07 0.04 0.02 0.05 0.03 0.03 0.01 0.02 0.05 0.04 0.02 0.03 0.03
From 1991 to 2006 the total number of applications varied without a specific
pattern. The share of patents in area A01N in field A reached fifty percent in 1996,
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however in 2006 summed twenty seven percent. The share of patents in area A01N
with respect to all patents applied by DuPont kept in most of this period under five
percent.
In order to analyze the direction of the innovative activity in this area, the
DuPont’s A01N patent profile in 1991 and 2006 was calculated. Table 6.31 shows
the summarized profile and definitions of the most relevant areas associated with
patents in area A01N applied by DuPont in these years.
Table 6.31: A01N: Summarized patent application profile and definitions – DuPont
IPC 1991 2006 Definition
A – 8.3% Human necessities
A61K – 5.0% Preparations for medical, dental, or toilet purposes
A61Q – 3.3% Use of cosmetics or similar toilet preparations (IPC)
B – 30.0% Performing operations; transporting
B27K – 30.0%
Processes, apparatus or selection of substances for impregnating, staining, dyeing, bleaching of
wood or similar materials, or treating of of wood or similar materials with permeant liquids,
not otherwise provided for; chemical or physical treatment of cork, cane, reed, straw or similar
materials
C 100.0% 61.7% Chemistry; metallurgy
C07C 15.5% 3.3% Acyclic or carbocyclic compounds
C07D 69.0% 48.3% Heterocyclic compounds
C07F 8.3% –
Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen,
halogen, oxygen, nitrogen, sulfur, selenium, or tellurium
C07K 5.0% Peptides
C12N – 5.0%
Micro-organisms or enzymes; compositions thereof; propagating, preserving, or maintaining micro-
organisms; mutation or genetic engineering; culture media
C12Q 7.1%
Measuring or testing processes involving enzymes or micro-organisms (immunoassay G01N 33/53);
compositions or test papers therefor; processes of preparing such compositions; condition-response
control in microbiological or enzymological processes
Pearson χ2 = 15.20 (p-value = 0.055; df = 8)
From 1991 to 2006 the patent profile associated with area A01N saw major changes.
In 1991 applications were associated only with field C. Patents were characterized by
new substances (C07C and C07F), new formulations of new or existing substances
(C07D), and microbiological or enzymological processes (C12Q) .
In 2006 the association with areas C07C and C07D decreased even though they
continued to be important areas. New products emerged associated with preparations
for medical, dental, and cosmetic uses (A61Q and A61K), preparations for wood
preservation (B27K), and genetic engineering (C12N). Some examples are shown in
Table 6.32.
In 1997, with the creation of the joint venture Optimum Quality Grains, there
was an increase in the developments of hybrid seeds not necessarily associated with
biocides (A01N). After 2000 the company initiated the development of herbicides-
resistant seeds – all innovations associated with code A01N. These two events might
have favored the re-emergence of applications in this regulated area in the beginning
of the 2000s.
In addition, as observed in Chapter 5 (Section 5.3), technologies associated with
areas A61K and A61Q were not regulated. This might have favored the application
of biocides in non-regulated uses.
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Table 6.32: A01N: Examples of patent applications in 1991 and 2006.
Classification Patent application title Applicant name
1991
A01N C12Q
“Anthraquinones as inhibitors of sulfide production from
sulfate-reducing bacteria”
E. I. du Pont de Nemours and Co. (US)
A01N C07C C07D C07F “Crop-selective herbicidal sulfonamides” E. I. du Pont de Nemours and Co. (US)
A01N C07C C07D C07F
“Arthropodicidal pyrazolines, pyrazolidines and hy-
drazines”
E. I. du Pont de Nemours and Co. (US)
2006
A01N A61Q C07C C07D “Puleganic amides as insect repellants” E. I. du Pont de Nemours and Co. (US)
A01N C07K C12N “Insect-specific protease recognition sequences”
E. I. du Pont de Nemours and Co. (US) and
Pioneer-Hi-Bred International Inc. (US)
A01N B27K “Tropolone complexes as wood preservatives” E. I. du Pont de Nemours and Co. (US)
A01N A61K C07D “5-aryl isoxazolines for controlling invertebrate pests” E. I. du Pont de Nemours and Co. (US)
C08F, J, and K The number of patent applications in macromolecular technology is
shown in Table 6.33, from 1991 to 2006. In addition, it is shown the share of each of
these regulated areas with respect to field C and with respect to all patents applied
by DuPont.
Table 6.33: C08F, C08J, and C08K: Evolution of patenting in Germany by DuPont
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
C08F
Total 22 16 29 20 25 49 41 43 56 49 38 30 27 15 25 36
C08F/ C 0.09 0.07 0.15 0.10 0.12 0.21 0.16 0.17 0.20 0.21 0.19 0.16 0.11 0.06 0.08 0.12
C08F/
total pat.
0.05 0.04 0.09 0.07 0.09 0.16 0.11 0.12 0.15 0.14 0.12 0.09 0.07 0.04 0.05 0.07
C08J
Total 50 45 31 42 28 28 46 22 26 25 20 26 25 25 42 41
C08J/ C 0.20 0.20 0.16 0.21 0.14 0.12 0.18 0.08 0.09 0.11 0.10 0.13 0.11 0.10 0.13 0.13
C08J/
total pat.
0.10 0.12 0.10 0.14 0.10 0.09 0.12 0.06 0.07 0.07 0.07 0.08 0.06 0.06 0.09 0.08
C08K
Total 26 30 20 24 25 31 27 29 28 24 21 16 38 33 41 39
C08K/ C 0.11 0.14 0.10 0.12 0.12 0.13 0.10 0.11 0.10 0.10 0.11 0.08 0.16 0.14 0.13 0.13
C08K/
total pat.
0.05 0.08 0.06 0.08 0.09 0.10 0.07 0.08 0.07 0.07 0.07 0.05 0.10 0.08 0.08 0.08
From 1991 to 2006, areas C08F and C08K increased sixty four and fifty percent,
respectively. Their respective shares in field C and in all patents by DuPont also
increased.
Conversely, area C08J decreased over the 1990s, recovering after 2001. However,
from 1991 to 2006 decreased eighteen percent. Yet, area C08J is responsible for
the largest number of applications per year among the three regulated areas from
macromolecular technology. In 1991 twenty percent of patents applied by DuPont in
field C were associated with area C08J, while in 2006 this share decreased down to
thirteen percent.
Nevertheless, these three regulated areas are associated with the core business of
the company: material science. Next, the patent application profiles are analyzed
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to observe if there is a change in the direction of the patenting activity. Table 6.34
shows the summarized profile and definitions of the most important areas associated
with these three regulated areas, in 1991 and 2006.
Table 6.34: C08F, C08J, and C08K: Summarized patent application profile and definitions –
DuPont
IPC 1991 2006 Definition
C08F
C 68.5% 76.0% Chemistry; metallurgy
C07C 13.6% 3.8% Acyclic or carbocyclic compounds
C08G 6.9% 6.7%
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon
unsaturated bonds
C08J 4.7% 10.9% Working-up; general processes of compounding; after-treatment not covered by subclasses
C08K 10.6% 3.2% Use of inorganic or non-macromolecular organic substances as compounding ingredients
C08L 17.1% 26.6% Compositions of macromolecular compounds
C09D 5.6% 19.9%
Coating compositions (e.g. paints, varnishes, lacquers; filling pastes; chemical paint or ink re-
movers; inks; correcting fluids; wood stains; pastes or solids for coloring or printing; use of mate-
rials therefor)
Pearson χ2 = 7.72 (p-value = 0.172; df = 5)
C08J
B 21.4% 14.5% Performing operations; transporting
B32B 4.9% 11.1% Layered products, i.e. products built-up of strata of flat (e.g. cellular or honeycomb, form)
C 57.3% 66.1% Chemistry; metallurgy
C07C 5.3% Acyclic or carbocyclic compounds
C08F 1.5% 7.7%
Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated
bonds
C08G 11.1% 4.3%
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon
unsaturated bonds
C08K 5.6% 9.3% Use of inorganic or non-macromolecular organic substances as compounding ingredients
C08L 11.8% 25.2% Compositions of macromolecular compounds
C09D 1.5% 7.7%
Coating compositions (e.g. paints, varnishes, lacquers; filling pastes; chemical paint or ink re-
movers; inks; correcting fluids; wood stains; pastes pr solids for coloring or printing; use of mate-
rials therefor)
C09K 8.0% 9.5% Materials for miscellaneous applications, not provided elsewhere
D 10.5% 3.2% Textiles and paper
Pearson χ2 = 21.50 (p-value = 0.003; df = 7)
C08K
B 5.8% 15.7% Performing operations; transporting
B32B 10.8% Layered products, i.e. products built-up of strata of flat (e.g. cellular or honeycomb, form)
C 76.2% 58.3% Chemistry; metallurgy
C08F 6.1% 2.4%
Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated
bonds
C08G 11.0% <1%
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon
unsaturated bonds
C08J 10.4% 9.9% Working-up; general processes of compounding; after-treatment not covered by subclasses
C08L 36.0% 28.9% Compositions of macromolecular compounds
C09D 3.2% 6.0%
Coating compositions (e.g. paints, varnishes, lacquers; filling pastes; chemical paint or ink re-
movers; inks; correcting fluids; wood stains; pastes pr solids for coloring or printing; use of mate-
rials therefor)
D 9.6% 4.1% Textiles and paper
D01F 9.6% 2.9%
Chemical features in the manufacture of artificial filaments, threads, fibers, bristles, or ribbons;
apparatus specially adapted for the manufacture of carbon filaments
H 6.5% 16.0% Electricity
Pearson χ2 = 22.10 (p-value = 0.001; df = 6)
Concerning area C08F, from 1991 to 2006 decreased the association with the de-
velopment of new organic substances (C07C) and the use of non-macromolecular
substances as ingredient for new formulations (C08K). Conversely, increased the as-
sociation with processes (C08J), compositions of macromolecular compounds and of
finished products (C08L and C09D).
Concerning area C08J, from 1991 to 2006 decreased the association with processes
for the development of new organic substances and new polymers (C07C and C08G).
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Conversely, increased the association with new processes for new formulations, com-
positions of macromolecular or not substances, and compositions of final products
(C08F, C08K, C09D, and B32B).
Concerning area C08K, decreased the association with new substances (polymers
– C08F and C08G). Conversely, increased the association with development of me-
chanical processes (B32B).
C09D The evolution of DuPont’s patenting activity in area C09D is illustrated by
Table 6.35. From 1991 to 2006 the number of patent applications more than tripled
from 1991 to 2006. The share of C09D applications with respect to field C and with
respect to the total number of applications increased. In 1991 nine percent of all
patents applied in field C belonged to area C09D, in 2006 this share reached against
twenty one percent.
Table 6.35: C09D: Evolution of patenting in Germany by DuPont
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
Total 21 21 27 23 34 45 49 56 46 43 33 29 42 67 69 66
C09D/ C 0.09 0.10 0.14 0.11 0.17 0.19 0.19 0.22 0.16 0.18 0.17 0.15 0.18 0.28 0.22 0.21
C09D/
total pat.
0.04 0.06 0.09 0.07 0.12 0.14 0.13 0.15 0.12 0.12 0.11 0.09 0.11 0.17 0.14 0.13
In order to observe if occurred a change in the direction of patenting from 1991
to 2006, the DuPont’s C09D patent profile was calculated. Table 6.36 shows the
summarized proÞle and definitions of the most important areas associated with C09D,
in 1991 and 2006.
Table 6.36: C09D: Summarized patent application profile and definitions – DuPont
IPC 1991 2006 Definition
B 17.7% 17.7% Performing operations; transporting
B05D 8.5% 11.0% Processes for applying liquids or other fluent materials to surfaces, in general
B32B 6.7% 2.4% Layered products, i.e. products built-up of strata of flat (e.g. cellular or honeycomb, form)
C 67.7% 75.2% Chemistry; metallurgy
C08F 5.2% 11.0%
Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated
bonds
C08G 24.4% 32.3%
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon
unsaturated bonds
C08J 4.6% 6.0% Working-up; general processes of compounding; after-treatment not covered by subclasses
C08K 5.2% 4.5% Use of inorganic or non-macromolecular organic substances as compounding ingredients
C08L 27.1% 9.9% Compositions of macromolecular compounds
H 12.5% Electricity
H01B 12.5%
Cables; conductors; insulators; selection of materials for their conductive, insulating, or dielectric
properties
Pearson χ2 = 8.06 (p-value = 0.328; df = 7)
In 1991 the most important areas were related to area C09D were new products
(substances and formulations of new or existing substances) and processes on macro-
molecular technology (C08). Also, the development of processes for applying dyes,
paints, lacquers, and coatings (B05D and B32B), and development of new materials
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special insulating or dielectric properties (H01B).
In 2006 there was an increase of areas related to macromolecular technology (C08),
new substances and their respective processes (C08F and C08G). Some examples are
illustrated in Table 6.37.
Table 6.37: C09D: Examples of patent applications in 1991 and 2006.
Year Classification Patent application title Applicant name
1991 C09D H01B “Non-carbon black containing conductive coating composition” E. I. du Pont de Nemours and Co. (US)
1991
B05D B32B C08L
C09D
“Non-stick coating system with PTFE and PFA or FEP for
concentration gradient”
E. I. du Pont de Nemours and Co. (US)
2006 C08G C09D
“Durable coating compositions containing aspartic amine com-
pounds with improved potlife”
E. I. du Pont de Nemours and Co. (US)
2006 C08F C08L C09D “Rapid drying lacquers containing triblock copolymer” E. I. du Pont de Nemours and Co. (US)
In Chapter 5 regulated area C09D also showed an increasing trend. The most
important areas in chemicals technology (field C) associated with C09D for DuPont –
C08G and C08L – were also highlighted as important in the overall patenting for both
years. As observed in BASF’s case, in 2006 DuPont also concentrated developments
in macromolecular technology (C08).
When looking at the company’s recent history, even though DuPont sold its acrylic
resins division in 1993 (C09D), by the end of the 1990s the company acquired Herberts
GmbH, the coatings division of Hoechst AG focusing on commercial acrylic (C08) and
automotive lacquers (C09D). Accordingly, in 1990 DuPont did not figure among the
top ten applicants in this regulated area, while in 2006 the company reached the
second place.
Remarks
The panel data showed neither positive nor negative regulatory impact on this firm’s
overall patent profile. From 1991 to 2006 DuPont’s patent applications increased in
areas C08F, C08K, and C09D, decreased in area C08J, and decreased over the 1990s
and increased over the 2000s in area A01N.
When investigating the direction of patenting, the Pearson χ2 was shown to be
significant for areas A01N, C08J, and C08K.
6.2.4 3M
Founded in 1902 under the name “Minnesota Mining and Manufacturing Company,”
it first started as a mining company and fast moved to the production of abrasives
and sandpaper. During the twentieth century 3M developed a vast branch of differ-
ent goods, from pressure-sensitive tapes to defense materials. After the 1970s 3M
expanded its business to radiology, energy control, and health care (medical and
dental care and pharmaceuticals).
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In the 1980s there was an expansion in production plants, establishing wholly
owned companies in the United Arab Emirates, China, India, and Turkey. The
expansion was also marked by the acquisition of Unitek Corporation, a supplier of
orthodontic products, and the creation of a joint venture with Harris Corporation,
on copiers and facsimile machines. 3M also established another research center in the
US (Texas) and six in Europe.
3M has been over the years focusing on customer requirements over a wide range
of technological areas. The company introduced the Post-it Notes, improved tech-
nologies related to magnetic films, and started commercializing the pharmaceutical
Tambocor.20
In the beginning of the 1990s most of 3M sales came from outside the US and one
third of sales derived from recently introduced products (less than five years). By
the end of the decade the company expanded its operations in Europe, Asia, Middle
East, and Africa.21
Products continued to be developed in diverse areas and by the end of the decade
the company was reorganized by the company into six major fields: industrial; trans-
portation, graphics and safety; health care; consumer and office; electro and commu-
nications; and specialty material.22
In all these business fields the company has diverse products associated with the
chemicals technology. These innovations are present in polymers, films, adhesives,
dyes, surface materials, abrasives, constituents of computer screens, flexible electronic
circuits, HFEs (hydrofluoroethers), chlorofluorocarbon substitutes (free of ozone de-
pleting chlorofluorocarbons), and pharmaceuticals. In 1999, Dyneon LLC became a
subsidiary of 3M, leader on fluoropolymers products and processes.
In the 2000s more than one third of total sales came from new products (intro-
duced in four years or less). On chemicals there was an increase in R&D, new phar-
maceuticals (immune response modifiers) and cleaning products were marketed. In
addition, optical films, abrasives, adhesives, and other products which have chemical
components.23
In order to extract data from the ESPACE Bulletin database, keywords used were
“minnesota,” “3M,” “dyneon,” and “unitek”. The last two referred to the Business unit
Dyneon LLC and 3M Unitek Corporation, however patents from all business units of
3M were found to be applied with the names “Minnesota Mining and Company” or
“3M Innovative Properties Company.” This data is described in the following sections.
20Drug approved by the US FDA in 1985 for heart diseases.
21Czech Republic, Hungary, Poland, Russia, Pakistan, Egypt, Sri Lanka, Vietnam, Israel, Morocco, and
Romania.
22Products included Including immune response modifier pharmaceuticals; brightness enhancement films
for electronic displays; and flexible circuits used in inkjet printers, cell phones and other electronic devices.
23Information on the 3M company were extracted from the website http://solutions.3m.com/wps/
portal/3M/en_US/about-3M/information/more-info/history/ (visited between 26 May and 15 July 2009)
and the book “A century of innovation: The 3M story,” 2002.
160
6.2 CASE STUDIES
Evolution of patenting activity
From 1991 to 2006 the number of patent applications by 3M in Germany almost
doubled. Table 6.38 illustrates this increasing trend where the vast majority of patent
applications have originated from 3M research centers in the US (over 94%).
Table 6.38: Patent applications in Germany by 3M classified per country of origin
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
US 277 396 401 490 453 579 390 393 485 425 420 561 504 586 510 534
DE 1 3 18 9 26 27 13 18 22 16 3
KN 1
AU 2
IT 1 1
Total 277 396 402 490 454 581 393 411 495 451 447 575 522 608 526 537
% US 1.00 1.00 0.99 1.00 0.99 0.99 0.99 0.96 0.98 0.94 0.94 0.98 0.97 0.96 0.97 0.99
Similarly to the other firms, a fixed effect panel data was estimated with 3M’s
patent profile. Table 6.39 shows these results.
Table 6.39: 3M and the Porter hypothesis: 1991 – 2006
Patent profile Coefficient t-value P > |t|
restrict -0.039 -2.13 0.033 F(1,1844) = 4.55 (0.033)
L1 -0.057 -2.98 0.003 F(1,1721) = 8.90 (0.003)
L2 -0.056 -2.72 0.007 F(1,1598) = 7.41 (0.007)
Results indicate a small but significant negative impact of regulatory stringency
on 3M’s patent profile.
The evolution of the relationship among technological areas
Differently from the other three firms studied in this chapter, 3M has patent appli-
cations distributed among the different technological fields. 3M’s patent profile is
shown in Table 6.40.
Table 6.40: 3M: Patent profile in 1991 and 2006
A B C D E F G H Total
1991 16.8% 24.3% 25.7% 1.2% 1.4% 1.3% 23.0% 6.3% 100.0%
2006 16.8% 23.7% 21.4% 1.0% 1.0% 1.8% 19.3% 15.0% 100.0%
Pearson χ2 = 21.90 (p-value = 0.003; df = 7)
In 1991 patent applications were associated mostly with fields A, B, C, and G. In
2006 also field H appeared as highly relevant.
161
6. THE INNOVATIVE BEHAVIOR OF FIRMS
In field A, for both years, the most important areas were associated with hygiene,
medical and veterinary science. These reflect innovation on pharmaceuticals and
odontology business. In field C, for both years, the most important technological areas
belonged to organic macromolecular technology (preparations and compositions) and
adhesives (processes, compositions, and applications).
In 1991, most important areas from field B were associated with layered products,
packaging elements, printing, or copying processes. In 2006 arose technological areas
associated with shaping or joining plastics, shaping of substances in a plastic state,
after-treatment methods and separation processes (by wet, magnetic, or electrostatic
methods).
In 1991, most important technological areas from field G – on physics – were as-
sociated with photosensitive materials for photographic purposes, photomechanical
production of textured or patterned surfaces (for printing, processing of semiconduc-
tor devices, and materials therefor), electrography, electrophotography, and magne-
tography. In 2006, most important areas were associated with the application of this
science to optical elements, systems, or apparatus; and electric digital data processing
(related to computers) associated with the investigation or analysis of materials by
determining their chemical or physical properties.
From 1991 to 2006 the share of field H more than doubled. In 1991 the impor-
tance of this field was associated with semiconductor devices, electrically-conductive
connections, structural associations of mutually-insulated electrical connecting ele-
ments. In 2006 these technological areas increased their importance and, in addition,
increased the share of technological areas associated with batteries (conversion of
chemical into electrical energy).
Observing the behavior of the concerning regulated technological areas, Table 6.41
shows that they represent a small share in 3M patent profile. Overall the sum of these
shares is small, with little variation from 1991 to 2006.
Table 6.41: Share of regulated technological areas in 3M’s patent profile
A01N C08F C08J C08K C09B C09D Total share
1991 – 2.8% 0.6% 1.0% 0.5% 1.7% 6.6%
2006 0.5% 2.1% 1.6% 1.6% – 1.3% 7.1%
This data corroborates with the strategy and focus of the company described
above. For 3M, chemicals technology is a tool for the development of new products
associated with all kinds of consumer goods.
The behavior of the patenting activity in these areas by 3M is detailed next.
However, area A01N will not be investigated given that the company does not figure
among the top ten in either years. Thus, it is not an important field for the firm’s
technological development.
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C08F, J, and K Table 6.42 shows the number of patent applications per country of
origin from 1991 to 2006, in the areas C08F, C08J, and C08K. With few exceptions,
nearly all applications are originated in the US. In addition, it is shown the share of
each of these regulated areas with respect to Þeld C and with respect to all patents
applied by 3M.
Table 6.42: C08F, C08J, and C08K: Evolution of patenting in Germany by 3M
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
C08F
Total 24 37 26 41 30 35 31 22 30 33 34 30 40 29 23 17
C08F/ C 0.25 0.24 0.06 0.19 0.18 0.17 0.23 0.16 0.16 0.19 0.19 0.14 0.24 0.14 0.16 0.12
C08F/
total pat.
0.09 0.09 0.06 0.08 0.07 0.06 0.08 0.05 0.06 0.07 0.08 0.05 0.08 0.05 0.04 0.03
C08J
Total 8 25 22 31 19 16 27 20 28 23 19 25 13 30 22 17
C08J/ C 0.08 0.16 0.05 0.14 0.12 0.08 0.20 0.14 0.16 0.14 0.11 0.12 0.08 0.15 0.16 0.12
C08J/
total pat.
0.03 0.06 0.05 0.06 0.04 0.03 0.07 0.05 0.06 0.05 0.04 0.04 0.02 0.05 0.04 0.03
C08K
Total 9 17 16 14 12 20 12 13 16 13 9 26 17 12 28 20
C08K/ C 0.09 0.11 0.04 0.07 0.07 0.10 0.09 0.09 0.09 0.08 0.05 0.13 0.10 0.06 0.19 0.14
C08K/
total pat.
0.03 0.04 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.05 0.03 0.02 0.05 0.04
In 1991, 9% of the total patent applications by 3M were also classified under the
technological area C08F (new macromolecular substances). Over the 2000s there was
a decrease in the share of applications containing this classification code, down to 3%
in 2006, although with a small decrease in the absolute numbers.
From 1991 to 2006 there was an increase in the absolute numbers of patent appli-
cations by 3M classified under technological areas C08J and C08K. Differently from
C08F, these last two technological areas are associated with compounding of polymers
with non-macromolecular or inorganic ingredients, new processes of compounding
and after-treatments. This may indicate that 3M has developed more innovations in
processing and new combinations of existing macromolecular substances with other
substances, and decreased the number of innovations in the development of new
macromolecules.
Next, Table 6.43 shows the summarized patent application profiles of these three
regulated areas. Investigating whether there was a change in the direction of patent-
ing, the Pearson χ2 tests indicate no significant results for C08F and C08J.
Table 6.43: C08F, C08J, and C08K: Summarized patent application profile and definitions –
3M
IPC 1991 2006 Definition
C08F
A 2.0% 5.6% Human necessities
A61K <1% 5.6% Preparations for medical, dental, or toilet purposes
B 13.8% 5.6% Performing operations; transporting
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IPC 1991 2006 Definition
C 69.1% 77.8% Chemistry; metallurgy
C08G 13.8% 18.9%
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon
unsaturated bonds
C08J 1.0% 22.2% Working-up; general processes of compounding; after-treatment not covered by subclasses
C08L 6.8% 16.7% Compositions of macromolecular compounds
C09D 8.6% 7.8%
Coating compositions (e.g. paints, varnishes, lacquers; filling pastes; chemical paint or ink re-
movers; inks; correcting fluids; wood stains; pastes pr solids for coloring or printing; use of mate-
rials therefor)
C09J 14.1% 5.6%
Adhesives; adhesive processes in general (non-mechanical part); adhesive processes not provided
for elsewhere; use of materials as adhesives
G 10.8% 11.1% Physics
G01N 2.8% 11.1% Investigating or analyzing materials by determining their chemical or physical properties
Pearson χ2 = 3.73 (p-value = 0.713; df = 6)
C08J
B 35.0% 29.5% Performing operations; transporting
B01D 5.1% 7.7% Separation
B29C 6.4%
Shaping or joining plastics; shaping of substances in a plastic state, in general; after-treatment of
the shaped products (e.g. repairing)
B32B 13.5% 10.3% Layered products, i.e. products built-up of strata of flat (e.g. cellular or honeycomb, form)
B41M 7.2% Printing, duplicating, marking, or copying processes; color printing
C 41.3% 50.0% Chemistry; metallurgy
C08F 3.1% 15.4%
Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated
bonds
C08K 6.3% 18.6% Use of inorganic or non-macromolecular organic substances as compounding ingredients
C08L 12.5% 6.4% Compositions of macromolecular compounds
C09D 7.2%
Coating compositions (e.g. paints, varnishes, lacquers; filling pastes; chemical paint or ink re-
movers; inks; correcting fluids; wood stains; pastes pr solids for coloring or printing; use of mate-
rials therefor)
C09K 6.3% Materials for miscellaneous applications, not provided elsewhere
G 10.4% 6.4% Physics
H 10.3% 14.1% Electricity
Pearson χ2 = 12.20 (p-value = 0.141; df = 8)
C08K
A 3.4% 5.6% Human necessities
A61K 3.4% 5.6% Preparations for medical, dental, or toilet purposes
C 88.2% 81.9% Chemistry; metallurgy
C01G 8.3% Compounds containing metals not covered by subclasses C01D or C01F
C07F 6.2%
Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen,
halogen, oxygen, nitrogen, sulfur, selenium, or tellurium
C08F 9.9% 1.1%
Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated
bonds
C08G 9.0% 5.3%
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon
unsaturated bonds
C08J 5.6% 13.4%
Working-up; general processes of compounding; after-treatment not covered by subclasses C08B,
C, F, and G
C08L 20.1% 33.8% Compositions of macromolecular compounds
C09C 8.3%
Treatment of inorganic materials, other than fibrous fillers, to enhance their pigmenting or filling
properties; preparation of carbon black
C09D 9.0% 6.7%
Coating compositions (e.g. paints, varnishes, lacquers; filling pastes; chemical paint or ink re-
movers; inks; correcting fluids; wood stains; pastes pr solids for coloring or printing; use of mate-
rials therefor)
C09J 22.9%
Adhesives; adhesive processes in general (non-mechanical part); adhesive processes not provided
for elsewhere; use of materials as adhesives
Pearson χ2 = 17.70 (p-value = 0.024; df = 8)
Regarding area C08K, from 1991 to 2006 increased the association with the appli-
cation on medical, dental, or toilet products, new inorganic compounds and formula-
tions of existing macromolecular compounds (C01G and C08L), and after treatment
processes to mold the final products (C08J and C09C). Conversely, decreased the
association with new substances (C07F, C08F, and C08G) and the application on
adhesives and their processes (C09J).
C09B and D The evolution of the last two technological areas analyzed is shown in
Table 6.44. There was small number of applications in area C09B, reaching at most
eight patents during the 1990s, and disappearing over the 2000s.
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Table 6.44: C09B and C09D: Evolution of patenting in Germany by 3M
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
C09B
Total 3 6 6 6 8 7 3 1 2 2 1
C09B/ C 0.03 0.04 0.01 0.03 0.05 0.03 0.02 0.01 0.01 0.01 0.01
C09B/
total pat.
0.01 0.02 0.01 0.01 0.02 0.01 0.01 <0.01 <0.01 <0.01 <0.01
C09D
Total 17 18 26 28 28 38 29 21 31 18 17 24 21 19 23 14
C09D/ C 0.18 0.12 0.06 0.14 0.17 0.18 0.22 0.15 0.18 0.11 0.10 0.12 0.13 0.09 0.16 0.10
C09D/
total pat.
0.06 0.05 0.06 0.06 0.06 0.07 0.07 0.05 0.06 0.04 0.04 0.04 0.04 0.03 0.04 0.03
The evolution of 3M’s patenting activity in area C09D was different, but without a
specific trent. Concerning the share in field C, in 1991 was eighteen percent, increasing
to twenty two in 1997, and decreasing to ten percent in 2006. Concerning the share
in all applications by 3M, it decreased from six to three percent over this period.
Next, Table 6.45 shows the summarized patent profile of applications in 1991 and
2006 for technological area C09D. This analysis was not developed for C09B given
that 3M stopped innovating in this area.
Table 6.45: C09D: Summarized patent application profile and definitions – 3M
IPC 1991 2006 Definition
B 12.6% 9.1% Performing operations; transporting
B32B 5.4% 9.1% Layered products, i.e. products built-up of strata of flat (e.g. cellular or honeycomb, form)
C 75.0% 87.9% Chemistry; metallurgy
C08F 12.1% 6.4%
Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated
bonds
C08G 14.1% 35.2%
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon
unsaturated bonds
C08K 4.8% 10.9% Use of inorganic or non-macromolecular organic substances as compounding ingredients
C08L 9.2% 16.7% Compositions of macromolecular compounds
C09J 18.5% 12.1%
Adhesives; adhesive processes in general (non-mechanical part); adhesive processes not provided
for elsewhere; use of materials as adhesives
Pearson χ2 = 2.94 (p-value = 0.710; df = 5)
In 1991 the most important areas associated with area C09D were related to
new macromolecular compounds and their respective processes (C08F, C08G, and
C08L) and adhesives (C09J). In 2006 there was an increase of the development of new
macromolecular substances, the use of inorganic substances in these compositions,
and respective processes (C08G, C08K, and C08L). The Pearson χ2 test shows no
significant change. Some examples are illustrated in Table 6.46.
Remarks
The panel data for 3M showed that regulatory stringency has impacted negatively
the firm’s patent profile. Also in this case the Porter hypothesis is not supported.
3M is a particular case among the selected group of firms because the company
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Table 6.46: C09D: Examples of patent applications in 1991 and 2006.
Year Classification Patent application title Applicant name
1991
B41M C08J C08K
C08L C09D
“Transparent liquid absorbent materials for use as ink-receptive
layers”
Minnesota Mining and Co. (US)
1991
C07D C08G C09D
C09J
“Process for the preparation of azlactone-functional Michael
adducts”
Minnesota Mining and Co. (US)
2006
C08G C08L C09D
C09J
“Adhesive composition and articles made therefrom” 3M Innovative Properties Co. (US)
2006 C08K C08L C09D “Damage-resistant epoxy compound” 3M Innovative Properties Co. (US)
uses the chemicals technology as a way to obtain its products, but the chemicals per
se are not the firm’s final output. Their final products are not chemical products,
but consumer products which contain chemicals. However, it figures among the top
applicants in five of the six investigated regulated areas. Nevertheless, although the
chemicals field has shared importance with several other fields as seen in its patent
profile (Table 6.40).
Concerning the first research question, if occurred an increase or decrease in
patenting from 1991 to 2006, 3M’s patent applications increased in areas C08J and
C08K, decreased in areas C08F and C09D, and exited the market in area C09B.
When investigating the direction of patenting, the Pearson χ2 was shown to be
significant for area C08K, and not significant for areas C08F, C08J, and C09D.
6.3 Findings
The aim of this chapter has been to investigate the innovative behavior of firms
impacted by the EU chemicals regulation from 1991 to 2006. Four firms, from among
the top ten patent applicants in 1990 in the most regulated technological areas, were
chosen to illustrate findings discussed previously in Chapter 5.
This chapter has focused on two of the research questions introduced in Chapter 5.
First, did regulation spur patenting activity? Second, has there been a change in the
direction of patenting? In order to simplify the analysis and enable comparison with
the findings obtained in the previous chapter, Tables 6.47 and 6.48 list the results
relative to each research question for each firm and in addition show the overall
findings obtained in Chapter 5.
A first interesting result can be observed when comparing the panels estimated
for each firm and the aggregate level estimated in Chapter 5. In the aggregate level
there is an overall positive significant impact of regulatory stringency on patenting
activity, while for three of the four investigated top players this effect was negative.
This suggests that regulation might impact in dissimilar ways different-size players;
or it might alter the market by stimulating new entrants in the market for innovation.
Next, I discuss separately the most impacted technological areas.
In Section 5.4, which summarized the results in Chapter 5, I argued that those
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Table 6.47: Summarized results.
Did regulation spur
patenting activity?
Has an increase or decrease in patenting occurred?
Panel
A01N C08F C08J C08K C09B C09D
Aggregate positive effect
increased decreased decreased decreased decreased increased
Bayer negative effect
increased decreased decreased decreased exited increased
BASF negative effect
increased increased increased stable decreased increased
DuPont no significant effect
stable increased decreased increased – increased
3M negative effect
– decreased increased increased exited decreased
Table 6.48: Summarized results: Has there been a change in the direction of patenting?
A01N C08F C08J C08K C09B C09D
Aggregate level yes no no no yes no
Bayer Group no yes no yes – yes
BASF yes yes yes yes yes no
DuPont yes no yes yes – no
3M – no no yes – no
areas which showed the greatest changes in patent activity over this period were
also those mostly restricted: A01N with 104, C09B with 86, and C09D with 101
restrictions. However, the changes in patenting activity in these highly regulated
areas were not consistently positive or negative. Regulated areas A01N and C09D
have seen an increase in the number of patent applications over this period despite
being highly regulated, while area C09B, which is also highly regulated, has seen a
decrease.
I first discuss area A01N where there was an increase in patent applications. This
area witnessed a number of new developments and new applications which permit-
ted firms to maintain innovative activity resulting in patents associated with non-
regulated usages. Applications associated with biotechnology also grew. At the same
time, there was less innovative activity relating to new organic substances which bore
the brunt of the increased regulation. Thus, in order to keep innovating in this area
firms needed to change the direction of technological innovation. This behavior can
be seen in BASF’s and DuPont’s A01N applications. By contrast, Bayer increased its
patenting in this area without changing substantially the pattern of its patent pro-
file over the period 1991 to 2006. Consistently with this lack of change is direction,
Bayer increased patent applications in this are proportionately less than BASF and
DuPont. (3M does not participate in A01N.)
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Area C09D also saw an increase in patent applications despite being highly regu-
lated. Much of the innovation in this area involves new formulations or applications
of new and existing substances. Innovative activity depends little on new science
and existing knowledge imparts inertia to the innovative process which is therefore
less sensitive to regulatory impact. Bayer’s, BASF’s, and DuPont’s C09D patent
applications all increased from 1991 to 2006, although 3M decreased patent applica-
tions. BASF, DuPont and 3M maintained the same general research direction in this
area whereas Bayer, whose patenting activity in this area was stable over the 2000s,
changed its innovative path from 1991 to 2006.
Area C09B, which is also highly regulated, saw a decrease in patenting activity.
It is characterized by the development of new substances. I argued in Chapter 5
that this may explain the decreasing trend in the number of innovations. In the last
years Bayer and 3M have not applied any patents in this area, effectively exiting
the market. BASF has decreased the number of patents and it left the market for
textile dyes, the use of which was restricted by the regulations introduced in 2003.
Regulation has effectively eliminated this product range with replacements falling in
other technological areas.
Detailed observation of firms’ managerial choices in conjunction with their patent
profiles has enabled a more precise characterization of the evolution of these tech-
nological areas over the most recent decades, during which most of the regulatory
restrictions have been imposed. These case studies have emphasized the claim made
in the previous chapter that, in order to continue innovating in areas intrinsically
associated with regulated families of substances, firms need to develop new techno-
logical directions. The choice is between doing this or exiting the area. The balance
of advantage differs across technological areas some of which therefore show increases
in patent activity while others show declines. To a lesser extent, firms choose different
strategies with some increasing patenting in the regulated area while others decrease
activity or even exit. This is consistent with a link between regulation and innovative
push but the chemicals experience shows that this link is not universal even within
relatively narrowly defined areas.
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Chapter 7
Conclusion
Economic problems and difficulties faced by researchers
The aim of this thesis has been to investigate and contribute to the study of the
relationship between innovation and regulatory stringency in the chemical industry.
Chapter 3 discusses the economic empirical literature on the possible impacts of
the regulatory stringency on firms. There are two different positions supported by
researchers on the relationship between innovation and regulation. From the orthodox
perspective, many economists claim that regulation implies extra costs for firms and
this may reduce funds available for R&D in order to comply with these extra costs
thereby reducing competitiveness in relation to less regulated firms.
Other researchers believe that regulation favors innovation because it signals new
opportunities. These may either be investment opportunities which were available
prior to regulation but were ignored by firms, or they may be opportunities created
by the need to comply with the regulations. This is not necessarily inconsistent
with the orthodox view that regulation increases costs since the need to circumvent
these cost may be a spur to innovation. Furthermore, the imposition of costs on
one technology can make other technologies economically viable. Regulation might
also reduce uncertainty about future returns on investments in more environmental
friendly products and processes thus spurring innovation and hence competitiveness.
The literature discussed in Chapter 3 and my subsequent analysis looked at differ-
ent kinds of regulation – impacting products or processes – and different regulatory
instruments – command and control or market-based. For Popp, Newell, and Jaffe
(2009), these different kinds of regulation are able to induce or oblige firms to under-
take technological changes of a desired type. Their contention is that regulation will
require firms to act in a manner differently from their previous practice.
It is difficult to estimate the extent of technological improvement toward higher
efficiency and greener products and this may vary across technological areas. As
Jaffe and Palmer (1997, pg.618) state, the impact of environmental regulation on
innovation is likely to differ for different manufacturing industries.
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These studies could focus on firms in heavily regulated industries (such as petroleum
refining, chemicals, metal products, and paper) and could include a more detailed
analysis of the impacts of particular classes of regulation, say, by media, on innovative
effort. Ideally an in-depth study of one or two companies in a particular industry, such
as chemicals, could be used to develop an understanding about how regulated firms
respond to new regulations and some related hypotheses which could then be tested
using data from other firms in the industry.
My analysis in Chapter 3 supported this conclusion.
A new approach toward the economic problem
In order to develop this thesis I have adopted a new approach, not previously ap-
plied in the economic literature, to investigate the relationship between environment,
health, and safety regulation and innovation. First, I selected a specific industrial
sector, the chemical industry, because product and process innovation is a key issue
for this science-based industry which uses its own resources to support R&D projects.
This industrial sector that emerged in the nineteenth century is responsible for pro-
viding inputs into all other industrial sectors and was a significant contributor factor
in the worldwide increase in wealth over the twentieth century.
At the same time, the chemical industry has seen major environmental accidents.
For this reason, starting in the second half of the twentieth century, the chemical
industry has been the focus of regulation in the most industrialized countries, which
were the first to face hazardous impacts of chemicals on human health and the envi-
ronment. A proper understanding of the relationship of this regulatory framework on
the innovative activity of this industry is fundamental for the strategic development
of the industry.
Second, a key problem faced by economists when studying regulation is how to de-
velop a reliable quantitative measure which can form the basis for empirical analysis.
My contribution in this thesis has been to derive a direct quantitative measure of reg-
ulatory impact which I am able to relate to innovative activity. By doing this, I have
transformed the economic measurement problem into a technological classification
issue.
Following on from the analysis of the regulatory framework developed in Section
3.4, I argued that the chemicals regulation has had a greater impact of the chemical
industry than have other environmental, health and safety regulations. This claim
is supported by the detail of the chemicals regulation embodied in REACH and im-
plemented by the EU in 2007 – see Section 3.3.1. Over the period 2001 to 2007
governments, firms, and NGOs debated the importance of easy access to information
on possible hazardous impacts of chemicals: firms defended their rights to industrial
secrecy while non-EU governments, in particular that of the United States, were con-
cerned about the possible negative impact on the exports of their chemical industries
to EU countries.
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Based on the finding that chemicals regulation resulted in the highest impact,
both direct and indirect, on the industry throughout the production chain, I chose to
research EU chemicals regulation from 1976 to 2003. Over this period, in excess of
nine hundred substances were restricted or prohibited for use and commercialization.
The measure of regulatory stringency
Chapter 4 was devoted to the implementation of the methodology developed to
measure the evolution of regulatory stringency over chemical substances in the EU
(EU Council Directive 76/769/EEC). The quantitative measure which I developed,
was the outcome of the impact imposed by each restriction on different chemicals
on technological areas associated with the products and processes of the chemical
industry (IPC-7). It was thereby possible to develop a quantitative measure, year by
year, of the stringency of regulation in the different technological areas.
Accordingly, six technological areas were selected given that they cover the most
impacted areas in their respective groups. In group A01 all restrictions implied by
the regulations were imposed over area A01N. In group C08, seventy nine percent
of the restrictions were imposed upon areas C08F, C08J, and C08K. In group C09,
sixty nine percent of the restrictions were imposed upon areas C09B and C09D. These
technological areas are directly associated to the sectors of agrochemicals and basic
chemicals. Table 7.1 illustrates the total number of restrictions over substances in
fields A and C, their groups A01, C08, and C09, and their most highly restricted
technological areas.
Table 7.1: Most regulated technological areas
A C
114 238
A01 C08 C09
104 105 184
A01N C08F C08J C08K C09B C09D
104 22 40 62 86 101
After the development of the measure of regulatory stringency over technological
areas I observed that most of the restrictions were imposed in two years: 1997 and
2003. The following step in my research was to investigate the patenting activity in
these restricted technological areas from 1990 to 2006.
Main findings and the economic hypotheses
Chapter 5 focused on four research questions derived from issues raised by the
economic literature to guide my empirical analysis.
1. Did regulation spur patenting activity?
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2. Has there been a change in the country of origin of patents?
3. Has there been any increase in patenting concentration?
4. Has there been a change in the direction of patenting?
As shown in Section 5.1, from 1990 to 2006, within the EU, Germany received the
highest number of patent applications in these technological groups. Since firms need
to patent their inventions in each country where they seek protection it is reasonable
to believe that the vast majority of innovations for which application was made in
the EU also resulted in applications in Germany. Therefore, I decided to focus only
on patent applications in Germany as representative of total EU patent applications.
My results shows heterogeneous behavior of innovative activity during the periods
of increasing regulatory stringency (1997 and 2003). A number of authors have
suggested that environmental, health, and safety regulations have different impacts
across industrial sectors. I find the same conclusion applies in relation to the impact
of regulation across different technological areas.
My main findings show an overall increase in innovations associated with new
processes and formulations. This results from increased incremental innovation and
fewer novel substances. There was also a shift from patenting in regulated to non-
regulated uses and in new technologies (e.g. biotechnology).
Areas which showed major changes over this period were also those that bore
the largest number of restrictions: A01N, C09B, and C09D. Conversely, among those
areas which I investigated those which had a stable patenting behavior were also
those which were less restricted.
Accordingly, technological areas which did not depend on novel substances (C09D),
or which had space to innovate in non-regulated uses (A01N), found space to continue
expanding patenting activity. By contrast, the number of applications in areas in
which these conditions did not apply saw a drastic fall (C09B).
An interesting issue which emerged from this research is the reduction in the
concentration of the innovative activity in five of the six regulated areas. In these
five areas there was an overall increase in patents applied by “small players,” meaning
a larger number of applicants with a smaller number of patents.
In Chapter 6 four case studies were developed to corroborate the aggregate results
obtained previously at firm level. A brief history of managerial decision-making
regarding investments, mergers, and acquisitions complemented the foregoing study
of the patenting activity of these companies.
The research questions were inspired by the Porter’s Hypothesis which says that
regulatory stringency positively impacts innovation and, by consequence, competi-
tiveness. This thesis shows that the Porter hypothesis is supported for the chemical
industry. Yet, this occurs not because Þrms innovate under more stringent regulation,
but because it stimulates new entrants in the market of innovation.
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Moreover, my results suggest that “new” technologies appear to be benefited by
regulatory stringency while “old” technologies appear to be discouraged. Or, it can be
that regulation is imposed when there is enough knowledge about a specific technology
and while restricting it regulation might spur the development of substitutes better
adapted to the regulatory framework.
General observations
The most highly regulated areas concern technologies developed prior to the 1950s.
It took decades for governments to realize the dangers presented by these technologies
and to decide to regulate them. Similarly, we must expect that it may take a number
of decades to accumulate the evidence and experience which will enable us to evaluate
the risks imposed by today’s new technologies and to reach an informed judgment on
whether and how they should be regulated.
Innovation is a crucial factor in economic development but it can also be respon-
sible for environmental pollution and health hazards. Society, through the agency of
government, must regulate in order to choose the best trade off between development
and possible hazards that might emerge as a cost for society and the environment.
The concentration of power in large groups may be a matter for concern. Never-
theless, larger firms are more easily able to cope with the risks of the technological
development and the costs of regulations. With new regulatory frameworks such
as REACH, the public authorities recognize that it is firms that are most capable
of accessing the risks of its products and processes. Given the increasing level of
technological specialization and emerging technologies (such as biotechnology and
nanotechnology) with new uses emerging every day, it is firms that must manage the
risk and assist the development of impact studies in parallel.
The reality of the twenty first century brings new problems. In a number of
manufacturing industries such as, textiles and clothing, ceramics, toys, the third in-
dustrial revolution with instant communication and market globalization has resulted
in disconnection of production from the ownership of intellectual property. Develop-
ing economies have benefited from the relocation of large production facilities and
outsourcing by multinational companies. Usually, these products are produced us-
ing relatively poorly qualified labor. The intellectual property capital continues to
reside in the developed economies. Multinational firms own trademarks and patents,
focusing their strength on R&D for new products and developing new market strate-
gies. Concerns about production processes, and labor health and safety, have been
largely transferred to producing firms, many of which are located in the developing
economies.
The chemical industry does not conform to this paradigm. As seen in Chapter
6, the three chemical firms analyzed – Bayer, BASF, and DuPont – did not expe-
rience this kind of behavior. The last decades saw both expansion of their plants
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in Europe and North America and development of new plants in emerging markets.
Outsourcing has not been a feature of chemicals production. Differently from many
of these industries, the chemicals industry is characterized by a low share of labor
in total costs, reliance on skilled and specifically trained personnel, and a dominant
importance of product quality. Furthermore, because it is more difficult to protect in-
tellectual property in many emerging markets, firms in the chemical industry are also
very wary of transferring processes which may allow developing countries competitors
to benefit from their experience.
The process of innovation is also different in the chemicals industry. Basic chem-
icals have been known since the beginning of the twentieth century. In this sector,
innovation entirely takes the form of process innovation. Processes can be patented
but patents on the basic chemicals have now expired. The consequence is that firms
have differing production costs for the same basic chemicals, depending on the success
with which they have innovated. Oligopolistic competition will result in the price be-
ing set in relation to the production costs of the marginal producer. Firms compete
through process innovation which allows them to reduce production costs and obtain
competitive advantage gaining an implied rent relative to the costs of the marginal
(non innovating) producers.
Future research: directions and open questions
Two issues are crucial in order to better understand the relationship between
regulation and innovation in the chemical industry, and as a consequence, help develop
better regulation. The first issue concerns the impact of regulation on the innovative
activity on different size firms. The second relates to regulation under uncertainty.
I have argued that large corporations can cope with regulation more easily than
smaller firms. Given the increasingly complexity of the dossiers requested by regula-
tors, a multidisciplinary group of experts (biologists, toxicologists, chemists, lawyers,
among others) is needed in order to complete all studies to assure safety of the new
product.
However, even though regulation may favor larger firms, I observed that this
has not translated into increased concentration in innovative activity. Two reasons
may be advanced to explain this phenomena. First, because compliance is costly,
large companies might have diverted resources from R&D to be able to comply with
regulation when marketing a new product. Secondly, and in specific relationship
to specialty chemicals, large firms might be too cumbersome (given their complex
corporative structure) to move away from well established technological paths to new
ones. Smaller and more nimble players would be “lighter” enabling faster movement
into emerging technologies. A possible consequence is that large corporations would
become specialized in logistics, know-how about chemical processes, and regulatory
issues in marketing new chemicals, while small players would concentrate their efforts
174
on developing new products.
The second issue which I have highlighted as important is the effects of uncertainty
in relation to new substances. A group of methodologies is available to investigate
the possible hazards and negative impacts on the environment and human health
in dealing with such new chemicals. These methodologies have been developed and
improved throughout the decades. Nevertheless, it can happen that a chemical can
generate an unexpected impact not anticipated by existing methodologies. Alter-
natively, it may be that there were no methodologies to test for this impact. The
impact will only become apparent subsequently, perhaps after an extended period of
time. For example, a food additive can be discovered to cause anxiety after decades
in the market. As this kind of impact on health was not anticipated, no tests were
undertaken which might have suggested this impact.
Novel technologies have the disadvantage of a lack of empirical tests to acquire
information on possible future impacts. The initial focus is on possible market ap-
plications of the new substance. Subsequently, researchers explore possible impacts
of the substance on the environment and human health. Two current examples that
have stimulated debate since the 1980s were developments derived from biotechnology
(GMOs) and nanotechnology (nano materials). Recently, in launching a report on the
environmental impact of nanotechnology (RCEP, 2008), the UK Royal Commission
on Environmental Pollution (RCEP) has highlighted the lack of scientific evidence in
favor or against the partial or total restriction of new nano-substances.
Regulatory suggestions
The complexity of the chemical industry and its allied technologies poses a chal-
lenge for regulators, who are required to reduce the knowledge asymmetry between
producers and consumers and to devise timely regulation. In Chapter 3 a summary
of the chemicals for the European Union (past and actual), the US, and Japan was
provided. This overview illustrated three different regulatory regimes to control pro-
duction, commercialization, and uses of chemicals.
Given the increasingly level of technological specialization and with new tech-
nologies and new uses of old technologies emerging continuously, firms must simul-
taneously manage risks and undertake impact studies. My findings showed that,
in the three major technological cycles of the chemical industry, regulation arrived
decades after the substances were first marketed. In the same spirit, the RCEP
(2008) highlighted the time gap between the emergence of new nano-substances and
the generation of environmental, health, and safety data.
Another study developed by the UK RCEP (RCEP, 2003) focused on chemicals
regulation. They recommended the formation of a new body, as part of the envi-
ronmental agency, specifically to assess and manage chemical risks, and monitor and
enforce restrictions on the use of chemicals. This body would also be responsible for
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sponsoring the research that we see as necessary to take forward longer-term improve-
ments in our understanding of the fate and effects of chemicals and new techniques
for assessing chemicals (RCEP, 2003, pg.168).
The proposal to create a new and independent body is a useful response to the
continuous development and commercialization of new products. Prohibition of the
commercialization of new products deriving from new technological paths would harm
not only innovation but also prevent society from benefiting from these new develop-
ments. However, as already stated, it is the innovating company which is the most
able to undertake research on possible hazards coming from innovation. Innovating
firms are better able than regulators to evaluate the costs and benefits derived from a
new technology. At the same time, they will be less interested in diminishing knowl-
edge asymmetry between producers and consumers. An independent body, formed
not only by the regulator (government represented by all involved agencies), but also
by representative industry associations, research centers and universities, would be
well placed to monitor technological developments and arrive at an informed judge-
ment on issues regarding possible positive and negative impacts. Ideally, this body
should be a pan-European level.
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Appendix A
International Patent Classification
(IPC)
Table A.1: International Patent Classification: IPC-7
Code Definition
A Human necessities
B Performing operations and transporting
C Chemistry and metallurgy
D Textiles and paper
E Fixed constructions
F Mechanical engineering; lighting; heating; weapons; and blasting
G Physics
H Electricity
Table A.2: SECTION A — HUMAN NECESSITIES CONTENTS OF SECTION
Subsection: AGRICULTURE A 01 AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING;
TRAPPING; FISHING
A 01 B
Soil working in agriculture or forestry; Parts, details, or accessories of agricultural machines or implements,
in general
A 01 C Planting; Sowing; Fertilising
A 01 D Harvesting; Mowing
A 01 F
Processing of harvested produce; Hay or straw presses; Devices for storing agricultural or horticultural
produce
A 01 G Horticulture; Cultivation of vegetables, flowers, rice, fruit, vines, hops, or seaweed; Forestry; Watering
A 01 H New plants or processes for obtaining them; Plant reproduction by tissue culture techniques
A 01 J Manufacture of dairy products
A 01 K
Animal husbandry; Care of birds, fishes, insects; Fishing; Rearing or breeding animals, not otherwise pro-
vided for; New breeds of animals
A 01 L Shoeing of animals
A 01 M Catching, trapping or scaring of animals; Apparatus for the destruction of noxious animals or noxious plants
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A. INTERNATIONAL PATENT CLASSIFICATION (IPC)
Subsection: AGRICULTURE A 01 AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING;
TRAPPING; FISHING
A 01 N
Preservation of bodies of humans or animals or plants or parts thereof; Biocides, e.g. as disinfectants, as
pesticides, as herbicides; Pest repellants or attractants; Plant growth regulators
Subsection: FOODSTUFFS; TOBACCO
A 21 BAKING; EDIBLE DOUGHS
A 21 B Bakers’ ovens; Machines or equipment for baking
A 21 C Machines or equipment for making or processing doughs; Handling baked articles made from dough
A 21 D
Treatment, e.g. preservation, of flour or dough, e.g. by addition of materials; Baking; Bakery products;
Preservation thereof
A 22 BUTCHERING; MEAT TREATMENT; PROCESSING POULTRY OR FISH
A 22 B Slaughtering
A 22 C Processing meat, poultry, or fish
A 23 FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
A 23 B
Preserving, e.g. by canning, meat, fish, eggs, fruit, vegetables, edible seeds; Chemical ripening of fruit or
vegetables; The preserved, ripened, or canned products
A 23 C Dairy products, e.g. milk, butter, cheese; Milk or cheese substitutes; Making thereof
A 23 D Edible oils or fats, e.g. margarines, shortenings, cooking oils
A 23 F Coffee; Tea; Their substitutes; Manufacture, preparation, or infusion thereof
A 23 G Cocoa; Chocolate; Confectionery; Ice-cream
A 23 J
Protein compositions for foodstuffs; Working-up proteins for foodstuffs; Phosphatide compositions for food-
stuffs
A 23 K Fodder
A 23 L
Foods, foodstuffs, or non-alcoholic beverages, not covered by subclasses A 23 B to J; Their preparation
or treatment, e.g. cooking, modification of nutritive qualities, physical treatment; Preservation of foods or
foodstuffs, in general
A 23 N
Machines or apparatus for treating harvested fruit, vegetables, or flower bulbs in bulk, not otherwise provided
for; Peeling vegetables or fruit in bulk; Apparatus for preparing animal feeding-stuffs
A 23 P Shaping or working of foodstuffs, not fully covered by a single other subclass
A 24 TOBACCO; CIGARS; CIGARETTES; SMOKERSÕ REQUISITES
A 24 B Manufacture or preparation of tobacco for smoking or chewing; Tobacco; Snuff
A 24 C Machines for making cigars or cigarettes
A 24 D
Cigars; Cigarettes; Tobacco smoke filters; Mouthpieces for cigars or cigarettes; Manufacture of tobacco
smoke filters or mouthpieces
A 24 F Smokers’ requisites; Match boxes
Subsection: PERSONAL OR DOMESTIC ARTICLES
A 41 WEARING APPAREL
A 41 B Shirts; Underwear; Baby linen; Handkerchiefs
A 41 C Corsets; Brassières
A 41 D Outerwear; Protective garments; Accessories
A 41 F Garment fastenings; Suspenders
A 41 G Artificial flowers; Wigs; Masks; Feathers
A 41 H Appliances or methods for making clothes, e.g. for dress-making, for tailoring, not otherwise provided for
A 42 HEADWEAR
A 42 B Hats; Head coverings
A 42 C Manufacturing or trimming hats or other head coverings
A 43 FOOTWEAR
A 43 B Characteristic features of footwear; Parts of footwear
A 43 C Fastenings or attachments for footwear; Laces in general
A 43 D Machines, tools, equipment or methods for manufacturing or repairing footwear
A 44 HABERDASHERY; JEWELLERY
A 44 B Buttons, pins, buckles, slide fasteners, or the like
A 44 C Jewellery; Bracelets; Other personal adornments; Coins
A 45 HAND OR TRAVELLING ARTICLES
A 45 B Walking sticks; Umbrellas; Ladies’ or like fans
A 45 C Purses; Travelling bags or baskets; Suitcases
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Subsection: AGRICULTURE A 01 AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING;
TRAPPING; FISHING
A 45 D Hairdressing or shaving equipment; Manicuring or other cosmetic treatment
A 45 F Travelling or camp equipment
A 46 BRUSHWARE
A 46 B Brushes
A 46 D Manufacture of brushes
A 47
FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION
CLEANERS IN GENERAL
A 47 B Tables; Desks; Office furniture; Cabinets; Drawers; General details of furniture
A 47 C Chairs; Sofas; Beds
A 47 D Furniture specially adapted for children
A 47 F Special furniture, fittings, or accessories for shops, storehouses, bars, restaurants, or the like; Paying counters
A 47 G Household or table equipment
A 47 H Furnishings for windows or doors
A 47 J Kitchen equipment; Coffee mills; Spice mills; Apparatus for making beverages
A 47 K Sanitary equipment not otherwise provided for; Toilet accessories
A 47 L Domestic washing or cleaning; Suction cleaners in general
Subsection: HEALTH; AMUSEMENT
A 61 MEDICAL OR VETERINARY SCIENCE; HYGIENE
A 61 B Diagnosis; Surgery; Identification
A 61 C Dentistry; Oral or dental hygiene
A 61 D Veterinary instruments, implements, tools, or methods
A 61 F
Filters implantable into blood vessels; Prostheses; Orthopaedic, nursing or contraceptive devices; Fomenta-
tion; Treatment or protection of eyes or ears; Bandages, dressings or absorbent pads; First-aid kits
A 61 G Transport or accommodation for patients; Operating tables or chairs; Chairs for dentistry; Funereal devices
A 61 H
Physical therapy apparatus, e.g. devices for locating or stimulating reflex points in the body; Artificial
respiration; Massage; Bathing devices for special therapeutic or hygienic purposes or specific parts of the
body
A 61 J
Containers specially adapted for medical or pharmaceutical purposes; Devices or methods specially adapted
for bringing pharmaceutical products into particular physical or administering forms; Devices for adminis-
tering food or medicines orally; Baby comforters; Devices for receiving spittle
A 61 K Preparations for medical, dental, or toilet purposes
Subsection: HEALTH; AMUSEMENT
A 61 L
Methods or apparatus for sterilising materials or objects in general; Disinfection, sterilisation, or deodor-
isation of air; Chemical aspects of bandages, dressings, absorbent pads, or surgical articles; Materials for
bandages, dressings, absorbent pads, or surgical articles
A 61 M
Devices for introducing media into, or onto, the body; Devices for transducing body media or for taking
media from the body; Devices for producing or ending sleep or stupor
A 61 N Electrotherapy; Magnetotherapy; Radiation therapy; Ultrasound therapy
A 61 P Therapeutic activity of chemical compounds or medicinal preparations
A 62 LIFE-SAVING; FIRE-FIGHTING
A 62 B Devices, apparatus, or methods for life-saving
A 62 C Fire-fighting
A 62 D
Chemical means for extinguishing fires or for combating or protecting against harmful chemical agents;
Chemical materials for use in breathing apparatus
A 63 SPORTS; GAMES; AMUSEMENTS
A 63 B Apparatus for physical training, gymnastics, swimming, climbing, or fencing; Ball games; Training equipment
A 63 C Skates; Skis; Roller skates; Design or layout of courts, rinks or the like
A 63 D Bowling-alleys; Bowling games; Boccia; Bowls; Bagatelle; Billiards
A 63 F Card, board, or roulette games; Indoor games using small moving playing bodies; Miscellaneous games
A 63 G Merry-go-rounds; Swings; Rocking-horses; Chutes; Switchbacks; Similar devices for public amusement
A 63 H Toys, e.g. tops, dolls, hoops, building blocks
A 63 J Devices for theatres, circuses, or the like; Conjuring appliances or the like
A 63 K Racing; Riding sports; Equipment or accessories therefor
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A. INTERNATIONAL PATENT CLASSIFICATION (IPC)
Subsection: AGRICULTURE A 01 AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING;
TRAPPING; FISHING
Table A.3: SECTION C — CHEMISTRY; METALLURGY
Subsection: CHEMISTRY
C 01 INORGANIC CHEMISTRY
C 01 B Non-metallic elements; Compounds thereof
C 01 C Ammonia; Cyanogen; Compounds thereof
C 01 D Compounds of alkali metals, i.e. lithium, sodium, potassium, rubidium, caesium, or francium
C 01 F
Compounds of the metals beryllium, magnesium, aluminium, calcium, strontium, barium, radium, thorium,
or of the rare-earth metals
C 01 G Compounds containing metals not covered by subclasses C 01 D or F
C 02 TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
C 02 F Treatment of water, waste water, sewage, or sludge
C 03 GLASS; MINERAL OR SLAG WOOL
C 03 B Manufacture, shaping, or supplementary processes
C 03 C
Chemical composition of glasses, glazes, or vitreous enamels; Surface treatment of glass; Surface treatment
of fibres or filaments from glass, minerals or slags; Joining glass to glass or other materials
C 04 CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
C 04 B
Lime; Magnesia; Slag; Cements; Compositions thereof, e.g. mortars, concrete or like building materials;
Artificial stone; Ceramics; Refractories; Treatment of natural stone
C 05 FERTILISERS; MANUFACTURE THEREOF
C 05 B Phosphatic fertilisers
C 05 C Nitrogenous fertilisers
C 05 D Inorganic fertilisers not covered by subclasses C 05 B, C; Fertilisers producing carbon dioxide
C 05 F Organic fertilisers not covered by subclasses C 05 B, C, e.g. fertilisers from waste or refuse
C 05 G
Mixtures of fertilisers covered individually by different subclasses of class C 05; Mixtures of one or more
fertilisers with materials not having a specific fertilising activity, e.g. pesticides, soil-conditioners, wetting
agents; Fertilisers characterised by their form
C 06 EXPLOSIVES; MATCHES
C 06 B Explosive or thermic compositions; Manufacture thereof; Use of single substances as explosives
C 06 C Detonating or priming devices; Fuses; Chemical lighters; Pyrophoric compositions
C 06 D Means for generating smoke or mist; Gas-attack compositions; Generation of gas for blasting or propulsion
C 06 F Matches; Manufacture of matches
C 07 ORGANIC CHEMISTRY
C 07 B General methods of organic chemistry; Apparatus therefor
C 07 C Acyclic or carbocyclic compounds
C 07 D Heterocyclic compounds
C 07 F
Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen,
oxygen, nitrogen, sulfur, selenium, or tellurium
C 07 G Compounds of unknown constitution
C 07 H Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids
C 07 J Steroids
C 07 K Peptides
C 07 M Indexing scheme associated with subclasses C 07 B to K, relating to specific properties of organic compounds
C 08
ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL
WORKING-UP; COMPOSITIONS BASED THEREON
C 08 B Polysaccharides; Derivatives thereof
C 08 C Treatment or chemical modification of rubbers
C 08 F Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
C 08 G
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsatu-
rated bonds
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Subsection: CHEMISTRY
C 08 H Derivatives of natural macromolecular compounds
C 08 J Working-up; General processes of compounding; After-treatment not covered by subclasses C 08 B, C, F, G
C 08 K Use of inorganic or non-macromolecular organic substances as compounding ingredients
C 08 L Compositions of macromolecular compounds
C 09
DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; MISCELLANEOUS COMPOSITIONS;
MISCELLANEOUS APPLICATIONS OF MATERIALS
C 09 B Organic dyes or closely-related compounds for producing dyes; Mordants; Lakes
C 09 C
Treatment of inorganic materials, other than fibrous fillers, to enhance their pigmenting or filling properties;
Preparation of carbon black
C 09 D
Coating compositions, e.g. paints, varnishes, lacquers; Filling pastes; Chemical paint or ink removers; Inks;
Correcting fluids; Woodstains; Pastes or solids for colouring or printing; Use of materials therefor
C 09 F Natural resins; French polish; Drying-oils; Driers; Turpentine
C 09 G Polishing compositions other than french polish; Ski waxes
C 09 H Preparation of glue or gelatine
C 09 J
Adhesives; Adhesive processes in general; Adhesive processes not provided for elsewhere; Use of materials as
adhesives
C 09 K Materials for miscellaneous applications, not provided for elsewhere
C 10
PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBONMONOX-
IDE; FUELS; LUBRICANTS; PEAT
C 10 B Destructive distillation of carbonaceous materials for production of gas, coke, tar, or similar materials
C 10 C Working-up tar, pitch, asphalt, bitumen; Pyroligneous acid
C 10 F Drying or working-up of peat
C 10 G
Cracking hydrocarbon oils; Production of liquid hydrocarbon mixtures, e.g. by destructive hydrogenation,
oligomerisation, polymerisation; Recovery of hydrocarbon oils from oil-shale, oil-sand, or gases; Refining
mixtures mainly consisting of hydrocarbons; Reforming of naphtha; Mineral waxes
C 10 H Production of acetylene by wet methods
C 10 J
Production of producer gas, water-gas, synthesis gas from solid carbonaceous material, or mixtures containing
these gases; Carburetting air or other gases
C 10 K Purifying or modifying the chemical compositions of combustible gases containing carbon monoxide
C 10 L
Fuels not otherwise provided for; Natural gas; Synthetic natural gas obtained by processes not covered
by subclasses C 10 G, K; Liquefied petroleum gas; Adding materials to fuels or fires to reduce smoke or
undesirable deposits or to facilitate soot removal; Fire-lighters
C 10 M
Lubricating compositions; Use of chemical substances either alone or as lubricating ingredients in a lubri-
cating composition
C 10 N Indexing scheme associated with subclass C 10 M
C 11
ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THERE-
FROM; DETERGENTS; CANDLES
C 11 B
Producing, refining or preserving fats, fatty substances, fatty oils or waxes, including extraction from waste
materials; Essential oils; Perfumes
C 11 C
Fatty acids from fats, oils or waxes; Candles; Fats, oils or fatty acids by chemical modification of fats, oils,
or fatty acids obtained therefrom
C 11 D
Detergent compositions; Use of single substances as detergents; Soap or soap-making; Resin soaps; Recovery
of glycerol
C 12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTA-
TION OR GENETIC ENGINEERING
C 12 C Brewing of beer
C 12 F Recovery of by-products of fermented solutions; Denaturing of, or denatured, alcohol
C 12 G Wine; Other alcoholic beverages; Preparation thereof
C 12 H
Pasteurisation, sterilisation, preservation, purification, clarification, ageing of alcoholic beverages or removal
of alcohol therefrom
C 12 J Vinegar; Its preparation
C 12 L Pitching or depitching machines; Cellar tools
C 12 M Apparatus for enzymology or microbiology
C 12 N
Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-
organisms; Mutation or genetic engineering; Culture media
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Subsection: CHEMISTRY
C 12 P
Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to
separate optical isomers from a racemic mixture
C 12 Q
Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor;
Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological
processes
C 12 R Indexing scheme associated with subclasses C 12 C to Q or S, relating to micro-organisms
C 12 S
Processes using enzymes or micro-organisms to liberate, separate or purify a pre-existing compound or
composition; Processes using enzymes or micro-organisms to treat textiles or to clean solid surfaces of
materials
C 13 SUGAR INDUSTRY
C 13 C Cutting mills; Shredding knives; Pulp presses
C 13 D Production or purification of sugar juices
C 13 F Preparation or processing of raw sugar, sugar, or syrup
C 13 G Evaporation apparatus; Boiling pans
C 13 H Cutting machines for sugar; Combined cutting, sorting and packing machines for sugar
C 13 J Extraction of sugar from molasses
C 13 K Glucose; Invert sugar; Lactose; Maltose; Synthesis of sugars by hydrolysis of di- or polysaccharides
C 14 SKINS; HIDES; PELTS; LEATHER
C 14 B
Mechanical treatment or processing of skins, hides, or leather in general; Pelt-shearing machines; Intestine-
splitting machines
C 14 C
Chemical treatment of hides, skins or leather, e.g. tanning, impregnating, finishing; Apparatus therefor;
Compositions for tanning
Table A.4: SECTION C — CHEMISTRY; METALLURGY
Subsection: METALLURGY
C 21 METALLURGY OF IRON
C 21 B Manufacture of iron or steel
C 21 C
Processing of pig-iron, e.g. refining, manufacture of wrought-iron or steel; Treatment in molten state of
ferrous alloys
C 21 D
Modifying the physical structure of ferrous metals; General devices for heat treatment of ferrous or non-
ferrous metals or alloys; Making metal malleable by decarburisation, tempering, or other treatments
C 22
METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-
FERROUS METALS
C 22 B Production or refining of metals; Pretreatment of raw materials
C 22 C Alloys
C 22 F Changing the physical structure of non-ferrous metals or non-ferrous alloys
C 22 K
Indexing scheme associated with subclasses C 21 D, C 22 C or F, relating to changing the physical charac-
teristics of alloys
C 23
COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEM-
ICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING
BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL
VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR
INCRUSTATION IN GENERAL
C 23 C
Coating metallic material; Coating material with metallic material; Surface treatment of metallic material
by diffusion into the surface, by chemical conversion or substitution; Coating by vacuum evaporation, by
sputtering, by ion implantation or by chemical vapour deposition, in general
C 23 D Enamelling of, or applying a vitreous layer to, metals
C 23 F
Non-mechanical removal of metallic material from surfaces; Inhibiting corrosion of metallic material; In-
hibiting incrustation in general; Multi-step processes for surface treatment of metallic material involving at
least one process provided for in class C 23 and at least one process covered by subclass C 21 D or C 22 F
or class C 25
C 23 G Cleaning or de-greasing of metallic material by chemical methods other than electrolysis
C 25 ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
C 25 B Electrolytic or electrophoretic processes for the production of compounds or non- metals; Apparatus therefor
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Subsection: METALLURGY
C 25 C Processes for the electrolytic production, recovery or refining of metals; Apparatus therefor
C 25 D
Processes for the electrolytic or electrophoretic production of coatings; Electroforming; Joining workpieces
by electrolysis; Apparatus therefor
C 25 F Processes for the electrolytic removal of materials from objects; Apparatus therefor
C 30 CRYSTAL GROWTH
C 30 B
Single-crystal growth; Unidirectional solidification of eutectic material or unidirectional demixing of eutectoid
material; Refining by zone-melting of material; Production of a homogeneous polycrystalline material with
defined structure; Single crystals or homogeneous polycrystalline material with defined structure; After-
treatment of single crystals or a homogeneous polycrystalline material with defined structure; Apparatus
therefor
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Appendix B
Top Applicants
B.1 IPC-A01: Agriculture; forestry; animal husbandry; hunt-
ing; trapping; and fishing
• In 1990, four of the top applicants were based in Germany and two in US, while in 2006 two
were German and four from US.
• From all, five are present in both years however a deeper analysis considering mergers and
acquisitions would clarify the perpetuation of the leadership in a given technological area.
Table B.1: Top applicants on the IPC-A01N in Germany
1990 2006
DE Bayer AG 116 DE Basf SE 107
DE Basf AG 89 DE Bayer CropScience AG 91
CH Ciba-Geigy AG 53 CH Syngenta Participations AG 44
GB Zeneca Ltd 24 US Merck and Co Inc 22
NL
Shell Internationale Research Maatschappij
BV
22 FR Bayer CropScience SA 17
US Rohm and Haas Company 22 US Smithkline Beecham Corporation 16
DE Hoechst Schering AgrEvo GmbH 22 GB Syngenta Ltd 16
US E.I. Du Pont de Nemours and Company 16 US E.I. Du Pont de Nemours and Company 15
JP Sumitomo Chemical Company Ltd 15 US Rohm and Haas Company 14
DE Schering AG 14 JP Sumitomo Chemical Company Ltd 13
393 355
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B. TOP APPLICANTS
B.2 IPC-C08: Organic macromolecular compounds; their prepa-
ration or chemical working-up; compositions based thereon
• For both years Basf leads the top applicants on the technological areas C08F and C08J.
• For area C08F:
– In 1990 there were three German and three US firms in the top, while in 2006 there
were two German and five US firms.
– In 2006 the were four applicants with the same number of applications. The fourth firm
with seventeen applications is Basell Poliolefine Italia Srl, from Italy.
• For area C08K:
– In 2006 the were two applicants with the same number of applications. The second firm
with fifteen applications is Sabic Innovative Plastics IP BV, from The Netherlands.
Table B.2: Top applicants on the IPC-C08F in Germany
1990 2006
DE Basf AG 61 DE Basf SE 90
DE Bayer AG 44 US Dow Global Technologies Inc 40
DE Hoechst AG 33 FI Borealis Technology Oy 35
US The Dow Chemical Company 31 US E.I. Du Pont de Nemours and Company 31
CH Ciba-Geigy AG 29 DE Basell Polyolefine GmbH 21
US Exxon Chemical Patents Inc 27 US Rohm and Haas Company 21
US
Minnesota Mining and Manufacturing Com-
pany (3M)
25 JP Mitsui Chemicals Inc 20
US E.I. Du Pont de Nemours and Company 25 US 3M Innovative Properties Company 17
NL
Shell Internationale Research Maatschappij
BV
24 US ExxonMobil Chemical Patents Inc 17
FR Elf Atochem SA 20 CH Ciba Holding Inc 17
319 309
192
B.3 IPC-C09: DYES; PAINTS; POLISHES; NATURAL RESINS;
ADHESIVES; MISCELLANEOUS COMPOSITIONS; MISCELLANEOUS
APPLICATIONS OF MATERIALS
Table B.3: Top applicants on the IPC-C08J in Germany
1990 2006
DE Basf AG 35 DE Basf SE 62
US E.I. Du Pont de Nemours and Company 33 US E.I. Du Pont de Nemours and Company 34
DE Bayer AG 31 US 3M Innovative Properties Company 17
US
Minnesota Mining and Manufacturing Com-
pany (3M)
22 JP FUJIFILM Corporation 16
JP Mitsui Toatsu Chemicals Inc. 16 KR LG Chemical Ltd 15
US The Dow Chemical Company 13 JP Toray Industries Inc 15
CH Ciba-Geigy AG 12 US Dow Global Technologies Inc 14
GB Imperial Chemical Industries PLC 12 FI Borealis Technology Oy 13
DE Hoechst AG 12 US Eastman Chemical Company 12
FR Rhone-Poulenc Chimie 11 JP Tonen Chemical Corporation 12
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Table B.4: Top applicants on the IPC-C08K in Germany
1990 2006
DE Bayer AG 44 US E.I. Du Pont de Nemours and Company 35
CH Ciba-Geigy AG 40 CH Ciba Holding Inc 30
US General Electric Company 30 JP Sumitomo Rubber Industries Ltd 28
DE Basf AG 29 DE Basf SE 26
US Dow Corning Corporation 26 FI Borealis Technology Oy 23
JP Sumitomo Chemical Company Ltd 23 US General Electric Company 22
US Eastman Kodak Company 18 US The Goodyear Tire & Rubber Company 22
DE Hoechst AG 17 US 3M Innovative Properties Company 20
JP Polyplastics Co Ltd 16 DE Wacker Chemie AG 17
US E.I. Du Pont de Nemours and Company 16 DE Evonik Degussa GmbH 15
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B.3 IPC-C09: Dyes; paints; polishes; natural resins; adhe-
sives; miscellaneous compositions; miscellaneous applica-
tions of materials
• For area C09D:
– Table B.6 signals an increase in the standard deviation, showing a considerable increase
in the difference between the first and the tenth applicant, from twenty-two applications
to thirty-nine.
– In 2006 the were two applicants with the same number of applications in the tenth
place of area C09D. The second firm with five applications is Nippon Kayaku Kabushiki
Kaisha, from Japan.
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Table B.5: Top applicants on the IPC-C09B in Germany
1990 2006
CH Ciba-Geigy AG 45 CH Ciba Holding Inc. 23
DE Basf AG 38 BE Agfa Graphics NV 16
DE Bayer AG 30 DE Basf SE 13
DE Hoechst AG 26 DE Clariant Produkte GmbH 13
US Eastman Kodak Company 10 JP FUJIFILM Corporation 12
JP Canon Kabushiki Kaisha 6 DE
DyStar Textilfarben GmbH & Co Deutschland
KG
11
JP Sumitomo Chemical Company Ltd 6 GB FUJIFILM Imaging Colorants Ltd 10
GB Zeneca Limited 6 CH Clariant International Ltd 7
JP Fuji Photo Film Co Ltd 5 CH Huntsman Advanced Materials GmbH 6
US
Minnesota Mining and Manufacturing Com-
pany (3M)
5 DE Lanxess Deutschland GmbH 5
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Table B.6: Top applicants on the IPC-C09D in Germany
1990 2006
DE Bayer AG 38 DE Basf SE 58
US Dow Corning Corporation 26 US E.I. Du Pont de Nemours and Company 57
CH Ciba-Geigy AG 22 JP FUJIFILM Corporation 42
JP Nippon Paint Co Ltd 21 BE Agfa Graphics NV 32
DE Basf AG 20 US PPG Industries Ohio Inc 27
DE Basf Lacke + Farben AG 20 DE Bayer MaterialScience AG 25
US
Minnesota Mining and Manfacturing Com-
pany (3M)
19 US Hewlett-Packard Development Company LP 25
DE Hoechst AG 18 US Rohm and Haas Company 22
US Basf Corporation 18 CH Ciba Holding Inc 20
US Rohm and Haas Company 16 DE Basf Coatings AG 19
Total 218 327
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Appendix C
Chapter 5: Regressions Results
C.1 Evolution of patenting activity
Table C.1: IPC-A01N: Modeling patents by OLS
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 801.102 52.45 15.3 0.0000 0.9472 F(3,13) = 2.352 (0.120)
Trend -1.16832 10.89 -0.107 0.9162 0.0009 mean(patents): 855.941
d_1 108.999 82.82 1.32 0.2109 0.1176 var(patents): 7059.23
d_2 114.257 134.2 0.851 0.4101 0.0528 R2: 0.351784
Test for excluding:
(0) = d_1
(1) = d_2
F(2,13) = 1.0545 (0.3764)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 717.654 56.25 12.8 0.0000 0.9313 F(3,12) = 3.931 (0.036)
Trend 14.5263 9.977 1.46 0.1711 0.1501 mean(patents): 850.688
d_1 8.62657 75.29 0.115 0.9107 0.0011 var(patents): 7031.21
d_2 -43.7419 119.6 -0.366 0.7208 0.0110 R2: 0.495675
Test for excluding:
(0) = d_1
(1) = d_2
F(2,12) = 0.43780 (0.6554)
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Table C.2: IPC-A01N: Modeling patents by OLS (spline)
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 828.922 48.52 17.1 0.0000 0.9574 F(3,13) = 2.911 (0.075)
Trend (T) -4.41903 8.194 -0.539 0.5988 0.0219 mean(patents): 855.941
d_1 T 27.2458 15.30 1.78 0.0984 0.1960 var(patents): 7059.23
d_2 T 56.3275 33.83 1.66 0.1198 0.1758 R2: 0.401809
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,13) = 1.6862 (0.2233)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 772.038 47.32 16.3 0.0000 0.9569 F(3,12) = 3.85 (0.038)
T 5.79794 8.453 0.686 0.5058 0.0377 mean(patents): 850.688
d_1 T 11.8164 15.55 0.760 0.4621 0.0459 var(patents): 7031.21
d_2 T 36.9543 43.42 0.851 0.4113 0.0569 R2: 0.49047
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,12) = 0.37204 (0.6970)
Table C.3: IPC-C08F: Modeling patents by OLS
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 1263.83 59.21 21.3 0.0000 0.9723 F(3,13) = 7.27 (0.004)
Trend -15.3861 12.29 -1.25 0.233 0.1076 mean(patents): 1236.59
d_1 255.058 93.49 2.73 0.017 0.3641 var(patents): 15614.7
d_2 90.1549 151.5 0.595 0.562 0.0265 R2: 0.626549
Test for excluding:
(0) = d_1
(1) = d_2
F(2,13) = 10.474 (0.0020)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 1223.02 82.43 14.8 0.0000 0.9483 F(3,12) = 4.296 (0.028)
Trend -4.74737 14.62 -0.325 0.751 0.0087 mean(patents): 1229.75
d_1 166.072 110.3 1.51 0.158 0.1588 var(patents): 15795.7
d_2 -55.7313 175.2 -0.318 0.756 0.0084 R2: 0.517863
Test for excluding:
(0) = d_1
(1) = d_2
F(2,12) = 6.3720 (0.0130)
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Table C.4: IPC-C08F: Modeling patents by OLS (spline)
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 1222.50 69.10 17.7 0.0000 0.9601 F(3,13) = 3.567 (0.044)
Trend (T) 1.38619 11.67 0.119 0.907 0.0011 mean(patents): 1236.59
d_1 T 24.4466 21.79 1.12 0.282 0.0882 var(patents): 15614.7
d_2 T -48.5921 48.18 -1.01 0.332 0.0726 R2: 0.451502
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,13) = 5.0570 (0.0237)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 1159.26 79.87 14.5 0.0000 0.9461 F(3,12) = 2.191 (0.142)
T 15.6077 14.27 1.09 0.295 0.0907 mean(patents): 1229.75
d_1 T -9.31881 26.25 -0.355 0.729 0.0104 var(patents): 15795.7
d_2 T -133.175 73.28 -1.82 0.094 0.2158 R2: 0.353854
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,12) = 3.2317 (0.0754)
Table C.5: IPC-C08J: Modeling patents by OLS
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 983.291 30.65 32.1 0.000 0.9875 F(3,13) = 5.374 (0.013)
Trend -11.2871 6.361 -1.77 0.099 0.1950 mean(patents): 948.882
d_1 132.557 48.39 2.74 0.017 0.3659 var(patents): 3500.1
d_2 86.6591 78.45 1.10 0.289 0.0858 R2: 0.553584
Test for excluding:
(0) = d_1
(1) = d_2
F(2,13) = 7.2548 (0.0077)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 966.444 47.83 20.2 0.000 0.9714 F(3,12) = 1.247 (0.336)
Trend -5.83158 8.484 -0.687 0.505 0.0379 mean(patents): 944.313
d_1 74.6195 64.03 1.17 0.266 0.1017 var(patents): 3363.84
d_2 28.1950 101.7 0.277 0.786 0.0064 R2: 0.23765
Test for excluding:
(0) = d_1
(1) = d_2
F(2,12) = 1.7461 (0.2160)
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Table C.6: IPC-C08J: Modeling patents by OLS (spline)
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 988.624 36.26 27.3 0.000 0.9828 F(3,13) = 2.097 (0.150)
Trend (T) -8.65135 6.124 -1.41 0.181 0.1331 mean(patents): 948.882
d_1 T 22.0980 11.44 1.93 0.075 0.2231 var(patents): 3500.1
d_2 T 18.3992 25.28 0.728 0.480 0.0391 R2: 0.32614
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,13) = 2.6122 (0.1113)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 942.964 44.43 21.2 0.000 0.9740 F(3,12) = 0.2592 (0.853)
T 1.39664 7.937 0.176 0.863 0.0026 mean(patents): 944.313
d_1 T -1.64440 14.61 -0.113 0.912 0.0011 var(patents): 3363.84
d_2 T -22.3053 40.77 -0.547 0.594 0.0243 R2: 0.0608526
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,12) = 0.28791 (0.7549)
Table C.7: IPC-C08K: Modeling patents by OLS
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 1049.71 39.48 26.6 0.000 0.9819 F(3,13) = 1.916 (0.177)
Trend -15.8911 8.195 -1.94 0.074 0.2244 mean(patents): 1008.59
d_1 148.483 62.34 2.38 0.033 0.3038 var(patents): 3739.65
d_2 210.355 101.1 2.08 0.058 0.2500 R2: 0.306568
Test for excluding:
(0) = d_1
(1) = d_2
F(2,13) = 2.8362 (0.0950)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 1008.81 39.25 25.7 0.000 0.9822 F(3,12) = 2.426 (0.116)
Trend -8.30526 6.962 -1.19 0.256 0.1060 mean(patents): 1000.19
d_1 111.865 52.54 2.13 0.055 0.2742 var(patents): 2773.65
d_2 151.072 83.43 1.81 0.095 0.2146 R2: 0.377539
Test for excluding:
(0) = d_1
(1) = d_2
F(2,12) = 2.2690 (0.1459)
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Table C.8: IPC-C08K: Modeling patents by OLS (spline)
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 1046.26 40.30 26.0 0.000 0.9811 F(3,13) = 1.229 (0.339)
Trend (T) -10.6060 6.807 -1.56 0.143 0.1574 mean(patents): 1008.59
d_1 T 22.7227 12.71 1.79 0.097 0.1973 var(patents): 3739.65
d_2 T 50.5121 28.10 1.80 0.096 0.1991 R2: 0.220919
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,13) = 1.8098 (0.2026)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 969.616 38.38 25.3 0.000 0.9815 F(3,12) = 0.707 (0.566)
T 3.06006 6.856 0.446 0.663 0.0163 mean(patents): 1000.19
d_1 T 0.887500 12.62 0.0703 0.945 0.0004 var(patents): 2773.65
d_2 T 9.05546 35.21 0.257 0.801 0.0055 R2: 0.15021
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,12) = 0.056950 (0.9449)
Table C.9: IPC-C09B: Modeling patents by OLS
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 326.734 12.41 26.3 0.000 0.9816 F(3,13) = 12.76 (0.000)
Trend -4.50495 2.576 -1.75 0.104 0.1904 mean(patents): 279.882
d_1 -8.43211 19.60 -0.430 0.674 0.0140 var(patents): 1011.16
d_2 -14.1574 31.77 -0.446 0.663 0.0150 R2: 0.746518
Test for excluding:
(0) = d_1
(1) = d_2
F(2,13) = 0.10282 (0.9030)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 327.211 13.65 24.0 0.000 0.9795 F(3,12) = 15.94 (0.000)
Trend -3.64211 2.422 -1.50 0.158 0.1586 mean(patents): 278.5
d_1 -22.6596 18.28 -1.24 0.239 0.1135 var(patents): 1041.88
d_2 -29.9368 29.02 -1.03 0.323 0.0814 R2: 0.799445
Test for excluding:
(0) = d_1
(1) = d_2
F(2,12) = 0.77202 (0.4837)
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Table C.10: IPC-C09B: Modeling patents by OLS (spline)
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 328.840 12.02 27.3 0.000 0.9829 F(3,13) = 12.56 (0.000)
Trend (T) -5.32034 2.031 -2.62 0.021 0.3455 mean(patents): 279.882
d_1 T -0.169248 3.792 -0.0446 0.965 0.0002 var(patents): 1011.16
d_2 T -1.47156 8.384 -0.176 0.863 0.0024 R2: 0.74353
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,13) = 0.02591 (0.9745)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 335.082 11.95 28.0 0.000 0.9850 F(3,12) = 14.24 (0.000)
T -7.28838 2.135 -3.41 0.005 0.4927 mean(patents): 278.5
d_1 T 2.41664 3.928 0.615 0.550 0.0306 var(patents): 1041.88
d_2 T 5.85997 10.96 0.534 0.603 0.0232 R2: 0.780666
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,12) = 0.1922 (0.8276)
Table C.11: IPC-C09D: Modeling patents by OLS
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 836.475 26.71 31.3 0.000 0.9869 F(3,13) = 36 (0.000)
Trend 22.8812 5.543 4.13 0.001 0.5673 mean(patents): 1036.88
d_1 37.7723 42.17 0.896 0.387 0.0581 var(patents): 11042.1
d_2 -80.1337 68.35 -1.17 0.262 0.0956 R2: 0.892559
Test for excluding:
(0) = d_1
(1) = d_2
F(2,13) = 8.4687 (0.0044)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 806.707 32.56 24.8 0.000 0.9808 F(3,12) = 29.34 (0.000)
Trend 30.7158 5.776 5.32 0.000 0.7021 mean(patents): 1047.25
d_1 -39.6050 43.59 -0.909 0.381 0.0644 var(patents): 9904.94
d_2 -194.159 69.22 -2.80 0.016 0.3960 R2: 0.880007
Test for excluding:
(0) = d_1
(1) = d_2
F(2,12) = 8.5377 (0.0049)
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Table C.12: IPC-C09D: Modeling patents by OLS (spline)
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 829.831 29.07 28.5 0.000 0.9843 F(3,13) = 27.24 (0.000)
Trend (T) 25.7199 4.909 5.24 0.000 0.6786 mean(patents): 1036.88
d_1 T -0.0525848 9.168 -0.00574 0.996 0.0000 var(patents): 11042.1
d_2 T -41.4165 20.27 -2.04 0.062 0.2431 R2: 0.862737
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,13) = 5.2165 (0.0217)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 856.194 35.48 24.1 0.000 0.9798 F(3,12) = 15.67 (0.000)
T 25.6325 6.338 4.04 0.002 0.5768 mean(patents): 1047.25
d_1 T -4.75408 11.66 -0.408 0.691 0.0137 var(patents): 9904.94
d_2 T -54.8827 32.56 -1.69 0.118 0.1915 R2: 0.796624
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,12) = 2.5773 (0.1172)
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C.2 Geographic origin of patent applications
Table C.13: IPC-A01N: Modeling patents by OLS
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 42.5983 35.46 1.20 0.251 0.0999 F(3,13) = 10.04 (0.001)
Trend 5.38614 7.359 0.732 0.477 0.0396 mean(dif): 146.529
d_1 107.681 55.99 1.92 0.077 0.2215 var(dif): 6934.96
d_2 74.1665 90.76 0.817 0.429 0.0489 R2: 0.69843
Test for excluding:
(0) = d_1
(1) = d_2
F(2,13) = 3.4217 (0.0640)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 42.1353 38.27 1.10 0.292 0.0918 F(3,12) = 11.29 (0.001)
Trend 7.91579 6.787 1.17 0.266 0.1018 mean(patents): 154.563
d_1 94.8331 51.22 1.85 0.089 0.2222 var(patents): 6271.37
d_2 8.87870 81.34 0.109 0.915 0.0010 R2: 0.738317
Test for excluding:
(0) = d_1
(1) = d_2
F(2,12) = 6.1620 (0.0144)
Table C.14: IPC-A01N: Modeling patents by OLS (spline)
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 25.5645 34.78 0.735 0.475 0.0399 F(3,13) = 9.516 (0.001)
Trend (T) 11.8509 5.874 2.02 0.065 0.2384 mean(dif): 146.529
d_1 T 14.7212 10.97 1.34 0.203 0.1217 var(dif): 6934.96
d_2 T -6.59294 24.25 -0.272 0.790 0.0057 R2: 0.687099
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,13) = 1.6862 (0.2233)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 74.8147 33.21 2.25 0.044 0.2972 F(3,12) = 10.22 (0.001)
T 4.03740 5.932 0.681 0.509 0.0372 mean(dif): 154.563
d_1 T 27.8241 10.92 2.55 0.026 0.3513 var(dif): 6271.37
d_2 T 23.7622 30.47 0.780 0.451 0.0482 R2: 0.718647
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,12) = 5.3117 (0.0223)
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Table C.15: IPC-C08F: Modeling patents by OLS
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 363.239 32.72 11.1 0.000 0.9046 F(3,13) = 3.755 (0.038)
Trend -11.8812 6.791 -1.75 0.104 0.1906 mean(dif): 294.235
d_1 70.8468 51.67 1.37 0.194 0.1264 var(dif): 3324.65
d_2 54.9194 83.75 0.656 0.523 0.0320 R2: 0.464251
Test for excluding:
(0) = d_1
(1) = d_2
F(2,13) = 1.5605 (0.2469)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 42.1353 38.27 1.10 0.292 0.0918 F(3,12) = 11.29 (0.001)
Trend 7.91579 6.787 1.17 0.266 0.1018 mean(dif): 154.563
d_1 94.8331 51.22 1.85 0.089 0.2222 var(dif): 6271.37
d_2 8.87870 81.34 0.109 0.915 0.0010 R2: 0.738317
Test for excluding:
(0) = d_1
(1) = d_2
F(2,12) = 6.1620 (0.0144)
Table C.16: IPC-C08F: Modeling patents by OLS (spline)
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 376.083 30.22 12.4 0.000 0.9226 F(3,13) = 4.462 (0.023)
Trend (T) -13.3516 5.104 -2.62 0.021 0.3449 mean(dif): 294.235
d_1 T 19.3289 9.531 2.03 0.064 0.2403 var(dif): 3324.65
d_2 T 24.5474 21.07 1.17 0.265 0.0945 R2: 0.507318
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,13) = 2.2651 (0.1432)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 7349.612 36.26 9.64 0.000 0.8857 F(3,12) = 1.743 (0.211)
T -9.24042 6.478 -1.43 0.179 0.1450 mean(dif): 288.75
d_1 T 9.85014 11.92 0.826 0.425 0.0538 var(dif): 3020.94
d_2 T 12.6747 33.27 0.381 0.710 0.0119 R2: 0.303553
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,12) = 0.44207 (0.6528)
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Table C.17: IPC-C08J: Modeling patents by OLS
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 304.731 31.15 9.78 0.000 0.8804 F(3,13) = 2.559 (0.100)
Trend -9.86139 6.464 -1.53 0.151 0.1518 mean(dif): 274.882
d_1 106.480 49.18 2.17 0.050 0.2650 var(dif): 2566.69
d_2 90.6202 79.72 1.14 0.276 0.0904 R2: 0.371249
Test for excluding:
(0) = d_1
(1) = d_2
F(2,13) = 3.5460 (0.0590)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 312.113 38.02 8.21 0.000 0.8488 F(3,12) = 2.369 (0.122)
Trend -10.7368 6.744 -1.59 0.137 0.1744 mean(dif): 271.938
d_1 114.361 50.89 2.25 0.044 0.2962 var(dif): 2579.68
d_2 101.010 80.82 1.25 0.235 0.1152 R2: 0.371953
Test for excluding:
(0) = d_1
(1) = d_2
F(2,12) = 3.4886 (0.0639)
Table C.18: IPC-C08J: Modeling patents by OLS (spline)
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 311.017 26.43 11.8 0.000 0.9142 F(3,13) = 4.545 (0.022)
Trend (T) -9.32136 4.463 -2.09 0.057 0.2512 mean(dif): 274.882
d_1 T 26.4190 8.335 3.17 0.007 0.4359 var(dif): 2566.69
d_2 T 25.7083 18.43 1.40 0.186 0.1302 R2: 0.511899
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,13) = 6.4409 (0.0114)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 287.865 35.26 8.16 0.000 0.8474 F(3,12) = 1.188 (0.356)
T -4.63021 6.298 -0.735 0.476 0.0431 mean(dif): 271.938
d_1 T 15.4267 11.59 1.33 0.208 0.1286 var(dif): 2579.68
d_2 T 8.48499 32.35 0.262 0.798 0.0057 R2: 0.228927
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,12) = 1.7286 (0.2189)
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Table C.19: IPC-C08K: Modeling patents by OLS
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 384.103 32.28 11.9 0.000 0.9159 F(3,13) = 2.042 (0.158)
Trend -15.9901 6.700 -2.39 0.033 0.3046 mean(dif): 324.824
d_1 118.793 50.98 2.33 0.037 0.2947 var(dif): 2550.62
d_2 181.493 82.63 2.20 0.047 0.2707 R2: 0.320266
Test for excluding:
(0) = d_1
(1) = d_2
F(2,13) = 2.7698 (0.0995)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 384.090 42.40 9.06 0.000 0.8724 F(3,12) = 1.073 (0.397)
Trend -13.1895 7.521 -1.75 0.105 0.2040 mean(dif): 321.813
d_1 88.7554 56.76 1.56 0.144 0.1693 var(dif): 2555.9
d_2 158.608 90.13 1.76 0.104 0.2051 R2: 0.211552
Test for excluding:
(0) = d_1
(1) = d_2
F(2,12) = 1.5515 (0.2516)
Table C.20: IPC-C08K: Modeling patents by OLS (spline)
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 372.130 34.51 10.8 0.000 0.8995 F(3,13) = 0.8409 (0.495)
Trend (T) -9.05136 5.828 -1.55 0.144 0.1565 mean(dif): 324.824
d_1 T 11.3022 10.88 1.04 0.318 0.0766 var(dif): 2550.62
d_2 T 34.3307 24.06 1.43 0.177 0.1354 R2: 0.162514
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,13) = 1.0237 (0.3865)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 338.882 38.29 8.85 0.000 0.8672 F(3,12) = 0.3591 (0.784)
T -2.21400 6.839 -0.324 0.752 0.0087 mean(dif): 321.813
d_1 T -2.79776 12.58 -0.222 0.828 0.0041 var(dif): 2555.9
d_2 T 14.4567 35.13 0.412 0.688 0.0139 R2: 0.082369
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,12) = 0.48844 (0.6253)
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Table C.21: IPC-C09B: Modeling patents by OLS
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 36.8699 15.50 2.38 0.033 0.3033 F(3,13) = 6.156 (0.008)
Trend -3.39604 3.217 -1.06 0.310 0.0790 mean(dif): 50.5882
d_1 72.1219 24.47 2.95 0.011 0.4005 var(dif): 967.301
d_2 80.0187 39.67 2.02 0.065 0.2384 R2: 0.586898
Test for excluding:
(0) = d_1
(1) = d_2
F(2,13) = 4.9984 (0.0245)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 30.2782 22.76 1.33 0.208 0.1286 F(3,12) = 2.536 (0.106)
Trend 0.315789 4.036 0.0782 0.939 0.0005 mean(dif): 52.75
d_1 40.0902 30.46 1.32 0.213 0.1261 var(dif): 948.313
d_2 23.6692 48.37 0.489 0.633 0.0196 R2: 0.387984
Test for excluding:
(0) = d_1
(1) = d_2
F(2,12) = 1.7085 (0.2224)
Table C.22: IPC-C09B: Modeling patents by OLS (spline)
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 11.2906 18.06 0.625 0.543 0.0292 F(3,13) = 2.831 (0.080)
Trend (T) 4.76507 3.050 1.56 0.142 0.1581 mean(dif): 50.5882
d_1 T 1.76716 5.696 0.310 0.761 0.0073 var(dif): 967.301
d_2 T -9.81055 12.59 -0.779 0.450 0.0446 R2: 0.395111
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,13) = 1.3527 (0.2926)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 16.5194 19.60 0.843 0.416 0.0559 F(3,12) = 2.174 (0.144)
T 4.81645 3.500 1.38 0.194 0.1363 mean(dif): 52.75
d_1 T 0.865679 6.441 0.134 0.895 0.0015 var(dif): 948.313
d_2 T -15.5879 17.98 -0.867 0.403 0.0589 R2: 0.35209
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,12) = 1.2815 (0.3130)
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Table C.23: IPC-C09D: Modeling patents by OLS
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 198.178 28.25 7.02 0.000 0.7910 F(3,13) = 6.126 (0.008)
Trend 3.45545 5.863 0.589 0.566 0.0260 mean(dif): 262.176
d_1 53.3729 44.61 1.20 0.253 0.0992 var(dif): 3204.5
d_2 59.7624 72.31 0.826 0.423 0.0499 R2: 0.585714
Test for excluding:
(0) = d_1
(1) = d_2
F(2,13) = 0.81685 (0.4633)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 184.722 24.54 7.53 0.000 0.8253 F(3,12) = 16.07 (0.000)
Trend 4.08421 4.352 0.938 0.367 0.0684 mean(dif): 263.25
d_1 82.3098 32.85 2.51 0.028 0.3435 var(dif): 3385.19
d_2 47.2642 52.16 0.906 0.383 0.0640 R2: 0.800654
Test for excluding:
(0) = d_1
(1) = d_2
F(2,12) = 6.3212 (0.0133)
Table C.24: IPC-C09D: Modeling patents by OLS (spline)
Sample: 1990 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 184.530 27.19 6.79 0.000 0.7799 F(3,13) = 6.14 (0.008)
Trend (T) 7.74828 4.592 1.69 0.115 0.1797 mean(dif): 262.176
d_1 T 6.72290 8.575 0.784 0.447 0.0451 var(dif): 3204.5
d_2 T -0.667415 18.96 -0.0352 0.972 0.0001 R2: 0.586264
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,13) = 0.82659 (0.4593)
1 year lag Sample: 1991 - 2006
Coefficient Std. Error t-value P > |t| Part. R2
Constant 187.966 23.98 7.84 0.000 0.8366 F(3,12) = 10.71 (0.001)
T 6.40156 4.284 1.49 0.161 0.1569 mean(dif): 263.25
d_1 T 13.8149 7.884 1.75 0.105 0.2037 var(dif): 3385.19
d_2 T 7.30450 22.01 0.332 0.746 0.0091 R2: 0.728101
Test for excluding:
(0) = d_1 T
(1) = d_2 T
F(2,12) = 3.0335 (0.0859)
207

Appendix D
Results from the Pearson’s χ2 test
from Chapter 5
The Pearson’s χ2 test was calculated to help analyze the fourth research question
raised in Chapter 5 on the change in the direction of the innovative activity. Consid-
ering the years of 1990 and 2006 for each regulated area two tests were calculated.
Firstly comparing the number of applications classified under the most expressive
IPC fields and secondly comparing the number of applications classified under high-
lighted technological areas. All tables show the real values, the expected values (in
parenthesis), Pearson’s χ2 number, and respective p-value.
D.1 IPC-A01: Agriculture; forestry; animal husbandry; hunt-
ing; trapping; and fishing
Table D.1: A01N: Results of chi-square test for the main IPC fields
IPC field 1990 2006
A 346 (448.7) 425 (322.3)
B 55 (57.6) 44 (41.4)
C 885 (778.6) 453 (559.4)
D 20 (16.9) 9 (12.1)
G 15 (19.2) 18 (13.8)
df = 4
Pearson χ2 = 94.8
p-value = 0.000
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Table D.2: A01N: Results of chi-square test for Table 5.14
IPC 1990 2006
A61K 120 (222.0) 263 (161.0)
C07C 131 (99.6) 41 (72.4)
C07D 358 (298.0) 156 (216.0)
C07F 54 (34.8) 6 (25.2)
C12N 50 (59.1) 52 (42.9)
df = 4
Pearson χ2 = 192.0
p-value = 0.000
D.2 IPC-C08: Organic macromolecular compounds; their prepa-
ration or chemical working-up; compositions based thereon
Table D.3: C08F: Results of chi-square test for the main IPC fields
IPC field 1990 2006
A 153 (156.0) 105 (102.0)
B 215 (233.0) 171 (153.0)
C 1321 (1319.0) 867 (869.0)
D 65 (55.5) 27 (36.5)
G 180 (163.0) 90 (107.0)
H 49 (57.9) 47 (38.1)
df = 5
Pearson χ2 = 15.6
p-value = 0.008
Table D.4: C08F: Results of chi-square test for Table 5.26
IPC 1990 2006
A61K 57 (57.3) 40 (39.7)
B01J 70 (80.4) 66 (55.6)
C08G 177 (154.0) 83 (106.0)
C08J 106 (119.0) 96 (82.6)
C08L 255 (271.0) 203 (187.0)
C09D 160 (159.0) 109 (110.0)
G02B 48 (42.0) 23 (29.0)
G03F 57 (47.9) 24 (33.1)
df = 7
Pearson χ2 = 24.2
p-value = 0.001
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D.2 IPC-C08: ORGANIC MACROMOLECULAR COMPOUNDS; THEIR
PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS
BASED THEREON
Table D.5: C08J: Results of chi-square test for the main IPC fields
IPC field 1990 2006
A 90 (110.0) 109 (88.5)
B 615 (588.0) 444 (471.0)
C 1096 (1106.0) 896 (886.0)
D 97 (84.9) 56 (68.1)
F 26 (21.1) 12 (16.9)
G 70 (68.3) 53 (54.7)
H 73 (88.8) 87 (71.2)
df = 6
Pearson χ2 = 24.4
p-value = 0.000
Table D.6: C08J: Results of chi-square test for Table 5.28
IPC 1990 2006
B29C 153 (133.0) 89 (109.0)
B32B 101 (120.0) 117 (98.3)
C08F 106 (111.0) 96 (91.1)
C08G 193 (156.0) 91 (128.0)
C08K 177 (187.0) 164 (154.0)
C08L 330 (354.0) 314 (290.0)
df = 5
Pearson χ2 = 38.0
p-value = 0.000
Table D.7: C08K: Results of chi-square test for the main IPC fields
IPC field 1990 2006
A 116 (109.0) 87 (93.9)
B 209 (260.0) 274 (223.0)
C 1612 (1572.0) 1312 (1352.0)
D 56 (55.9) 48 (48.1)
G 65 (69.9) 65 (60.1)
H 132 (124.0) 98 (106.0)
df = 5
Pearson χ2 = 26.5
p-value = 0.000
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Table D.8: C08K: Results of chi-square test for Table 5.30
IPC 1990 2006
B32B 28 (48.9) 64 (43.1)
B60C 16 (43.6) 66 (38.4)
C07D 66 (44.1) 17 (38.9)
C08G 160 (134.0) 92 (118.0)
C08J 177 (202.0) 203 (178.0)
C08L 661 (651.0) 564 (574.0)
C09D 109 (111.0) 100 (97.9)
C09K 86 (68.6) 43 (60.4)
df = 7
Pearson χ2 = 107.0
p-value = 0.000
D.3 IPC-C09: Dyes; paints; polishes; natural resins; adhe-
sives; miscellaneous compositions; miscellaneous applica-
tions of materials
Table D.9: C09B: Results of chi-square test for the main IPC fields
IPC field 1990 2006
A 32 (42.9) 45 (34.1)
B 45 (46.8) 39 (37.2)
C 201 (213.0) 182 (170.0)
D 99 (62.4) 13 (49.6)
G 71 (81.4) 75 (64.6)
H 4 (5.02) 5 (3.98)
df = 5
Pearson χ2 = 59.9
p-value = 0.000
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D.3 IPC-C09: DYES; PAINTS; POLISHES; NATURAL RESINS;
ADHESIVES; MISCELLANEOUS COMPOSITIONS; MISCELLANEOUS
APPLICATIONS OF MATERIALS
Table D.10: C09B: Results of chi-square test for Table 5.40
IPC 1990 2006
A61K 16 (22.3) 23 (16.7)
B41M 33 (26.4) 13 (19.6)
C07C 27 (19.5) 7 (14.5)
C07D 49 (44.1) 28 (32.9)
C09D 26 (57.3) 74 (42.7)
D06P 84 (52.7) 8 (39.3)
G01N 8 (12.6) 14 (9.4)
G02B 4 (16.6) 25 (12.4)
G03G 16 (11.5) 4 (8.5)
df = 8
Pearson χ2 = 130.0
p-value = 0.000
Table D.11: C09D: Results of chi-square test for the main IPC fields
IPC field 1990 2006
A 89 (83.8) 83 (88.2)
B 253 (312.0) 387 (328.0)
C 1111 (1091.0) 1129 (1149.0)
D 48 (43.3) 41 (45.7)
G 98 (93.0) 93 (98.0)
H 97 (73.5) 54 (77.5)
df = 5
Pearson χ2 = 39.0
p-value = 0.000
Table D.12: C09D: Results of chi-square test for Table 5.43
IPC 1990 2006
B05D 77 (74.4) 83 (85.6)
B41J 16 (35.3) 60 (40.7)
B41M 30 (46.9) 71 (54.1)
C08F 160 (129.0) 118 (149.0)
C08G 195 (202.0) 239 (232.0)
C08L 187 (157.0) 151 (181.0)
C09B 26 (46.5) 74 (53.5)
df = 6
Pearson χ2 = 73.0
p-value = 0.000
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Appendix E
Geographic origin of patents applied
by Bayer Group, Basf, 3M, and
DuPont
E.1 Bayer Group
Table E.1: A01N: Origin of patent applications
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
DE 47 77 82 77 96 92 104 71 100 91 80 84 79 92 95 95
FR 1 1 6 8 6 9 14 21 8 16 17 17
JP 2 5 10 6 11 11 4 4 8 6 7 4
US 1 4 3 1 1 1 2 1 6 5
GB 2 3 2 1 1 2
BE 1 1 1 1
CA 1
Total 49 84 95 87 114 109 116 85 110 109 103 111 87 109 119 118
% DE 0.96 0.92 0.86 0.89 0.84 0.84 0.90 0.84 0.91 0.83 0.78 0.76 0.91 0.84 0.80 0.81
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Table E.2: C08F, C08J, and C08K: Origin of patent applications
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
C08F
DE 26 25 24 11 26 30 32 29 50 38 21 18 8 7 4
CA 2 3 7 5 2 1 1 3 3 1 1
US 1 3 1 4 3 2 1 5 1
BE 1 2 2 1
Total 30 28 33 19 31 31 34 33 56 40 25 19 9 7 9 1
% DE 0.87 0.89 0.73 0.58 0.84 0.97 0.94 0.88 0.89 0.95 0.84 0.95 0.89 1.00 0.44
C08J
DE 29 27 34 31 40 15 30 20 25 38 18 7 10 7 11 8
US 3 2 3 2 5 2 1 1 3 4 4 2
BE 3 1 5
CA 1 1 2 2 1 2
JP 1 1 2 1
Total 29 32 35 33 43 21 34 28 29 46 19 7 13 11 15 10
% DE 1.00 0.84 0.97 0.94 0.93 0.71 0.88 0.71 0.86 0.83 0.95 1.00 0.77 0.64 0.73 0.80
C08K
DE 32 37 35 25 40 28 28 35 40 38 32 21 17 8 11 11
US 3 2 2 5 2 4 8 4 6 2 1 2 3
CA 3 1 1 2 4 2 1 1
BE 1 1 2
JP 1 1
Total 33 43 40 29 46 30 33 45 48 46 35 21 18 9 13 14
% DE 0.97 0.86 0.88 0.86 0.87 0.93 0.85 0.78 0.83 0.83 0.91 1.00 0.94 0.89 0.85 0.79
Table E.3: C09B and C09D: Origin of patent applications
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
C09B
DE 18 32 28 23 22 17 18 7 9 8 1 2 2
US 8 1 2 5 4 4 2 1
Total 18 40 29 25 27 17 22 11 11 9 1 2 2
% DE 1.00 0.80 0.97 0.92 0.81 1.00 0.82 0.64 0.82 0.89 1.00 1.00 1.00
C09D
DE 25 39 49 34 54 32 43 32 46 29 28 30 29 26 27 22
US 4 1 4 6 4 7 10 9 4 2 3 12 14 11
CA 1 1 2 1
BE 1
Total 25 45 50 38 60 36 50 43 57 34 30 30 32 38 41 33
% DE 1.00 0.87 0.98 0.89 0.90 0.89 0.86 0.74 0.81 0.85 0.93 1.00 0.91 0.68 0.66 0.67
.
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E.2 BASF
E.2 Basf
Table E.4: A01N: Origin of patent applications
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
DE 59 43 41 49 60 86 83 100 73 59 47 51 61 80 85 110
US 1 1 1 2 1 2 1 2 2 3 2 1 1 2
FR 1
CH 3 1 1 2 1 1
NL 1
Total 61 44 42 51 61 91 84 103 76 64 50 52 63 80 86 112
Table E.5: C08F, C08J, and C08K: Origin of patent applications
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
C08F
DE 74 84 100 86 86 93 135 70 101 83 89 65 62 73 59 96
US 2 4 4 1 4 4 6 2 3 5 2 2 3
BR 1
JP 1 2 1 2 1
Total 74 87 105 88 91 96 135 74 105 89 91 68 67 75 61 100
% DE 1.00 0.97 0.95 0.98 0.95 0.97 1.00 0.95 0.96 0.93 0.98 0.96 0.93 0.97 0.97 0.96
C08J
DE 23 36 35 26 50 50 67 37 52 30 35 25 28 35 45 70
US 3 3 3 1 2 3 1 1 3 2 4 3 2
FR 1
JP 1 2 2 2
Total 27 39 38 27 53 54 67 40 53 31 38 27 28 39 48 74
% DE 0.85 0.92 0.92 0.96 0.94 0.93 1.00 0.93 0.98 0.97 0.92 0.93 1.00 0.90 0.94 0.95
C08K
DE 35 39 29 33 39 31 44 22 34 35 26 31 21 14 28 35
US 2 7 4 1 2 1 1 2 3 1 3 1 1
JP 1 2
Total 35 41 37 39 39 32 46 23 35 37 26 34 22 17 29 36
% DE 1.00 0.95 0.78 0.85 1.00 0.97 0.96 0.96 0.97 0.95 1.00 0.91 0.95 0.82 0.97 0.97
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Table E.6: C09B and C09D: Origin of patent applications
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
C09B
DE 35 32 51 35 36 22 27 17 15 8 14 13 15 11 15 13
US 1 1 1 2 1 1
FR 1
JP 1
Total 37 32 52 36 36 22 27 17 15 9 16 14 16 11 15 13
C09D
DE 42 41 51 58 54 64 64 53 63 81 71 65 48 40 42 72
US 7 11 20 22 17 15 9 14 24 18 21 28 16 7 8 9
JP 1 2 1 1 1 2 1 3 8
Total 49 52 72 82 72 80 74 67 89 99 93 93 64 47 53 89
% DE 0.86 0.79 0.71 0.71 0.75 0.80 0.86 0.79 0.71 0.82 0.76 0.70 0.75 0.85 0.79 0.81
% US 0.14 0.21 0.28 0.27 0.24 0.19 0.12 0.21 0.27 0.18 0.23 0.30 0.25 0.15 0.15 0.10
E.3 3M
Table E.7: C08F, C08J, and C08K: Origin of patent applications
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
C08F
US 24 37 26 41 29 35 31 20 30 32 34 30 39 29 23 17
DE 1 2 1 1
Total 24 37 26 41 30 35 31 22 30 33 34 30 40 29 23 17
C08J
US 8 25 22 31 19 16 27 20 28 23 19 25 13 30 22 17
C08K
US 9 17 16 14 12 20 11 13 15 13 9 25 15 12 27 20
DE 1 1 1 2 1
Total 9 17 16 14 12 20 12 13 16 13 9 26 17 12 28 20
Table E.8: C09B and C09D: Origin of patent applications
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
C09B
US 3 6 6 6 8 7 3 1 2 2 1
C09D
US 17 18 26 28 28 38 29 20 31 18 17 23 21 19 23 14
DE 1 1
Total 17 18 26 28 28 38 29 21 31 18 17 24 21 19 23 14
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E.4 DuPont
Table E.9: A01N: Origin of patent applications
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
US 18 14 23 12 6 16 12 10 2 7 16 15 9 17 16
Table E.10: C08F, C08J, and C08K: Origin of patent applications
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
C08F
US 21 16 29 19 25 47 41 43 56 49 37 30 27 15 25 36
JP 1 1 2
GB 1
CA 1 1
DE 2
Total 22 16 29 20 25 49 41 43 56 49 38 30 27 15 25 36
C08J
US 49 43 31 40 29 28 46 22 24 22 16 24 21 21 34 37
JP 1 3 4 2 4 4 8 5
CA 1 2 2
CH 1
DE 1
Total 50 45 31 42 28 28 46 22 26 25 20 26 25 25 42 41
C08K
US 25 29 20 23 22 31 27 28 28 22 21 14 36 32 40 35
JP 1 2 1 2 2 1 2 4
GB 1
CA 1 1 1 1
DE 1 1
Total 26 30 20 24 25 31 27 29 28 24 21 16 38 33 41 39
Table E.11: C09D: Origin of patent applications
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
US 21 20 27 22 32 44 49 54 44 41 33 29 41 65 66 63
JP 1 2 2 2 1 2 2 1
DE 1 2
CH 1 1
FR 2
CA 1
SE 1
ES 1
Total 21 21 27 23 34 45 49 56 46 43 33 29 42 67 69 66
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Appendix F
Bayer Group, BASF, DuPont, and
3M: Patent profile of regulated areas
Only technological areas with share summing at least one percent, in 1991 or 2006,
are illustrated.
F.1 Bayer Group
Table F.1: A01N: Patent application profile by Bayer Group in Germany
A01K A01M A61K A61P B01J C05G C07B C07C C07D C07F C12N
1991 1.1% 1.1% 3.4% 1.2% 1.2% – 1.2% 13.0% 71.3% 5.6% –
2006 – – 4.5% 3.6% 1.8% 2.4% – 11.8% 69.1% – 1.8%
Table F.2: C08F, C08J, and C08K: Patent application profile by Bayer Group in Germany
C08F
A61K B01D B01J B05D C07B C07C C07D C07F C08C C08G C08J C08K C08L C09D C09K D21H
1991 7.7% 3.3% 10.0% 1.4% 3.5% 6.2% 1.4% 4.6% 12.3% 8.0% 6.2% 1.7% 12.8% 6.4% 1.9% 8.3%
C08J
A47C B05D B29C B29K B68G C08F C08G C08K C08L C09B C09D C09K
1991 1.2% 1.3% 3.0% 3.7% 1.2% 5.7% 25.5% 11.9% 26.9% 1.9% 4.1% 2.2%
B29C B32B C08G C08K C08L C09D C14C D06M G02B G02F G05B
2006 10.0% 3.3% 33.7% 13.7% 19.7% 8.7% 2.0% 2.0% 2.5% 2.5% 2.5%
C08K
A61K C01G C07D C08F C08G C08J C08L C09B C09C C09D C09J C09K D06P H05K
1991 1.5% 1.0% 1.0% 1.4% 6.8% 10.1% 57.7% 2.6% 1.0% 7.3% 1.0% 1.4% 1.0% 3.0%
A01N A01P A61L B32B C08G C08J C08L C09D C14C D06M
2006 2.4% 2.4% 14.3% 16.7% 13.3% 9.8% 31.0% 7.4% 1.4% 1.4%
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Table F.3: C09B and C09D: Patent application profile by Bayer Group in Germany
C09B
B01F B01J C07B C07C C07D C08G C08J C08K C08L C09D C09K C11D C14C D06L D06M D06P D21H G02B G02F
1991 1.0% 4.4% 1.1% 4.4% 13.9%1.0% 3.6% 5.8% 3.2% 1.7% 2.3% 1.1% 1.0% 1.1% 2.1% 48.2%1.7% 1.3% 1.3%
C09D
B05D C01G C04B C07D C08F C08G C08J C08K C08L C09B C09C C09J C09K C23C D06N D06P D21H G12B H05K
1991 6.1% 1.3% 1.0% 7.0% 6.6% 33.6%4.6% 9.7% 13.1%1.0% 1.3% 3.3% 2.0% 1.0% 1.3% 1.0% 2.3% 1.0% 1.0%
C07C C08G C08J C08K C08L C09J
2006 1.6% 85.5%2.7% 3.2% 4.2% 1.6%
.
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Table F.4: A01N: Patent application profile by BASF in Germany
A01C A01H A01K A23L A61K B01J B27K B65D C04B C07C C07D C07F C07K C08G C08L C12N C23C
1991 1.7% <1% 1.7% 21.6% 70.4% <1% 2.6%
2006 8.2% 1.5% 1.5% 2.1% 1.8% 1.8% 1.8% 10.0% 58.5% 2.4% 1.2% 1.5% 1.8% 3.9%
Table F.5: C08F, C08J, and C08K: Patent application profile by BASF in Germany
C08F 1991 2006 C08J 1991 2006 C08K 1991 2006
A 4.8% 22.0% A 11.6% A 7.6%
A61K 3.3% 12.0% A61F 2.5% A61K 1.0%
A61L 7.3% A61L 7.9% A61L 5.6%
A61Q 1.5% 2.7% A61Q 1.0%
B 12.5% 12.6% B 22.3% 18.2% B 1.4% 2.5%
B01D 2.9% B01D 1.0% <1% B01J 2.5%
B01F 2.1% B01F 1.0% 3.1% B22F 1.4%
B01J 5.7% 5.4% B01J 1.8% 1.1%
B05D 4.5% B05D <1% 3.1%
B29B 1.4% B29B <1% 3.0%
B29C 6.3% 2.5%
B29K 6.3%
B29L 2.6%
B32B 1.0% 4.1%
C 77.2% 60.3% C 67.9% 55.8% C 94.1% 87.4%
C04B 1.8% 1.3% C04B 3.0% C01B 2.5%
C07C 4.2% 2.5% C08B 2.8% C01G 1.4%
C07F 1.8% 2.0% C08F 8.1% 5.4% C04B 2.1%
C08C 1.8% 1.3% C08G 16.9% 7.5% C07F 3.6%
C08G 7.5% 4.8% C08K 14.1% 10.0% C08F 16.4% 10.5%
C08J 3.6% 3.8% C08L 14.9% 12.5% C08G 12.9% 3.0%
C08K 10.3% 4.6% C09B 4.0% C08J 10.1% 16.0%
C08L 21.9% 9.4% C09D 5.8% 12.5% C08L 39.9% 33.2%
C09D 8.9% 16.6% C09J 1.0% <1% C09B 4.5%
C09J 5.2% 2.6% C11D 3.8% C09C 1.4% 2.5%
C09K 1.2% C09D 3.9% 14.5%
C10L <1% 2.0% C09J 1.9%
C10M <1% 1.3%
C11D 5.4% <1%
C12N 1.3%
C14C 1.7%
C23C 1.3%
C23F 1.6%
D 2.4% 4.3% D 3.9% 5.7% D 3.0%
D06M 1.8% <1% D01D 1.0% D01F 1.0%
D21H 4.0% D06M <1% 2.8% D06N 1.5%
D06N 2.1% 1.9%
E <1% E 2.0%
E04F 2.0%
F <1% F 3.0% 2.0% F 1.4%
F16F 2.0% <1% F16F 1.4%
F16H 1.0%
F26B 1.1%
G 1.9% G <1%
G03F 1.5%
H <1% H <1% 6.3% H 2.5%
H01M 6.3% H01B 1.5%
H01M 1.0%
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Table F.6: C09B and C09D: Patent application profile by BASF in Germany
C09B
A23L A61K B01F B41M C07C C07D C07F C08J C08K C08L C09C C09D D06M D06P D21H G01D G02B G03F G11B
1991 1.5% 25.0% 8.1% 10.2% 3.2% <1% 1.5% 4.7% <1% 34.5% 2.7% 1.1% 1.1% 3.5%
2006 4.2% 4.2% 8.3% 29.2% 4.2% 18.8% 6.3% 12.5% 12.5%
C09D
B05D B27K C04B C08F C08G C08J C08K C08L C09B C09C C09J C09K C25D D06M G03F G11B H01B H01F H05K
1991 15.2% 4.4% 5.0% 11.1% 21.1% 3.2% 3.0% 10.8% 3.2% 4.3% 2.0% 1.5% 1.1% <1% 1.1% 4.4% 1.1% 2.2% 1.1%
A61L B05D B27K B27N B32B C04B C08F C08G C08J C08K C08L C09C C09J C23C C23F D06M H05B
2006 1.2% 3.3% 1.4% 1.4% 2.4% 1.2% 18.1% 28.6% 9.6% 6.9% 6.3% 2.2% 1.6% 3.1% 4.1% 1.8% <1%
Table F.7: C09B and C09D: Patent application profile by BASF in Germany
C09B
A B C D G H
1991 26.5% 29.2% 37.8% 5.6% 0.8%
2006 8.3% 66.7% 12.5% 12.5%
C09D
A B C D G H
1991 20.6% 67.0% 1.8% 6.1% 4.4%
2006 1.6% 10.5% 85.2% 1.8% 0.2% 0.7%
.
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Table F.8: A01N: Patent application profile – and respective definitions – by DuPont in
Germany
IPC 1991 2006 Definition
A – 8.3%
A61K – 5.0% Preparations for medical, dental, or toilet purposes
A61Q – 3.3% Use of cosmetics or similar toilet preparations (IPC)
B – 30.0%
B27K – 30.0%
Processes, apparatus or selection of substances for impregnating, staining, dyeing, bleaching of
wood or similar materials, or treating of of wood or similar materials with permeant liquids,
not otherwise provided for (applying liquids or other fluent materials to surfaces in general B05;
coating wood or similar material B44D); chemical or physical treatment of cork, cane, reed, straw
or similar materials
C 100.0% 61.7%
C07C 15.5% 3.3% Acyclic or carbocyclic compounds
C07D 69.0% 48.3%
Coating compositions (e.g. paints, varnishes, lacquers; filling pastes; chemical paint or ink re-
movers; inks; correcting fluids; wood stains; pastes or solids for coloring or printing; use of mate-
rials therefor)
C07F 8.3% –
Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen,
halogen, oxygen, nitrogen, sulfur, selenium, or tellurium
C07K 5.0% Peptides
C12N – 5.0%
Micro-organisms or enzymes; compositions thereof; propagating, preserving, or maintaining micro-
organisms; mutation or genetic engineering; culture media
C12Q 7.1%
Measuring or testing processes involving enzymes or micro-organisms (immunoassay G01N 33/53);
compositions or test papers therefor; processes of preparing such compositions; condition-response
control in microbiological or enzymological processes
Table F.9: C08F, C08J, and C08K: Patent application profile by DuPont in Germany
C08F 1991 2006 C08J 1991 2006 C08K 1991 2006
A A 2.5% 4.6% A 1.5%
A41D 3.2% A47J 1.0%
A62D <1% 1.4%
B 10.8% 7.4% B 21.4% 14.5% B 5.8% 15.7%
B05D 2.2% 5.1% B01D 1.0% B05D 2.5%
B29C 7.6% B27J 1.0% B29C 2.9%
B32B 1.0% 2.2% B29B 1.0% B29K 1.9%
B29C 6.4% 2.0% B29L 1.0%
B29K 1.9% B32B 10.8%
B29L 1.4%
B32B 4.9% 11.1%
B65D 1.3% <1%
C 68.5% 76.0% C 57.3% 66.1% C 76.2% 58.3%
C07C 13.6% 3.8% C03C 1.8% C03C 3.2%
C07D 3.6% 1.9% C07C 5.3% C07D 3.2% 1.0%
C07F – 1.9% C07K 1.0% C08F 6.1% 2.4%
C08C 3.3% – C08F 1.5% 7.7% C08G 11.0% <1%
C08G 6.9% 6.7% C08G 11.1% 4.3% C08J 10.4% 9.9%
C08J 4.7% 10.9% C08K 5.6% 9.3% C08L 36.0% 28.9%
C08K 10.6% 3.2% C08L 11.8% 25.2% C09B 1.3%
C08L 17.1% 26.6% C09D 1.5% 7.7% C09C 4.4%
C09D 5.6% 19.9% C09K 8.0% 9.5% C09D 3.2% 6.0%
C09J 3.3% 1.0% C10G 1.0% C09J 1.9% <1%
C11D 4.4% C09K 2.7%
C12N 1.0%
C23G 1.8%
D 3.8% 7.7% D 10.5% 3.2% D 9.6% 4.1%
D01D 1.0% D01D 1.9% D01F 9.6% 2.9%
D01F 1.0% D01F 3.5% <1% D06M 1.3%
D04H 1.0% D04H 4.6%
D06M 7.7% D06M <1% 1.2%
E E E 1.4%
E04C 1.4%
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C08F 1991 2006 C08J 1991 2006 C08K 1991 2006
F F 1.2% F 1.3%
F41H 1.2% F41H 1.3%
G 8.6% 1.0% G 2.5% 2.0% G 1.9% 1.7%
G02F 1.3% G11B 1.4% G01N 1.0%
G03F 7.2% 1.0% G03F 1.0%
H 8.3% 8.0% H 5.8% 8.3% H 6.5% 16.0%
H01B 2.2% 3.8% H01B 1.6% 2.7% H01B 3.2%
H01L 3.9% H01L 2.7% H01G 5.7%
H01M 4.2% H01M 1.6% H01L 2.9% 2.9%
H05K 2.2% H05K 4.2% 1.4% H01M 1.7%
H05B 1.4%
H05K <1% 4.3%
Table F.10: C09D: Patent application profile by DuPont in Germany
A B C D G H
1991 2.1% 17.7% 67.7% – – 12.5%
2006 <1% 17.7% 75.2% 4.3% 2.1% –
Table F.11: C09D: Patent application profile by DuPont in Germany
A47J B01J B05D B32B B65D C08F C08G C08J C08K C08L C23C H01B
1991 2.1% 1.3% 8.5% 6.7% 1.3% 5.2% 24.4% 4.6% 5.2% 27.1% 1.3% 12.5%
A47J B01J B05B B05D B32B C03C C07D C07F C08F C08G C08J C08K C08L C09B C09J C10M D06P G02B
2006 <1% 1.1% 2.1% 11.0% 2.4% 1.7% 1.1% 1.1% 11.0% 32.3% 6.0% 4.5% 9.9% 1.0% 4.3% 1.1% 4.3% 2.1%
.
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Table F.12: C08F, C08J, and C08K: Patent application profile by 3M in Germany
C08F 1991 2006 C08J 1991 2006 C08K 1991 2006
A 2.0% 5.6% A 2.9% A 3.4% 5.6%
A61K <1% 5.6% A23L 1.0% A61K 3.4% 5.6%
A61K 1.0%
A61M 1.0%
B 13.8% 5.6% B 35.0% 29.5% B 5.6% 5.1%
B01J 1.4% 5.6% B01D 5.1% 7.7% B29C 3.2%
B32B 4.9% B01J 5.1% 3.1% B32B 2.8%
B41M 3.8% B05D 2.6% B41M 2.8%
B05D 4.5% B24D 3.1% B65D 1.9%
B29C 6.4%
B32B 13.5% 10.3%
B41M 7.2%
B65D 1.0% 2.6%
C 69.1% 77.8% C 41.3% 50.0% C 88.2% 81.9%
C07C 4.3% C04B 1.0% C01G 8.3%
C07D 4.2% C08F 3.1% 15.4% C07C 2.8%
C07F 2.7% C08G 3.1% 5.8% C07D 2.8%
C07K 1.4% C08K 6.3% 18.6% C07F 6.2%
C08C 4.2% C08L 12.5% 6.4% C08F 9.9% 1.1%
C08G 13.8% 18.9% C09D 7.2% C08G 9.0% 5.3%
C08J 1.0% 22.2% C09K 6.3% C08J 5.6% 13.4%
C08K 3.7% 2.2% C12N 1.0% C08L 20.1% 33.8%
C08L 6.8% 16.7% C23C 3.8% C09C 8.3%
C09D 8.6% 7.8% C25D 1.0% C09D 9.0% 6.7%
C09J 14.1% 5.6% C09J 22.9%
C09K 2.9% 2.2% C09K 1.1%
C11D 2.2% C11D 1.1%
C12N 1.4% C25B 2.8%
D <1% D D
F 1.4% F F
F16F 1.4%
G 10.8% 11.1% G 10.4% 6.4% G 2.8% 6.0%
G01N 2.8% 11.1% G01N 4.2% G02B 3.2%
G03F 2.8% G02B 4.5% G02F 2.8%
G11B 4.5% G02F 1.9% G11B 2.8%
G03C 3.1%
G11B 3.1%
H 2.1% H 10.3% 14.1% H 1.4%
H01L 2.1% H01B 6.3% 3.8% H01J 1.4%
H01L 2.6%
H01M 1.0% 7.7%
H02G 3.1%
Table F.13: C09D: Patent application profile by 3M in Germany
A B C G H
1991 3.2% 12.6% 75.0% 8.8% <1%
2006 9.1% 87.9% 3.0%
Table F.14: C09D: Patent application profile by 3M in Germany
A61K B05D B32B B41M C07D C07F C08F C08G C08J C08K C08L C09G C09J C09K C11D G03F G11B H05B
1991 2.3% 2.0% 5.4% 3.9% 2.0% 1.8% 12.1% 14.1% 3.4% 4.8% 9.2% 2.9% 18.5% 2.0% 2.9% 3.9% 4.9%
2006 9.1% 6.4% 35.2% 10.9% 16.7% 12.1% 4.8% 1.8% 3.0%
227

Appendix G
Results from the Pearson’s χ2 test
from Chapter 6
G.1 Bayer Group
Table G.1: Results of chi-square test for the main IPC fields
IPC field 1991 2006
A 132.0 (274.0) 452.0 (310.0)
B 95.0 (60.9) 35.0 (69.1)
C 545.0 (438.0) 390.0 (497.0)
D 28.0 (14.1) 2.0 (15.9)
E 0.0 (1.41) 3.0 (1.59)
F 4.0 (5.62) 8.0 (6.38)
G 30.0 (44.1) 64.0 (49.9)
H 11.0 (7.03) 4.0 (7.97)
df = 7
Pearson χ2 = 265.0
p-value = 0.000
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G.1.1 IPC-A01: Agriculture; forestry; animal husbandry; hunting; trap-
ping; and fishing
Table G.2: A01N: Results of chi-square test for Table 6.8
IPC field 1991 2006
A61K 4.0 (3.53) 3.0 (3.47)
A61P 2.0 (2.52) 3.0 (2.48)
C05G 0.0 (1.01) 2.0 (0.99)
C07C 11.0 (10.6) 10.0 (10.4)
C07D 40.0 (41.3) 42.0 (40.7)
C07F 5.0 (2.52) 0.0 (2.48)
C12N 0.0 (0.504) 1.0 (0.496)
df = 6
Pearson χ2 = 8.43
p-value = 0.208
G.1.2 IPC-C08: Organic macromolecular compounds; their preparation
or chemical working-up; compositions based thereon
Table G.3: C08J and C08K: Results of chi-square test for Table 6.11
IPC field 1991 2006
C08J
B29C 2.0 (2.17) 1.0 (0.833)
C08G 13.0 (13.7) 6.0 (5.28)
C08K 9.0 (9.39) 4.0 (3.61)
C08L 15.0 (13.7) 4.0 (5.28)
df = 3
Pearson χ2 = 0.669
p-value = 0.880
C08K
A61L 0.0 (1.46) 2.0 (0.538)
B32B 0.0 (2.19) 3.0 (0.808)
C08J 9.0 (9.50) 4.0 (3.50)
C08L 29.0 (24.8) 5.0 (9.15)
df = 3
Pearson χ2 = 16.2
p-value = 0.001
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G.1.3 IPC-C09: Dyes; paints; polishes; natural resins; adhesives; miscel-
laneous compositions; miscellaneous applications of materials
Table G.4: C09D: Results of chi-square test for Table 6.13
IPC field 1991 2006
C08G 16.0 (19.3) 31.0 (27.7)
C08L 7.0 (3.70) 2.0 (5.30)
df = 1
Pearson χ2 = 5.97
p-value = 0.015
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Table G.5: Results of chi-square test for the main IPC fields
IPC field 1991 2006
A 114.0 (161.0) 286.0 (239.0)
B 137.0 (138.0) 206.0 (205.0)
C 667.0 (644.0) 936.0 (959.0)
D 49.0 (32.1) 31.0 (47.9)
E 1.0 (2.81) 6.0 (4.19)
F 11.0 (13.3) 22.0 (19.7)
G 44.0 (24.9) 18.0 (37.1)
H 10.0 (17.3) 33.0 (25.7)
df = 7
Pearson χ2 = 71.0
p-value = 0.000
G.2.1 IPC-A01: Agriculture; forestry; animal husbandry; hunting; trap-
ping; and fishing
Table G.6: A01N: Results of chi-square test for Table 6.19
IPC field 1991 2006
A01C 0.0 (2.78) 5.0 (2.22)
C07C 20.0 (15.0) 7.0 (12.0)
C07D 48.0 (46.2) 35.0 (36.8)
C07F 1.0 (1.67) 2.0 (1.33)
C12N 0.0 (1.67) 3.0 (1.33)
C23C 0.0 (1.67) 3.0 (1.33)
df = 5
Pearson χ2 = 18.3
p-value = 0.003
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G.2.2 IPC-C08: Organic macromolecular compounds; their preparation
or chemical working-up; compositions based thereon
Table G.7: C08F, C08J, and C08K: Results of chi-square test for Table 6.22
IPC field 1991 2006
C08F
A61K 3.0 (6.20) 11.0 (7.80)
A61L 0.0 (3.99) 9.0 (5.01)
B01J 5.0 (5.31) 7.0 (6.69)
C08G 11.0 (7.53) 6.0 (9.47)
C08K 13.0 (9.74) 9.0 (12.3)
C08L 18.0 (14.2) 14.0 (17.8)
C09D 12.0 (15.1) 22.0 (18.9)
df = 6
Pearson χ2 = 17.9
p-value = 0.006
C08J
A61L 0.0 (3.71) 8.0 (4.29)
B29C 6.0 (3.71) 2.0 (4.29)
B29K 6.0 (2.78) 0.0 (3.22)
C08F 6.0 (6.49) 8.0 (7.51)
C08G 8.0 (6.95) 7.0 (8.05)
C08K 10.0 (8.81) 9.0 (10.2)
C08L 12.0 (11.1) 12.0 (12.9)
C09D 3.0 (7.42) 13.0 (8.58)
df = 7
Pearson χ2 = 22.2
p-value = 0.002
C08K
A61L 0.0 (1.68) 3.0 (1.32)
C08F 13.0 (12.3) 9.0 (9.69)
C08G 12.0 (7.83) 2.0 (6.17)
C08J 10.0 (10.6) 9.0 (8.37)
C08L 26.0 (25.2) 19.0 (19.8)
C09D 5.0 (8.39) 10.0 (6.61)
df = 5
Pearson χ2 = 12.2
p-value = 0.032
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G.2.3 IPC-C09: Dyes; paints; polishes; natural resins; adhesives; miscel-
laneous compositions; miscellaneous applications of materials
Table G.8: C09B and C09D: Results of chi-square test for Table 6.24
IPC field 1991 2006
C09B
A23L 0.0 (0.810) 1.0 (0.190)
A61K 0.0 (0.810) 1.0 (0.190)
B41M 16.0 (13.0) 0.0 (3.03)
C07C 3.0 (4.05) 2.0 (0.948)
C07D 5.0 (6.48) 3.0 (1.52)
C08K 0.0 (1.62) 2.0 (0.379)
C08L 1.0 (1.62) 1.0 (0.379)
C09D 3.0 (2.43) 0.0 (0.569)
D06P 19.0 (16.2) 1.0 (3.79)
df = 8
Pearson χ2 = 28.6
p-value = 0.000
C09D
B05D 11.0 (6.93) 5.0 (9.07)
C04B 3.0 (2.16) 2.0 (2.84)
C08F 12.0 (14.7) 22.0 (19.3)
C08G 18.0 (18.2) 24.0 (23.8)
C08J 3.0 (6.93) 13.0 (9.07)
C08L 11.0 (9.09) 10.0 (11.9)
df = 5
Pearson χ2 = 10.3
p-value = 0.067
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Table G.9: Results of chi-square test for the main IPC fields
IPC field 1991 2006
A 52.0 (67.3) 76.0 (60.7)
B 160.0 (150.0) 126.0 (136.0)
C 478.0 (502.0) 477.0 (453.0)
D 122.0 (98.8) 66.0 (89.2)
E 5.0 (5.26) 5.0 (4.74)
F 11.0 (17.9) 23.0 (16.1)
G 108.0 (75.2) 35.0 (67.8)
H 72.0 (91.4) 102.0 (82.6)
df = 7
Pearson χ2 = 67.1
p-value = 0.000
G.3.1 IPC-A01: Agriculture; forestry; animal husbandry; hunting; trap-
ping; and fishing
Table G.10: A01N: Results of chi-square test for Table 6.31
IPC field 1991 2006
A61K 0.0 (0.611) 1.0 (0.389)
A61Q 0.0 (0.611) 1.0 (0.389)
B27K 0.0 (1.83) 3.0 (1.17)
C07C 5.0 (3.67) 1.0 (2.33)
C07D 13.0 (11.6) 6.0 (7.39)
C07F 3.0 (1.83) 0.0 (1.17)
C07K 0.0 (0.611) 1.0 (0.389)
C12N 0.0 (0.611) 1.0 (0.389)
C12Q 1.0 (0.611) 0.0 (0.389)
df = 8
Pearson χ2 = 15.2
p-value = 0.055
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G.3.2 IPC-C08: Organic macromolecular compounds; their preparation
or chemical working-up; compositions based thereon
Table G.11: C08F, C08J, and C08K: Results of chi-square test for Table 6.34
IPC field 1991 2006
C08F
C07C 4.0 (1.90) 1.0 (3.10)
C08G 3.0 (2.28) 3.0 (3.72)
C08J 2.0 (3.41) 7.0 (5.59)
C08K 4.0 (2.66) 3.0 (4.34)
C08L 7.0 (7.97) 14.0 (13.0)
C09D 2.0 (3.79) 8.0 (6.21)
df = 5
Pearson χ2 = 7.72
p-value = 0.172
C08J
B32B 9.0 (11.2) 11.0 (8.77)
C07C 9.0 (5.05) 0.0 (3.95)
C08F 2.0 (5.05) 7.0 (3.95)
C08G 15.0 (10.7) 4.0 (8.33)
C08K 7.0 (8.98) 9.0 (7.02)
C08L 16.0 (18.5) 17.0 (14.5)
C09D 3.0 (4.49) 5.0 (3.51)
C09K 12.0 (8.98) 4.0 (7.02)
df = 7
Pearson χ2 = 21.5
p-value = 0.003
C08K
B32B 0.0 (5.56) 11.0 (5.44)
C08F 4.0 (3.54) 3.0 (3.46)
C08G 8.0 (4.55) 1.0 (4.45)
C08J 7.0 (8.08) 9.0 (7.92)
C08L 21.0 (19.2) 17.0 (18.8)
C09D 2.0 (3.54) 5.0 (3.46)
D01F 6.0 (3.54) 1.0 (3.46)
df = 6
Pearson χ2 = 22.1
p-value = 0.001
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G.3.3 IPC-C09: Dyes; paints; polishes; natural resins; adhesives; miscel-
laneous compositions; miscellaneous applications of materials
Table G.12: C09D: Results of chi-square test for Table 6.36
IPC field 1991 2006
B05D 4.0 (4.09) 8.0 (7.91)
B32B 4.0 (2.73) 4.0 (5.27)
C08F 2.0 (3.41) 8.0 (6.59)
C08G 6.0 (8.86) 20.0 (17.1)
C08J 3.0 (2.73) 5.0 (5.27)
C08K 2.0 (2.38) 5.0 (4.62)
C08L 8.0 (6.13) 10.0 (11.9)
H01B 2.0 (0.681) 0.0 (1.32)
df = 7
Pearson χ2 = 8.06
p-value = 0.328
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G.4 3M
Table G.13: Results of chi-square test for the main IPC fields
IPC field 1991 2006
A 87.0 (91.0) 126.0 (122.0)
B 146.0 (144.0) 191.0 (193.0)
C 202.0 (176.0) 209.0 (235.0)
D 9.0 (7.26) 8.0 (9.74)
E 5.0 (5.13) 7.0 (6.87)
F 10.0 (11.5) 17.0 (15.5)
G 101.0 (105.0) 144.0 (140.0)
H 36.0 (56.8) 97.0 (76.2)
df = 7
Pearson χ2 = 21.9
p-value = 0.003
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G.4.1 IPC-C08: Organic macromolecular compounds; their preparation
or chemical working-up; compositions based thereon
Table G.14: C08F, C08J, and C08K: Results of chi-square test for Table 6.43
IPC field 1991 2006
C08F
A61K 1.0 (1.42) 1.0 (0.578)
C08G 9.0 (9.24) 4.0 (3.76)
C08J 1.0 (2.13) 2.0 (0.867)
C08L 6.0 (5.69) 2.0 (2.31)
C09D 6.0 (5.69) 2.0 (2.31)
C09J 7.0 (5.69) 1.0 (2.31)
G01N 2.0 (2.13) 1.0 (0.867)
df = 6
Pearson χ2 = 3.73
p-value = 0.713
C08J
B01D 2.0 (1.78) 1.0 (1.22)
C07C 0.0 (1.19) 2.0 (0.811)
C08F 5.0 (4.76) 3.0 (3.24)
C08G 3.0 (1.78) 0.0 (1.22)
C08K 1.0 (1.78) 2.0 (1.22)
C08L 2.0 (4.16) 5.0 (2.84)
C09D 4.0 (3.57) 2.0 (2.43)
C09D 3.0 (1.78) 0.0 (1.22)
C09K 2.0 (1.19) 0.0 (0.811)
df = 8
Pearson χ2 = 12.2
p-value = 0.141
C08K
C01G 0.0 (1.47) 3.0 (1.53)
C07F 3.0 (1.47) 0.0 (1.53)
C08F 3.0 (1.96) 1.0 (2.04)
C08G 4.0 (3.43) 3.0 (3.57)
C08J 2.0 (3.43) 5.0 (3.57)
C08L 5.0 (6.87) 9.0 (7.13)
C09C 0.0 (1.47) 3.0 (1.53)
C09D 4.0 (3.43) 3.0 (3.57)
C09J 5.0 (2.45) 0.0 (2.55)
df = 8
Pearson χ2 = 17.7
p-value = 0.024
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G.4.2 IPC-C09: Dyes; paints; polishes; natural resins; adhesives; miscel-
laneous compositions; miscellaneous applications of materials
Table G.15: C09D: Results of chi-square test for Table 6.45
IPC field 1991 2006
B32B 4.0 (3.33) 1.0 (1.67)
C08F 6.0 (5.33) 2.0 (2.67)
C08G 8.0 (10.0) 7.0 (5.00)
C08K 4.0 (4.67) 3.0 (2.33)
C08L 6.0 (6.00) 3.0 (3.00)
C09J 8.0 (6.67) 2.0 (3.33)
df = 5
Pearson χ2 = 2.94
p-value = 0.710
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